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Abstract
This thesis is presented in three parts: the first entitled “Proposal and Validation of an Al-
ternative Biogenesis for Halogenated Medium-Ring Ethers From Laurencia Species”; the second
“Towards the Total Synthesis of the Obtusallene Natural Products”; and the third provides exper-
imental details and characterising data for compounds.
Laurencia, which is a species of marine red algae produces an astonishingly diverse array of
halogenated acetogenic natural products, including 7-, 8- and 9-membered medium-ring ethers, as
well 11- and 12-membered ether-containing macrocycles. Part I of this thesis provides an alterna-
tive biogenesis to the long-standing Irie-Murai biogenesis for the halogenated medium-ring ether
natural products. The Irie-Murai biogenesis proposes that diol containing compounds undergo an
electrophilic bromoetherification reaction to produce the various compounds, whereas we instead
postulate that the compounds arise from electrophilic bromonium ion-assisted ring-opening of an
enantiopure epoxide.
Some initial studies on a model system for the key bromonium ion-assisted epoxide ring-
opening reaction are described, including an interesting concentration effect. The synthesis of an
enantioenriched epoxy-diene precursor to cyclisation is discussed, where a regioselective asym-
metric homoallylic epoxidation reaction was required. Some initial unsuccessful cyclisation at-
tempts are presented, as is a successful cyclisation in which bromine-containing 7-, 8- and 9-
membered ring-ethers were produced, which represent the core motifs of 5 structurally-diverse
natural products. Initial studies to prepare the novel β,γ-epoxy-enyne motif which is found in our
proposed biogenetic precursor are also described, culminating in the synthesis of a model system.
Part II of this thesis is a continuation of on-going work within this group towards the total syn-
thesis of the obtusallene family of natural products, the halogenated macrocyclic natural products
mentioned above. The gram-scale optimisation of reactions involving late-stage intermediates in
the total synthesis of obtusallenes II and IV is described. This includes improving the reproducibil-
ity of a biomimetic bromoetherification reaction, as well as providing insight into the mechanism of
an interesting cyanation reaction which is a synthetically-useful adaptation of a known procedure.
Also, an interesting diastereomer-dependent and catalyst-dependent ring-closing metathesis reac-
tion is discussed. Synthetic routes to highly advanced macrocyclic intermediates in the synthesis
of obtusallenes II and IV have now been firmly established.
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Part I
Proposal and Validation of an Alternative Biogenesis for Halogenated
Medium-Ring Ethers From Laurencia Species
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1 Preface
The numbering of all compounds relating to the halogenated medium-ring ethers will be in
accordance with the system first used by Irie after isolation of the laurediols (2a and 2b),1 which
has since been used consistently in nearly all reported studies towards the synthesis of these com-
pounds. This will allow facile comparison between the structures reported and discussed, with
those described in the literature. It will also facilitate the mapping of intermediates onto the tar-
get medium-ring ether compounds, allowing clear discussion regarding transformations observed
during reactions. Examples demonstrating the numbering scheme are shown in Figure 1. The
terminal carbon atom of the enyne is denoted as C-1, with the carbon atoms being numbered se-
quentially along the carbon chain, up to C-15 for the terminal methyl substituent.
O OBr
Br
OAc
H
H H
H
OH
OH
OH 1
2
3
4
5
6
7
8
910
11
12
13
14
15
1
2
3
4
5
6
7
8
910
11
12
13
14
15 1
2
3
4
5
6
7
89
10
11
12
13
14
15
Laurencin (1a) Prelaureatin (3)
(3E,6R,7R)-Laurediol (2a)
OH
OH
1
2
34
5
6
7
8
910
11
12
13
14
15
(3Z,6S,7S)-Laurediol (2b)
Figure 1: Numbering scheme used for the medium-ring ethers, and all other compounds in Part I
of this thesis.
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2 Introduction
2.1 Discovery of Novel Acetogenic Halogenated Medium-Ring Ether Natural Prod-
ucts from Laurencia Species
An astonishing variety of C15 acetogenic halogenated medium-ring ether natural products have
been isolated from Laurencia, a species of marine red algae. Representative examples of this fam-
ily of compounds are shown in Figure 2. Consisting of 7-, 8- and 9-membered ring ether cores,
these natural products are secondary metabolites that ultimately derive from fatty acids.2 The
compounds characteristically incorporate at least one halogen atom and exhibit either an enyne or
bromoallene side-chain.
Traditionally these natural products (in particular those compounds containing 8-membered
ring ethers) have been divided into two series, distinguished by their stereochemical configura-
OBr
H OR
H OBr
H
Br
O
H
O
Br
H H
O
Br
OBr
OH
H
H O
Br
O
Br
H
H O
Br
Br
O
H
H
OBr
H
H
O H
.
H
H
Br
OBr
H
H
O H
.
H
Br
H
OBr
H
H
O H
.
H
H
Br
O
Br
H H
O
.
H
H
Br
H
O
Br
H H
O
.
H
Br
H
H
R = Ac; Laurencin (1a)
R = H; Deacetyllaurencin (1b)
Laureoxanyne (4) Isoprelaurefucin (5)
Prelaureatin (3) Laureatin (6) Isolaureatin (7)
Laurallene (8) Nipponallene (9) Pannosallene (10)
Isolaurallene (11) Itomanallene A (12)
1
15
4
6
9
12
1
15
46
9
12
1
15
46
9
12
1
15
46
9
12
1
15
46
9
12
1
15
46
9
12
1
15
46
9
12
1
15
46
9
12 1
15
4
6
9
12
1
15
4
6
9
12
1
15
4
6
9
12
Figure 2: Representative examples of halogenated medium-ring ethers from Laurencia species that
are oxygenated at both C-6 and C-7.
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tions at C-6 and C-7.2 Those with a (6R,7R)-configuration have been termed “lauthisan” com-
pounds and include laurencin (1a) and laureoxanyne (4). Isoprelaurefucin (5) which exhibits a
7-membered ring ether core is also (R)-configured at both of these positions. Alternatively, those
natural products which are (S)-configured at both C-6 and C-7 have been designated as “laure-
nan” compounds. Prelaureatin (3), laureatin (6) and isolaureatin (7) are all examples of this series
of compound, as are bromoallene-containing laurallene (8), nipponallene (9) and pannosallene
(10). 9-Membered ring ethers isolaurallene (11) and itomanallene A (12) also have this (6S,7S)-
stereochemical configuration.
O
Br
H OAc
H
1
15
4
6
9
12
Figure 3: Reported structure of the natural product laurencin (1a).
The first member of either series of this family of natural products to be isolated was laurencin
(1a), which was discovered by Irie in 1965.3, 4 Originally isolated from Laurencia glandulifera, the
structure of laurencin (1a) was initially assigned based on UV, IR, mass spectrometry and NMR
data of the isolated compound itself, as well as those arising from degradation studies. It later
proved possible to confirm the structure of laurencin (1a) and determine both the relative and
absolute stereochemistries by single crystal X-ray diffraction.5, 6 Laurencin (1a) was found to have
an oxocine core with the (Z)-configured alkene at C(9)-C(10). The bromide substituent was found
to be endocyclic at C-12, with an ethyl group appended at C-13. On the opposite side of the ether
oxygen, a C6 fragment was attached, bearing an acetate moiety at C-6 and a terminal enyne at
C-4, which was determined to be (E)-configured. The four stereocentres in the compound were
assigned as being (6R,7R,12S,13R), overall providing structure 1a, represented in Figures 2 and 3.
The natural product laureoxanyne (4), which also belongs to the “lauthisan” series, was iso-
lated by Murai in 1990 from the red alga Laurencia nipponica.7 An initial assessment as to the
structural characteristics of this compound was made using IR, UV, mass spectrometry and NMR
data of the isolated material. Apparent similarities to the previously discovered laurencin (1a) led
Murai to conduct an interesting enzymatic study, where it was found that deacetyllaurencin (1b)
could be converted to laureoxanyne (4). As well as providing some insight as to the biogenesis of
laureoxanyne (4) this also provided enough material to conduct degradation studies to fully eluci-
16
O
Br
H
Br
O
H
1
15
46
9
12
Figure 4: Reported structure of the natural product laureoxanyne (4).
date the structure of the compound. Laureoxanyne (4) was found to contain a fused oxocane and
tetrahydropyran, and the compound incorporates two bromine atoms, one at C-9 and the other
at C-12. As in laurencin (1a), there is an ethyl unit attached at C-13 and an (E)-configured termi-
nal enyne at C-4. With consideration of the biogenetic experiment that had been undertaken, the
stereochemical configurations at C-6, C-7, C-12 and C-13 could be assigned by comparison with
laurencin (1a). This just left the stereochemistry at C-9 and C-10, which was assigned with the use
of NOE experiments.
O
Br
H H
O
Br
1
15
46
9
12
Figure 5: Reported structure of the natural product isoprelaurefucin (5).
Isoprelaurefucin (5), which contains the same (6R,7R)-configuration as laurencin (1a) and lau-
reoxanyne (4), was isolated by Irie in 1973 from Laurencia nipponica.8 The structure of this natural
product was again deduced using degradation studies and a range of spectroscopic techniques.
It was found to contain a core oxepane, fused to a tetrahydrofuran. The compound has two
bromide substituents, one endocyclic at C-10 and the other exocyclic at C-13. As for the pre-
viously discussed natural products, there is also a terminal enyne moiety at C-4, which is (E)-
configured. The absolute and relative stereochemistry was deduced from biogenetic considera-
tions (where these natural products had been assumed to derive from a common precursor – vide
infra) and chemical degradation studies, in which compounds prepared were identical to degrada-
tion products from other natural products. This resulted in the assignment of isoprelaurefucin (5)
as (6R,7R,9R,10R,12R,13S).
In 1968 the first two natural products that would come to be termed “laurenan” compounds
were reported by Irie. Both laureatin (6)9 and isolaureatin (7)10 were isolated from the red alga Lau-
rencia nipponica.11 As for the other natural products, the structures were initially assigned based on
17
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15
46
9
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15
46
9
12
Figure 6: Reported structures of the natural products laureatin (6, left) and isolaureatin (7, right).
degradation studies and spectroscopic information. It was found that each natural product com-
prises an oxocane core with two bromide substituents, one exocyclic at C-13 and one endocyclic
at either C-9 in the case of isolaureatin (7), or C-10 for laureatin (6). Both compounds also have a
terminal (Z)-configured enyne situated at C-4. It was found that the key difference between the
two natural products was the second position of attachment of the C-7 ether oxygen. In laureatin
(6), this is at C-9 giving an oxetane as the second ring, whereas in isolaureatin (7) it is at C-10,
forming a tetrahydrofuran. The structural relationship between these two natural products was
also established by studies involving acid-catalysed rearrangements.12 In terms of the absolute
and relative stereochemistries, these were initially assigned based on biogenetic considerations
and degradation studies, where one degradation product was found to be the enantiomer of one
of the degradation products of laurencin (1a). It later proved possible to confirm the structural and
stereochemical assignments for isolaureatin (7), and by comparison laureatin (6), by single crystal
X-ray diffraction.13
OBr
OH
H
H
1
15
46
9
12
Figure 7: Reported structure of the natural product prelaureatin (3).
Prelaureatin (3), a presumed biogenetic precursor to laureatin (6) and isolaureatin (7) was iso-
lated from Laurencia nipponica in 1991 by Murai.14 Initial spectroscopic studies indicated the pres-
ence of a single bromide substituent as well as an enyne, a hydroxyl group and an ether. It also
appeared that the compound had an oxocane or oxocine core. In order to confirm the anticipated
structure of the isolated natural product, laureatin (6) was chemically converted into a compound
that was identical in all respects to the isolated material, thus confirming the structure and ab-
solute stereochemistry of prelaureatin (3) to be as represented in Figures 2 and 7, containing an
oxocine core with the alkene at C(9)-C(10), an exocyclic bromide substituent at C-13, an endocyclic
18
hydroxyl moiety at C-7 and a terminal (Z)-configured enyne at C-4.
Three bromoallene-containing natural products that have an oxocine core and belong to the
“laurenan” series have also been reported: laurallene (8),15 which was isolated by Fukuzawa in
1979 from Laurencia nipponica; pannosallene (10),16 isolated by Suzuki in 1996 from Laurencia pan-
nosa; and thirdly nipponallene (9),17 isolated from Laurencia nipponica by Stonik in 2006. The struc-
tural motif of laurallene (8) was deduced from spectroscopic data of the isolated compound itself,
as well as degradation products. For nipponallene (9) and pannosallene (10), the structural as-
signments were largely determined using a range of different NMR techniques that had become
available, as well as by comparison to the assigned structure of laurallene (8). The relative and ab-
solute stereochemistry of laurallene (8) could be assigned for the C-6, C-7, C-12 and C-13 positions
when it was found that one of the degradation products was identical to a degradation product
of laureatin (6). However, the stereochemistry at C-4 and for the bromoallene moiety was unas-
signed. For pannosallene (10) it was found that the relative stereochemistry at C-4, C-6, C-7, C-12
and C-13 could be elucidated using NOESY correlations. Biogenetic considerations led to the as-
signment of the absolute stereochemistries at these positions. The absolute stereochemistry of the
bromoallene could then be assigned as S based on the strong positive optical rotation, with the ap-
plication of Lowe’s rule.18 As laurallene (8) also showed a strong positive optical rotation, then the
bromoallene stereochemistry could also be assigned as S, meaning that the stereochemistry at C-4
in laurallene (8) had to be the opposite to that of pannosallene (10). Finally, the absolute and rela-
tive stereochemistries of nipponallene (9) were assigned by NOESY correlations, the application of
Lowe’s rule and also by forming Mosher esters.19 Overall it was found that these three compounds
contain a core oxocine with the alkene at C(9)-C(10), an exocyclic bromide at C-13, a tetrahydrofu-
ran attached to the medium-ring at C-6 and C-7 and a bromoallene situated at C-4. The difference
between these three natural products just lies in the stereochemistry of the bromoallene moiety
and also at the C-4 position.
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Figure 8: Reported structures of the natural products laurallene (8, left), nipponallene (9, middle)
and pannosallene (10, right).
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Isolaurallene (11) and itomanallene A (12), which both contain 9-membered ring ether cores,
exhibit the (6S,7S) configuration which is required to also belong to the “laurenan” series. Iso-
laurallene (11) was isolated from Laurencia nipponica in 1982 by Kurata20 and its stereoisomer, it-
omanallene A (12), was later reported by Suzuki in 2002, having been isolated from the red alga
Laurencia intricata.21 The structure and absolute stereochemistry of isolaurallene (11) was initially
assigned using spectroscopic data along with biogenetic considerations. X-ray crystallographic
studies confirmed the absolute configuration to be as shown in Figures 2 and 9. The structure of it-
omanallene A (12) was elucidated using various spectroscopic data including a range of NMR tech-
niques. The stereochemistry of the bromoallene moiety was established by application of Lowe’s
rule and then this, in combination with NOESY correlation data, allowed for the assignment of
the relative and absolute stereochemistry of the compound. It was found that the natural products
exhibit the same structural features: a core oxonine with the (Z)-configured olefin situated at C(9)-
C(10); a tetrahydrofuran ring attached to the oxonine at C-6 and C-7; an endocyclic bromide at
C-12; and a terminal bromoallene moiety attached at C-4. The two natural products are therefore
diastereomers of one another, differing in the stereochemistry of the bromoallene moiety, as well
as at C-12 and C-13.
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Figure 9: Reported structures of the natural products isolaurallene (11, left) and itomanallene A
(12, right).
All of the natural products described so far are oxygenated at both the C-6 and C-7 positions.
There are also a number of bromine-containing medium-ring ether natural products that have
been isolated from Laurencia species, which contain chloride at one of these positions. As can be
seen in Figure 10, although these compounds exhibit the same (6R,7R)- or (6S,7S)-stereochemical
configurations as natural products 1a, 1b and 3-12, the stereochemistry present at C-12 and C-13 is
somewhat different, being (12R,13S) or (12S,13R) for 1a, 1b and 3-12, whereas for these chloride-
containing natural products it is (12R,13R) or (12S,13S).
Laurepinnacin (13), which has the same oxocine core as laurencin (1a), was isolated from Lau-
rencia pinnata by Masamune in 1981.22 Spectroscopic data, including proton decoupling NMR
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Figure 10: Representative examples of halogenated medium-ring ethers from Laurencia species
that are chlorinated at either C-6 or C-7.
experiments, allowed for the structure of the natural product to be determined. It was found that
as well as the oxocine core, the compound exhibited an endocyclic bromide at C-12, an exocyclic
chloride at C-6 and a terminal enyne at C-4. The absolute stereochemistry was then deduced by
chemical correlation with laurencin (1a). Oxepine-containing isolaurepinnacin (14) was reported
at the same time, by the same group.22 Spectroscopic data of the isolated compound itself as well
as degradation products allowed the structure to be assigned by comparison with the information
uncovered for laurepinnacin (13). The compound was found to exhibit both an exocyclic bromide
(C-13) and an exocyclic chloride (C-6) as well as an (E)-configured enyne at C-4. In 1992 a stereoiso-
mer of isolaurepinnacin (14) was also isolated by Guella from the red alga Laurencia microcladia.23
Although it contained the same oxepine core and identical positioning of bromide and chloride
substituents, the natural product rogioloxepane A (15) was found to be diastereomeric at the C-12
and C-13 positions, as well as exhibiting a (Z)- rather then (E)-enyne.
A number of natural products with the (6S,7S)-stereochemistry required for the “laurenan” se-
ries of compounds have also been isolated. Pinnatifidenyne (16), which contains a core oxocine
with the prelaureatin-type motif (3) was originally isolated from Laurencia pinnatifida by Gonza´lez
in 1982.24 Two different compounds were isolated which were found to differ in the geometry of
the terminal enyne at C-4. A range of spectroscopic data, as well as single crystal X-ray diffraction
of the (E)-isomer revealed the compound to contain an oxocine with the (Z)-configured olefin at
C(9)-C(10), an exocyclic bromide substituent at C-13 and an endocyclic chloride at C-7, as well as
the enyne at C-4. Based on the X-ray diffraction study of the (E)-isomer, the absolute stereochem-
istry was initially assigned as (6R,7R,12R,13R). The structure and absolute stereochemistry of the
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Figure 11: Reported structures of the natural products pinnatifidenyne (16, left) and
12,13-epi-pinnatifidenyne (17, right).
(Z)-isomer of pinnatifidenyne (16) was based on comparison of the spectroscopic data and also by
chemical interconversion with the (E)-isomer. However, on the basis of further X-ray analysis, it
was later found that the absolute stereochemistries of both of these pinnatifidenyne (16) natural
products needed to be reassigned as (6S,7S,12S,13S).25
A diastereomer of pinnatifidenyne (16) was isolated in 2002 by Roussis from the red alga Lau-
rencia obtusa.26 Analysis of the spectral data revealed the same core motif as pinnatifidenyne (16)
with an oxocine core, an exocyclic C-13 bromide and endocyclic C-7 chloride, as well as an (E)-
configured enyne. The absolute stereochemistry for the compound was initially reported to be
(6S,7S,12S,13R), however this was later reassigned as (6S,7S,12R,13R).27 With the absence of a for-
mal name for this natural product, herein it will be termed 12,13-epi-pinnatifidenyne (17).
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Figure 12: Reported structures of the natural products obtusenyne (18, left) and
12,13-epi-obtusenyne (19, right).
The final two compounds to be represented in Figure 10 are obtusenyne (18) and 12,13-epi-
obtusenyne (19). These both also exhibit the same (6S,7S)-configuration as pinnatifidenyne (16)
and 12,13-epi-pinnatifidenyne (17). Obtusenyne (18) was reported independently by Imre28 in 1979
and Fenical29 in 1980, in both cases isolated from Laurencia obtusa. Fenical used spectroscopic data
of the isolated compound itself, as well as degradation products, to assign the structure. It was
found that the natural product contains a core oxonine with the alkene at C(9)-C(10). There is also
an endocyclic bromide substituent at C-12 and an endocyclic chloride at C-7. Finally the com-
pound exhibits a terminal (Z)-configured enyne at C-4. Fenical did not propose either relative
or absolute stereochemistries for the stereocentres present in the compound. However, in Imre’s
22
hands obtusenyne (18) proved to be crystalline, with X-ray crystallography confirming the struc-
tural assignments made and also the absolute stereochemistry as being (6S,7S,12S,13S). A diastere-
omer of obtusenyne (18) was isolated from Laurencia pinnatifida by Norte in 1991.25 Spectroscopic
studies demonstrated that this compound must have the same structural features as obtusenyne
(18), but with the stereochemistry at C-13 inverted. The stereochemistry at C-12 remained unde-
fined until Murai synthesised both possible stereoisomers in 199930 and found that C-12 is also
inverted in comparison to obtusenyne (18), meaning the overall structure and stereochemistry for
12,13-epi-obtusenyne (19) is as represented in Figures 10 and 12.
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2.2 Previously Reported Synthetic Efforts Towards this Family of Natural Products
Ever since Masamune’s pioneering first synthesis of (±)-laurencin (1a) in 197731 there has been
a vast amount of synthetic effort focused towards the total synthesis of these halogenated medium-
ring ether natural products. With over 35 formal and total syntheses of various members having
been reported, as well as a number of studies towards the synthesis of these compounds, different
research groups’ endeavours have resulted in the development of a number of fascinating and
ingenious methods to construct the challenging structures present in these natural products.
An excellent review on the synthetic work in this field was conducted by Fujiwara in 2006.32
Due to the quantity of synthetic work reported and the availability of Fujiwara’s comprehensive
review, this introduction will not attempt a comprehensive review of all syntheses of the natu-
ral products represented in Figures 2 and 10. Instead, the main focus will be on the three key
challenges that have to be overcome during any synthesis of these natural products – bromide
incorporation, enyne or bromoallene formation and formation of the medium-ring ether itself.
2.2.1 Method of Bromide Incorporation
The medium-ring ethers from Laurencia species all incorporate at least one bromide substituent,
at either C-12 or C-13. Laureoxanyne (4), isoprelaurefucin (5), laureatin (6) and isolaureatin (7) all
contain a second bromide substituent, this time at either the C-9 or C-10 position. Finally, laurallene
(8), nipponallene (9), pannosallene (10), isolaurallene (11) and itomanallene A (12) all incorporate a
second bromide substituent, in this case as part of a bromoallene moiety. This section will focus on
the methods that have been used for incorporation of those bromide substituents that are attached
to sp3 hybridised carbon atoms – for the incorporation of bromide in the bromoallene moieties see
the following section.
For the synthesis of these natural products the bromide needs to be incorporated in a stere-
ospecific manner. The most common method by far for achieving this is the use of the Appel
reaction (see Table 1 for a summary of the various methods utilised). The Appel reaction tradition-
ally uses tetrabromomethane or tetrachloromethane, along with a trialkylphosphine (commonly
trioctylphosphine in the synthesis of these natural products) to effect an SN2 displacement of an
alcohol by bromide or chloride respectively, with inversion of configuration.33
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Table 1: Summary of the methods to incorporate bromide.
Method Natural Product Ring Size Research Group / Year
Appel reaction isolaurepinnacin 7 Suzuki / 200134
isoprelaurefucin 7 Kim / 200535
rogioloxepane A 7 Suzuki / 200136
rogioloxepane A 7 Crimmins / 200337
isolaureatin 8 Kim / 200738
laurallene 8 Crimmins / 200039
laurallene 8 Suzuki / 200340
laureatin 8 Suzuki / 200741
laureatin 8 Kim / 200738
laurencin 8 Masamune / 197731
laurencin 8 Murai / 199242
laurencin 8 Holmes / 199743
laurencin 8 Crimmins / 199944
laurencin 8 Kim / 200545
laurencin 8 Fujiwara / 200546
pinnatifidenyne 8 Kim / 200347
prelaureatin 8 Crimmins / 200039
12,13-epi-obtusenyne 9 Murai / 199930
12,13-epi-obtusenyne 9 Suzuki / 200748
isolaurallene 9 Crimmins / 200149, 50
itomanallene A 9 Kim / 200951
obtusenyne 9 Murai / 199952
obtusenyne 9 Crimmins / 200353
obtusenyne 9 Holmes / 200554, 55
obtusenyne 9 Suzuki / 200756
bromoetherification isoprelaurefucin 7 Kim / 200535
DPPE and Br2 laurencin 8 Overman / 199557
epoxide ring-opening isolaurepinnacin 7 Overman / 199358, 59
Wulff protocol isolaureatin 8 Kim / 200738
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Scheme 1: Use of the Appel reaction to incorporate bromide: (a) Suzuki’s total synthesis of
rogioloxepane A (15);36 (b) Holmes’ total synthesis of laurencin (1a);43 (c) Kim’s total synthesis of
itomanallene A (12).51
Scheme 1 demonstrates that this method can be used successfully regardless of ring-size, or
whether the bromide is required to be exocyclic (rogioloxepane A (15)) or endocyclic (laurencin
(1a), itomanallene A (12)) to the medium-ring, generally giving the desired product in good yield.
However, Appel bromination requires the stereochemistry to be set in an earlier step, so that upon
treatment with tetrabromomethane and trioctylphosphine, the stereochemistry of the alcohol at
the requisite position undergoes inversion to provide the desired configuration in the bromide
product. Regardless of this, for all but four reported syntheses, the Appel bromination reaction is
the method of choice for installing the bromide substituent.
In Kim’s total synthesis of isoprelaurefucin (5) an Appel reaction was used to incorporate the
first bromide at C-13, but a more biomimetic approach was used to install the second bromide
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Scheme 2: Diastereoselective bromoetherification to incorporate the second bromide in Kim’s
total synthesis of isoprelaurefucin (5).35
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at C-10 (Scheme 2).35 It was found that if oxepine 24 is treated with NBS then the C-6 hydroxyl
undergoes 5-exo attack onto an incipient bromonium ion at C(9)-C(10). This forms the required
tetrahydrofuran and also installs the bromide substituent in a diastereospecific manner concur-
rently. This increase in structural complexity upon the addition of electrophilic bromine makes
this biomimetic approach to installing the bromide very appealing.
A similar approach to the Appel reaction was used in Overman’s total synthesis of laurencin
(1a), where the bromide was installed by SN2 displacement of an activated secondary alcohol
(Scheme 3).57 However, instead of tetrabromomethane and trioctylphosphine being used, molecu-
lar bromine and DPPE were used instead. This forms a bromophosphonium salt in situ which goes
on to brominate the C-12 alcohol of 26 to provide product 27. This was followed by deprotection
of the TIPS protecting group to provide laurencin (1a) in a 40% yield over the two steps. Overman
reported that the use of more traditional Appel conditions gave the same yield over the two steps.
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Scheme 3: Molecular bromine and DPPE to incorporate bromide in Overman’s total synthesis of
laurencin (1a).57
The introduction of bromide in Overman’s synthesis of isolaurepinnacin (14) is the only ex-
ample where the bromide is installed at an early stage in the synthesis (Scheme 4).58, 59 Epoxide
28 was prepared in an asymmetric fashion using the Sharpless asymmetric epoxidation reaction,
followed by conversion to the phenylsulfonate derivative. The epoxide was then ring-opened by
bromide in a regioselective and stereospecific fashion. According to the method of Murai,60 epox-
ide 28 was treated with the Lewis acid diethylaluminum chloride. This can coordinate to both the
epoxide oxygen and the sulfonate, ensuring the desired regioselectivity. The diethylammonium
bromide then supplies the bromide nucleophile, which attacks the epoxide in an SN2 sense, giving
OSO2Ph
O
OSO2Ph
Br OH
28 29
Et2AlCl
Et2NH2Br
94%
Scheme 4: Stereospecific nucleophilic ring-opening of an epoxide to incorporate bromide in
Overman’s total synthesis of isolaurepinnacin (14).58, 59
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Scheme 5: Use of the Wulff protocol to incorporate bromide in Kim’s total synthesis of
isolaureatin (7).38
inversion of configuration at the reacting centre. This method of introducing the bromide was very
successful, providing bromohydrin 29 in a 94% yield.
The final method to have been used is that of the Wulff protocol, which Kim used in the total
synthesis of isolaureatin (7).38 Initial attempts to install bromide using the Appel reaction were
found to be poor yielding with retention of configuration at the reacting centre, instead of the
anticipated inversion of stereochemistry. To overcome this problem a different approach was re-
quired. Enol triflate 30 was prepared from the corresponding ketone by treatment with KHMDS,
followed by PhNTf2. This could then be converted to vinyl bromide 31 using Wulff’s protocol
– treatment with hexamethyldistannane and Pd(PPh3)4, followed by the addition of molecular
bromine (Scheme 5).61 Although the use of this method provided a good yield for the incorpo-
ration of bromide, another step was then required to set the stereochemistry at this position. Di-
astereoselective reduction of the olefin was subsequently achieved using diimide, providing the
requisite stereochemistry for the natural product.
2.2.2 Method of Enyne and Bromoallene Incorporation
Another challenge in the total synthesis of these medium-ring ether natural products is the
stereoselective formation of the enyne and bromoallene moieties. For incorporation of an enyne
there has to be control over the geometry, in order to selectively form either the (E)- or (Z)-isomer.
Similarly, for those compounds containing a bromoallene, it is important to be able to selectively
form either the (R)- or (S)-configured stereoisomer.
In Suzuki’s total synthesis of rogioloxepane A (15)36 a modified Corey-Fuchs method62 was
used to incorporate the (Z)-configured enyne (Scheme 6). Chemoselective oxidation of the allylic
alcohol in 32 was achieved using manganese dioxide. The resulting α,β-unsaturated aldehyde was
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Scheme 6: Use of the Corey-Fuchs method to form the enyne in Suzuki’s total synthesis of
rogioloxepane A (15).36
found to be unstable, so was immediately treated with tetrabromomethane and HMPT. This pro-
vided (Z)-configured 1,1-dibromodiene 33. Deprotection of the acetyl group was achieved using
potassium carbonate, which was followed by treatment with nBuLi to form the enyne of 34. This
sequence was achieved in 56% yield over the four steps and with excellent stereoselectivity, with a
ratio of 20 : 1 in favour of the desired (Z)-enyne.
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Scheme 7: Cross metathesis in the construction of the enyne in Kim’s total synthesis of laureatin
(6).38
Kim adopted a different approach for the formation of (Z)-configured enynes (Scheme 7), using
cross metathesis to form the enynes of laureatin (6) and isolaureatin (7).38 Initial attempts at in-
stalling the enyne using a Wittig reaction resulted in an undesirable E2 elimination occurring, with
ring-opening of the oxocane. The use of cross metathesis instead presumably stopped this mecha-
nism from occurring, where treatment of oxocane 35 with 36 and Grubbs’ catalyst 37 provided the
desired products in 69% and 76% yield, in the total synthesis of laureatin (6) and isolaureatin (7),
respectively.
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Table 2: Summary of the methods to incorporate an enyne side-chain.
Method Natural Product Ring Size Research Group / Year
Corey-Fuchs rogioloxepane A 7 Suzuki / 200136
cross metathesis isolaureatin 8 Kim / 200738
laureatin 8 Kim / 200738
dehydration of propargyl alcohol isolaurepinnacin 7 Overman / 199358, 59
organolithium epoxide opening laurencin 8 Fujiwara / 200546
Peterson olefination obtusenyne 9 Holmes / 200554, 55
SmI2-mediated Barbier laurencin 8 Murai / 1992
42
laurencin 8 Holmes / 199743
Stork-Zhao and Sonogashira rogioloxepane A 7 Crimmins / 200337
pinnatifidenyne 8 Kim / 200347
prelaureatin 8 Crimmins / 200039
obtusenyne 9 Crimmins / 200353
obtusenyne 9 Holmes / 200554, 54
Takai and Sonogashira isoprelaurefucin 7 Kim / 200535
Uenishi and Sonogashira laureatin 8 Suzuki / 200741
12,13-epi-obtusenyne 9 Murai / 199930
12,13-epi-obtusenyne 9 Suzuki / 200748
obtusenyne 9 Murai / 199952
obtusenyne 9 Suzuki / 200756
Wittig reaction laurallene 8 Crimmins / 200039
laurencin 8 Masamune / 197731
laurencin 8 Overman / 199557
laurencin 8 Crimmins / 199944
laurencin 8 Kim / 200545
Metathesis catalyst 37 offers much greater rates over the more commonly used Grubbs I and
II or Hoveyda-Grubbs I and II, making it an inherently better catalyst for cross metathesis.63 Ad-
ditionally, work by Lee using catalyst 37 had indicated that cross metathesis of conjugated enynes
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Scheme 8: Dehydration of the hexacarbonyldicolbalt complex of a propargyl alcohol to form the
enyne in Overman’s total synthesis of isolaurepinnacin (14).58, 59
with alkenes proceeds under kinetic control to provide predominantly (Z)-configured enynes,
rather than the thermodynamically expected (E)-enynes.64 This observation translated success-
fully to Kim’s work, providing the desired (Z)-enynes in a ratio of 7 : 1 in both cases.
For the total synthesis of isolaurepinnacin (14), Overman had to selectively incorporate an (E)-
configured enyne (Scheme 8).58, 59 Propargyl alcohol 39 was prepared by a Grignard reaction using
ethynylmagnesium bromide, which subsequently underwent dehydration using a three-step pro-
cedure. The compound was first converted to the hexacarbonyl dicobalt complex, which upon
treatment with triflic anhydride provided the hexacarbonyl dicobalt complex of the natural prod-
uct. Final decomplexation using CAN provided isolaurepinnacin (14) in 65% yield and with high
selectivity for the desired stereoisomer, providing a ratio of 24 : 1 in favour of the (E)-enyne.
A direct ring-opening of an enantiopure epoxide was used to incorporate the enyne in Fuji-
wara’s synthesis of laurencin (1a).46 Vinyl stannane 40 was first treated with nBuLi to form the cor-
responding organolithium in situ. Epoxide-containing 41 was then added followed by BF3 ·Et2O,
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Scheme 9: Ring-opening of an epoxide with an organolithium reagent in order to incorporate the
enyne in Fujiwara’s total synthesis of laurencin (1a).46
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which resulted in regioselective ring-opening of the epoxide by the organolithium reagent to fur-
nish enyne-containing 42 in 73% yield (Scheme 9). As (E)-configured vinyl stannane (40) could
be prepared as a single stereoisomer using known literature procedures,65 the product from this
epoxide ring-opening reaction contained exclusively (E)-configured enyne.
The Peterson reaction66 is one of a number of different olefination reactions that have been used
to prepare the enynes present in these natural products. Holmes used the Peterson-type olefination
method to incorporate the (Z)-enyne in the total synthesis of obtusenyne (18).54, 55 Corey’s 1,3-bis-
TIPS-propyne reagent 4367 was first lithiated in situ using nBuLi, followed by addition of aldehyde
44. This reaction gave a separable mixture of (E)- and (Z)-stereoisomers, so the required (Z)-enyne
could be isolated in 50% yield (Scheme 10).
O
TBDPSO OPMB
H H
O
O
TBDPSO OPMB
H H
TMS
44
45
TIPS
TIPS
43
50%
THF
!78°C " r.t.
nBuLii)
ii)
Scheme 10: Use of the Peterson olefination reaction to install the enyne in Holmes’ total synthesis
of obtusenyne (18).54, 55
In the total synthesis of laurencin (1a) however, Holmes instead had to selectively install an
(E)-configured enyne rather than the (Z)-enyne that was required for obtusenyne (18). To accom-
plish this a samarium(II)-mediated Barbier-type coupling68 was used instead (Scheme 11).43 The
reaction involved treating aldehyde 46 with samarium(II) iodide and allylic bromide 47.42, 69 As
the (E)-stereochemistry was set in the starting material, the enyne product 48 was predominantly
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Scheme 11: Samarium(II) iodide-mediated Barbier coupling to incorporate the enyne moiety in
Holmes’ total synthesis of laurencin (1a).43
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(E)-configured, although it was reported that a small amount of (Z)-enyne could be observed in
the unpurified reaction mixture. A mixture of diastereomers in a 1 : 1 ratio was reported for 48,
arising from indiscriminate attack on the aldehyde. However, the undesirable (6S)-isomer could be
converted to the required (6R)-configuration via oxidation to the ketone, with subsequent diastere-
oselective reduction using L-Selectride. Murai had previously used this Barbier-type procedure
for the synthesis of laurencin (1a), but with a TBDPS protecting group in place of the PMB in the
aldehyde starting material.42
One method of producing (Z)-enynes that has been used in a number of total syntheses is a
combination of a Stork-Zhao olefination followed by a Sonogashira coupling reaction.37, 39, 47, 53–55
Stork-Zhao olefination is a variant of the Wittig reaction.70 Generally iodomethyltriphenylphos-
phonium iodide is treated with a base to generate the corresponding ylid in situ. This can then react
with an aldehyde to form a vinyl iodide with preference for a (Z)-configuration. For example, in
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Scheme 12: Stork-Zhao olefination and Sonogashira reactions to prepare enynes: (a) Crimmins’
total synthesis of rogioloxepane A (15);37 (b) Kim’s total synthesis of pinnatifidenyne (16);47 (c)
Crimmins’ total synthesis of obtusenyne (18).53
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Crimmins total synthesis of obtusenyne (18)53 the Stork-Zhao olefination reaction provided vinyl
iodide 56 in 72% yield and a ratio of 9 : 1 in favour of the desired stereoisomer (Scheme 12c). The
alkyne portion of the enyne is then incorporated via a palladium-catalysed Sonogashira coupling71
of the vinyl iodide with either trimethylsilylacetylene or triethylsilylacetylene. This is generally
achieved in good to high yield and with no effect on the level of stereochemistry secured in the
formation of the vinyl iodide.
In Kim’s total synthesis of isoprelaurefucin (5), what may be viewed as a complementary
method to the Stork-Zhao / Sonogashira method was used to incorporate the enyne.35 In this
case a Takai olefination reaction, followed again by a Sonogashira coupling was used to selectively
produce the required (E)-enyne (Scheme 13). The Takai olefination involves the reaction of an
aldehyde with iodoform and chromium(II) chloride to form an (E)-vinyl iodide.72 In the case of
aldehyde 58, the corresponding vinyl iodide was prepared in 80% yield and with a ratio of 5 : 1 in
favour of the desired stereoisomer. As for the (Z)-vinyl iodide arising from a Stork-Zhao reaction,
this compound then underwent a Sonogashira coupling with trimethylsilylacetylene to form 60 in
a 75% yield.
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Scheme 13: Takai reaction, followed by Sonogashira reaction to install the enyne in Kim’s total
synthesis of isoprelaurefucin (5).35
An alternative to the Stork-Zhao method for preparing (Z)-configured vinyl halides is the use
of Uenishi hydrogenolysis. This method, followed by Sonogashira coupling, has been used to
incorporate a (Z)-configured enyne in a number of total syntheses,30, 41, 48, 52, 56 two examples of
which are shown in Scheme 14. Prior to the Uenishi hydrogenolysis an aldehyde is treated with
tetrabromomethane and HMPT to generate a 1,1-dibromo-1-alkene. The Uenishi reaction then in-
volves palladium-catalysed treatment of this with tributyltin hydride.73 This replaces one of the
bromides with a hydrogen atom, selectively forming a (Z)-configured vinyl bromide. For exam-
ple, in Suzuki’s total synthesis of laureatin (6) these two steps are achieved in an overall yield
of 76% and with exclusive formation of the (Z)-compound (Scheme 14a).41 Palladium-catalysed
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Scheme 14: Olefination, Uenishi hydrogenolysis and Sonogashira coupling to prepare
(Z)-configured enynes: (a) Suzuki’s total synthesis of laureatin (6);41 (b) Suzuki’s total synthesis of
12,13-epi-obtusenyne (19).48
Sonogashira coupling of vinyl bromide 62 with tert-butyldimethylsilylacetylene provided the nec-
essary (Z)-enyne 66 in 90% yield.
The final method that has been used to incorporate enynes into these natural products is the
Wittig reaction, which has been used in four syntheses of laurencin (1a)31, 44, 45, 57 as well as Crim-
min’s total synthesis of laurallene (8).39 For example, in Crimmins’ synthesis of laurencin (1a) the
aldehyde generated from reduction of the chiral auxiliary was immediately treated with ylid 68,
which had been prepared in situ from the corresponding bromide phosphonium salt (Scheme 15).
This provided 69 in 74% yield over the two steps, and in a ratio of 5.5 : 1.0 in favour of the (E)-
stereoisomer. Accessing the aldehyde by reduction rather than oxidation meant that the secondary
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Scheme 15: Use of the Wittig reaction to incorporate an enyne in Crimmins’ total synthesis of
laurencin (1a).44
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Table 3: Summary of the methods to incorporate a bromoallene side-chain.
Method Natural Product Ring Size Research Group / Year
activated propargyl alcohol laurallene 8 Suzuki / 200340
isolaurallene 9 Crimmins / 200149, 50
itomanallene A 9 Kim / 200951
bromoetherification laurallene 8 Crimmins / 200039
alcohol that is present did not require protecting. This is an approach that has been used in other
syntheses, such as Kim’s synthesis of laurencin (1a), where the aldehyde for the Wittig reaction
was produced by the reduction of a nitrile group.45
Perhaps owing to the smaller number of natural products containing the bromoallene motif,
only two different methods for incorporating a bromoallene have been used in the synthesis of
these natural products (Table 3), compared to ten methods for incorporating an enyne. Suzuki’s
synthesis of laurallene (8),40 Crimmins’ synthesis of isolaurallene (11)49, 50 and Kim’s synthesis of
itomanallene A (12)51 all used the same method to form the bromoallene in a stereospecific manner
(Scheme 16). For this method a propargyl alcohol is activated by conversion to the trisylate deriva-
tive. Subsequent treatment with LiCuBr2 results in stereospecific nucleophilic attack by bromide
in an SN2’ sense at the terminus of the alkyne.74 This provides the product as a single stereoisomer,
generally in moderate to good yields.
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Scheme 16: SN2’ displacement of an activated propargyl alcohol in the synthesis of bromoallenes:
(a) Suzuki’s total synthesis of laurallene (8);40 (b) Crimmins’ total synthesis of isolaurallene
(11).49, 50
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A more biomimetic approach to bromoallene formation was used in Crimmins’ synthesis of the
natural product laurallene (8).39 The enyne of (E)-prelaureatin ((E)-3) had been prepared using a
Wittig reaction. After deprotection of the C-7 hydroxyl and the alkynic proton, this compound was
ready to undergo electrophilic bromination. Exposure of (E)-3 to TBCO provided two compounds,
laurallene (8) and a diastereomer, in an overall yield of 53% (Scheme 17). These diastereomers
could be separated by preparative HPLC, which provided pure laurallene (8) in a 24% yield from
(E)-3. Presumably this reaction proceeds through bromonium ion formation on the alkyne portion
of the enyne, with subsequent nucleophilic attack by the C-7 hydroxyl at C-4 of the enyne. It is
important to note that as well as incorporating the bromide and forming the bromoallene motif,
this biomimetic reaction also results in the construction of a second ring in the molecule. This
increase in complexity results from the simple addition of electrophilic bromine.
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Scheme 17: Biomimetic bromoetherification to produce the bromoallene moiety in Crimmins’
total synthesis of laurallene (8).39
2.2.3 Method of Medium-Ring Ether Formation
The formation of the medium-ring ether itself is perhaps the greatest challenge in any total or
formal synthesis of these natural products. The formation of 7-, 8- and 9-membered ring ethers is
inherently unfavourable based on considerations of entropy. Also, transannular interactions in the
product can destabilise the medium-sized rings, rendering their formation unfavourable on the
basis of enthalpy. Nonetheless, a number of powerful and useful methods have been developed in
order to overcome these problems, allowing for the formation of the various core ether structures.
Indeed, the total synthesis of these natural products from Laurencia species has provided an ex-
cellent opportunity for various groups to develop methods to prepare medium-sized rings. Each
method that has been reported is described in this section, a summary of which is given in Table 4.
In a recent formal synthesis of prelaureatin (3) and laurallene (8), a Brook rearrangement-
mediated [3 + 4] annulation was used by Takeda to prepare the core oxocine motifs (Scheme
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Scheme 18: Takeda’s method for forming the medium-ring ether core of prelaureatin (3) via ring
closing metathesis and subsequent diastereoselective Brook rearrangement-mediated [3 + 4]
annulation.76
18).75, 76 Initially an RCM reaction (vide infra) was used to construct oxepine 75. This could then
be treated with NaHMDS to form sodium enolate 76 in situ, which was then ready to undergo the
key [3 + 4] annulation reaction. In general, a Brook rearrangement is base catalysed and involves
deprotonation of a hydroxyl group followed by attack of the negatively charged oxygen onto an
adjacent organosilyl group, breaking the Si−C bond and giving a silyl ether.77 Overall the hy-
droxyl proton and the organosilyl group effectively switch places. In Takeda’s adaptation of this
to 8-membered ring-ether formation,78 enolate 76 initially attacks the carbonyl of acryloylsilane 77
to form the corresponding tetrahedral intermediate 78 (Scheme 18). This new negatively charged
oxygen can then abstract the adjacent TBDMS group, breaking the Si−C bond and in turn forming
cyclopropane 79. Finally this then undergoes a rearrangement to produce the target oxocine 80.79
The reaction was found to proceed to give a single diastereomer in 80% yield.
The stereochemical control is thought to arise from initial approach of the acryloylsilane onto
the same face as the propyl substituent. This is due to the propyl substituent adopting a pseudo-
equatorial position, rendering this face the least sterically hindered. Takeda also reports that calcu-
lations indicate the other face is effectively blocked due to chelation between the sodium and the
methoxy of the PMB protecting group.76
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Table 4: Summary of the methods to form the medium-ring ether.
Method Natural Product Ring Size Research Group / Year
Brook rearrangement [3 + 4] laurallene 8 Takeda / 200875, 76
prelaureatin 8 Takeda / 201076
Claisen rearrangement obtusenyne 9 Holmes / 200554, 55
hydroxy-epoxide cyclisation isolaurepinnacin 7 Suzuki / 200134
rogioloxepane A 7 Suzuki / 200136
laurallene 8 Suzuki / 200340
laureatin 8 Suzuki / 200741
12,13-epi-obtusenyne 9 Suzuki / 200748
obtusenyne 9 Suzuki / 200756
intramolecular alkylation isolaureatin 8 Kim / 200738
laureatin 8 Kim / 200738
laurencin 8 Kim / 200545
pinnatifidenyne 8 Kim / 200347
intramolecular allylboration laurencin 8 Hoffmann / 199780
intramolecular Prins isolaurepinnacin 7 Overman / 199358, 59
laurencin 8 Overman / 199557
Keck lactonisation 12,13-epi-obtusenyne 9 Murai / 199930
obtusenyne 9 Murai / 199952
oxidative ring-expansion laurencin 8 Murai / 199242
ring-closing metathesis isoprelaurefucin 7 Kim / 200535
rogioloxepane A 7 Crimmins / 200337
laurallene 8 Crimmins / 200039
laurallene 8 Takeda / 201076
laurencin 8 Crimmins / 199944
laurencin 8 Fujiwara / 200546
laurencin 8 Pansare / 200881
laurencin 8 Martin / 201082
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Method Natural Product Ring Size Research Group / Year
ring-closing metathesis prelaureatin 8 Crimmins / 200039
prelaureatin 8 Takeda / 201076
isolaurallene 9 Crimmins / 200149
itomanallene A 9 Kim / 200951
obtusenyne 9 Crimmins / 200353
Robinson-Scho¨pf laurencin 8 Masamune / 197731
Yamaguchi lactonisation laurencin 8 Holmes / 199743
Holmes’ synthesis of obtusenyne (18) used a Claisen rearrangement to access the 9-membered
ring-ether core of the natural product (Scheme 19).54, 55 Initially developed for the preparation of 8-
membered lactones,84 this methodology was later extended to include 9-membered lactones.83 In
this synthesis, acetal-containing oxepane 81 was first prepared from the corresponding diol. Three
diastereomers of 81 could be observed in the 1H NMR spectrum, however these could be taken
forward as a mixture because they will all result in the same product.
Oxidation to the selenoxides was achieved using sodium periodate and after work-up the crude
product was treated with DBU in toluene at reflux. Elimination of the selenoxide provided the
direct precursor to the key Claisen rearrangement in situ – vinyl ketene acetal 82. This intermediate
then underwent the classic [3,3]-sigmatropic rearrangement to provide 9-membered lactone 83.
The only stereochemical consideration in this rearrangement is that of the geometry of the alkene
in the lactone product. Holmes proposes that the transition state adopts a chair-like conformation,
which results in the formation of a (Z)-configured alkene.83 Overall this Claisen rearrangement
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Scheme 19: Use of a Claisen rearrangement to construct the medium-ring ether in Holmes’ total
synthesis of obtusenyne (18).54, 55, 83
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approach provides a high yield of oxonine 83 and also provides the alkene required for the total
synthesis of obtusenyne (18) in the correct position and also with the desired stereochemistry.
Suzuki’s approach towards the synthesis of the medium-ring ethers has involved the Lewis
acid promoted cyclisation of an acyclic hydroxy-epoxide. This methodology has allowed for the
synthesis of a number of natural products, containing 7-,34, 36 8-,40, 41 or 9-membered rings.48, 56 An
example for each of these ring-sizes is shown in Scheme 20. This method was initially optimised
for the formation of oxepanes85 and then used to form the core oxepines of isolaurepinnacin (14)34
and rogioloxepane A (15).36 Once a hydroxy epoxide such as 84 had been prepared it was first
treated with tributyltin ether in order to form the tin ether of 84, thus effectively enhancing the
nucleophilicity of the hydroxyl group.86 The addition of zinc triflate then results in cyclisation,
with exo attack of the activated hydroxyl onto the epoxide, and with inversion of stereochemistry
at this centre. As this cyclisation occurs stereospecifically, the stereochemistry at each of the ether
carbons could be set by incorporating the requisite steroechemistry in the acyclic hydroxy-epoxide.
This effective and high yielding method for forming 7-membered ring-ethers was later modified to
allow for the formation of 8- and 9-membered rings.87 It was found that for these larger ring-sizes
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Scheme 20: Suzuki’s method of medium-ring ether formation by Lewis acid mediated cyclisation
of hydroxy-epoxides: (a) formal synthesis of isolaurepinnacin (14);34 (b) total synthesis of
laurallene (8);40 (c) total synthesis of obtusenyne (18).56
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the Lewis acid Eu(fod)3 was more effective than the (Bu3Sn)2O / Zn(OTf)2 system. As before, the
cyclisation was found to occur in an exo manner with SN2 attack of the hydroxyl onto the epoxide,
providing the oxocine and oxonine cores in good yield.
An effective diastereoselective internal alkylation reaction has been used by Kim in the total
synthesis of a number of oxocine-containing natural products.38, 45, 47 An example of this method of
forming 8-membered ring ethers is shown in Scheme 21. Interestingly, Kim serendipitously discov-
ered this method for forming oxocines during some studies on intramolecular SN2’ alkylations.47
It was found that the geometry of the alkene is very important. When this is (E)-configured then
this exclusively gives a tetrahydropyran product via an SN2’ reaction. However, when the alkene
is (Z)-configured then the reaction predominantly or exclusively provides the 8-membered ring.
Kim proposes that this configuration may decrease the entropic and enthalpic barriers of medium-
ring formation. In the case of the formation of the oxocine core of laurencin (1a), compound 90 was
treated with KHMDS to form the amide enolate in situ (Scheme 21).45 This presumably then under-
went SN2 attack onto the C−Cl bond to form 8-membered 91. The cyclisation was high yielding
and there was no observation of the formation of a tetrahydropyran. Interestingly this reaction
also proceeds with a high level of diastereoselectivity, in this case in a 25 : 1 ratio in favour of the
desired α,α’-cis diastereomer. The formation of a diastereomer where these two ether protons are
cis was also desirable for total synthesis of pinnatifidenyne (16). However, in the case of laure-
atin (6) and isolaureatin (7), where these two protons are trans relative to one another, a second
epimerisation step was later required to achieve the correct relative stereochemistry.
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Scheme 21: Kim’s diastereoselective internal alkylation in the formation of the medium-ring
ether of laurencin (1a).45
In Hoffmann’s formal synthesis of laurencin (1a) an intramolecular allylboration reaction was
used to form the medium-ring ether (Scheme 22).80 This approach utilised a four-step one-pot
approach to convert Weinreb amide 92 into oxocine 95. Reduction of the Weinreb amide with
DIBAL-H was followed by the addition of sec-butyllithium in order to lithiate the allyloxy system.
After regioselective borylation with the pinacol borate ester, treatment with pH 7 buffer solution
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Scheme 22: An intramolecular allylboration reaction to construct the medium-ring ether in
Hoffmann’s formal synthesis of laurencin (1a).80
presumably resulted in the generation of aldehyde-containing 94. This then cyclises to form ox-
ocine 95. Analysis of the product revealed that cyclisation had occurred in a diastereoselective
manner, only producing the desired cis diastereomer in 38% yield.
An intramolecular Prins reaction has been used to construct both 7- and 8-membered ring
ethers in Overman’s syntheses of isolaurepinnacin (14)58, 59 and laurencin (1a),57 respectively. Us-
ing methodology developed previously,88 Overman prepared compounds that contained an acetal
moiety as well as a 1,1-disubstituted alkene (96 and 99). The substitution on the alkene was im-
portant in order to control the ring-size – for example, in the cyclisation of 96 a tertiary α-silyl
carbocation is more stable than a primary β-silyl carbocation. Treatment with a Lewis acid initi-
ated the key intramolecular Prins reaction. In both cases shown in Scheme 23, the methoxy group
was lost to form intermediate oxonium species. These then underwent intramolecular nucleophilic
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Scheme 23: Overman’s method of medium-ring ether formation using an intramolecular Prins
reaction: (a) total synthesis of isolaurepinnacin (14);58, 59 (b) total synthesis of laurencin (1a).57
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attack by the alkene. The cyclisations were found to occur in a diastereoselective manner to form
only the desired cis diastereomers.59 In the cyclisation of 96 it was proposed that there was a hy-
dride migration from C-10 to C-9, with subsequent nucleophilic attack by the necessarily present
chloride at silicon, to generate the C(9)-C(10) alkene of 98.59 In the cyclisation of 99 simple elim-
ination of a proton at C-10 forms the C(9)-C(10) alkene.57 Overall, as well as forming the 7- and
8-membered rings of isolaurepinnacin (14) and laurencin (1a), these intramolecular Prins reactions
set the correct stereochemistry at C-7 and install the C(9)-C(10) olefin that is present in both natural
products. However, although the yield of oxepine 98 is high, that of oxocine 100 is considerably
lower due to side-product formation.
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Scheme 24: Keck lactonisation to prepare the medium-ring ether in Murai’s total synthesis of
obtusenyne (18).52
Murai utilised a Keck lactonisation89 reaction to prepare a 9-membered lactone for the total
synthesis of obtusenyne (18)52 and 12,13-epi-obtusenyne (19).30 Scheme 24 shows that once cycli-
sation precursor 101 had been prepared, treatment with EDCI and DMAP resulted in an 83% yield
of lactone 102. Although this method provides a good yield of the desired 9-membered ring ether
product, it does not have the same benefit as other methods discussed here of simultaneously in-
stalling stereocentres in a stereoselective manner. Therefore a lot of additional functionalisation
of 102 was required to form the natural product. However, the C(9)-C(10) alkene present in ob-
tusenyne (18) is already in place, and this presumably functioned as a conformational constraint
to assist the Keck lactonisation reaction.
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Scheme 25: Murai’s method of forming the medium-ring ether of laurencin (1a) by an oxidative
ring-expansion.42
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For Murai’s total synthesis of laurencin (1a) a different strategy was adopted to construct the
core oxocine (Scheme 25).42 The fused cyclobutane-tetrahydropyran 103 was prepared in four
steps from a cyclobutanone and an enantiomerically-pure alkyl bromide. Once this had been syn-
thesised then simple treatment with lead(IV) acetate resulted in an oxidative ring-expansion to
form 8-membered lactone 104. As for the Keck lactonisation above, this method does not result
in the concomitant formation of any stereocentres, so three stereocentres as well as the C(9)-C(10)
alkene needed to be installed at a later stage of the synthesis. However, this ring-expansion ap-
proach to the formation of the laurencin (1a) core did provide oxocane 104 in an excellent yield of
92%.
The most common method for constructing the 7-, 8- and 9-membered ring ethers of these nat-
ural products is now ring-closing metathesis.90, 91 Scheme 26 gives an example of the formation of
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each ring size using either Grubbs’ first or second generation metathesis catalysts. The widespread
use of Grubbs’ catalyst in the synthesis of these Laurencia natural products underlines how useful
the RCM reaction is and how much it is valued as a tool in organic synthesis. As demonstrated
in Scheme 26, in each case the addition of one of Grubbs’ catalysts to an appropriate diene results
in the formation of a medium-sized ring in good to excellent yield and with the required (Z)-
configured olefin. There is some decrease in the yield as ring-size increases, however this is to be
expected as the formation of the ring becomes increasingly energetically unfavourable. Nonethe-
less, the practical utility and the reliability of this method evidently makes RCM an attractive
approach to medium-ring ether formation.
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Scheme 27: Medium-ring formation in Masamune’s total synthesis of laurencin (1a), by
ozonolysis and subsequent Robinson-Scho¨pf reaction.31, 92
In Masamune’s pioneering first synthesis of laurencin (1a), a Robinson-Scho¨pf reaction was
used to construct the 8-membered ether core.31, 92–95 A mixture of dihydrofuran diastereomers
113 was treated with ozone in order to generate the corresponding dialdehydes. This was then
treated directly with methylamine and acetonedicarboxylic acid. The mixture of products from this
Robinson-Scho¨pf condensation was acetylated and then separated by column chromatography.
Although this method (a variant of which was famously demonstrated by Robinson in 1917 in his
landmark total synthesis of tropinone)96 did provide the core oxocane motif of laurencin (1a), only
a 7.8% yield of product 114 was isolated and this in itself contained three diastereomers of the
compound.
The final remaining method that has been used to construct the medium-ring cores of these
Laurencia natural products is the Yamaguchi lactonisation,97 used in Holmes’ total synthesis of lau-
rencin (1a).43 Cyclisation prescursor 115 was treated with 2,4,6-trichlorobenzoyl chloride in the
presence of triethylamine and DMAP to furnish oxocine 116 in a very good yield (Scheme 28). As
with the use of the Keck lactonisation in Murai’s synthesis of obtusenyne (18),52 the cyclisation
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does not occur with the concomitant formation of additional stereocentres, so the C-6 and C-13
stereocentres needed to be installed at a later stage in the synthesis. However, the product of cycli-
sation does have the olefin in the correct place on the ring and with the desired (Z)-stereochemistry.
Presumably this alkene functioned as a conformational constraint to encourage cyclisation.
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Scheme 28: Yamaguchi lactonisation to prepare the medium-ring ether in Holmes’ total synthesis
of laurencin (1a).43
2.2.4 Potential for a Biomimetic Approach to Medium-Ring Ether Formation
In most of the total syntheses of these medium-ring ether natural products, the C-12 or C-13
bromide is incorporated at a very late stage in the synthesis. Interestingly, in Kim’s synthesis of iso-
prelaurefucin (5)35 and Crimmins’ synthesis of laurallene (8),39 a second bromide substituent was
installed using a source of electrophilic bromine to initiate a bromoetherification reaction (Schemes
2 and 17). In a single step this simultaneously produces an ether ring and incorporates bromide in a
stereoselective manner, increasing the complexity of the compound to a reasonably large extent. In
both of these biomimetic bromoetherification reactions the result is a 5-membered ether ring. If this
use of biomimetic bromonium ion initiated cyclisations could be used to form medium-ring ethers,
then this should represent an efficient approach to the synthesis of the core bromine-containing
medium-ring ether motifs of the various natural products described herein.
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2.3 Irie and Murai’s Proposed Biogenesis
2.3.1 Discovery of Laurediols From Laurencia Species
Seven years after the pioneering isolation and characterisation of laurencin (1a), Irie isolated
trans- and cis-laurediols (2a and 2b) from Laurencia nipponica in 1972.1 Ever since the isolation of
these compounds, and even earlier, these laurediols have been assumed to be the direct biogenetic
precursors to the halogenated medium-ring ethers that are produced by Laurencia species. They
are believed to originally derive from the unsaturated fatty acid 117, which is converted to enyne-
containing 118, and then transformed into the laurediols (2a and 2b) via epoxide-formation (119)
and subsequent ring-opening.2
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Scheme 29: Proposed biogenesis of the laurediols (2a and 2b) isolated from Laurencia species.
Since the discovery of the laurediols (2a and 2b), Murai has conducted a range of investiga-
tions, largely enzymatic, in an effort to provide evidence to support the assumption that these
laurediols (2a and 2b) are in fact the direct biogenetic precursors to the halogenated medium-ring
ethers.2 Irie had already shown that treatment of deacetyllaurencin (1b) with zinc and acetic acid
in ethanol gives rise to (3E,6R,7R)-laurediol (2a), whereas if laureatin (6) was subjected to the same
conditions, (3Z,6S,7S)-laurediol (2b) was produced.1 Therefore, the enzyme-mediated formation
of deacetyllaurencin (1b) and prelaureatin (3) from the laurediols (2a and 2b) was the focus of
Murai’s work.
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2.3.2 Murai’s Studies Using the Enzyme Lactoperoxidase
When these initial enzymatic studies were undertaken, the lactoperoxidase enzyme which was
commercially available was employed in place of the bromoperoxidase enzyme. BPO activity had
been detected in Laurencia nipponica, however it was not possible to adequately purify the enzyme
at the time.98 LPO can be prepared from cow’s milk and is known to contain an iron atom in the
porphyrin skeleton. In the presence of hydrogen peroxide, the Fe is oxidised from the +III to the
+V oxidation state. This complex can then effect two-electron oxidation of Br – to give a source of
electrophilic bromine.2
After studies using LPO for the brominative cyclisation of some model substrates,98 the enzyme
was used in an effort to promote bromoetherification of the laurediols (2a and 2b). (3E,6R,7R)-
Laurediol (2a) was prepared from isolated natural laurencin (1a), after which it was immediately
subjected to the enzymatic reaction with LPO (Scheme 30). It was found that deacetyllaurencin
(1b) was produced in 1% yield, via an 8-endo cyclisation of the C-7 hydroxyl onto the bromonium
ion, along with 1% of an unidentified cyclic ether. The reaction also produced a relatively large
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Scheme 30: Electrophilic bromination of laurediols (2a and 2b) catalysed by lactoperoxidase.
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amount of bromohydrins, presumably due to direct opening of bromonium ions with water, and
52% of the starting material was recovered.99
Two years later, (3Z,6S,7S)-laurediol (2b) was subjected to the same enzymatic conditions, after
being prepared from laureatin (6) (Scheme 30).100 The reaction produced prelaureatin (3), via 8-exo
cyclisation of the C-6 hydroxyl onto the bromonium ion, in 3% yield. Two inseparable oxetanes
120, which vary in the geometry around the C(12)-C(13) olefin, were also formed in the reaction
in 1.0% yield along with a 0.3% yield of laureatin (6), which was presumably produced from the
laurediol (2b) via prelaureatin (3) or oxetane 120. Again, some formation of bromohydrins was
observed, but the majority of the starting material remained unconverted to product, with 72%
being recovered.
From the results of these two enzymatic reactions, Murai concluded that the laurediols are the
real direct precursors to the halogenated medium-ring ethers from Laurencia species. The poor
yields of 8-membered cyclic ethers were explained as being due to low substrate specificity of
the LPO, as it is not the enzyme which is present in Laurencia species. However, it was noted
that the configuration of the diol appears to perfectly control the pathway for either laurencin-
type structures, in the case of (3E,6R,7R)-laurediol (2a), or laureatin-type structures, in the case of
(3Z,6S,7S)-laurediol (2b).
In order to investigate whether the enyne geometry has any effect on the outcome of the en-
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Scheme 31: Example of competitive 5-endo cyclisation in the electrophilic bromination of
laurediols.
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zymatic reaction, (3E,6S,7S)-laurediol 121 was subjected to electrophilic bromination mediated by
LPO (Scheme 31).2 (E)-Prelaureatin ((E)-3) was formed in 0.05% yield via 8-exo cyclisation. This
yield is two degrees of magnitude lower than that of (Z)-prelaureatin (3) in the previously dis-
cussed reaction. It was postulated by Murai that “the steric repulsion of the (E)-enyne side-chain
in an enzymatic pocket restricted the formation of the eight-membered ring”.2 In this reaction
both 4- and 5-membered ring-ethers were formed competitively via 4-exo and 5-endo attack of the
C-7 hydroxyl onto a C(9)-C(10) bromonium ion. Murai concluded that it is the stereochemistry
at C-6 and C-7 in the laurediol, rather than the enyne geometry, that is important in determining
regioselectivity in the cyclisation.
2.3.3 Murai’s Studies Using the Enzyme Bromoperoxidase, Isolated from Laurencia Species
It later proved possible to adequately purify BPO from Laurencia nipponica, allowing for some
enzymatic studies to be conducted using what has been accepted to be the actual enzyme respon-
sible for the bromoetherification of the laurediols (2a and 2b).101 After the BPO had been shown
to be active during reactions using a model substrate, (3E,6R,7R)-laurediol (2a) was subjected to
enzymatic conditions. The reaction afforded the same products as were observed in the reaction
with LPO, but with largely reduced yields (Scheme 32). Deacetyllaurencin (1b) was isolated in
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Scheme 32: Electrophilic bromination of the laurediols (2a and 2b) catalysed by the enzyme
bromoperoxidase.
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0.015% yield, along with 0.074% of an unidentified cyclic bromoether. Bromohydrins were also
present in 2.24% yield, and the majority of the starting material was recovered. Murai concluded
that this result demonstrates that “BPO is the real enzyme for the direct bromoether cyclisation” of
(3E,6R,7R)-laurediol (2a) to deacetyllaurencin (1b).101
Murai also attempted the enzymatic bromoetherification of (3Z,6S,7S)-laurediol (2b) using BPO.
Starting material was largely recovered from the reaction, with an 8.0% yield of bromohydrins and
a trace of prelaureatin (3) was observed, identified by its retention time on HPLC. In this instance
there was no observation of laureatin (6) or the oxetanes 120 which were produced in the reaction
using LPO. Murai offers no explanation as to why the yields should be so low when using the BPO
enzyme.
2.3.4 Inconsistencies in the Irie-Murai Proposed Biogenesis from Laurediols 2a and 2b
The pioneering work performed by Irie and Murai is magnificent, but there are several ques-
tions that legitimately arise. Firstly, why are five-membered rings not formed preferentially in-
stead? The desired cyclisations invoke the attack of the C-6 or C-7 alcohol of the laurediols (2a
and 2b) onto a bromonium ion at C(12)-C(13) to form the 8-membered ether rings. However, there
is the opportunity for the C-6 alcohol to attack a bromonium ion formed at C(9)-C(10) or the C-7
alcohol to attack a bromonium ion at C(3)-C(4), to form 5-membered tetrahydrofuran rings in ki-
netically favourable 5-exo cyclisations. For example, in our own group’s previously reported work
towards the biomimetic synthesis of the obtusallene family of natural products (vide infra) it was
found that 5-exo cyclisation of a chlorohydrin onto a bromonium ion in a very closely related sys-
tem occurred readily and in good yield without any observation of competitive medium-ring ether
formation.102
Secondly, why does (3E,6R,7R)-laurediol (2a) only give rise to deacetyllaurencin (1b), whilst
(3Z,6S,7S)-laurediol (2b) only produces the fundamentally different core of prelaureatin (3) (Scheme
33)? If the bromoetherification actually occurs within the enzyme, then presumably two different
enzymatic pockets would be required for the different transformations. Alternatively, if the cyclisa-
tion occurs outside of the enzyme itself, it would seem logical to expect that each enantiomerically
pure laurediol would be capable of producing the enantiomer of deacetyllaurencin (1b), in the
case of (3Z,6S,7S)-laurediol (2b), and the enantiomer of prelaureatin (3) in the case of (3E,6R,7R)-
laurediol (2a). Murai himself notes that such an observation “seems to be very rare in nature”.2
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Scheme 33: Deacetyllaurencin (1b) and prelaureatin (3) are derived from two different laurediols
(2a and 2b, respectively) with no crossover between the series.
Also, why are the enzymatic yields of these reactions so low? The work performed by Murai
initially used lactoperoxidase as the enzyme in conjunction with hydrogen peroxide and a source
of bromide.7, 98–100 The isolated yields of the desired products are low, with major side-products
including bromohydrins and tetrahydrofurans (i.e. from 5-exo cyclisation), and the majority of the
substrate remained untouched. Moreover, when the actual enzyme from Laurencia species – bro-
moperoxidase – was employed, the isolated yields became as low as 0.015% for deacetyllaurencin
(1b) and only ‘traces’ of prelaureatin (3) were observed.101
Finally, why should the (R,R)-laurediol exist as the (E)-enyne and the (S,S)-laurediol exist as
the (Z)-enyne? Laurediol was originally isolated as a 1 : 1 mixture of (3E)- and (3Z)-enynes.1 The
(3E)-compound was found to be approximately a 4 : 1 mixture of (R,R) to (S,S), whilst the (3Z)-
compound was shown to be approximately a 7 : 3 mixture of (R,R) to (S,S). This is inconsistent
with Irie and Murai’s proposed biogenesis which would suggest exclusively (R,R) for the (3E)-
compound and (S,S) for the (3Z)-compound.
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2.4 An Alternative Unifying Biogenesis
We propose that all of the medium-ring ethers shown in Figure 2 are formed via electrophilic
bromonium ion-assisted nucleophilic ring-opening of enantiomerically-pure (3E or 3Z, 6S,7R)-
epoxide 127, where water functions as a nucleophile (Scheme 34). Compared to the laurediols
(2a and 2b), the oxygen of epoxide 127 is not able to attack an incipient bromonium ion at C(3)-
C(4) or C(9)-C(10) to give 5-membered rings as the resulting strain would be too high. Moreover,
it now looks perfectly reasonable for attack on a bromonium ion at C(12)-C(13) (Intermediates A
and B), where the (Z)-configured C(9)-C(10) alkene provides a conformational constraint to en-
courage cyclisation. Furthermore, it seems likely that nature is employing a strategy where the
unfavourable entropy associated with medium-ring formation can be partially overcome by the
enthalpically favoured simultaneous opening of two small rings – a bromonium ion and epoxide.
In Intermediate A, attack of the epoxide oxygen at C-13 of the bromonium ion (with inversion)
will result in the formation of an oxonium ion with an endocyclic bromide substituent (Interme-
diate C). Subsequent attack by water at C-6 (with inversion) results in the direct formation of
deacetyllaurencin (1b), with the required (6R,7R,12S,13R)-configuration. Acetylation of the C-6
hydroxyl gives laurencin (1a), whilst further electrophilic bromination of the C(9)-C(10) alkene,
followed by nucleophilic attack by the C-6 hydroxyl at C-10 will lead to laureoxanyne (4). Alter-
natively, nucleophilic attack by water (with inversion) at C-7 will form the 9-membered ring ether
core 128 of isolaurallene (11). This has the necessary (6S,7S,12S,13R)-configuration for the natural
product, and electrophilic bromination of the enyne followed by attack by the C-7 hydroxyl at C-4
should provide the bromoallene moiety.
If nucleophilic attack by the epoxide oxygen occurred instead at C-12 of the bromonium ion
(with inversion) this will instead form an oxonium ion with an exocyclic bromide (Intermediate D).
Attack by water (with inversion) at C-6 will result in the formation of 7-membered ring ether 129.
This has the required core structural motif and (6R,7R,12R,13S)-configuration for isoprelaurefucin
(5). Indeed, subsequent electrophilic bromination of the C(9)-C(10) olefin followed by 5-exo attack
by the C-6 hydroxyl at C-9 should furnish this natural product. Alternatively, SN2 attack by water
at C-7 will directly result in the formation of prelaureatin (3), with the required (6S,7S,12R,13S)-
configuration set. Further electrophilic bromination of the C(9)-C(10) alkene, with nucleophilic
attack by the C-7 hydroxyl at either side of the bromonium ion will provide laureatin (6) and
isolaureatin (7).
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undiscovered natural products from Laurencia species).
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Table 5: Summary correlation of our proposed mechanism (Scheme 34) with medium-ring ether
products.
Bromonium Ion Attack of Epoxide Attack of Water Ring Size Product
(S,S) C-12 C-6 7 129a
(S,S) C-12 C-7 8 3b
(S,S) C-13 C-6 8 1bb
(S,S) C-13 C-7 9 128c
(R,R) C-12 C-6 7 12,13-epi-129d
(R,R) C-12 C-7 8 12,13-epi-3d
(R,R) C-13 C-6 8 12,13-epi-1bd
(R,R) C-13 C-7 9 12,13-epi-128e
a undiscovered precursor to isoprelaurefucin (5).
b known compound.
c undiscovered precursor to isolaurallene (11).
d undiscovered compound.
e undiscovered precursor to itomanallene A (12).
Alternatively, bromonium ion formation at the enyne, with attack by the C-7 hydroxyl at C-4
would result in the formation of laurallene (8), nipponallene (9) and pannosallene (10). All of these
natural products, formed from Intermediate A, require the initial formation of an (S,S)-configured
bromonium ion. Electrophilic bromination could equally occur on the opposite face of the C(12)-
C(13) alkene, forming an (R,R)-configured bromonium ion (Intermediate B). Indeed, this has to
occur for the formation of the natural product itomanallene A (12). Nucleophilic attack by the
epoxide oxygen at C-13 of Intermediate B to give an oxonium ion (Intermediate E), followed by
attack by water at C-7 with inversion would form 12,13-epi-128. Due to the configuration of the
initial bromonium ion, this compound has the required (6S,7S,12R,13S)-stereochemistry set for the
required natural product. Further electrophilic bromination of the enyne with subsequent 5-exo
nucleophilic attack by the C-7 hydroxyl at C-4 will produce the natural product.
The product of nucleophilic attack by water at C-6 in Intermediate E would be the C-12, C-13
diastereomer of deacetyllaurencin, 12,13-epi-1b. This compound has not been reported to date, but
we propose it is an, as yet, undiscovered natural product from Laurencia species. Similarly, the
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products of the two modes of attack shown in Intermediate F would be epimers of prelaureatin
(3) and 129 at the C-12 and C-13 positions. Again, we propose that these are yet to be discovered
natural products from Laurencia species. Furthermore, as compounds 128, 12,13-epi-128 and 129 are
invoked as intermediates in the biogenesis of 11, 12 and 5, we propose that these are also natural
products yet to be isolated.
A similar model can be proposed for the biogenesis of the chlorine-containing medium-ring
ether natural products (Figure 10) isolated from Laurencia species. Analysis of the C-12 and C-13
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stereochemistries of these compounds reveals that they must arise from electrophilic bromination
of a (Z)-configured alkene at C(12)-C(13), rather than (E). Acetylated (12Z)-stereoisomers of the
laurediols have previously been isolated by Murai.103 Thus we propose that (3E or 3Z)-epoxide
130 acts as the precursor, where the attacking nucleophile is now chloride anion, and where a
bromonium ion can again form on either face of the C(12)-C(13) alkene (Scheme 35).
Also, the fact that the laurediols (2a and 2b) were isolated for both the (E)- and (Z)-enyne as
a mixture of (R,R)- and (S,S)-configured diols, can now be explained by invoking ring-opening of
epoxide 127 at either C-6 (giving (R,R)) or C-7 (giving (S,S)) with water, either in the organism itself
or during isolation.
Our proposed biogenesis accounts for all of the questions that arise from Irie and Murai’s work.
It is unifying for the bromine-containing medium-ring ether natural products isolated from Lau-
rencia species that are formed via intramolecular bromination events. The model completely and
correctly unifies ring-size, the position of the halogen substituents, and all absolute and relative
configurations for these metabolites.
2.4.1 Precedence for the Bromonium Ion-Assisted Nucleophilic Ring-Opening of Epoxides
In 1985 Davies and Thomas found that if cyclooctene epoxide 131 is exposed to bromine it
will undergo a rearrangement to form the two bromine-containing ethers 134 and 135, shown in
Scheme 36.104, 105 This must occur via formation of a bromonium ion, attack of the epoxide to form
oxonium ion 133, and subsequent quench by bromide. Also, upon treatment with bromine, the
epoxide oxygen in acyclic epoxy-olefin 136 was shown to attack a bromonium ion via 5-exo and 6-
endo cyclisation to form oxonium ions 138 and 139, which were subsequently quenched by bromide
to furnish 5-, 6- and 7-membered halogenated ethers.
It has also been demonstrated that an internal nucleophile can be used to trap the oxonium
ion formed after opening of a bromonium ion by an epoxide. In 2004, McDonald protected the
hydroxyl functionality in an epoxy-alcohol with a Boc group to give 143. This compound was sub-
sequently subjected to a source of electrophilic bromine in acetonitrile at −40 ◦C (Scheme 37).106
Cyclisation occurred, to give two bromine-containing 7-membered ring ethers 144 and 145, which
are epimers. This methodology has been used recently in the first example of a bromonium
ion-assisted ring-opening of epoxides in a biomimetic synthesis of a natural product.107 Jami-
son showed how Boc-protected 146 can be treated with NBS in HFIP to initiate an impressive
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Scheme 36: Examples of bromonium ion-assisted ring-opening of epoxides.
poly-epoxide cascade which proceeded with excellent regioselectivity to give epimers 147 and 148
(Scheme 38). Five further steps from 148 furnished the desired bromine-containing ent-dioxepand-
ehydrothyrsiferol (149).
Interestingly, both of these examples give two products which are epimeric at the carbon bear-
ing bromide. In the example from McDonald, a very slight excess of one epimer was isolated,
whereas in the case reported by Jamison the ratio was 1 : 1. Therefore the two epimers arise from
indiscriminate attack of bromonium ions that have been formed on both faces of the olefin. In the
case of Jamison’s synthesis of ent-dioxepandehydrothyrsiferol (149), this was an undesired out-
come, as epimer 147 was unusable. However, this observation that bromonium ions which are
formed on two faces of an olefin can be subject to nucleophilic attack by an epoxide gives good
precedence for the proposed biogenesis of the halogenated medium-ring ethers from Laurencia
species, where bromonium ion formation and trapping on both faces of the C(12)-C(13) olefin is
tBu O
O
O
O
O OO
O
O
OO O
H H
BrBr
+
Br(coll)2ClO4
CH3CN
!40°C, 50 min
143 144 145
51%
3         :         2
Scheme 37: Use of an internal nucleophile in the bromonium ion-assisted nucleophilic
ring-opening of epoxide 143
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Scheme 38: The first example of a bromonium ion-assisted ring-opening of epoxides in the
biomimetic synthesis of a natural product.
invoked.
As well as Jamison’s work, there has been a further example of bromonium ion-assisted epox-
ide ring-opening reported in the literature since the beginning of this project. In 2010, Yeung re-
ported the synthesis of substituted morpholines via a multicomponent reaction involving elec-
trophilic bromination (Scheme 39).108 Alkene 150 can undergo electrophilic bromination by NBS,
with subsequent trapping in an intermolecular fashion by ethylene oxide (151). This oxonium
ion can then be opened by nucleophilic attack of NsNH2, again in an intermolecular sense. This
results in the formation of 152, which after treatment with base undergoes ring-closure to form
morpholine 153.
Ph
Me
O
NsNH2
+
150
151
Ph
Me
Br
O
NHNs
NBS
CH2Cl2
25°C, 8 h
152
74%
K2CO3
MeCN
25°C, 6 h
O
NNs
Ph
Me
153
87%
Scheme 39: Intermolecular bromonium ion-assisted epoxide ring-opening in the synthesis of
morpholines.
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2.5 Aims and Objectives
The overall aim of this project is to provide evidence to support the biogenesis which has been
described in this introduction. This will involve the bromonium ion-assisted epoxide ring-opening
of a representative epoxide, where an intermediate oxonium ion is then quenched with a nucle-
ophile, in order to form the 7-, 8- and 9-membered ring ether cores of the various natural products.
It will be necessary to develop a method in order to assign each of the undoubtedly spectroscopi-
cally similar compounds. For example, the size of the ring, the position of the bromide and the po-
sition of the nucleophile will need to be assigned in each case, as will the relative stereochemistries
present in each cyclised compound.
OH
O
OH
OH
Br
OH Br OH
[O] [H]
C!C
forming FGI
FGI
C!C
forming
160 159
158 157
156 155 154
Scheme 40: A proposed retrosynthesis for epoxy-diene 160.
This work will focus on the biogenesis of those natural products represented in Figure 2, which
are oxygenated at both C-6 and C-7. A suitable epoxide surrogate for 127 will first need to be
prepared. Scheme 40 shows a proposed retrosynthesis for epoxy-diene 160. This compound has
the same C-5 to C-15 fragment as the proposed biogenetic precursor to these natural products
(127) and should be prepared in 6 steps from commercially available starting materials. In order
to render the synthesis asymmetric, a regioselective asymmetric homoallylic epoxidation of the
C(6)-C(7) olefin will be required. There are far fewer methods for asymmetric epoxidation of ho-
moallylic alcohols than there are for allylic alcohols, therefore some investigation into this area will
be required.
Once epoxy-diene 160 has been prepared, then this compound and / or derivatives of it could
be investigated for their ability to undergo cyclisation in a bromonium ion-assisted epoxide ring-
opening reaction. However, before using this compound it would be intuitive to conduct some
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Scheme 41: Proposed model studies to investigate the key bromonium ion-assisted epoxide
ring-opening reaction.
initial model studies. Cyclooctene epoxide 131 will be used in order to see what nucleophiles
other than bromide can be incorporated into the system (Scheme 41). Obviously in order to sup-
port our proposed alternative biogenesis for the medium-ring natural products it will be important
to show that both oxygen-based nucleophiles as well as chloride can be incorporated. These stud-
ies should also give more insight into the mechanics of this key bromonium ion-assisted epoxide
ring-opening reaction. Conditions that are optimised in this model system will then be used to
encourage cyclisation of epoxy-diene 160.
It is anticipated that the target compounds will need to be separated by preparative HPLC.
Once this has been achieved then extensive spectroscopic techniques will be required to assign
each of the structures. The isolation of compounds with the correct core structural motifs of the
various Laurencia medium-ring ether natural products will validate the proposed biogenesis as a
possible alternative to the long-standing Irie-Murai proposed biogenesis.
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3 Results and Discussion
3.1 Preparation of Doubly-Skipped (E,Z,Z)-Triene 159
The first step in the preparation of (E,Z,Z)-triene 159 is bromination of commercially available
(E)-2-penten-1-ol (154) to form (E)-1-bromopent-2-ene (155). Initially phosphorous tribromide in
pentane was used109 to promote this reaction and gave a 64% yield after 3 hours (Scheme 42).
However, a mixture of regioisomers was formed in the reaction, in a 10 : 1 ratio in favour of the
desired product. The side-product formed in the reaction was 3-bromo-1-pentene (165), which
must have been produced by SN2’-like attack of bromide, as shown in Scheme 43.
OH Br
Br
+
PBr3
pentane
r.t., 3 h
64%
10               :              1
154 155 165
Scheme 42: Bromination of (E)-2-penten-1-ol (154) using phosphorous tribromide.
An alternative method was investigated in an attempt to reduce the amount of unwanted re-
gioisomer formed. Triphenylphosphine dibromide was prepared in situ by adding a solution of
bromine in dichloromethane to a stirred solution of triphenylphosphine in the same solvent at
0 ◦C.110 Pyridine and a solution of (E)-2-penten-1-ol (154) in dichloromethane were added111 and
after stirring at room temperature for 2 hours there had been complete conversion to product, as
judged by TLC. The reaction mixture was worked-up by washing with 1 M hydrochloric acid to
remove the pyridine, and then both the product and dichloromethane were removed from the
triphenylphosphine oxide by-product by heating the mixture under vacuum and collection of the
liquid in a cold trap.
It was found that subsequent isolation of the desired compound 155 from the dichloromethane
was somewhat problematic. (E)-1-Bromopent-2-ene (155) is a reasonably volatile compound so
there is an inherent difficulty in removing the dichloromethane solvent by distillation. The sub-
OH
P Br
Br
Br
H
O
PBr
2
Br
- PBr
2
OH
Br
154 165
Scheme 43: Formation of the bromide regioisomer by SN2’-like attack.
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sequent step in the synthesis utilises a Grignard reagent, so there is potential for formation of
chlorocarbenes if any dichloromethane remains, which would obviously be detrimental in this
subsequent reaction. It was found that to remove all traces of dichloromethane from the product,
the flask had to be heated at 140 ◦C. However, at this temperature a large amount of isomerisation
of the product to 3-bromo-1-pentene (165) is observed, giving a 5 : 1 ratio in favour of the desired
regioisomer 155.
This isomerisation can occur via loss of bromide to form an allylic-stabilised carbocation. Sub-
sequent quenching of the positive charge by bromide at the secondary position will give the
undesired isomerised product 165 (Scheme 44). Heating at this temperature also resulted in a
large reduction in the yield of the reaction as the bromide was found to form an azeotrope with
dichloromethane. There was obviously a need to improve this reaction as separation of the isomers
would be very difficult and the issue would persist throughout the synthesis.
Br
Br
Br
155
165
Scheme 44: Proposed mechanism for the isomerisation of (E)-1-bromopent-2-ene (155).
Initially other solvents with low boiling points were investigated in place of dichloromethane,
with the view that other solvents might be easier to remove by distillation, also avoiding the issue
of azeotropes, giving a greater yield of product. Also, the danger of forming chlorocarbenes in
the subsequent reaction is eliminated if dichloromethane is not used, and therefore it would not
be as crucial to remove all traces of solvent. The two low boiling solvents investigated were pen-
tane and diethyl ether. With pentane the low solubility of triphenylphosphine meant that it was
not possible to form triphenylphosphine dibromide. When diethyl ether was used as the solvent
triphenylphosphine was completely soluble. However, on addition of bromine a viscous brown
oil was produced instead of the orange-yellow suspension which is observed when the reaction is
conducted in dichloromethane. Therefore it appears that the use of a chlorinated solvent is neces-
sary for the preparation of triphenylphosphine dibromide.
Another potential solution was to form the tosylate derivative 166 of (E)-2-penten-1-ol (154)
instead of bromide 155 as this would be far less volatile. It has previously been demonstrated
that the tosylate of (Z)-2-penten-1-ol can be formed and then used immediately for an alkylation
reaction,112 which provided good precedent for the use of tosylate in this synthesis.
64
Initially the reaction was conducted using one equivalent of triethylamine as the base (Scheme
45). (E)-2-Penten-1-ol (154) was stirred in dichloromethane at 0 ◦C and to this was added one
equivalent of tosyl chloride and one equivalent of triethylamine. It was then stirred for two hours
at room temperature after which the reaction was worked-up. Unfortunately it was not possible to
observe any of desired tosylate 166 by 1H NMR. It was thought that perhaps triethylamine was not
a strong enough base and consequently the tosylate was not being formed. Therefore the tosylation
was attempted again, this time using a much more concentrated solution of (E)-2-penten-1-ol (154).
Pyridine was used as both the base and solvent and 10 mol% DMAP was also added. The reaction
mixture was stirred at 0 ◦C for six hours and then stored in the refrigerator overnight. Again there
was no observation of product by 1H NMR after work-up.
OH
OH
TsCl
NEt3
CH2Cl2
TsCl
DMAP
pyridine
154
154
OTs
OTs
166
166
Scheme 45: Attempted preparation of the tosylate derivative of (E)-2-penten-1-ol (154).
After using such forcing conditions it would be expected that the desired tosylate 166 would
almost certainly be formed. However, tosylate 166 would be reasonably unstable due to the fact
that it is an allylic derivative, and therefore would be more susceptible to decomposition upon
work-up, to give the alcohol starting material 154. Therefore a different procedure was investigated
whereby the tosylate is prepared in situ113 and then used directly in the next step of the synthesis
which involves reaction with propargyl alcohol (167) to give enyne 156 (Scheme 46).
(E)-2-Penten-1-ol (154) was added to THF at−78 ◦C and n-butyllithium was added to this drop-
wise to affect deprotonation of the alcohol. After stirring for an hour at −78 ◦C, tosyl chloride was
added and stirring was continued for a further hour. Simultaneously isopropylmagnesium chlo-
ride was added to a solution of propargyl alcohol (167) in THF, which was heated at reflux for one
hour. After cooling to 0 ◦C, copper(I) chloride was added, followed by the solution of tosylate in
THF. The mixture was stirred at 0 ◦C for 30 minutes, after which it was worked-up.
1H NMR showed that the distribution of products was as shown in Scheme 46. Unfortunately
the desired enyne 156 only represented 37% of the mixture, with the majority being starting ma-
terial, from unreacted tosylate 166 being hydrolysed by water during the work-up. Undesired
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Scheme 46: Reaction of propargyl alcohol (167) with the tosylate-derivative 166 of
(E)-2-penten-1-ol (154), formed in situ (percentages refer to the proportion of each compound
present in the crude mixture after work-up, as assessed by 1H NMR spectroscopy).
regioisomer 168, which represented 11% of the mixture, could be formed either by SN2’-like attack
of the deprotonated propargyl alcohol at the alkene, or elimination of tosylate with subsequent
quenching by deprotonated propargyl alcohol at the secondary position, in a mechanism similar
to the one shown in Scheme 43. Therefore formation of the tosylate derivative 166 is not a viable
solution to the problem.
Finally, the use of a solvent with a high boiling point was investigated (Scheme 47). It was
considered that if a solvent with a boiling point sufficiently greater than the boiling point of (E)-
1-bromopent-2-ene (155) was used then the product could be distilled from the solvent under re-
duced pressure. 1,2,4-Trichlorobenzene was the solvent of choice for this reaction as it was found
that a chlorinated solvent appears to be necessary for the formation of triphenylphosphine dibro-
mide. Also, the boiling point of 1,2,4-trichlorobenzene is 214 ◦C, which is sufficiently higher than
the boiling point of (E)-1-bromopent-2-ene (155) at 122 ◦C. Unfortunately it was not possible to
isolate any of the product by distillation.
As the attempted improvements to the reaction using triphenylphosphine dibromide were un-
successful, a compromise had to be found between the desire to remove as much dichloromethane
as possible, and not heating the mixture so much as to promote isomerisation in the product.
Accordingly, the bromination reaction was conducted using 10.0 g of (E)-2-penten-1-ol (154).
OH
PPh3Br2, pyridine
1,2,4-trichlorobenzene
154
Br
155
Scheme 47: Attempted bromination of (E)-2-penten-1-ol (154) using 1,2,4-trichlorobenzene as the
solvent.
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Triphenylphosphine dibromide was generated in situ and to this was added pyridine and a so-
lution of alcohol 154 in dichloromethane. After stirring at room temperature for 30 minutes, the
reaction had gone to completion. The work-up involved washing with 1 M hydrochloric acid
to remove the pyridine and then the mixture was heated under vacuum to remove the solvent
and (E)-1-bromopent-2-ene (155) from the triphenylphosphine oxide by-product. The solvent and
bromide product were collected in a cold trap and the triphenylphosphine oxide was rinsed thor-
oughly with pentane.
OH Br
Br
+
PPh3Br2
pyridine
CH2Cl2
r.t., 0.5 h154 155 165
81%
42               :              1
Scheme 48: Bromination of (E)-2-penten-1-ol (154) using triphenylphosphine dibromide.
Distillation of the solvent away from the product was carried out carefully, initially using a Vi-
greaux column. The progress of the distillation was monitored carefully by 1H NMR spectroscopy
and at the first sign of isomerisation the distillation was stopped. The product was used directly
in the next step of the synthesis with the small quantity of residual dichloromethane present. By
1H NMR it was possible to estimate that the yield of the reaction was 81% and the distribution of
products was 42 : 1 in favour of the desired isomer (Scheme 48).
After preparation of the desired bromide 155, the next step was to use alkyne coupling method-
ology to couple it with propargyl alcohol (167). Initially the conditions used were stoichiometric
copper(I) iodide, potassium carbonate and sodium iodide.114 The reaction mixture was stirred in
acetone overnight, after which all of the starting material had been consumed, as judged by TLC. It
was discovered that an unwanted regioisomer 168 had been formed in large amounts, giving just a
2 : 1 ratio of products in favour of the desired regioisomer 156 (Scheme 49). This unwanted regioi-
Br OH
OH
+OH+
acetone
K2CO3
NaI
CuI
r.t., 24 h
2                     :                    1
155 167
156
168
Scheme 49: Coupling of (E)-1-bromopent-2-ene (155) with propargyl alcohol (167) using CuI and
NaI.
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Scheme 50: Formation of undesired regioisomer 168 via SN2’-like attack of iodide and subsequent
alkyne coupling.
somer could either arise from SN2’-like attack of iodide at the olefin to give 3-iodo-1-pentene (169)
followed by coupling with propargyl alcohol (167) (Scheme 50), or direct substitution of bromide
with iodide in (E)-1-bromo-pent-2-ene (155), followed by SN2’-like attack of propargyl alcohol (167)
at the alkene.
In order to reduce the amount of undesired regioisomer 168 that was formed, a new procedure
for the coupling was investigated.115 Propargyl alcohol (167) and isopropylmagnesium chloride
were heated at reflux in THF for one hour. isoPropylmagnesium chloride acts as a base in the
reaction and two equivalents have to be used to ensure that there is deprotonation of the alkynic
proton as well as the hydroxyl proton. Catalytic copper(I) chloride was added, followed by a
solution of (E)-1-bromopent-2-ene (155) in diethyl ether. The reaction mixture was then heated for
two hours at reflux, after which it was worked-up. After purification of the product by column
chromatography, 6.45 g of a pale yellow oil was isolated. This corresponds to an overall yield of
45% over the first two steps, and gratifyingly the ratio of products using this method is found to
be much improved at 35 : 1 in favour of the desired product 156 (Scheme 51). The slight decrease
OH
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PPh3Br2
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CH2Cl2
154 155
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168
42              :              1
35                  :                  1
6.45 g, 45% over two steps
OH
iPrMgCl, CuCl,
THF, 70°C, 5 h
r.t., 0.5 h
167
Scheme 51: Optimised conditions for the preparation of (E)-oct-5-en-2-yn-1-ol (156).
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in the proportion of desired product is due to SN2’-like attack of deprotonated propargyl alcohol
at the alkene.
After successful coupling the next step in the synthesis was conversion of alcohol 156 into bro-
mide 157 via an Appel reaction.116 The reaction used just over one equivalent of carbon tetrabro-
mide and triphenylphosphine and was initially conducted at −15 ◦C, with subsequent warming
to room temperature. After an hour the reaction had gone to completion and was worked-up.
The product was purified by column chromatography to give 6.72 g of the desired product as a
colourless oil, in a yield of 69% (Scheme 52). The product was contaminated with a very small
quantity of bromoform, which is a side-product formed during the reaction. Gratifyingly, after
column chromatography the distribution of regioisomers had improved to 50 : 1 in favour of the
desired bromide regioisomer 157.
OH
OH
+
156
168
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Br
Br
+
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50                  :                  1
CBr4, PPh3
CH2Cl2
!10°C " r.t., 1 h
6.72 g, 69%
Scheme 52: Appel bromination of (E)-oct-5-en-2-yn-1-ol (156).
(E)-1-Bromooct-5-en-2-yne (157) was then coupled with 3-butyn-1-ol (170) using the method
that was initially used to couple (E)-1-bromopent-2-ene (155) with propargyl alcohol (167).114 Sto-
ichiometric copper(I) iodide was used in the reaction as well as sodium iodide and potassium
carbonate (Scheme 53). It was found that it is necessary to heat the reaction mixture at reflux
overnight in order to achieve complete conversion into product. The enediyne product 158 was
purified by column chromatography and isolated in a 49% yield, to give 3.09 g of a yellow oil. After
Br
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+
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K2CO3, NaI, CuI
acetone
70°C, 20 h
OH
OH
+
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172
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171
Scheme 53: Coupling of (E)-1-bromooct-5-en-2-yne (157) with 3-butyn-1-ol (170) using CuI and
NaI.
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purification only 1% of the undesired regioisomer 172 was observed by 1H NMR, which demon-
strates how the distribution of products can be improved by column chromatography throughout
the synthesis.
After formation of enediyne 158 the next step was (Z)-selective reduction of the two alkynes to
form the doubly-skipped (E,Z,Z)-triene 159. Initially Lindlar’s catalyst was used, with quinoline
as a poison and the reaction was conducted in methanol. As the reaction progressed three differ-
ent spots could be observed by TLC. The one with the lowest R f was starting material, with the
intermediate spot being partially-reduced dienynes and the component with the highest R f was
believed to be the desired product. The 1H NMR spectrum initially appeared promising. However,
the 13C NMR spectrum showed over 40 signals in the alkene region. It was thought that this could
potentially be due to isomerisation. During the work-up the reaction mixture was washed with 1
M hydrochloric acid to remove the quinoline. The presence of this acid could promote isomerisa-
tion of the alkenes, as there would be a thermodynamic driving force for the alkenes to move into
conjugation.
In order to reduce the possibility of these potential acid-catalysed olefin isomerisation pro-
cesses, the crude reaction mixture was immediately subjected to column chromatography without
washing with hydrochloric acid. This would serve the purpose of both removing the quinoline
and purifying the product. Unfortunately there were still a large number of signals in the alkene
region of the 13C NMR spectrum. Therefore this must be due to over-reduction of the compound
past the triene stage. As the desired product appears to have the same R f as over-reduced material,
it was found that the solution to avoid over-reduction was to monitor the progress of the reaction
carefully by TLC and 1H NMR spectroscopy in order to observe the disappearence of enediyne 158
and intermediate dienyne. In particular, the appearance of two distinct signals, each integrating
for 2H, just below 3 ppm is diagnostic for formation of the desired product 159.
In order to slow the hydrogenation and consequently make it easier to monitor, palladium on
OH OH
158 159
0.87 g, 62%
5% Pd-BaSO4
MeOH, H2
quinoline
r.t., 20 min
Scheme 54: Conditions for the (Z)-selective hydrogenation of enediyne 158 to form
doubly-skipped triene 159.
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barium sulfate was used instead of Lindlar’s catalyst and more quinoline was used. The reac-
tion mixture was stirred vigorously in methanol under a hydrogen atmosphere (Scheme 54).116
The reaction was monitored constantly by TLC and when it appeared that most of the dienyne
intermediate had been converted to product, the hydrogen source was removed and the reaction
mixture was filtered through a plug of silica gel to remove the palladium catalyst. 13C NMR spec-
troscopy appeared to show that the desired product had been formed without over-reduction, as
only 6 alkene signals could be observed. However, integration of the alkene resonances in the 1H
NMR spectrum relative to the signals for the skipped-methylene groups revealed that there was
still approximately 10-15% over-reduction. This prompted us to investigate other modifications in
order to minimise the amount of over-reduction and make the results more readily reproducible.
One method for selective reduction of alkynes to alkenes that has recently been employed in
the group is transfer hydrogenation using a zinc-copper couple with isopropanol and water as the
solvent.117 It was found that enediyne 173 could be reduced to doubly-skipped (Z,Z)-triene 174
with excellent chemoselectivity (Scheme 55).
OH
OH
173
174
Zn / Cu
iPrOH / H2O
Scheme 55: Transfer hydrogenation of enediyne 173 using a zinc-copper couple.
Although the level of selectivity provided by this reaction is obviously very desirable, there
are some negative aspects in using this procedure. It was found that in order to achieve a rea-
sonable reaction rate, 40 g of zinc-copper couple was required for every 1 g of enediyne 173 to
be reduced. This demonstrates the inefficiency of this method, with large amounts of metal-waste
being produced. The quantity of zinc-copper couple required also rendered the reaction difficult to
conduct in a practical sense. In order to prepare the zinc-copper couple, a large quantity of potas-
sium hydroxide was used and before the couple could be used in the reduction reaction it had to
be neutralised by repeated washings with distilled water. Also, once the reduction reactions had
gone to completion the metal had to be washed numerous times in order to recover all of the triene
product.
Considering these negative aspects of the transfer hydrogenation reaction, we decided to op-
timise the conditions for the palladium-catalysed hydrogenation of enediyne 158 instead (Scheme
56). It was considered that the use of a sacrificial alkene in the reaction mixture should prove ben-
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"conditions"
158 159
Conditions:
A) Pd-BaSO4, quinoline, H2, allyl alcohol
B) Pd-BaSO4, quinoline, H2, benzene
C) Pd-BaSO4, quinoline, H2, 
     methanol / cyclohexene (1 / 1)
Scheme 56: Conditions screened for the selective hydrogenation of enediyne 158.
eficial as once the more reactive alkynes in enediyne 158 have been reduced to the corresponding
alkene, then the palladium should reduce the sacrificial alkene which will be used in a large ex-
cess instead of the newly formed alkenes. This should slow the reaction sufficiently to allow for
easier monitoring and should avoid the problem of over-hydrogenation that was observed when
methanol was used as the solvent.
Our initial choice of solvent was allyl alcohol as this should have similar hydrogen-uptake and
solubility properties as methanol. The reaction was conducted at five-times the dilution compared
to when methanol was used in order to increase the number of equivalents of sacrificial alkene,
and with added quinoline to act as a poison and decrease the reactivity of the catalyst. After two
hours of stirring at room temperature the reaction was stopped and the product purified. It was
found that the alkene signals in the 1H NMR spectrum integrated for 6H as desired and the 13C
NMR spectrum was also pleasing, with just 6 resonances observed in the alkene region as expected.
However, although the reaction could be monitored to a certain extent by TLC when methanol was
used as the solvent, when allyl alcohol was used instead this was not possible as it has the same R f
as enediyne 158. Therefore although using allyl alcohol as a sacrificial alkene had given desirable
results in terms of chemoselectivity, we decided to investigate other solvents that may be more
practically useful.
We subsequently chose to investigate the use of benzene as a solvent for the reaction, as this
would avoid the problem of the solvent co-eluting with the product on TLC. Rather than acting as a
sacrificial alkene, it was thought that the benzene should be able to provide stability to the alkenes
in the product through pi-interactions and consequently stop over-hydrogenation from occurring.
After a comparatively long time of 6 hours (compared to 2 hours for allyl alcohol) the reaction
was worked-up and subjected to column chromatography. Although there was no over-reduction
apparent in the NMR spectra, there was evidently still some under-reduced compound present
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and the yield was disappointingly low at 37%.
As benzene had not given a very satisfying result, we decided to pursue solvents or addi-
tives that can act as sacrificial alkenes. The use of cyclohexene appeared attractive as it is a 1,2-
disubstituted alkene just like the alkenes that will be formed in triene 159, but also the relief of
a small amount of ring-strain upon hydrogenation to cyclohexane should render it slightly more
reactive. Also, the non-polar nature means that the problem of co-elution with triene 159 on TLC
that was present when allyl alcohol was used should be avoided, allowing easier monitoring of
the reaction progress.
Cyclohexene was used as solvent in a 1 : 1 mixture with methanol, to aid solubility and
hydrogen-uptake. Quinoline was used in order to poison the palladium catalyst and the reaction
was conducted under relatively dilute conditions in order to increase the number of equivalents
of cyclohexene. The reaction was monitored by TLC until all of enediyne 158 and intermediate
dienyne had been consumed and was subsequently left stirring for a further hour before being
worked-up. After column chromatography triene 159 was isolated in 64% yield. Gratifyingly
NMR spectroscopy revealed that the alkene resonances only under-integrated by approximately
5-10%, compared to 10-15% when methanol was used, and importantly the results were repro-
ducible and monitoring of the reaction by NMR spectroscopy was not required.
As the reaction with cyclohexene as a sacrificial alkene was convenient to conduct in a practical
sense, went to completion in a short time, provided a reasonable yield of product and offered good
chemoselectivity, this method was chosen to use in the synthesis. It was found that the reaction
scaled-up well, with 2 g of enediyne 158 being hydrogenated to triene 159 with the same level of
chemoselectivity and in a yield of 68%.
Therefore the first objective had been achieved with the successful synthesis of doubly-skipped
(E,Z,Z)-triene 159. The optimised route to produce this compound on a multi-gram scale is demon-
strated in Scheme 57. Commercially available (E)-2-penten-1-ol (154) was subjected to PPh3Br2-
mediated bromination to furnish (E)-1-bromopent-2-ene (155), which subsequently underwent
copper-catalysed coupling with deprotonated propargyl alcohol to give enyne 156 in up to 68%
yield over the first two steps. Appel bromination furnished bromine-containing enyne 157 and
this was then subjected to a Finkelstein reaction with sodium iodide, followed by copper-mediated
coupling with homopropargyl alcohol 171 in one-pot to furnish enediyne 158 in up to 39% yield
from enyne 156. Finally this then underwent (Z)-selective hydrogenation, catalysed by palladium
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on barium sulfate and in the presence of cyclohexene as a sacrificial alkene to give the desired
(E,Z,Z)-triene 159 in up to 68% yield.
OH Br
OH
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OH
OH
PPh3Br2
pyridine
CH2Cl2
r.t., 0.5 h
iPrMgCl, CuCl
THF
70°C, 5 h
OH
154 155 156
68% over two steps
CBr4, PPh3
CH2Cl2
!10°C " r.t., 1 h
K2CO3, CuI, NaI
acetone
70°C, 20 h
OH
167
171
5% Pd-BaSO4
H2, quinoline
r.t., 3 h
157 158
159
39% over two steps
68%
cyclohexene / MeOH
(1 / 1)
Scheme 57: Optimised route in the preparation of triene 159.
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3.2 Regioselective Homoallylic Epoxidation
After formation of doubly skipped (E,Z,Z)-triene 159, the next step was selective epoxidation
of the olefin adjacent to the alcohol (Scheme 58). This could be carried out racemically by using
vanadyl acetylacetonate to direct the epoxidation, in the absence of a chiral ligand. Triene 159 was
dissolved in dichloromethane and cooled to 0 ◦C. Vanadyl acetylacetonate was added first and
then TBHP was added dropwise. After 16 hours the reaction was judged to have gone to comple-
tion by TLC, so the reaction mixture was worked-up and subjected to column chromatography.
Epoxy-diene (±)-160 was isolated as a yellow oil in a 59% yield and again this reaction could be
conducted on a gram-scale with ease. However, in order to render the synthesis asymmetric, it
was necessary to pursue an asymmetric variant of the regioselective asymmetric epoxidation.
OH OH
O
159 (±)-160
V(O)(acac)2
TBHP, CH2Cl2
r.t., 16 h
59%
Scheme 58: Regioselective epoxidation of doubly-skipped triene 159.
3.2.1 Enantioselective Epoxidation of a Model Homoallylic Alcohol
Asymmetric epoxidation is a valuable reaction for use in the synthesis of chiral natural prod-
ucts. Regioselective asymmetric epoxidation of allylic alcohols has been a solved problem ever
since Sharpless’ 1980 publication,118 in which enantiomeric excesses of over 90% were consistently
imparted on a wide range of substrates using titanium(IV) isopropoxide, diethyl tartrate as a chiral
ligand, and TBHP as the oxidant. In 1986, Sharpless reported that the addition of molecular sieves
allows this previously stoichiometric system to be rendered catalytic in titanium(IV) isopropoxide
and tartrate ester, with no (or minimal) loss of enantiomeric excess.119
Although the Sharpless method has allowed for the selective catalytic asymmetric epoxidation
of allylic alcohols, there have been far fewer publications detailing research on regioselective asym-
metric epoxidation of homoallylic alcohols, compared to allylic alcohols. It is only in the past few
years, with Yamamoto’s work using bishydroxamic acid ligands,121–123 that a method for catalytic
asymmetric epoxidation of homoallylic alcohols that consistently gives high e.e.s for a wide range
of substrates has been available.
Shortly after Sharpless’ initial publication on asymmetric epoxidation of allylic alcohols,118 Mi-
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Scheme 59: Mihelich’s method for directed diastereoselective epoxidation of racemic homoallylic
alcohols.120
helich reported a diastereoselective epoxidation of homoallylic alcohols.120 The reaction uses cat-
alytic V(O)(acac)2 with TBHP as the oxidant (Scheme 59). It was found that the epoxide oxygen
was directed to one face of the olefin by a homoallylic secondary alcohol substituent, generally
with good to excellent diastereoselectivities. Mihelich proposes the tetrahedral vanadate ester
transition state 179 in order to explain the observed diastereoselectivity in the reaction. This chair
conformation minimises the steric interactions between the various substituents R1-R6. For exam-
ple, in (Z)-configured alkenes such as 175 and 177 there is an alkyl substituent present at R5 and H
at R6. Therefore there is going to be unfavourable allylic 1,3-strain between the substituent at R4
and the alkyl substituent at R5. This strain can be minimised in the transition state by placing the
largest group in the equatorial position (R3). Although this particular interaction is inconsequen-
tial in the formation of 176 (as R3 = R4 = H), it is particularly important in the formation of 178
where there is a methyl substituent present at the allylic position. These interactions ensure that
one face of the olefin is preferentially presented to the peroxide oxygen, providing a good level of
diastereoselectivity in the epoxide product.
Although Mihelich’s method does allow for the stereoselective installation of an epoxide into
a homoallylic alcohol, it requires already present chirality to direct the epoxidation, and conse-
quently is generally only applicable for homoallylic systems containing a secondary alcohol sub-
stituent. An alternative method was still required to provide asymmetric induction in the epoxida-
tion of prochiral homoallylic alcohols. In 1984 Sharpless reported his efforts in applying the system
developed for asymmetric epoxidation of allylic alcohols, to homoallylic alcohols.124 Treatment of
a range of homoallylic primary alcohols with stoichiometric Ti(OiPr)4 and DET (188) with TBHP as
the oxidant resulted in asymmetric epoxidation in low to modest e.e.s (Scheme 60). Most reactions
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Scheme 60: Sharpless’ method for directed asymmetric epoxidation of homoallylic alcohols using
diethyltartrate (188) as a chiral ligand.124
were conducted at 0 ◦C or −20 ◦C, with lower temperatures resulting in poor reactivity. Epoxida-
tion of the terminal monosubstituted alkene of homoallylic alcohol 180 was found to proceed with
the highest e.e. of 55%, whereas the inherently more reactive tri-substituted alkene of 186 could
only be epoxidised with an e.e. of 27%. 1,2-Disubstituted homoallylic alcohols (Z)- and (E)-hexen-
1-ol (182 and 184) underwent epoxidation in modest e.e.’s of 50 and 41% respectively. Interestingly
it was found that the use of the same ligand resulted in an opposite sense of asymmetric induction
for homoallylic alcohols, compared to allylic alcohols.
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Scheme 61: Yamaguchi’s method for directed asymmetric epoxidation of homoallylic alcohols
using tartramides as chiral ligands.125
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Three years later Yamaguchi reported a system which provided improved e.e.s for asymmetric
epoxidation of homoallylic alcohols.125 Yamaguchi suggests that the low asymmetric induction
observed with Sharpless’ system is due to “repulsion in the folded conformation of the carbon
chain” of the homoallylic alcohol, in the transition state which leads to the major stereoisomer.
Consequently Zr(OPr)4 was used instead of Ti(O
iPr)4, as it was considered that the longer metal-
oxygen bond should allow for stretching of the carbon chain, reducing the undesirable repulsion
in the transition state. TBHP was used as the oxidant in the system, with the ligands being amide
derivatives of tartaric acid. Although the use of Zr(OPr)4 and DCTA (190) still generally resulted in
relatively low levels of asymmetric induction for terminal (180) and (E)-configured (184) alkenes,
the use of tartramide ligands in the asymmetric epoxidation of (Z)-configured alkene 182 proved
more successful (Scheme 61). Using DBTA (189) as the ligand furnished 183 in 62% e.e., with
DCTA (190) providing an even greater level of asymmetric induction. Although the use of the
larger zirconium and bulkier tartramide ligands had generally resulted in improvements to the
asymmetric epoxidation of homoallylic alcohols, the system was still stoichiometric as opposed to
catalytic, and long reaction times were required (for example, 8 days at 0 ◦C for the epoxidation of
182 when DCTA (190) was the ligand).
In 1998 Hormi reported his efforts towards asymmetric epoxidation of homoallylic alcohols
using polymer-supported Ti(IV) catalysts.126 Polytartrate ligands 193 were prepared by polymeri-
sation of L-(+)-tartaric acid (191) with 1,8-octanediol (192), mediated by PTSA (Scheme 62). The
active catalyst was generated from polytartrate ligand 193 and Ti(OiPr)4, and TBHP was used as
the oxidant in the reactions. It was found that stoichiometric quantities of catalyst were required
for the reaction to proceed effectively, however reaction times of many days were often required
to achieve modest yields of epoxide product. The terminal alkene 180 was epoxidised to 181 with
a good level of asymmetric induction (80% e.e.). However, as the alkenes become increasingly
substituted, this level of induction was not maintained. Both (Z)- and (E)-alkenes (182 and 184)
underwent asymmetric epoxidation catalysed by the polymer-supported Ti(IV) catalyst with rel-
atively low e.e.s of 51% and 54% respectively. When trisubstituted alkene 186 was subjected to
the same conditions the enantioselectivity decreased further still to 36% e.e. Although this method
does allow for facile purification, as the polymer catalyst is simply filtered away from the products,
the reaction is still stoichiometric in both metal and ligand and the levels of asymmetric induction
do not represent any improvement over Yamaguchi’s method.125 Therefore there was still a re-
quirement for a catalytic system for asymmetric epoxidation of homoallylic alcohols that could
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Scheme 62: Hormi’s method for directed asymmetric epoxidation of homoallylic alcohols using
polymer-supported Ti(IV) catalysts.126
provide consistently high levels of asymmetric induction.
In 2003 the first real catalytic systems for asymmetric epoxidation of homoallylic alcohols were
reported by Yamamoto127 and Onaka.128 Yamamoto used chiral hydroxamic acid ligands with
VO(OiPr)3 and CHP to effect asymmetric epoxidation of a range of homoallylic alcohols in com-
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Scheme 63: Yamamoto’s method for directed asymmetric epoxidation of homoallylic alcohols
using chiral hydroxamic acid ligands.127
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paratively short reaction times (hours as opposed to days), and using a catalyst loading of just
2 mol%. After an extensive screening, hydroxamic acid ligand 196 with a tert-butyl substituent
adjacent to the hydroxamic acid moiety was found to give the best results. The 3,4-disubstituted
alkenes, 182 and 184, underwent asymmetric epoxidation to form 183 and 185 with only modest
asymmetric inductions of 52% and 40% e.e. respectively (Scheme 63). Epoxidation of trisubstituted
alkene 186 proceeded with an even lower level of asymmetric induction, furnishing epoxide 187
in just 36% e.e. However, when disubstituted alkene 194 was subjected to the same conditions the
e.e. improved to 84%. This improved asymmetric induction for the disubstituted alkene 194 was
also found to be the case for a range of other disubstituted homoallylic alcohols (not shown here).
This observation led to the conclusion that “the 3-position of homoallylic alcohols is strongly rec-
ognized by catalysts with a positive effect on the selectivity, and that substituents in the 4-position
provide a slightly negative effect.”127
Onaka’s catalytic method for asymmetric epoxidation utilised Zr(OtBu)4 and tartrate ester or
tartramide ligands, with CHP as the stoichiometric oxidant.128 The reactions were conducted in
chlorobenzene and it was found that the use of 4A˚ molecular sieves was important to achieve
good yields and e.e.s. Although the catalytic loading was greater than that used by Yamamoto127
(20 mol% c.f. 2 mol%), the reaction consistently provided greater levels of asymmetric induction
(Scheme 64). Monosubstituted alkene 180 underwent asymmetric epoxidation with good asym-
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Scheme 64: Onaka’s method for directed asymmetric epoxidation of homoallylic alcohols using
dibenzyltartramide (189) as a chiral ligand.128
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metric induction when DBTA (189) was used as the ligand, providing epoxide 181 in 78% e.e. Both
(Z)- and (E)-configured alkenes 182 and 184 could also be epoxidised with good enantioselectivity,
providing 183 and 185 with e.e.s of 72% and 87% respectively. Although the levels of asymmetric
induction were respectable for mono and disubstituted alkenes, when trisubstituted alkene 186
was subjected to the same conditions the e.e. of the epoxide product 187 was found to be signif-
icantly lower at 47%. However, overall this method for asymmetric epoxidation of homoallylic
alcohols does represent a considerable improvement over those reported previously, in terms of
asymmetric induction, reaction times, and also the fact that the reaction is catalytic.
In 2007 Yamamoto reported an improvement to the previously described system, using chi-
ral bishydroxamic acid ligands in place of chiral hydroxamic acid ligands.121, 122 The active cata-
lyst is generated in situ from the bishydroxamic acid ligand with VO(OiPr)3, and the stoichiomet-
ric oxidant used is CHP. It was found that the catalytic loading can be as low as 1 mol%, with
good to excellent yields of epoxide products being produced within 24 hours of stirring at room
temperature. A range of bishydroxamic acid ligands bearing various aryl groups were prepared
and screened for their use in the asymmetric epoxidation of both allylic and homoallylic alco-
hols.122 It was found that ligand 199, bearing 4-tert-butylphenyl groups and ligand 200, bearing
4-(2,4,6-triethylphenyl)phenyl moieties provided the best level of asymmetric induction (Scheme
65). Homoallylic alcohol 197 was found to undergo reasonably efficient asymmetric epoxidation
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Scheme 65: Yamamoto’s method for directed asymmetric epoxidation of homoallylic alcohols
using V(V) and chiral bishydroxamic acid ligands (199 and 200).121, 122
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when bishydroxamic acid 199 was used, providing epoxide 198 in 90% e.e. after 12 hours. When
the bulkier ligand 200 was used, the e.e. was found to increase to 96% and the yield also im-
proved from 56% previously, to 90% in the case of ligand 200. However, the reaction time for this
bishydroxamic acid was twice that of the reaction using ligand 199. Homoallylic alcohols 182 and
184 were also found to undergo epoxidation with very high levels of asymmetric induction when
bishydroxamic acid 199 was used as a ligand, with epoxides 183 and 185 being produced with
e.e.s of 95% and 93% respectively. These high levels of asymmetric induction were found to be
maintained for a range of (E)- and (Z)-configured 3,4-disubstituted homoallylic alcohols.122
Recently, Yamamoto has reported a further improvement to this methodology whereby the lev-
els of asymmetric induction in the reaction were further increased by changing the metal used in
the reaction, and also the solvent.123 Yamamoto believed that they had previously “depleted the
catalytic ability of the vanadium-BHA system with a very bulky BHA ligand”123 and so chose to
adopt a different approach to increase levels of enantiomeric excess. As Zr(IV) had previously been
utilised by Onaka for asymmetric epoxidation of homoallylic alcohols,128 Yamamoto decided to try
zirconium and hafnium in place of vanadium, in order to investigate their use in asymmetric epox-
idation with chiral bishydroxamic acid ligands. The use of Zr(OtBu)4 immediately gave a much
higher level of selectivity than VO(OiPr)3 when a representative homoallylic alcohol was subjected
to otherwise identical reaction conditions (90% e.e. for Zr(OtBu)4 c.f. 69% e.e. for VO(O
iPr)3). It
was found that bishydroxamic acid ligand 201 gave better levels of reactivity and selectivity than
when bulkier ligands similar to 200 were used. Interestingly it was found that the results were
improved when a polar aprotic solvent such as DMPU was used in addition to toluene, and also
the addition of 4A˚ molecular sieves were found to have a positive effect on both the yield and level
of asymmetric induction.
Subsequent screening of a range of homoallylic alcohols with the optimised conditions demon-
strated that Hf(OtBu)4 is even more selective and gives rise to better reactivity than Zr(O
tBu)4
(Scheme 66). The reaction of monosubstituted homoallylic alcohol 180 with Hf(OtBu)4 and lig-
and 201 furnished epoxide 181 with a fairly modest e.e. of 63%. However, subjecting various
disubstituted homoallylic alcohols to the same conditions resulted in very high levels of selectiv-
ity. Asymmetric epoxidation of 3,3’-disubstituted alkene 194 using Zr(IV) provided epoxide 195 in
91% e.e., which increased to 97% upon switching to Hf(IV). (Z)-3-Hexen-1-ol (182) also underwent
asymmetric epoxidation with very good levels of asymmetric induction, providing epoxide 183 in
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Scheme 66: Yamamoto’s method for directed asymmetric epoxidation of homoallylic alcohols
using Zr(IV) and Hf(IV) with chiral bishydroxamic acid ligand 201.123
93% e.e. when Zr(IV) was used and 94% e.e. when the metal was changed to Hf(IV). The level of
selectivity was found to decrease slightly though for trisubstituted alkene 186, with the epoxide
product 187 being provided in 71% e.e. Interestingly, it was found that these reaction conditions for
asymmetric epoxidation of homoallylic alcohols could also be extended to that of bishomoallylic
alcohols, with e.e.s in the region of 95-99% being achieved for a range of compounds.123
Although Yamamoto’s work with bishydroxamic acids does represent the best method for
asymmetric epoxidation of homoallylic alcohols currently available in terms of asymmetric in-
duction, there are still some issues with the general utility of the method. The levels of asymmetric
induction are not consistently above 90% for all types of homoallylic alcohol, reaction times are
still generally of the order of days rather than hours, and most importantly synthesis of the bishy-
droxamic acid ligands is not facile. Preparation of the various ligands requires 8 synthetic steps
from commercially available 1,2-diaminocyclohexane tartrates,122 and purification of some inter-
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Table 6: Summary of asymmetric homoallylic epoxidations of (Z)-3-hexen-1-ol (182) reported in
the literature.
OH
O
OH
182 (3S,4R)-183
"conditions"
Entry Metal Ligand Oxidant Solvent Temperature Duration Yield e.e.
/ ◦C / h / % / %
1a,h Ti(OiPr)4 DET TBHP CH2Cl2 0 120 50 36
2a,h Ti(OiPr)4 DET TBHP CH2Cl2 −20 N / A 30 50
3b,h Zr(OPr)4 DBTA TBHP CH2Cl2 0 168 22 62
4b,h Zr(OPr)4 DCTA TBHP CH2Cl2 0 192 23 72
5c,h Ti(OiPr)4 193 TBHP CH2Cl2 −20 500 20 51
6d,i VO(OiPr)4 196 CHP PhMe 0 10 41 52
7e,i Zr(OtBu)4 DBTA CHP PhCl −40 24 93 72
8f,i VO(OiPr)4 BHA 199 CHP PhMe r. t. 24 92 95
9g,i Zr(OtBu)4 BHA 201 CHP PhMe r. t. 40 45 93
10g,i Hf(OtBu)4 BHA 201 CHP PhMe r. t. 40 82 94
a reported by Sharpless, 1984;124 b reported by Yamaguchi, 1987;125 c reported by Hormi,
1998;126 d reported by Yamamoto, 2003;127 e reported by Onaka, 2003;128 f reported by Ya-
mamoto, 2007;121, 122 g reported by Yamamoto, 2010.123
h stoichiometric system.
i catalytic system.
mediates and especially the final bishydroxamic acid product proved quite challenging and time-
consuming during previous syntheses in our group.117, 129 Therefore there still remains a need to
develop a catalytic system for asymmetric epoxidation of homoallylic alcohols which consistently
provides high levels of asymmetric induction with short reaction times for all types of homoallylic
alcohols, and which uses a ligand that can be readily made.
We chose homoallylic alcohol (Z)-3-hexen-1-ol (182) as a suitable model for (E,Z,Z)-triene 159,
the homoallylic alcohol which must undergo directed asymmetric epoxidation of the homoallylic
olefin as part of the synthesis of the medium-ring ethers from Laurencia species. Levels of asym-
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metric induction obtained in previously reported asymmetric epoxidations of homoallylic alcohol
182 are summarised in Table 6. The highest levels of selectivity were obtained using Yamamoto’s
protocol (Entries 8-10), but this method involves the rather lengthy synthesis of the chiral bishy-
droxamic acid ligands 199 and 201. Aside from these values reported by Yamamoto, the next
highest level of e.e. was 72% reported by both Yamaguchi125 (Entry 4) and Onaka128 (Entry 7). In
both of these cases the ligand used was an amide derivative of tartaric acid. Although both of the
methods produced the same level of asymmetric induction, Onaka’s method was catalytic whereas
Yamaguchi’s required a stoichiometric quantity of metal and ligand to be used. Therefore Onaka’s
method which provided a 72% e.e. in the epoxidation of (Z)-3-hexen-1-ol (182) using Zr(OtBu)4
and DBTA (189) was chosen as a good basis for developing new tartramide ligands and conditions
to improve the level of enantioselectivity.
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Scheme 67: Racemic epoxidation of 182 and subsequent tritylation in order to determine chiral
HPLC conditions for separation.
In order to determine the level of enantiomeric excess of the epoxide product 183 achieved
in the various asymmetric epoxidation reactions, chiral HPLC conditions for separation of the
enantiomers had to be determined. Therefore (Z)-3-hexen-1-ol (182) was subjected to mCPBA in
dichloromethane to provide racemic epoxide 183 in 87% yield (Scheme 67). To allow easy detection
by UV, the product was converted into the tritylated derivative 202, thus providing a good UV-
active chromophore for detection. After screening various HPLC conditions, a set of optimised
parameters were found which allowed baseline separation of the enantiomers of 202.
Initially DBTA (189) was prepared in order to investigate temperature affects on the asym-
metric epoxidation reaction. Using Frankland’s method reported in 1903,130 benzylamine (204)
was stirred with the commercially-available and inexpensive tartaric acid derivative DMT (203) in
methanol at room temperature overnight. The white solid product was found to precipitate during
this time and could be simply filtered and washed with methanol to cleanly provide the desired
DBTA (189) product (Scheme 68). This procedure could be scaled-up to provide multiple gram
quantities of the DBTA (189) ligand.
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Scheme 68: Preparation of DBTA (189) using Frankland’s 1903 procedure.130
The conditions optimised by Onaka for asymmetric epoxidation128 were utilised initially to
ensure that similar levels of enantioselectivity could be achieved. DBTA (189) was stirred with
Zr(OtBu)4 in chlorobenzene for 1 h at room temperature in order to generate the active catalyst in
situ. The reaction mixture was then cooled to −40 ◦C and the bulky stoichiometric oxidant CHP
was added, followed by a solution of homoallylic alcohol 182 in chlorobenzene (Table 7, Entry 3).
The reaction was monitored by TLC until all of the starting material had been converted to product
and the reaction mixture was then quenched. After column chromatography the epoxide product
183 was tritylated and the ratio of enantiomers assessed by chiral HPLC. It was found that the
reaction had provided 183 with an e.e. of 47%, which is considerably lower than the 72% reported
by Onaka.128
It was thought that this could be due to the presence of some zirconium in the reaction mixture,
which is not complexed by the DBTA ligand (189). Epoxidation of homoallylic alcohol 182 could
also occur at this zirconium to produce racemic 183, potentially at a faster rate than epoxidation
occurs at the actual asymmetric catalyst centre. This would lead to an erosion of the level of enan-
tioselectivity obtained in the reaction. In order to reduce the possibility of this occurring it was
considered that the ratio of ligand to metal should be increased. Therefore rather than 22 mol%
: 20 mol% (ligand : Zr(OtBu)4) being used, 60 mol% : 40 mol% was used for the majority of the
screening reactions instead.
With the melting point of chlorobenzene being −45 ◦C, it became apparent that a change of
solvent was necessary to allow access to lower temperatures than that used by Onaka, with the
potential for increased levels of asymmetric induction. Dichloromethane was chosen as a suitable
chlorinated alternative with a lower melting point and was initially used for an asymmetric epoxi-
dation reaction at−40 ◦C with the altered catalyst ratio (Table 7, Entry 4). Gratifyingly it was found
that complete conversion was achieved after 18 hours and an e.e. of 71% was obtained (Figure 13),
which is in excellent agreement with Onaka’s reaction which was conducted in chlorobenzene.
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Table 7: Conditions for asymmetric homoallylic epoxidation of (Z)-3-hexen-1-ol (182).
OH
O
OH
182 183
O
OCPh3
202
Ph3CCl
NEt3
CH2Cl2
r.t., 6 h
"conditions"
Entry Metal Ligand Solvent Temperature Duration Conversiona e.e.b
/ ◦C / h / % / %
1 Ti(OiPr)4
d DMTe CH2Cl2 0 −→ r. t. 64 80 −13c
2 Ti(OiPr)4
d DBTAe CH2Cl2 0 −→ r. t. 64 40 31
3 Zr(OtBu)4
f DBTAg PhCl −40 40 100 47
4 Zr(OtBu)4
h DBTAi CH2Cl2 −40 18 100 71
5 Zr(OtBu)4
h DBTAi CH2Cl2 −60 70 80 72
6 Zr(OtBu)4
h DBTAi CH2Cl2 −80 90 0 N/A
7 Zr(OtBu)4
h DBTAi CH2Cl2 r. t. 6 90 52
8 Zr(OtBu)4
h 206i CH2Cl2 −40 92 50 5
9 Zr(OtBu)4
h 207i CH2Cl2 −40 92 25 37
10 Zr(OtBu)4
h 209i CH2Cl2 −40 88 100 68
11 Zr(OtBu)4
f 218g CH2Cl2 −40 88 90 66
12 Zr(OtBu)4
h 220i CH2Cl2 −40 92 0 N/A
13 Zr(OtBu)4
h 220i CH2Cl2 r. t. 19 65 −35c
14 VO(OiPr)3
j 199k PhMe r. t. 140 90 −52c
a estimated from the 1H NMR spectrum of the crude mixture after work-up.
b measured using the trityl derivative 202 of 3,4-epoxyhexan-1-ol (183).
c provided the opposite sense of asymmetric induction than that which is required.
d 1.00 equivalent; e 1.25 equivalents; f 0.20 equivalents; g 0.22 equivalents; h 0.40 equiva-
lents; i 0.60 equivalents; j 0.02 equivalents; k 0.01 equivalents.
This allowed for investigations using DBTA (189) at lower temperatures. It was found that
lowering the temperature to −60 ◦C resulted in a longer reaction time, as would be expected, with
80% conversion after 70 hours (Table 7, Entry 5). However, this change of temperature had no
impact on the level of asymmetric induction, with a 72% e.e. recorded for the reaction. Decreasing
the temperature further to −80 ◦C resulted in no reaction, even after 90 hours (Table 7, Entry 6).
87


 





 



Figure 13: Chromatograms to show the chiral HPLC separation of the enantiomers of the trityl
derivative of epoxide 183: racemic epoxidation (top) and asymmetric epoxidation using
Zr(OtBu)4 and DBTA (189) at −40 ◦C (bottom).
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After decreasing the temperature had not led to an increase in the level of enantioselectivity, it
was thought it would be interesting to conduct a reaction at room temperature in order to inves-
tigate the robustness of the catalytic system in providing asymmetric induction (Table 7, Entry 7).
There was 90% conversion to the epoxide product 183 after just 6 hours and the e.e. was 52%. This
is a very respectable level of asymmetric induction considering that the temperature of the reaction
had been raised by 60 ◦C and this was accompanied by a decrease in the e.e. of just 21%. Inter-
estingly, this level of asymmetric induction is comparable to when Yamamoto’s conditions121, 122
with VO(OiPr)3 and bishydroxamic acid ligand 199 were used in the asymmetric epoxidation of
homoallylic alcohol 182 (Table 7, Entry 14). This reaction was also conducted at room temperature,
but had a much longer reaction time of 140 hours, as opposed to 6.
Once the effect of changing the reaction temperature had been studied, we decided to investi-
gate the effect of changing the metal size on the asymmetric epoxidation reaction using DBTA (189)
as the ligand. Sharpless-type conditions124 were chosen, with stoichiometric Ti(OiPr)4 and ligand
in dichloromethane, and with TBHP as the oxidant. DMT (203) was initially used as the ligand in
order to closely replicate Sharpless’ original conditions which used DET (188). It was found that
after 64 hours at room temperature epoxide product 183 was furnished in 80% conversion and with
an e.e. of 13% (Table 7, Entry 1). However, the sense of asymmetric induction was opposite to that
observed with the Zr(OtBu)4/DBTA system, and opposite to that which is required for the asym-
metric epoxidation of triene 159. Upon altering the ligand to the bulkier DBTA (189), it was found
that the rate of reaction slowed considerably, as would be expected, with only 40% conversion in
64 hours at room temperature (Table 7, Entry 2). The sense of asymmetric induction was found to
be the same as for the Zr(OtBu)4/DBTA system. However the e.e. was only 31%, which compares
to 71% when Zr(OtBu)4 was used. This observation that the use of a smaller metal (Ti) results in a
lower level of enantioselectivity is in agreement with results reported by other groups.123, 125
As altering the temperature had not had the desired effect, it was thought that altering the
DBTA ligand (189) for a bulkier tartramide may have a more positive effect. Initially tartramides
206, 207 and 209 were chosen as suitable targets as they have the same core structure as DBTA (189),
but with an extra moiety added at the benzylic position, which should provide more steric bulk for
the asymmetric epoxidation reaction. Attempts to prepare these ligands in the same way as DBTA
(189) by stirring DMT (203) with the requisite amine in methanol proved unsuccessful. Presumably
this is due to the inherent solubility of these tartramide products in methanol. DBTA (189) is
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completely insoluble in methanol and so this product precipitates from solution upon formation,
effectively making the reaction irreversible. Le Chatelier’s principle therefore acts to give clean
and complete conversion to the desired DBTA (189) product. As tartramides 206, 207 and 209 are
at least partially soluble in methanol, the products will be in equilibrium with both mono-amide
and the DMT (203) starting material, making product formation and isolation difficult.
As stirring the amine with DMT (203) in methanol had proven unsuccessful, it was considered
that using a non-nucleophilic polar solvent such as HFIP with a large excess of amine may help
to encourage the desired reaction to occur. HFIP should not be sufficiently nucleophilic to attack
either the ester or the amide in order to form a tetrahedral intermediate. Therefore apart from the
amine, only the methanol which is liberated upon formation of the amide is capable of nucleophilic
attack at the carbonyl. A large excess of amine should therefore ensure the equilibrium is driven
towards formation of the desired tartramide products.
In order to achieve product formation it was found that elevated temperatures were required.
The high boiling points of the various amines and the fact that they were present in a large ex-
cess allowed the temperature of the reaction mixture to be raised to 120 ◦C, considerably higher
than the boiling point of HFIP. It was found that the tartramides were produced with reasonable
conversions using these conditions. However, by 1H NMR spectroscopy we observed a consid-
erable amount of epimerisation, especially in the formation of tartramides 207 and 209 (24% and
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Scheme 69: Attempted one-step preparation of other tartramide ligands from DMT (203).
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20% mono-epimerisation, respectively – Scheme 69). There is also the possibility that there was
epimerisation of both alcohols resulting in racemisation, although obviously this will not be ap-
parent from analysis of the 1H NMR spectra. This α-deprotonation and resultant epimerisation
is presumably due to the high temperatures which were required for amide formation, combined
with the presence of a large excess of amine.
As this one-step approach to form other tartramide ligands was resulting in undesirable epimeri-
sation, a different approach had to be pursued in order to avoid this. It was considered that the
formation of protected tartaric acid derivative 212, followed by DCC couplings with a range of
different amines would provide protected tartramides, which could subsequently be deprotected
to furnish the desired tartramides. Although this preparation involves additional steps, the reac-
tions should be trivial to perform and also it should avoid harsh conditions which could otherwise
result in epimerisation.
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Scheme 70: Synthesis of the acetonide-protected derivative of tartaric acid.
The vicinal diol in DMT (203) was protected by formation of the acetonide 211 by heating with
2,2-dimethoxypropane (210) and PTSA in acetone at 60 ◦C for 15 h (Scheme 70). This furnished
the acetonide-protected product 211 in 46% yield. Subsequent saponification of the diester with
lithium hydroxide in methanol produced the corresponding dilithium salt in 96% yield. This was
then treated with aqueous acid in order to provide the acetonide-protected tartaric acid 212 which
would function as a common intermediate in the preparation of the various tartramides.
Reaction of 212 with (R)-(+)-α-methylbenzylamine ((R)-205), DCC and DMAP produced pro-
tected tartramide 213 in 62% yield after column chromatography (Scheme 71). Subsequent treat-
ment with TFA at 70 ◦C with methanol and water as a mixed solvent resulted in acetonide hy-
drolysis, providing the desired tartramide 206 in 60% yield. Gratifyingly there was no sign of any
epimer by 1H NMR spectroscopy. Repeating the two-reaction sequence using (S)-205 in place of
(R)-205 resulted in the formation of the tartramide diastereomer 207 in an overall yield of 62%,
again with no observation of epimerisation.
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Scheme 71: Preparation of tartramide ligands by DCC coupling and subsequent acetonide
cleavage.
DCC coupling of the bulkier benzhydrylamine (208) with 212 provided acetonide-protected
tartramide 215 in a pleasing 86% yield after column chromatography. TFA-mediated removal of
the acetonide furnished the tartramide ligand 209 in 74% yield, again with no epimerisation ev-
ident by 1H NMR spectroscopy. Finally, we considered that it would be interesting to prepare a
ligand with an extra substituent present at the benzylic position to further increase the steric bulk
of the ligand. Thus tritylamine (216) was subjected to DCC coupling with 212 in order to prepare
protected tartramide 217 in 73% yield. By TLC it was found that acetonide removal using TFA pro-
ceeded to give complete conversion to product. However, poor solubility of tartramide product
218 in a wide-range of solvents rendered product isolation and purification problematic, resulting
in a low yield of 13%.
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With the four tartramides (206, 207, 209, 218) successfully prepared without epimerisation, all
that remained was to screen their use as ligands in the asymmetric epoxidation of (Z)-3-hexen-
1-ol (182). Tartramides 206 and 207 prepared from α-methylbenzylamines (R)- and (S)-205 were
found to give poor levels of conversion to epoxide 183 even after 4 days at −40 ◦C (50% and 25%
respectively). Asymmetric induction was also found to be disappointingly low in these reactions
– the reaction with tartramide 206 was almost racemic with an e.e. of 5% (Table 7, Entry 8), whilst
tartramide 207 provided epoxide 183 with a 37% e.e. (Table 7, Entry 9).
Tartramides 209 and 218 prepared from benzhydrylamine (208) and tritylamine (216) respec-
tively were found to represent an improvement over tartramides 206 and 207. Conversions of close
to 100% were obtained within 4 days at −40 ◦C, but the level of asymmetric induction of 68% e.e.
for 209 (Table 7, Entry 10) and 66% for 218 (Table 7, Entry 11) is akin to the 71% e.e. obtained
within 18 hours when DBTA (189) was used as the ligand (Table 7, Entry 4). Owing to the ease
of preparation of DBTA (189) over tartramides 209 and 218, and also the rates of reaction, DBTA
(189) would still obviously be the ligand of choice over 209 and 218 for asymmetric homoallylic
epoxidation in this reaction system of Zr(OtBu)4 with tartramide ligands.
As adding extra phenyl moieties at the benzylic position in the tartramide ligand (209 and 218)
had resulted in virtually the same level of asymmetric induction as the less sterically encumbered
DBTA ligand (189), this implied that one of the phenyl groups was involved in creating the chiral
environment, whereas the other phenyl groups were directed away from the chiral environment
of the catalyst, effectively having no impact on asymmetric induction. Therefore instead of adding
more steric bulk at the benzylic position, this indicated that increasing the steric bulk of the aro-
matic moiety itself may help to increase the level of enantioselectivity. Commercially available
1-naphthylmethylamine (219) was chosen as a suitable alternative to benzylamine, which should
provide extra steric bulk in the aromatic part of the tartramide ligand, as required. It was found
that the desired tartramide 220 could be prepared using the same method as for DBTA (189). DMT
(203) was stirred with 1-naphthylmethylamine (219) in methanol at room temperature for 18 hours,
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Scheme 72: Preparation of tartramide 220.
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after which the desired product had precipitated from solution (Scheme 72). Tartramide 220 was
isolated in 63% yield after simply filtering and washing with methanol.
Once tartramide 220 had been prepared, its potential use in asymmetric epoxidations was
investigated. Analogous conditions as for the successful reaction of (Z)-3-hexen-1-ol (182) with
Zr(OtBu)4 and DBTA (189) were used initially, however it was found that even after 4 days at
−40 ◦C there was no conversion to product observed by TLC (Table 7, Entry 12). As the increased
steric bulk of the ligand had evidently reduced the reactivity of the catalyst, a reaction was con-
ducted at room temperature instead of −40 ◦C. After 19 hours at room temperature the reaction
was quenched and it was found that there had been 65% conversion to epoxide 183 in that time
(Table 7, Entry 13). After conversion to the trityl derivative 202 it was revealed that the epoxide had
been produced in 35% e.e. However, somewhat unexpectedly the sense of asymmetric induction
was opposite to that observed when DBTA (189) was used as the ligand.
Investigations into the Zr(OtBu)4 / tartramide ligand system for asymmetric epoxidation of ho-
moallylic alcohols have revealed that the catalyst scope for activity and enantioselectivity is very
limited. When DBTA (189) was used as the ligand, an optimum temperature for both reactivity and
asymmetric induction was found to be−40 ◦C. Decreasing the temperature by 20 ◦C drastically in-
creased the reaction time with just a 1% increase in the e.e. to accompany it, and decreasing the
temperature further still to −80 ◦C resulted in the catalyst becoming completely inactive. When
ligands with increased steric bulk were investigated, tartramides with extra phenyl substituents
at the benzylic positions (209 and 218) were found to have almost negligible impact on the enan-
tioselectivity, whereas increasing the steric bulk of the actual aromatic moiety from a phenyl to a
naphthyl group resulted in the sense of asymmetric induction completely switching. After screen-
ing a range of temperatures and a variety of tartramide ligands it appears that Onaka’s initially
reported procedure128 of using Zr(OtBu)4 and DBTA at −40 ◦C should be used for the asymmetric
epoxidation of the homoallylic alcohol in triene 159, with the minor modification that the more
readily-available dichloromethane can be used as the solvent in place of chlorobenzene.
3.2.2 Asymmetric Homoallylic Epoxidation of Triene 159
After this investigation using various tartramide ligands and zirconium(IV) tert-butoxide to
effect asymmetric homoallylic epoxidation of (Z)-3-hexen-1-ol (182), the slightly modified version
of Onaka’s initially reported conditions was used on triene 159. The asymmetric catalyst for the
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reaction was formed in situ by stirring Zr(OtBu)4 and DBTA (189) in dichloromethane at room tem-
perature for 2 hours. The mixture was then cooled to −40 ◦C before the oxidant CHP was added,
followed by a solution of triene 159 in dichloromethane. The reaction mixture was left at −40 ◦C
overnight before being worked-up. The epoxide 160 was purified by column chromatography.
It was found that rigorously dry conditions were required for the reaction to proceed and give
good conversion. Any water present in the reaction mixture presumably destroyed the zirconium-
based asymmetric catalyst. Therefore some activated 4A˚ molecular sieves were used in the reaction
and the DBTA ligand was dried on a high vacuum pump for several hours prior to use. If the re-
action conditions were rigorously dry, then it was found that the asymmetric epoxidation reaction
could be conducted on a gram-scale to give epoxide 160 in 82% yield (Scheme 73).
OH OH
O
Zr(OtBu)4, DBTA
CHP, 4Å M.S.
CH2Cl2
!40°C, 44 h159 160
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Scheme 73: Asymmetric homoallylic epoxidation of triene 159.
In order to unveil the level of asymmetry imparted by the epoxidation reaction, the trityl
derivative of epoxy-diene 160 had to be prepared. This would provide a good chromophore for de-
tection during analytical chiral HPLC assessment. Epoxy-diene 160 was treated with trityl chloride
and triethylamine in dichloromethane at room temperature overnight (Scheme 74). After work-up
and column chromatography the trityl derivative 221 was isolated in 73% yield. Chiral HPLC anal-
ysis revealed that the enantiomeric ratio imparted by the asymmetric epoxidation reaction was 78
: 22 (Figure 14). Although lower than the level of asymmetric induction observed when (Z)-3-
hexen-1-ol (182) was used, this level of enantioenrichment in the epoxidation of the homoallylic
alcohol was satisfactory enough to carry the material forward.
O
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O
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Ph3CCl, NEt3
CH2Cl2
0°C ! r. t., 18 h160 221
73%
["]     = #0.9 (c 0.98, CH2Cl2)
e.r. = 78 : 22
(6S,7R : 6R,7S)
D
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Scheme 74: Preparation of the trityl-derivative of epoxide 160 in order to determine the level of
asymmetric induction in the previous epoxidation reaction.
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Figure 14: Chromatograms to show the enantiomeric excess of the trityl derivative of epoxy-diene
160: racemic (top) and enantioenriched (bottom). The absolute stereochemistry of the major
enantiomer was assigned by analogy to the model substrate 202.
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3.3 Bromonium Ion-Assisted Epoxide Ring-Opening in a Model System
Prior to conducting studies on the bromonium ion-assisted epoxide ring-opening of epoxy-
diene 160 we decided to develop suitable conditions and investigate this reaction using a model
system. Following on from the work by Davies and Thomas (vide supra),104, 105 we chose cy-
clooctene epoxide 131 as a suitable model substrate (Scheme 75).131 We used NBS as the source
of electrophilic bromine, along with the addition of a range of different nucleophiles to trap the
intermediate oxonium ion species 133.
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Scheme 75: Bromonium ion-assisted epoxide ring-opening of cyclooctene epoxide 131.131
It was found that acetic acid, benzoic acid, 4-nitrobenzoic acid and 2,3,4,5-tetrafluorobenzoic
acid could all be incorporated into the system when catalytic quantities of TMG132 were added to
the reaction mixture. In the case of these acids, as well as forming the two bicycloethers 161 and 162
(which must arise from bromonium ion-assisted epoxide ring-opening, with subsequent capture of
the oxonium ion by the acid nucleophile), two epoxide-containing compounds 163 and 164 were
also isolated. These must arise from bromonium ion formation on the alkene, with subsequent
direct attack by the acid nucleophile on the bromonium ion, without interception by the epoxide
oxygen. The structures of epoxides 163 and 164 show that for both compounds, the bromide and
carboxylate substituents have anti relative stereochemistry. There is a possible third mode of attack
that could be envisaged, where the epoxide oxygen attacks an incipient bromonium ion, and then
attack by the acid nucleophile occurs on the oxonium ion species at the position adjacent to the
bromide. This would provide a compound with syn relative stereochemistry for the bromide and
carboxylate substituents. As compounds with this relative stereochemistry were not observed, it
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Table 8: The product distribution after treatment of cyclooctene epoxide 131 with one
equivalent of NBS in the presence of acetic acid. All reactions were conducted at room
temperature and stirred for 2.5 h unless otherwise stated.
131 Concentration / Nucleophile Solvent % Conversion % 163 & 164 % 161 & 162
mol dm−3
0.25 AcOH CH2Cl2 99 70 30
0.025 AcOH CH2Cl2 95 45 55
0.0025 AcOH CH2Cl2 63 20 80
0.00025 AcOH CH2Cl2 72
a 15 85
a after stirring for 3 days at room temperature.
indicates that the bromide substituent acts as a steric shield to nucleophilic attack at the position
adjacent to it.131
It became apparent that there is a concentration affect in the reactions using these acid nucle-
ophiles. In order to investigate this some dilution studies were conducted using acetic acid as the
added nucleophile (Table 8). One equivalent of NBS was added, along with TMG, and the reactions
were conducted at room temperature using dichloromethane as the solvent. In most cases (apart
from the most dilute conditions where the reaction time was 3 days) the reaction mixture was
quenched after stirring for 2.5 hours, and the crude mixture submitted for 1H NMR spectroscopy.
The ratio of epoxide to ether products was estimated by integration of the relevant signals in the
spectrum. It was found that at high concentration the epoxide-containing products 163 and 164
were favoured. However, at high dilution the selectivity completely switches, to provide bicy-
cloethers 161 and 162 at the major products.
If it is assumed that attack by the nucleophile is the rate determining step, then in both cases
the rate determining step is bimolecular and the product distribution should be independent of
changes in concentration (Scheme 76).131 This raised the possibility that perhaps there is some ac-
cumulation of oxonium ion 133 in solution. This accumulation, via unimolecular intramolecular
nucleophilic attack by the epoxide oxygen, would therefore be favoured at high dilution over bi-
molecular attack by the acetate nucleophile on bromonium ion 132. If the oxonium ion is able to
accumulate in this manner at high dilution, it can then subsequently react with the acetate nucle-
ophile to form the bicycloether products. However, for this mode of selectivity to take place, it is
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Scheme 76: The equilibrium between bromonium ion 132 and oxonium ion 133.
necessary to assume that there is not rapid interconversion between the bromonium ion 132 and
oxonium ion 133.131
Some recently published research showed that oxonium ions may not necessarily always be
as fleeting and as reactive as they are generally considered to be.133 The rigid tricyclic structures
of oxatriquinane 222 and oxatriquinacene 223 (Figure 15) were prepared from cyclononatriene,
and the structure of the SbF6− salt of 222 was solved by X-ray crystallography. It was found
that oxatriquinane 222 could be recrystallised from water, and even after heating it at reflux in
water for 72 hours there was no sign of decomposition. These are certainly not properties that
would generally be associated with oxonium ions. The oxonium ion 133 formed after ring-opening
of bromonium ion 132 by the epoxide oxygen is a similarly rigid, tricyclic structure. In order
to investigate whether the oxonium ion 133 accumulates in our system, we conducted an NMR
scale reaction where one equivalent of NBS was added to a solution of cyclooctene epoxide 131 in
deuterated chloroform. However, we did not observe the formation of either bromonium ion 132
or oxonium ion 133 in solution, indicating that neither of these intermediates accumulates to any
great extent.131
O O
H
H H H
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Figure 15: Oxonium ions that display an unusual level of stability.
As high dilution conditions appear to be necessary to encourage ether formation when acid
nucleophiles are used, in a practical sense the large volumes of solvent that would be required
for this would be undesirable. In order to avoid having to use large volumes of solvent in the
reactions using the real system, it has been found that slow addition of the nucleophile by syringe
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Table 9: Product distribution after different rates of addition of acetic acid.
250 mg of 131 in 80 mL of dichloromethane was treated with one equivalent
of NBS and catalytic TMG for 2.5 h at room temperature. Addition of acetic
acid began as soon as the NBS had been added.
Duration of Addition / min % Conversion % 163 & 164 % 161 & 162
immediate 75 27 73
60 60 18 82
150 56 13 87
pump also gives a desirable product distribution. Table 9 shows that as the period of time over
which the nucleophile is added is increased, the proportion of ethers formed is greater. This is
presumably due to the effective nucleophile concentration in solution being lower. The reaction
rate does decrease somewhat with slower addition of nucleophile, however the desirable product
distribution should outweigh having to endure this increased reaction time.
The use of alcohols (methanol and ethanol) as both solvent and nucleophile gave predom-
inantly bicycloether 161 and 162 formation, with only methanol producing a small amount of
epoxides 163 and 164. Interestingly, the use of water as solvent and nucleophile gave exclusively
bicycloether formation, with no observation of any epoxide-containing compounds. The yields
in this reaction were also consistently very high, giving overall yields for 161 and 162 of 84-96%.
The success of this reaction is important considering that we are invoking the use of water as
an external nucleophile in the biogenesis of the halogenated medium-ring ethers from Laurencia
species. The polar nature of the water, and also methanol and ethanol, evidently must help to
encourage the bromonium ion-assisted epoxide ring-opening reaction – this should also be true
in the biogenesis of the natural products. Although the reaction does exhibit a small amount of
selectivity, producing a 3 : 1 mixture of regioisomers in favour of 162, the reaction is essentially not
inherently very selective. This is also an important observation, as in the bromonium ion-assisted
epoxide ring-opening of 127 (the compound we propose as being the biogenetic precursor to the
natural products) the reaction must necessarily be non-regioselective, allowing for the formation
of a variety of different structural motifs via energetically similar pathways.
Upon assigning the NMR spectroscopic data to the various compounds it became apparent
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Table 10: Comparison of 13C NMR chemical shifts for the bromide-bearing carbon
of [4.2.1]bicyclo ethers 161 and [3.3.1]bicyclo ethers 162.
Nu [4.2.1] (161): δ CBr / ppm [3.3.1] (162): δ CBr / ppm ∆δ / ppm
OAc 53.70 50.56 +3.14
OBz 53.64 50.58 +3.06
OBz-4-NO2 53.23 50.14 +3.09
OBz-2,3,4,5-F4 53.17 50.18 +2.99
Cl 53.38 50.34 +3.04
OMe 54.56 51.17 +3.39
OEt 54.73 51.37 +3.36
OH 54.30 51.04 +3.26
Br 53.41 50.35 +3.06
that there is a strong correlation for the chemical shift of the carbon atom bearing the bromide
substituent (Table 10).131 For a [4.2.1]bicyclo ether 161 this carbon atom resonates at 54.0 ± 1 ppm,
whereas for a [3.3.1]bicyclo ether 162 the bromide-bearing carbon has a chemical shift of 50.5 ±
1 ppm. For a given substituent the difference in this carbon resonance between the two different
bicyclic compounds is ∆δ ≥ 3 ppm. This consistent correlation for the different structural motifs
raises the possibility that in later studies on bromonium ion-assisted epoxide ring-opening, similar
correlations should be anticipated, and this may aid structure elucidation.
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3.4 Attempted Bromonium Ion-Assisted Epoxide Ring-Opening of Epoxy-Diene 160
3.4.1 Reaction of Epoxy-Diene 160 with Electrophilic Bromine in Water
After observing the excellent selectivity for ether formation in the reaction of model substrate
131 with NBS in water, the same conditions were used for the first attempted cyclisation of epoxy-
diene 160. It was thought that the hydrophobic effect would encourage the largely lipophilic
molecule to undergo bromonium ion-assisted epoxide ring-opening, in the same way as in the
case of cyclooctene epoxide 131. Epoxy-diene 160 was stirred in water for approximately 20 min-
utes, prior to the addition of catalytic TMG and NBS. The concentration of epoxy-diene 160 was
kept relatively low at 0.01 M, in an effort to discourage intermolecular attack of the C-4 alcohol
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Scheme 77: Distribution of products after treatment of epoxy-diene 160 with NBS in water.
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onto a bromonium ion formed on a second molecule of 160. After stirring for 3 days at room
temperature, the reaction was worked-up and the crude mixture was observed to comprise 9 com-
ponents by TLC. These components were successfully separated by column chromatography, and
the compounds subsequently identified to be those shown in Scheme 77.
All of the compounds produced in this reaction were found to be epoxide-containing, by virtue
of the 1H NMR spectra containing two signals at 2.9-3.3 ppm which were found by HSQC spectra
to correlate to signals at approximately 55 ppm in the 13C NMR spectra. It would be anticipated
that for the medium-ring ethers, signals for the α-protons will appear at a higher chemical shift
of approximately 3.4-4.5 ppm, and the 13C NMR spectra will contain signals at approximately 70-
90 ppm due to the ether. Therefore, the desired cyclisation via bromonium ion-assisted epoxide
ring-opening with water was unsuccessful.
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Scheme 78: Mechanism for formation of bromohydrins 224 and 225.
The compounds isolated in the greatest yield from the reaction were bromohydrin regioisomers
224 and 225. These bromohydrins result from bromonium ion formation on the C(12)-C(13) olefin
and subsequent ring-opening by nucleophilic attack of water at either C-12 to give 225, or C-13 to
give 224 (Scheme 78). Two diastereomers of each regioisomer were produced due to formation of
the bromonium ion on opposite faces of the olefin, and stereospecific ring-opening. It was possible
to separate the four compounds by preparative HPLC to allow characterisation, but so far it has
not been possible to fully assign relative stereochemistry within each isolated diastereomer. Inter-
estingly, bromohydrin 224 which results from nucleophilic attack by water at C-13 was isolated by
HPLC in a yield of 87 mg (13%), whereas only 18 mg (3%) of bromohydrin 225, which results from
attack on the bromonium ion at C-12, was isolated.
The identity of the bromohydrin regioisomers was elucidated using a range of NMR experi-
ments. COSY spectra confirmed that it was in fact the C(12)-C(13) olefin that had been attacked,
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Figure 16: Use of the bromine isotope effect in 13C NMR to prove the identity of the
bromide-bearing carbon.
as opposed to the C(9)-C(10) olefin, which remained intact in these compounds. In the case of
regioisomer 224, analysis of the HSQC spectrum of one of the diastereomers, in conjunction with
the COSY spectrum showed that the C-13 carbon had a chemical shift of 75.0 ppm, whereas the
resonance for the C-12 carbon appeared at a shift of 60.6 ppm. A chemical shift of 75.0 ppm is typ-
ical for a secondary alcohol, which demonstrated that the hydroxyl is present at C-13. The signal
at 60.6 ppm is in the same region in which the primary alcohol in the molecule would be expected
to resonate. Analysis of the DEPT-135 spectrum confirmed that the signal at 60.6 ppm in the 13C
NMR spectrum was in fact due to a CH or CH3 carbon, whereas the signal at 60.5 ppm is due
to a CH2 carbon. Finally, the presence of bromide at C-12 was confirmed by the observation of a
bromine isotope effect on the signal corresponding to this carbon (Figure 16). Enhanced resolution
of this area of the spectrum showed two signals of equal intensity split by 2 ppb, due to the two
naturally occurring isotopes of bromine. HRMS confirmed the proposed molecular formula of the
compound. The structures of all four compounds with a bromohydrin present at the C(12)-C(13)
position were elucidated using this process, and bromine isotope effects were observed in all but
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one case, confirming the identity of the bromide-bearing carbon.
There was also a 4% yield of what is believed to be bromohydrin regioisomers 226 and 227.
The 1H and 13C NMR spectra of the crude mixture of compounds looks very similar to that of the
crude mixture of bromohydrins 224 and 225, and the R f value was very similar. However, it has
not proven possible to separate the compounds by preparative HPLC in order to aid identifica-
tion. These bromohydrins will have been produced by bromonium ion formation at the C(9)-C(10)
olefin, followed by nucleophilic ring-opening by water at C-9 or C-10 to give 227 or 226 respec-
tively. There can potentially be two diastereomers of each regioisomer formed, due to formation of
the bromonium ion on different faces of the olefin. It is interesting to note that there was a signifi-
cantly greater yield of bromohydrins formed from the C(12)-C(13) olefin, compared to those from
the C(9)-C(10) olefin.
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Scheme 79: Mechanism to show the reaction of epoxy-diene 160 with molecular bromine.
Also isolated from the reaction mixture in a yield of 1%, was dibromide-containing 228 as a
mixture of two diastereomers. This compound is produced by the reaction of epoxy-diene 160
with molecular bromine, which is formed via radical decomposition of NBS in the presence of
light. Bromonium ion formation would have occurred on either face of the C(12)-C(13) olefin
and then stereospecific nucleophilic ring-opening by the bromide anion at either C-12 or C-13
would have led to the formation of the two diastereomers (Scheme 79). Analysis of the COSY
spectrum confirmed that it was the C(12)-C(13), rather than the C(9)-C(10) olefin that was attacked.
The HSQC NMR spectrum showed that the signals for both the C-9 and C-10 carbons were at a
chemical shift of approximately 60 ppm in the 13C NMR spectrum. As demonstrated previously,
this appears to be a typical chemical shift for carbon atoms bearing secondary bromides in these
compounds. Finally, the ammonium CI+ mass spectrum of the compound showed three signals
for the molecular ion at m/z 372, 374 and 376, in a 1 : 2 : 1 ratio which is as would be expected for a
compound containing two bromine atoms, due to the two naturally occurring isotopes of bromine.
HRMS supported the proposed molecular formula for the diastereomers.
Four diastereomers of tetrahydrofuran 229 were produced in the reaction and they were iso-
lated as two separate mixtures of compounds, each comprising of two diastereomers, in an overall
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yield of 2%. These compounds were presumably produced from bromohydrin 224, by attack of
the C-13 hydroxyl onto an incipient bromonium ion formed on the C(9)-C(10) olefin (Scheme 80).
Cyclisation presumably occurred in a favourable 5-exo manner to furnish the tetrahydrofuran 229.
Four diastereomers of this compound will have arisen due to the fact that there are two diastere-
omers of bromohydrin 224 produced, and each of these is capable of undergoing cyclisation onto
a bromonium ion which can be formed on two faces of the C(9)-C(10) olefin. Consequently, each
bromohydrin diastereomer gives rise to two diastereomers of tetrahydrofuran 229.
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Scheme 80: Mechanism for the formation of tetrahydrofurans.
The identity of the compounds was again elucidated largely using a combination of COSY and
HSQC NMR spectra. 1H and 13C NMR spectra showed that the compounds were not alkene con-
taining, but from the TLC of the reaction mixture it appeared that the compounds were not dibro-
mohydrins, as they were less polar than the monobromohydrins that were isolated. Ammonium
CI+ mass spectrometry also confirmed that a second water molecule had not been incorporated
to form dibromohydrins. However, the compounds did appear to contain two bromine atoms, by
virtue of there being three signals present for the molecular ion, in a 1 : 2 : 1 ratio. In the COSY
NMR spectra, the H-14 protons were found to couple with protons reponsible for a multiplet at
approximately 4 ppm. This was found to correlate to signals at 87-88 ppm in the 13C NMR spectra,
which would be a typical chemical shift for an α-carbon in a cyclic ether. The protons responsible
for this multiplet were found to couple with protons that produced a signal at approximately 3.8
ppm in the 1H NMR spectrum. This correlated to signals at 46 ppm in the 13C NMR spectrum,
which were confirmed to be for CH or CH3 carbons by DEPT-135, as opposed to CH2 units. This
would be consistent with a carbon bearing a secondary bromide as part of the tetrahydrofuran.
The proton attached to this carbon was found to couple to a methylene unit, which subse-
quently coupled to a proton which had a chemical shift of approximately 4 ppm. HSQC NMR
spectra showed that this proton is directly attached to a carbon that appears in the ether region of
the 13C NMR spectrum. Finally, this proton was found to couple to another proton which had a
chemical shift in the same region of the 1H NMR spectrum. This proton was found to be attached
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to a carbon that had a chemical shift of approximately 54 ppm, which would be consistent for the
second bromide-bearing carbon in the molecule. Analysis of the COSY and HSQC NMR spectra
shows coupling through to the epoxide and finally the C-4 primary alcohol, as expected.
Interestingly, tetrahydrofuran 229 comprises the core structure of laureepoxide (230), which is
another natural product isolated from Laurencia species.134 Laureepoxide (230) presumably arises
via bromohydrin formation, followed by ring-opening of an incipient bromonium ion in a mech-
anism similar to that which is proposed in Scheme 80. Analysis of the stereochemistry reveals
that laureepoxide (230) would be produced from (9E,12E)-configured skipped epoxy-diene 231
(Scheme 81). This has been the only product isolated from Laurencia species to date that contains
both an epoxide and a tetrahydrofuran. It is possible that this is due to the geometry of the C(9)-
C(10) olefin. Epoxy-dienes containing a (Z)-alkene at the C(9)-C(10) position are proposed to be the
biogenetic precursors to the halogenated medium-ring ethers, and it is believed that the (Z)-alkene
gives some conformational constraint. In laureepoxide (230), the (E)-alkene at the C(9)-C(10) posi-
tion would prevent attack of the epoxide onto a bromonium ion formed at the C(12)-C(13) olefin.
Therefore, this route to form medium-ring ethers is not available, and bromohydrin formation,
followed by cyclisation to a 5-membered ring ether occurs instead.
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Scheme 81: Laureepoxide (230) and its proposed biogenetic precursor.
There was also an unidentified epoxy-diene compound isolated in a yield of 25 mg, as well as
a 10% yield of a mixture of dibromohydrins. As there was no observation of medium-ring ether
formation in this reaction, this could be due to the presence of an alcohol in the epoxy-diene start-
ing material 160. It was anticipated that by conducting the reaction in water, the hydrophobic
effect would have a large impact in encouraging nucleophilic attack of the epoxide onto a bromo-
nium ion. However, the presence of the alcohol may have rendered the molecule not sufficiently
lipophilic. Consequently, hydrogen-bonding of the alcohol with water may have restricted the abil-
ity of the molecule to cyclise. In order to overcome this, there are two potential solutions: firstly
the alcohol could be converted into something that is less able to interact with the water, and sec-
ondly, the reaction could be conducted in a solvent that is less able to form hydrogen-bonds with
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the alcohol.
3.4.2 Treatment of Epoxy-Diene 160 with Electrophilic Bromine in THF with Water as the Nu-
cleophile
THF was chosen as the solvent for the second attempted cyclisation of epoxy-diene 160, as
it is miscible with water, and the polar nature of the THF should still encourage the molecule
to cyclise. THF has been used previously as the solvent in reactions using NBS. For example,
van Tamelen showed how methyl farnesate can undergo bromonium ion-induced cyclisation in
aqueous ethylene glycol or THF, when NBS is used as the source of electrophilic bromine.135
Epoxy-diene 160 was dissolved in THF under nitrogen and to this was added NBS and cat-
alytic TMG. The concentration of epoxy-diene 160 in the THF was 0.01 M, as it was in the reaction
conducted in water. As studies on the model system had indicated that it was necessary to keep
the nucleophile concentration minimal, one equivalent of water was added to the reaction mixture
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Scheme 82: Product distribution after treatment of epoxy-diene 160 with NBS and water in THF
(a estimated from the 1H NMR spectrum of the crude mixture of products).
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dropwise via syringe pump over a period of 25 hours. After stirring at room temperature under
a nitrogen atmosphere for 3 days, it was judged that there was still starting material present by
TLC. A further stoichiometric quantity of water was added by syringe pump and then the reaction
mixture was stirred for 24 hours. After this time the TLC profile had not appeared to change, so
the reaction mixture was worked-up.
Three components were visible by TLC, the least polar of which was successfully separated
by flash column chromatography. From analysis of the 1H NMR spectrum of the two more polar
components, it became evident that it was comprised a number of compounds. The major product
visible in the spectrum consisted of 3 signals at 2.3, 2.5 and 4.4 ppm, each integrating for 2H. The
COSY NMR spectrum of the mixture showed that the protons responsible for the multiplet at 2.3
ppm coupled directly with the protons responsible for the signals at 2.5 and 4.4 ppm, and there
were no other protons coupled to these. Analysis of the HSQC and DEPT-135 NMR spectra con-
firmed that all three carbon atoms were methylene units. It transpired that these signals were due
to the presence of γ-butyrolactone (234), which is a known compound and is commercially avail-
able. This compound will have arisen via NBS-mediated oxidation of the THF solvent (Scheme 83).
Electrophilic bromination of the THF oxygen followed by elimination would provide oxonium ion
235. Quenching of the oxonium ion by water would furnish a lactol, which can undergo further
oxidation to produce γ-butyrolactone (234).
Separation of the other components of this fraction by preparative HPLC allowed the identi-
fication of a number of compounds. Two diastereomers of dibromide 228 were produced in an
overall yield of 11%, and 28% of the starting material 160 was recovered. Compound 233 which
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Scheme 83: γ-Butyrolactone formation via NBS-mediated oxidation of THF.
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also arises from a reaction of the THF solvent was produced in the reaction. NBS-mediated oxida-
tion of THF to oxonium ion 235 would have been followed by nucleophilic attack of succinimide
(236) (Scheme 84). The 1H NMR spectrum showed a singlet at 2.7 ppm, which integrated for 4H
and is characteristic for the ethylene group in succinimide. As the multiplicity of the signal is a
singlet, this indicates that nucleophilic attack took place through the nitrogen, rather than one of
the oxygen atoms in succinimide. There are seven other signals in the 1H NMR spectrum, each
integrating for 1H. The proton α- to the tetrahydrofuran oxygen and nitrogen appears at a chemi-
cal shift of 5.9 ppm, and as it is diastereotopic, the signal appears as a double doublet. The COSY
NMR spectrum shows that this proton couples to a methylene group, which itself couples to a
second methylene group, both at a chemical shift of 2.0-2.4 ppm. Finally this is observed to cou-
ple with the protons of a third methylene group, with signals at approximately 3.9 and 4.2 ppm.
Analysis of the HSQC shows that these protons are both attached to a carbon that has a chemical
shift of 70 ppm in the 13C NMR spectrum, which would be characteristic for a carbon situated α-
to an ether oxygen. The 13C NMR spectrum also displays a single signal at 176 ppm which is due
to the imide. All of these observations support the proposed structure, and HRMS confirms the
molecular formula. There was also an unidentified epoxy-diene containing compound formed in
the reaction.
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Scheme 84: Succinimide (236) acting as a nucleophile in the quenching of oxonium ion 235.
The least polar fraction, which was isolated by column chromatography, was found to consist
of a mixture of one major and two minor products by analysis of the 1H NMR spectrum. Attempts
to separate these compounds by preparative HPLC led to decomposition, with just a small quantity
of the major product being sufficiently pure to allow identification. After careful analysis of the
spectra from a range of NMR experiments, it became clear that the C(4)-C(15) epoxy-diene unit
was still intact as it was in the starting material. However, the C-4 signal had shifted downfield
by approximately 7 ppm in the 13C NMR spectrum, which indicated that there was no longer a
hydroxyl group attached to this carbon. The 13C NMR spectrum also suggested that the mixture
was comprised two diastereomers, therefore a new stereocentre must have been generated in the
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Scheme 85: Mechanism for the reaction of epoxy-diene 160 with oxidised THF.
reaction. After the identification of other products formed from the oxidation of THF, it appeared
likely that the alcohol in epoxy-diene 160 could quench oxonium ion 235 and form acetal 232
(Scheme 85).
This structure is supported by both NMR and HRMS. The 1H NMR spectrum contains a mul-
tiplet at 5.1 ppm, which correlates by the HSQC spectrum to a signal at 104 ppm in the 13C NMR
spectrum. These chemical shifts are as would be expected for the carbon atom bearing the two ac-
etal oxygen atoms. The proton responsible for this signal is found to couple to two diastereotopic
protons, which then subsequently couple with a further 2 protons, all in the region of 1.6-2.0 ppm.
This methylene finally couples to another 2 protons, which are found to have a chemical shift
which would be typical for protons that are α- to an ether oxygen.
There was no observation of bromonium ion-assisted epoxide ring-opening in this reaction,
and also no bromohydrin formation. Oxidation of the THF solvent by NBS was a major issue
in this reaction, producing a range of tetrahydrofuran-containing compounds, at the expense of
bromination of the intended compound, epoxy-diene 160. Therefore THF, as well as any other sol-
vent that could potentially be oxidised by NBS, does not appear to be suitable for use in reactions
where electrophilic bromine is utilised.
3.4.3 Treatment of Epoxy-Diene 160 with Electrophilic Bromine and Acetic Acid as the Nucle-
ophile
During investigations with the model substrate it was found that bromonium ion-assisted nu-
cleophilic ring-opening of the epoxide also occurred when acetic acid was used as the nucleophile
and the reaction was conducted in dichloromethane. If this reaction could be implemented suc-
cessfully using epoxy-diene 160 then this would give direct access to the acetylated precursor of
laurencin (1a).
Epoxy-diene 160 was stirred in dichloromethane at 0.01 M, which is the same concentration as
used previously. NBS and catalytic TMG was added, and subsequently one equivalent of acetic
acid was added dropwise via syringe pump over a period of 25 hours. Model studies had demon-
111
OH
O
AcOH, NBS
5 mol% TMG
CH2Cl2, r.t., 165 h
160
OH
O
OH
O
OAc
Br
Br
OAc
237
(2 diastereomers)
238
(2 diastereomers)
18%
4
612
OH
O
160
19%a
OH
O
228
7%
(2 diastereomers)
Br
Br
4
612
4
612
4
612
4
612
9
15
9
15
9
15
9
15
9
15
Br
OH
O
OH
OBr
241
2%a
(2 diastereomers)
242
2%a
(2 diastereomers)
OH
O
OH
O
239
(2 diastereomers)
240
(2 diastereomers)
4%a
4
612
4
612
915
915
Br OAc
AcO Br
4
6
12
9
15
4
6
12
9
15
Scheme 86: Product distribution after treatment of epoxy-diene 160 with NBS and acetic acid in
dichloromethane (a estimated from the 1H NMR spectrum of the crude mixture of products).
strated that it is especially important to ensure the concentration of nucleophile is as low as possible
when acetic acid is used as the nucleophile. After stirring for four days at room temperature there
was still some starting material present by TLC. A further equivalent of acetic acid was added
slowly by syringe pump and then after a further day of stirring at room temperature the reaction
mixture was worked-up.
Flash column chromatography allowed the isolation of 7% of dibromide 228 and also the recov-
ery of 19% of the starting material (Scheme 86). Unfortunately there was no evidence of medium-
ring ether formation having taken place in this reaction. The major compounds produced in the
reaction were bromoacetate regioisomers 237 and 238. These compounds will have been produced
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via the same mechanism as that which was invoked for the formation of bromohydrins 224 and
225. Bromonium ion formation and subsequent nucleophilic attack by acetic acid at either the C-12
or C-13 position would give 238 and 237 respectively. As a bromonium ion could form on opposite
sides of the C(12)-C(13) olefin, two diastereomers of each regioisomer were produced.
Attempted separation of the bromoacetates by HPLC proved to be unsuccessful under a range
of conditions, therefore the exact bromoacetate isomers present had to be deduced from spectra
of the mixture of compounds. The HSQC NMR spectrum showed that the compounds were still
epoxide-containing, due to signals at 2.9-3.2 ppm in the 1H NMR spectrum correlating to signals
at 55-56 ppm in the 13C NMR spectrum. As discussed earlier, this is diagnostic for the presence of
epoxide in these compounds. The 13C NMR spectrum also contains four signals at 170 ppm which
confirms that the acetate group has been incorporated. Analysis of the COSY spectrum showed
that the protons at C-14 coupled to protons which have signals at either 4.0-4.2 ppm or 4.9-5.1 ppm.
There was no coupling observed between the H-14 protons and alkenic protons, which confirms
that it is the C(12)-C(13) olefin that has been attacked, as opposed to the C(9)-C(10) one. From
analysis of the COSY and HSQC NMR spectra, it becomes apparent that the C-13 carbon atoms for
two of the compounds have a chemical shift of approximately 55 ppm, which is consistent with
a carbon bearing a secondary bromide, whereas for the other two compounds, the C-13 carbon
atom has a chemical shift of approximately 77 ppm which is as would be expected for a carbon
atom bearing an acetate group. Therefore, the two compounds that contain a bromide at C-13
are the two diastereomers of bromoacetate 238, whereas the two compounds with an acetate at
C-13 are two diastereomers of 237. Mass spectrometry confirms that the compounds are bromine-
containing, due to the presence of two signals for the molecular ion at m/z 335 and 337 in a 1 : 1
ratio, due to the two naturally occurring isotopes of bromine.
There was also the observation of what has been assigned as bromoacetates formed from ring-
opening of a C(9)-C(10) bromonium ion, albeit in a much lower yield of 4%. Stereospecific ring-
opening of the bromonium ion by acetate at the C-9 position would have provided two diastere-
omers of bromoacetate 239, whereas attack by acetate at C-10 would have furnished two diastere-
omers of bromoacetate 240. The mixture was initially isolated after column chromatography as a
complex mixture of many products at the same R f as epoxy-diene 160. It was possible to isolate a
small quantity of what is believed to be the C(9)-C(10) bromoacetates as a mixture after preparative
HPLC. The 1H NMR spectrum shares a number of features in common with that of bromoacetates
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237 and 238. Firstly, there are two triplets signals observed at approximately 1 ppm which are due
to the terminal methyl groups. In the spectrum of 237 and 238 there were two triplets observed at
approximately this chemical shift, one for each regioisomer. There are signals at approximately 5
ppm, which was found to be due to protons attached to the same carbon atom as acetate in these
other, related compounds. There are also two multiplets at 4.2 and 4.4 ppm which would be char-
acteristic for protons attached to bromide-bearing carbons. The spectrum also demonstrates there
is still the presence of alkenic and epoxide protons. Analysis of the COSY spectrum of the mix-
ture of compounds confirms that it is the C(9)-C(10) olefin that has been subject to bromonium ion
formation, as the H-7 epoxide proton was found to couple with a methylene group, which subse-
quently coupled with a proton that was responsible for a signal at 4.4 ppm. The COSY spectrum
also demonstrates that the C(12)-C(13) olefin is intact, as the H-14 protons can be observed to cou-
ple with protons that have a chemical shift of approximately 5.7 ppm, which is characteristic for
alkenic protons.
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Scheme 87: Proposed mechanism for the formation of 241 and 242.
Two other compounds were also isolated by preparative HPLC from the mixture of products
at the same R f as epoxy-diene 160, and these have been tentatively assigned as epoxy-dienes 241
and 242. Formation of these compounds will have occurred via bromonium ion formation at either
C(12)-C(13) or C(9)-C(10), followed by proton abstraction at the C-11 position to form 241 or 242
respectively. The formation of a conjugated diene is the thermodynamic driving force for this
process. Two diastereomers of each compound could have been formed due to bromonium ion
formation on different faces of the alkenes. Both 1H NMR spectra contain signals in the alkenic
and epoxide regions. In the COSY NMR spectrum of what has been assigned as 241, the H-7
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epoxide proton is observed to couple with methylene protons, which subsequently couple with a
proton that has a chemical shift of 5.5 ppm. The subsequent 3 carbon atoms in the chain are all
attached to protons that have signals which appear in the alkene region of the 1H NMR spectrum,
which is as would be expected for a conjugated diene. Finally, the H-12 proton is observed to then
couple with a proton which appears as a multiplet at a chemical shift of approximately 4.2 ppm in
the 1H NMR spectrum, characteristic of a proton attached to a bromide-bearing carbon.
In the COSY spectrum of what has been assigned as 242, the H-7 epoxide proton is observed to
couple with methylene protons, which subsequently couple to a proton which has a chemical shift
of approximately 4.5 ppm in the 1H NMR spectrum. Again, this would be characteristic of a proton
attached to a bromide-bearing carbon. This proton then couples with a proton which appears as
a double doublet at approximately 5.6 ppm. As for 241, the COSY NMR spectrum demonstrates
that the following 3 carbon atoms in the chain are all attached to protons that have signals in the
alkene region of the 1H NMR spectrum. As well as these two epoxy-diene containing compounds,
there were also two other unidentified epoxy-diene containing compounds isolated by preparative
HPLC from the reaction mixture.
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3.5 Bromonium Ion-Assisted Epoxide Ring-Opening of Boc-Protected Epoxy-Diene
243
3.5.1 Use of an Intramolecular Terminating Nucleophile
It was considered that the lack of medium-ring ether formation in the attempted cyclisations
of epoxy-diene 160 may be due to hydrogen-bonding between the C-4 hydroxyl and the epoxide
oxygen (Figure 17). This would reduce the inherent nucleophilicity of the epoxide, thus hindering
the desired bromonium ion-assisted epoxide ring-opening reaction. In order to overcome this, it
was necessary to protect the C-4 hydroxyl in some manner, and this raised the prospect of incorpo-
rating a group that could function as an internal nucleophile. Capturing the intermediate oxonium
ion in an intramolecular sense was particularly attractive, considering that the attempts using an
external nucleophile had proven unsuccessful.
O O
H
H-Bond
160
Figure 17: Proposed hydrogen-bonding between the C-4 hydroxyl and epoxide oxygen, reducing
the nucleophilicity of the epoxide.
In 2009, Jamison reported the first example of a bromonium ion-assisted ring-opening of epox-
ides in a biomimetic synthesis of a natural product.107 Treatment of Boc-protected 146 with NBS in
HFIP initiated an impressive poly-epoxide cascade which proceeded with excellent regioselectivity
to give two epimers of the desired product 147 and 148 in good yield (Scheme 88).
As Jamison had demonstrated that a Boc-protected alcohol can serve as an excellent terminat-
ing intramolecular nucleophile for bromonium ion-induced polyepoxide cascades, it was consid-
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HBr
NBS, HFIP
4Å M.S.
0°C, 15 min
146
147 and 148
72%
(1 : 1 mixture of 2 epimers)
Scheme 88: The first example of a bromonium ion-assisted ring-opening of epoxides in the
biomimetic synthesis of a natural product.
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Scheme 89: Bromonium ion-assisted ring-opening of Boc-protected epoxy-diene 243, with
termination by an internal nucleophile.
ered that this could be applied to the synthesis of the medium-ring ethers from Laurencia species.
Boc-protection of the alcohol in epoxy-diene 160 would furnish 243, and this could then be sub-
jected to electrophilic bromination to potentially provide an array of products (Scheme 89).
Bromonium ion formation could occur on either face of the C(12)-C(13) alkene and then nu-
cleophilic attack could occur by the epoxide oxygen at either C-12 or C-13, in the same way as
proposed for the C15 epoxy-enyne 127. This would form oxonium ion intermediates 245 and 246.
Intramolecular nucleophilic attack by the well-placed tert-butyl carbonate moiety could then occur
at either C-6 or C-7 of oxonium ion 245 or 246, forming either a 6- or 7-membered carbonate de-
pending on the position of attack. Overall this could give the formation of four different medium-
ring ether motifs: 7-membered 250; 8-membered 248 with an endocyclic bromide; 8-membered 249
with an exocyclic bromide; and 9-membered 247. Two diastereomers of each of these compounds
could be formed due to the possibility of bromonium ion formation occurring on either face of the
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C(12)-C(13) alkene. Subsequent hydrolysis of the cyclic carbonates would provide the correspond-
ing diols, revealing the core structural motifs and stereochemistries of a whole plethora of natural
products.
In the case of Jamison’s work, the regioselectivity observed for attack by the epoxides and
also the tert-butyl carbonate moiety is controlled by the substituents present at the bromonium
ion or the intermediate oxonium ion undergoing attack. In particular, the alkene and each of
the epoxides present in 146 are trisubstituted. The stabilising influence of the additional alkyl
substituent means that in each bromonium ion or oxonium ion intermediate, the carbon that bears
the extra substituent will have more carbocation character and therefore will undergo nucleophilic
attack. This controls the ring size of the cyclic ethers formed and also dictates that the cyclic
carbonate formed must be 5-membered.
On the contrary, in the brominative cyclisation of 243 there is no inherent bias towards either
end of the bromonium ion or intermediate oxonium ions on the basis of the substituents, as both
the epoxide and the C(12)-C(13) alkene are 1,2-disubstituted as opposed to trisubstituted. This is
important in terms of the medium-ring ether formation, as it allows for non-regioselective cyclisa-
tion of the epoxide onto the bromonium ion, which is required for the formation of the different
core motifs. However, in the case of the cyclisation of the tert-butyl carbonate onto the intermediate
oxonium ion, this does raise an issue. The product of this second cyclisation will be an additional
ring system (a 6- or 7-membered carbonate), whereas in the real C15 epoxy-enyne system it is wa-
ter that attacks at either C-6 or C-7 of the oxonium ion, so there is no second ring formation. This
raises the possibility that the relative favourability of 6-exo versus 7-endo cyclisation may influence
the product distribution, or even perhaps limit the types of compound that could be formed in
the reaction. Therefore we decided to investigate the favourability of 6-exo and 7-endo cyclisations
before attempting the brominative cyclisation of 243.
3.5.2 6-Exo versus 7-Endo Cyclisation
In 1989 Nicolaou reported his investigations into the acid promoted intramolecular cyclisation
of alcohols onto 1,2-disubstituted epoxides to form either 6- or 7-membered ring ethers.136 It was
found that the regioselectivity observed was dependent on the nature of the substituents adjacent
to the epoxide, the stereochemistry of the epoxide, and also whether additional rings were present.
Scheme 90 shows the cyclisation of trans-hydroxy-epoxide 251 to form oxepane 252 or tetrahy-
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Scheme 90: Nicolaou’s studies of 6-exo versus 7-endo cyclisation of hydroxy-epoxides.136
dropyran 253. When the saturated compound 251 (R = CH2CH2CO2Me) was treated with catalytic
CSA it was found to undergo exclusive 6-exo cyclisation to produce the corresponding tetrahy-
dropyran, which was isolated as lactone 254. The 6-exo cyclisation observed was anticipated due
to kinetic considerations favouring this mode of attack of the hydroxyl onto the epoxide. However,
when an electron rich alkene was adjacent to the epoxide 251 (R = CH−CHCl), the regioselectivity
of the cyclisation was almost entirely reversed, with 92% selectivity for 7-endo cyclisation, result-
ing in predominant formation of oxepane 252. This change in regioselectivity is presumably due to
the ability of the pi-orbital of the alkene to stabilise the developing positive charge at the adjacent
epoxide carbon in the transition state. The corresponding alkene-containing (Z)-hydroxy-epoxide
was found to give lower selectivity towards 7-endo cyclisation, with only 68% of the corresponding
oxepane being formed.
Nicolaou concluded that kinetically favoured 6-exo cyclisation occurs to form tetrahydropyrans
unless the epoxide bears a group that is capable of stabilising an incipient partial positive charge at
the position furthest from the nucleophilic hydroxyl, such as an electron-rich alkene. This results
in a change of regioselectivity to predominant 7-endo cyclisation, forming oxepanes preferentially.
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Scheme 91: McDonald’s endo-regioselective oxacyclisation to form bisoxepanes.137
McDonald arrived at similar conclusions in his work on biomimetic polyether synthesis via
polyepoxide cascades, terminated by an intramolecular carbonate nucleophile.106, 137–140 McDon-
ald has found that tri-substituted epoxides can be used to encourage “endo”-regioselective cycli-
sations in order to form kinetically disfavoured oxepane and bisoxepane systems. For example,
it was found that when triepoxide 255 was treated with BF3 ·Et2O, a triply endo-regioselective ox-
119
O ONu LANu
OLA
O
Nu
OH
O
Nu
O
258
260
OLA
Nu
O
OH
259
261
257
exo endo
Scheme 92: McDonald’s proposed explanation for the observed endo-regioselectivity.138
acyclisation took place to form bisoxepane 256 in 26% yield (Scheme 91).137 In this poly-epoxide
cascade, 7-endo attack of the epoxides was found to be preferential over 6-exo attack, and 6-endo
attack of the carbonate was favoured over the kinetically expected 5-exo cyclisation.
McDonald’s proposed explanation for this observed endo-regioselectivity is that formation of
the oxonium ion species 258 or 259, which results from attack of an epoxide onto a second activated
epoxide (257), may be easily reversible (Scheme 92).138 Consequently, the oxacyclisation reaction
would be dominated by thermodynamic as opposed to kinetic factors, with attack of the epoxide
occurring at the carbon atom of the activated epoxide which can best stabilise the developing
partial positive charge: in this case the one bearing two alkyl substituents. It is also postulated that
the smaller ring size in the oxonium ion resulting from exo-cyclisation (258) will have more strain
than the oxonium ion arising from endo-cyclisation (259), possibly providing a further driving force
for regioselective endo-oxacyclisation.
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Scheme 93: Unexpected endo,endo-cyclisation of 1,2-disubstituted epoxides in a polyepoxide
cascade.140
McDonald also investigated the cyclisation of both carbonates and epoxides onto either acti-
vated 1,2-disubstituted epoxides or their corresponding oxonium ion intermediates.140 Although
it was anticipated that cyclisation of an epoxide onto a 1,2-disubstituted epoxide would result in
6-exo cyclisation due to kinetic and stereoelectronic reasons, tetraepoxide 262 unexpectedly under-
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went all endo-oxacyclisation upon treatment with BF3 ·Et2O (Scheme 93). It was proposed that this
regioselectivity was due to minimisation of ring strain in the bicyclic oxonium ion intermediate
(Scheme 92), where 6-exo cyclisation results in a [3.1.0] oxonium ion, whereas 7-endo cyclisation
would produce a less strained [4.1.0] oxonium ion.
However, cyclisation of the terminal carbonate onto a 1,2-disubstituted epoxide or its corre-
sponding oxonium ion does not have to involve formation of a bicyclic intermediate. Therefore
ring strain is not a concern in this cyclisation and the kinetically anticipated exo-product 265 should
predominate. Indeed, this was found to be the case, with the regioselectivity of carbonyl nucle-
ophilic attack only changing to endo (267) when there was a substituent present to stabilise a de-
veloping partial positive charge in the oxonium ion intermediate 266 (Scheme 94).140
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Scheme 94: Kinetically anticipated exo-cyclisation of carbonyl nucleophiles onto 1,2-disubstituted
epoxides.140
Considering these previous investigations reported by Nicolaou and McDonald, it should be
anticipated that 6-exo cyclisation would be favoured over 7-endo cyclisation of the terminating
carbonyl nucleophile in the brominative cyclisation of Boc-protected epoxy-diene 243. As the car-
bonate cyclisation does not result in the reversible formation of a bicyclic intermediate, ring strain
should not have a predominant effect. Also, there are no groups present that are capable of stabil-
ising a developing partial positive charge in the oxonium ion intermediate, which would create a
bias for the larger 7-membered ring. Consideration of these factors leads to the conclusion that the
kinetically favoured outcome of 6-exo cyclisation should predominate.
To allow this hypothesis to be investigated, a model epoxy-carbonate system had to be pro-
duced, which could then undergo Lewis acid promoted oxacyclisation. Epoxidation of (Z)-3-
hexen-1-ol (182) using mCPBA in dichloromethane provided (3R*,4S*)-epoxyhexan-1-ol (183) in
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Scheme 95: Preparation of carbonate 268 from (Z)-3-hexen-1-ol (182).
87% yield (Scheme 95). Protection of the primary alcohol as the tert-butyl carbonate using di-tert-
butyl dicarbonate and 1-methylimidazole gave the epoxy-carbonate precursor to cyclisation 268 in
38% yield. Treatment of this compound with BF3 ·Et2O in dichloromethane at −40 ◦C resulted in
complete conversion of the starting material after 40 min, to provide two separable products in a 7
: 1 ratio (Scheme 96).
Analysis of the NMR spectra revealed that both compounds were not epoxide-containing due
to the disappearence of characteristic signals at 3 ppm in the 1H NMR spectra, which are invariably
found to couple with signals at approximately 55 ppm in the 13C NMR spectrum by HSQC. The
major compound was initially assigned as either six-membered carbonate 269, which would result
from 6-exo cyclisation (Scheme 96, Path A), or as seven-membered carbonate 271, which would
arise from 7-endo cyclisation (Path B). The minor compound was assigned as the tert-butyl ether
270 or 272 of the major product due to the presence of a singlet at approximately 1 ppm in the 1H
NMR spectrum which integrated for 9H and is characteristic of the tert-butyl moiety. This signal
was absent in the NMR spectrum of the major compound.
Although it was apparent that cyclisation had occurred, it was not possible to assign the struc-
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Scheme 96: BF3 promoted cyclisation of carbonate 268 to form either 269 and 270 via Path A, or
271 and 272 via Path B.
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ture as either 269 or 271 from the NMR evidence alone. From analysis of the COSY and HSQC
NMR experiments it was found that the H-3 proton had a chemical shift of 4.55 ppm in the 1H
NMR spectrum and the carbon had a chemical shift of 79 ppm in the 13C NMR spectrum, whereas
the H-4 proton had a chemical shift of 4.35 ppm and the carbon a shift of 83 ppm. Although all
of this data is consistent with both carbon atoms bearing a secondary oxygen substituent, it is not
possible to deduce which carbon is bearing a hydroxyl and which is part of the carbonate moiety.
Mass spectrometry confirmed the mass of the cyclised product, though evidently this was also not
able to discriminate between the two carbonate ring sizes, 269 and 271.
As it was not possible to deduce whether 6-exo or 7-endo cyclisation had occurred from the
NMR spectra alone, chemical methods were pursued in an effort to elucidate the structure. It
was confidently predicted that acetylation of the secondary alcohol would result in deshielding of
the proton on the carbon bearing the acetate group from approximately 4.5 ppm to 5.0-5.5 ppm
(Scheme 97). Therefore if the product of cyclisation was carbonate 269, then NMR experiments of
the acetylated derivative would reveal that the acetate is present at the C-4 position (273), whereas
if the product was carbonate 271 then acetylation would reveal the C-3 position as bearing the
acetate moiety (274).
Treatment of the carbonate with acetyl chloride and pyridine in toluene provided a single prod-
uct in 83% yield (Scheme 97). Mass spectrometry confirmed the mass of the acetylated carbonate,
and the 13C NMR spectrum contained two signals in the carbonyl region of the spectrum as would
be expected for the desired product. However, the anticipated downfield shift of either the H-3 or
H-4 proton was not observed. There was minimal change in the chemical shifts of these protons,
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Scheme 97: Acetylation as an attempt to elucidate the structure of the cyclic carbonate – the
carbonate was treated with acetyl chloride and pyridine in toluene at 0 ◦C to produce a single
acetylated product in 83% yield after 2 h.
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with the only major difference between the spectra of the starting material and product being an
unexpected deshielding of the H-1 protons from 3.9 ppm to 4.3 ppm in the acetylated derivative.
As acetylation had not allowed the unambiguous assignment of the compound as a 6- or 7-
membered carbonate, it was considered that Appel bromination of the alcohol may provide evi-
dence for structure elucidation (Scheme 98). In the 13C NMR spectrum a carbon atom bearing a
secondary oxygen substituent typically has a chemical shift of 75-85 ppm whereas a carbon atom
bearing a secondary bromide is generally relatively shielded, with a chemical shift of 55-65 ppm.
Therefore if the product of oxacyclisation was carbonate 269, then Appel bromination should result
in shielding of the C-4 carbon (275), whereas bromination of carbonate 271 should result in shield-
ing of the C-3 carbon (276), with NMR experiments revealing the anticipated shift of the signal in
the 13C NMR spectrum.
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Scheme 98: Appel bromination as an attempt to elucidate the structure of the cyclic carbonate –
the carbonate was treated with carbon tetrabromide and triphenylphosphine in dichloromethane
to produce a single brominated product in 92% yield after 45 min.
Treatment of the carbonate with carbon tetrabromide and triphenylphosphine furnished a sin-
gle product in 92% yield after 45 min (Scheme 98). Mass spectrometry confirmed the mass of the
desired brominated product, with two peaks of equal intensity for the molecular ion separated by
two mass units, which is characteristic for the incorporation of bromine due to the two naturally
occurring isotopes. Analysis of the NMR spectra revealed that the H-3 and H-4 protons have very
similar chemical shifts in the 1H NMR spectrum to those of the starting material. However, the
H-1 protons were relatively shielded, with the signal shifting upfield from 3.9 ppm in the starting
material, to 3.6 ppm in the brominated product. The 13C NMR spectrum reveals a similar effect,
with neither the C-3 nor C-4 carbon signal exhibiting the anticipated upfield shift, whereas the C-1
carbon was relatively shielded in the product, with the signal shifting from 58 ppm in the starting
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Figure 18: Proposed structures for the acetate and bromide derivatives of the cyclic carbonate.
material, to 37 ppm in the bromine-containing product.
Evidence from the formation of these derivatives indicates that the primary acetate 277 and
bromide 278 was formed as opposed to the anticipated secondary derivatives. These structures
are consistent with the NMR evidence for both compounds. Although it is possible to propose
mechanisms whereby the 5-membered carbonates 277 and 278 are formed via rearrangement reac-
tions occurring during acetylation and Appel bromination (Scheme 99), it seems more feasible that
this unexpected rearrangement occurred under the strongly Lewis acidic conditions present in the
initial cyclisation reaction of epoxy-carbonate 268.
Scheme 100 demonstrates that upon treatment with boron trifluoride diethyl etherate, epoxy-
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Scheme 99: Possible mechanisms for carbonate rearrangement during (a) acetylation, and (b)
Appel bromination, using carbonate 269 as a representative example.
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Table 11: Comparison of the carbonyl infrared stretching frequencies in carbonates 277, 278 and
279, and those of known 5-, 6-, and 7-membered cyclic carbonates 280, 281 and 282.
Compound C=O IR stretch / cm−1 Compound C=O IR stretch / cm−1
OO
OH
O
279
1773 OO
O
280
1773141
OO
OAc
O
277
1791 O O
O
281
1726142
OO
Br
O
278
1789 OO
O
282
1718143
carbonate 268 must have initially undergone either 6-exo or 7-endo cyclisation to form 269 or 271
respectively. Subsequent Lewis acid activation of the carbonyl moiety results in a favourable 5-
exo-trig cyclisation of the secondary alcohol, which is allowed under Baldwin’s rules. In the case
of both 269 and 271, this would result in liberation of a primary alcohol and formation of a ther-
modynamically preferred 5-membered cyclic carbonate 279, where the relative stereochemistry of
the two secondary oxygen substituents is anti.
A comparison of the C−O infrared absorption frequencies of alcohol 279, acetate 277 and bro-
mide 278 also supports the proposal that the rearrangement occurred in the initial cyclisation of
epoxy-carbonate 268 (Table 11). The carbonyl IR stretching frequency of known 5-membered cyclic
carbonate 280141 is in good agreement with that of carbonates 277, 278 and 279. However, the
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Scheme 100: Proposed mechanism for the formation of five-membered carbonate 279.
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C−O IR stretching frequencies for known 6- and 7-membered carbonates 281142 and 282143 are
significantly lower at 1726 and 1718 cm−1 respectively. This large difference in the IR absorption
frequencies from 5- to 6- and 7-membered carbonates, along with the close agreement in the val-
ues for compounds 277, 278 and 279, supports the analysis that all of these compounds contain
5-membered cyclic carbonates. Consequently the ring-contraction must have occurred during the
initial cyclisation reaction as opposed to the subsequent acetylation and bromination reactions.
DFT calculations also find that both 6- and 7-membered cyclic carbonates 269 and 271 could ac-
cess low energy conformations in which the secondary alcohol substituent is perfectly positioned
to achieve a Bu¨rgi-Dunitz trajectory onto the carbonyl moiety (Figure 19). This demonstrates that
the carbonate rearrangement reaction must presumably be a favourable process when the carbon-
ate is activated by a Lewis acid, as both molecules 269 and 271 can easily achieve a low energy
conformation in which the secondary alcohol is perfectly positioned to undergo nucleophilic at-
tack, and the reaction is 5-exo-trig, which satisfies Baldwin’s rules.
Although it has not been possible to determine whether 6-exo or 7-endo cyclisation predomi-
nates in the reaction, the unexpected carbonate rearrangement reaction which occurred may prove
useful in an asymmetric synthesis of the laurediols (2a and 2b),1 the previously assumed precur-


Figure 19: DFT (B3LYP / 6-31G) calculations for the energy minimisation of carbonates 269 and
271: (a) six-membered carbonate 269; (b) seven-membered carbonate 271.
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Scheme 101: Potential use of the carbonate rearrangement reaction in the synthesis of the
laurediols (2a and 2b).
sors to the halogenated medium-ring ethers from Laurencia species.2 After (6S,7R)-epoxy-diene
carbonate 243 is prepared by asymmetric epoxidation and subsequent Boc-protection, treatment
with a Lewis acid should initiate the carbonate cyclisation onto the epoxide, and subsequent car-
bonate rearrangement (Scheme 101). Assuming that the initial cyclisation occurs via a 6-exo cyclisa-
tion (as Nicolaou and McDonald’s work would predict under the kinetic conditions), the reaction
should regio- and stereospecifically produce 5-membered cyclic carbonate 283, with a (6R,7R)-
configuration. Further elaboration should allow for the formation of (R,R)-laurediol (2a). Alter-
natively, carbonate cyclisation and rearrangement of (6R,7S)-243 should form 5-membered cyclic
carbonate 283 with a (6S,7S)-configuration, assuming initial 6-exo cyclisation. This could be further
elaborated to produce (S,S)-laurediol (2b).
3.5.3 Boc-Protection of the Alcohol in Epoxy-Diene 160
Although the previous study had not proven conclusive in determining whether 6-exo or 7-
endo cyclisation should be favoured in the brominative cyclisation of 243, we decided to pursue
this reaction regardless. We considered that if the reaction was not conducted under conditions
that would promote kinetic control (i.e. at low temperature) then we should be able to access the
energies required for competitive 7-endo cyclisation.
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Firstly we needed to derivatise epoxy-diene 160 as the corresponding tert-butyl carbonate. The
initial conditions attempted for Boc-protection utilised 1.35 equivalents of Boc anhydride along
with catalytic DMAP and stoichiometric triethylamine in toluene (Scheme 102). After 16 hours of
stirring at room temperature it was found that all of the starting material had been consumed, as
judged by TLC. The desired Boc-protected epoxy-diene 243 was isolated in 51% yield after column
chromatography. However, 109 mg of a second product was also isolated which was assigned as
being diepoxy-carbonate 284. This presumably arises via Boc-protection of one alcohol followed
by attack of another alcohol on the resulting carbonate, to liberate tert-butanol.
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Scheme 102: First attempt at Boc-protection of the alcohol in epoxy-diene 160.
It was considered that decreasing the concentration of alcohol, whilst increasing the number of
equivalents of Boc anhydride, should result in more of the alcohol reacting with the Boc anhydride
before having a chance to react with a Boc-protected alcohol. Therefore a 0.08 M solution of epoxy-
diene 160 in toluene was used, as opposed to the 0.32 M solution used previously, and the number
of equivalents of Boc anhydride used was increased from 1.4 to 5.4 (Scheme 103). The proportions
of triethylamine and DMAP were the same as used previously. It was found that the amount
of diepoxy-carbonate 284 produced was much reduced, but there was an issue with purification
of the desired Boc-protected 243. It was not possible to separate the excess Boc anhydride from
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Scheme 103: Second attempt at Boc-protection of the alcohol in epoxy-diene 160.
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Boc-protected 243 by column chromatography, and any attempt to remove the Boc anhydride by
chemical means would also be likely to damage the product.
Removal of the majority of the Boc anhydride was achieved by addition of n-pentane to the
product mixture, followed by cooling to −78 ◦C, and subsequent decanting of the solution from
the solid Boc anhydride. This process was repeated a number of times, but it was not possible
to remove the final traces of Boc anhydride. Final purification was achieved via distillation of the
Boc anhydride from the Boc-protected product 243 by heating under vacuum using a Kugelrohr.
Although the proportion of diepoxy-carbonate 284 produced in the reaction was much reduced,
the final yield of Boc-protected epoxy-diene 243 was 7% lower than the original Boc-protection
due to the difficulties encountered during purification. Therefore we decided to use the initial
conditions to scale-up the reaction and found that multi-gram quantities could be prepared.
3.5.4 Attempted Brominative Cyclisation of 243 Using Jamison’s Conditions
With Boc-protected epoxy-diene 243 in hand it was subjected to Jamison’s reported conditions
for bromonium ion-assisted epoxide ring-opening (Scheme 104).107 Some molecular sieves were
dried thoroughly, and HFIP was stirred with these for approximately 30 min in an effort to remove
all traces of water from the solvent. A solution of Boc-protected epoxy-diene 243 in a small quantity
of HFIP was then added, and the flask was cooled to 0 ◦C. NBS was added in the dark, and the
reaction mixture was allowed to stir for 1 h at room temperature before being worked-up.
O
O O
O
Bromohydrins
NBS, HFIP
4Å M.S.
0°C, 1 h
243
Scheme 104: Attempted bromonium ion-assisted epoxide ring-opening of 243 using NBS as the
source of electrophilic bromine.
There were found to be four components present in the crude mixture by TLC, which were
subsequently separated by column chromatography. A small quantity of starting material was
recovered, and the other components which were isolated were submitted for a range of NMR
experiments. It was found that each of the samples was comprised a large number of compounds.
There were new signals at 4-5 ppm in the 1H NMR spectra, which would be a typical chemical shift
for protons α- to a heteroatom. This suggested the incorporation of bromine, and GCMS demon-
strated that bromine-containing compounds had been formed. However, the compounds formed
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were found to still be epoxide-containing, by virtue of HSQC NMR spectra showing a correlation
between signals at approximately 3.1 ppm in the 1H NMR spectrum and signals at approximately
55 ppm in the 13C NMR spectrum. Therefore the attempted cyclisation was unsuccessful, and it is
likely that bromohydrins were formed during the reaction instead, via bromonium ion formation
on one of the alkenes in Boc-protected epoxy-diene 243, and subsequent nucleophilic ring-opening
by adventitious water.
3.5.5 Successful Bromonium Ion-Assisted Epoxide Ring-Opening of 243 – the Use of Snyder’s
BDSB Reagent
Recently, Snyder reported the preparation of a new reagent for electrophilic bromination, which
has proven very successful in bromonium ion-induced polyene cyclisations.144 For example, when
Boc-protected monoterpene 285 was subjected to NBS and triphenylphosphine there was less than
5% of the desired cyclised product 286 formed, even after 6 h (Scheme 105). The use of TBCO gave
a similar result, with bromine and AgBF4 only giving a slightly improved yield of 18%. However,
when BDSB was used the product was formed in 65% yield after just 30 min.
After NBS in HFIP had failed to promote the bromonium ion-assisted epoxide ring-opening of
Boc-protected epoxy-diene 243, it was considered that BDSB may prove more successful. BDSB
was prepared in almost quantitative yield, from bromine, diethyl sulfide and antimony pentachlo-
ride, according to the literature procedure (Scheme 106). This gave an orange crystalline solid
which was ready to be used in the key biomimetic reaction. Nitromethane was chosen as the
solvent in line with Snyder’s reported procedure.144 This highly polar solvent should encourage
cyclisation to take place.
O O
O
O
O
Br
O
conditions
Conditions:
NBS / PPh3, CH2Cl2, 6 h ! < 5%
TBCO, CH3CN, 1 h ! < 5%
Br2 / AgBF4, CH3NO2, 0.5 h ! 18%
BDSB, CH3NO2, 0.5 h ! 65%
285
286
Scheme 105: Cyclisation of a Boc-protected polyene using various sources of electrophilic
bromine.
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Et2S  +  Br2  +  SbCl5                                             Et2SBr•SbCl5Br
1,2-dichloroethane
!42°C " 40°C
99%
(BDSB)
Scheme 106: Preparation of BDSB.
Boc-protected epoxy-diene 243 was dissolved in nitromethane and a solution of BDSB in ni-
tromethane was added rapidly. The overall concentration of the reaction was 0.02M – the dilute
conditions being used to encourage intramolecular cyclisation as opposed to intermolecular reac-
tions between two molecules of 243. Also, the reaction was conducted at room temperature in
order to hopefully allow access to the energies required to form the 7-membered carbonates, as
well as the 6-membered ones. After an hour it was found by TLC that all of the starting material
had been consumed and the reaction mixture was worked-up. Column chromatography provided
two components, each of which comprised a number of compounds. These two components will
be termed Mixture A and Mixture B, where Mixture A eluted first from the column. After sep-
aration of the various compounds and careful analysis by NMR experiments it was found that
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O
OBr
H O O
O
H
O
Br
H H
H
H
O
O
O
243
248a
250a
250b
247a
247b
248b
Mixture A Mixture B
1) BDSB, NO2Me, r.t., 1 h
2) Column Chromatography
287
(2 diastereomers)
Scheme 107: Cyclic carbonates formed in the BDSB-mediated bromonium ion-assisted
ring-opening of 243.
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the major carbonate-containing compounds isolated are as shown in Scheme 107. The following
sections detail the process of separating and identifying these compounds.
3.5.6 Successful Bromonium Ion-Assisted Epoxide Ring-Opening of 243 – Isolation and Struc-
tural Elucidation of Medium-Ring Ether Compounds From Mixture A
After column chromatography, the constituent compounds of Mixture A were directly sep-
arated by preparative HPLC (Figure 20). It was found that five alkene-containing compounds
could be isolated, as highlighted on the HPLC chromatogram. The rest of the components sepa-
rated were saturated compounds with no alkene resonances in the 1H NMR spectrum. These must
arise from undesired reactions occurring upon the addition of BDSB (vide infra).
Although it was possible to elucidate parts of the structures of these compounds based on
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Figure 20: HPLC chromatogram of Mixture A.
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the NMR spectra of the carbonates, it was found that hydrolysing the carbonates to form the corre-
sponding diols provided the remaining information required. In order to hydrolyse the carbonates,
each compound was individually treated with sodium hydroxide in methanol at room tempera-
ture and in each case after 2 h the reaction had gone to completion to give the corresponding diol in
quantitative yield (Scheme 108). Importantly, it was found that this hydrolysis could be achieved
without E2 elimination of HBr, which had been a concern prior to carrying out the reaction. Espe-
cially in the cases of medium-ring ethers 247a, 247b and 248a, elimination of HBr at C(11)-C(12)
would have provided an alkene with a certain level of conjugation with the C(9)-C(10) alkene.
However, mass spectrometry and NMR spectroscopy confirmed that this undesirable elimination
had not occurred.
Elucidation of the various structures was achieved using a range of NMR techniques. 2D COSY
NMR experiments were used to determine the resonances for each of the protons in the H(4)-H(15)
spin system. Subsequent correlation with the HSQC NMR spectra provided information about the
substituents present at each position (typically resonances for C-Br appeared at 55-62 ppm and
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Scheme 108: Base-mediated cleavage of the cyclic carbonates.
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C-O appeared downfield of this in each case in the 13C NMR spectrum – see Table 12. DEPT-135
NMR experiments confirmed which carbon resonances were due to CXH and CH2-type carbons.
The information from these spectra allowed for the substitution pattern of the C(8)-C(15) fragment
of each compound to be identified.
This just left the C-4 to C-7 portion of the compounds to be elucidated. As in each compound
there are oxygen substituents present at both C-6 and C-7, the 13C NMR resonances for these car-
bons invariably had similar chemical shifts, meaning distinguishing between the two on this prin-
ciple was difficult. Hydrolysing the carbonates of 247a, 247b, 248a, 250a and 250b to form diols
290a, 290b, 288a, 289a and 289b respectively revealed an upfield shift of the H-4 and either the
H-6 or H-7 carbonate protons in the 1H NMR spectrum upon loss of the carbonate, whereas the
ether proton chemical shifts remained largely unchanged. This revealed the size of the cyclic car-
bonate, and with the assignments for C-12 and C-13 allowed for the overall assignment of the
structural motif of the various medium-ring compounds. HMBC NMR correlations were also ob-
served between H-7 and C-12 of 250a and also H-7 and C-13 of 288a, thus inherently confirming
the formation of the medium-ring itself and also supporting the assignment of a 7-membered ring
ether in the case of 250a, and 8-membered for 288a.
Interestingly, although the IR stretching frequencies of the C−O allows for the confirmation
of which compounds exhibit the same-sized cyclic carbonate (1748 cm−1 for 6-membered car-
bonates 248a, 250a and 250b, and 1793 cm−1 for 7-membered carbonates 247a and 247b), these
values are not in agreement with the absorptions reported in Table 11 for the unsubstituted 6-
and 7-membered carbonates, 281 and 282. For these unsubstituted compounds, the IR stretching
frequency decreases with increased ring size, with 6-membered carbonate 281 exhibiting an ab-
sorption at 1726 cm−1, whilst the IR spectrum of 7-membered carbonate 282 has an absorption due
to C−O at 1718 cm−1. For 6-membered carbonates 248a, 250a and 250b there is only a relatively
small discrepancy of 22 cm−1, compared to compound 281. However, in the case of compounds
247a and 247b, which we know to contain 7-membered carbonates based on NMR evidence (vide
supra), the discrepancy in the IR stretching frequency compared to compound 282 is 75 cm−1.
In order to rationalise this observation, the various electronic effects that impact upon the
stretching frequency of a carbonyl need to be considered. Figure 21 shows the three key orbital
interactions in a simple ester: (a) donation from an oxygen sp2 lone pair into the σ*-orbital of the
carbonyl; (b) donation from a lone pair in a p-orbital on oxygen into the pi* orbital of the carbonyl;
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Figure 21: Main orbital interactions involved in determining the stretching frequency of a
carbonyl in an ester.
(c) donation from an sp2 lone pair on the carbonyl oxygen into the C−O σ*-orbital. The first two
modes result in a weakening of the carbonyl bond, whilst the third strengthens the bond.
For donation into the carbonyl σ*-orbital, the ester (or carbonate) is required to be in the s-cis
conformation in order to achieve the necessary orbital overlap. In small or medium-sized lac-
tones or cyclic carbonates this is unable to occur, resulting in a strengthening of the carbonyl and
a greater stretching frequency. Therefore for the cyclic carbonates, only the other two orbital inter-
actions need to be considered. Donation from an sp2 lone pair of electrons on the carbonyl oxygen
into the σ*-orbital of the C−O could be viewed as a representation of an inductive effect. With
any change of conformation this orbital overlap is unlikely to be affected. However, the amount of
donation from the oxygen p-orbital into the carbonyl pi*-orbital is dependent upon the conforma-
tion of the molecule. If the p-orbital is less able to interact with the pi*-orbital then this will result
in a strengthening of the carbonyl bond, meaning a greater IR stretching frequency. In unsubsti-
tuted 7-membered carbonate 282 the molecule is presumably able to easily access a conformation
in which this orbital overlap is at a maximum. However, when the carbonates are substituted,
the available conformations may be more restricted, resulting in less orbital overlap and a higher
stretching frequency. This affect of restricted conformations is likely to be even more apparent in
fused bicyclic compounds, such as 247a and 247b. A search of the literature has revealed other
examples of fused bicyclic 7-membered carbonates, where the stretching frequency is higher than
may be anticipated based on 282. For example, the carbonyl in carbonate 292145 has a stretching
frequency of 1740 cm−1, whilst in compound 293146 it is even higher, at 1757 cm−1 (Figure 22). In
carbonates 247a and 247b the position where the carbonate is fused is one carbon atom closer to
the carbonate moiety than in compounds 292 and 293. This proximity could result in even less
orbital overlap, accounting for the IR stretching frequency of 1793 cm−1 observed for carbonates
247a and 247b.
Therefore, the carbonyl IR stretching frequency can be used to confirm that compounds formed
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Figure 22: IR stretching frequencies and 13C NMR chemical shifts for the carbonyls of substituted
6- and 7-membered carbonates.
in the bromonium ion-assisted epoxide ring-opening reaction have the same-sized carbonate, but
is not suitable to be used as a diagnostic tool to determine the specific size of the carbonate in
this case. Determining the size of the cyclic carbonates must therefore rely on NMR evidence (vide
supra). However, an interesting observation from the cyclic carbonates in Figure 22 is that the 13C
NMR shifts of the carbonyl carbon are in agreement with the assignments made for the medium-
ring ether carbonates isolated, where the carbonyl carbon for 6-membered carbonates 248a, 250a
and 250b was found to resonate at approximately 149-150 ppm whilst for 7-membered carbonates
247a and 247b the same carbon exhibited a chemical shift of approximately 154 ppm (vide infra).
The absolute and relative stereochemistry at the C-6 and C-7 positions was set according to the
(6S,7R)-configuration of the initial epoxide, with inversion of configuration at the centre which had
undergone attack by the carbonate. The relative stereochemistry of the C-12 and C-13 positions was
also set as either (12R,13S) or (12S,13R) due to the trans geometry of the initial alkene. The absolute
stereochemistry only differed according to the face of the alkene that the bromonium ion formed
on, forming a (12R,13R)- or (12S,13S)-configured bromonium ion, which subsequently underwent
stereospecific attack with inversion at either the C-12 or C-13 position. Therefore only the relative
stereochemistry across the ether oxygen needs to be known in order to be able to assign the overall
absolute and relative stereochemistry for the compounds.
It was found that there is a strong correlation between the chemical shift of the ether protons
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and the relative stereochemistry across this ether oxygen for the 7- and 8-membered ring ethers
(see Figures 23, 24 and 25). When the relative stereochemistry of these two protons is syn, then the
conformation of the molecule places the protons adjacent to the pi-system of the C(9)-C(10) alkene.
This results in shielding of the protons, accompanied with an upfield shift in the resonances for
these protons in the 1H NMR spectrum. When the relative stereochemistry is anti, the conformation
no longer results in this shielding and the chemical shift of the protons is comparatively downfield.
Comparison of two compounds that have been assigned as having the same-sized ring ether allows
for assignment of the relative stereochemistry across the ether oxygen, on this basis of ether proton
chemical shift. The 1H NMR spectra of structurally related natural products exhibited the same
anti vs syn effect, supporting the assignments made. In the case of 8-membered ring ether 288a, an
NOE was also observed between H-7 and H-12, confirming the syn relationship across the ether
oxygen. This also supported the stereochemical assignments that had been made based on NMR
chemical shifts. Specific details for the assignments of carbonates 247a, 247b, 248a, 250a, 250b and
diols 288a, 289a, 289b, 290a and 290b are as follows:
Carbonate 248a and Diol 288a
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Analysis of the COSY NMR spectrum of 248a allowed for the assignment of the H(4)-H(15)
protons, starting from the terminal C-15 methyl group. The signal in the alkene region of the
spectrum (6.0 ppm) was found to integrate for 2H and was due to the H-9 and H-10 protons, as
expected. After each of the protons had been assigned, correlation with the HSQC NMR spectrum
allowed for the assignment of each of the carbon resonances in the 13C NMR spectrum. Signals
that integrated for 8H from 1.6-3.3 ppm in the 1H NMR spectrum were confirmed as being due to
4 different methylene groups at C-5, C-8, C-11 and C-14 (a DEPT-135 NMR experiment confirmed
the corresponding 13C NMR resonances as being due to CH2-type carbons).
The HSQC NMR spectrum showed the C-12 carbon as having a chemical shift of 56 ppm,
which is characteristic of a carbon atom bearing a secondary bromide substituent (see Table 12).
The other CHX resonances (C-6, C-7 and C-13) were found to have a chemical shift of 80-85 ppm.
This is characteristic of a carbon atom bearing a secondary oxygen substituent, such as an alcohol
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or an ether. As C-12 had been shown to be C-Br and C-13 to be C-O, this confirmed the bromine
must be endocyclic with respect to the medium-ring ether. As the C-6 and C-7 carbons both have
very similar chemical shifts it was not possible to distinguish between the two positions based on
this. However, it was observed that there is a 1 ppm difference between the H-6 and H-7 1H NMR
resonances. We considered that the chemical shift for the proton which is part of the carbonate
may change upon hydrolysis of the carbonate.
Analysis of the COSY and HSQC NMR spectra of 288a provided largely the same observations
as for 248a. However, importantly both the H-4 and H-6 1H NMR signals had shifted upfield by
∆δ 0.5-0.6 ppm. Although the signal for H-7 had also shifted slightly, this was comparatively small
at approximately 0.1 ppm. Therefore this observation confirmed the C-6 position as being part
of the cyclic carbonate, whereas C-7 must be part of the medium-ring ether. An HMBC correla-
tion between H-7 and C-13 of compound 288a confirmed the presence of the medium-ring ether,
and inherently confirmed the connectivity as being an 8-membered ring ether with an endocyclic
bromide, and a 6-membered carbonate attached at C-7.
The stereochemistry of 248a was assigned by analysis of the chemical shift of the H-7 and H-13
ether protons (see Figure 23). It may be anticipated that the chemical shift of ether protons would
be approximately 4 ppm, however in compound 248a they were found to resonate at 3.4 ppm. This
apparent shielding of the protons is also observed in the 1H NMR spectrum of the natural product
laurencin (1a), where both ether protons again appear at 3.4 ppm. In laurencin (1a) the protons
are syn relative to each other across the ether oxygen. The result of this is that the ether protons
are placed adjacent to the C(9)-C(10) pi-system, effectively shielding them. It was anticipated that
if the protons were anti across the ether oxygen, then the resulting conformation of the ether ring
would no longer result in this shielding effect for the ether protons. Consequently the apparent
upfield shift of the ether protons in 248a must also be due to the same effect, meaning the relative
stereochemistry must be syn. The observation of an NOE between H-7 and H-13 in compound
288a supported this assignment of syn relative stereochemistry.
As the absolute stereochemistry is set by the initial (6S,7R)-epoxide and stereospecific attack by
the carbonate evidently must have occurred at C-6 to form the observed motif, then the absolute
stereochemistry at these positions must be (6R,7R). Also, the relative stereochemistry at C-12 and
C-13 must be (12R,13S) or (12S,13R) as required by the initial alkene geometry.
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Figure 23: Comparison of the 1H NMR spectrum of carbonate 248a with that of the
structurally-related laurencin (1a). Resonances for protons that are common to both compounds
are labelled.
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As the relative stereochemistry is syn across the ether oxygen and C-7 is (R)-configured, then C-
13 must be (R)-configured and the compound must have arisen from a (12S,13S)-bromonium ion,
with attack by the epoxide oxygen with inversion at C-13. Therefore the overall absolute stereo-
chemistry for this compound has been assigned as (6R,7R,12S,13R). The 1H and 13C NMR spectra
of compound 248a and laurencin (1a) (see Figure 23 and Table 13, respectively) show excellent
correlation.
Carbonate 250a and Diol 289a
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The H-4 to H-15 spin system of carbonate 250a was again assigned using the COSY NMR
spectrum, starting from the C-15 terminal methyl. The C(9)-C(10) position of the alkene was con-
firmed, and the HSQC NMR spectrum was then used to assign the chemical shifts for each of the
carbon atoms in the molecule. For this compound it was found that C-12 had a chemical shift of
approximately 80 ppm, whereas C-13 was upfield at around 60 ppm (see Table 12). This placed
the bromide at C-13 and exocyclic, whereas the C-12 carbon must have been oxygen-bearing and
therefore adjacent to the ether oxygen. Again it was found that the chemical shifts of the 13C NMR
resonances for the C-6 and C-7 positions were very similar and so the structure of this part of the
molecule could not be deduced from this.
As for carbonate 248a, the cyclic carbonate of 250a was hydrolysed to form diol 289a. The
COSY and HSQC NMR spectra provided largely the same information as for 250a, however again
an upfield shift of approximately 0.6-0.9 ppm for the H-4 and H-6 protons was observed, whereas
the H-7 proton only shifted from 3.5 to 3.3 ppm. This allowed us to assign the C-7 position as being
part of the medium-ring ether, whereas C-6 was part of the cyclic carbonate. An HMBC correlation
was also observed for compound 250a, between H-7 and C-12. This confirmed the formation of
the ether ring, proved the size of the medium-ring ether to be 7-membered, and also inherently
confirmed the presence of an exocyclic bromide and a 6-membered cyclic carbonate.
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Figure 24: Comparison of the 1H NMR spectrum of carbonate 250a with that of the
structurally-related isolaurepinnacin (14). Resonances for protons that are common to both
compounds are labelled.
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The relative stereochemistry could again be assigned on the basis of the chemical shift of the
ether protons at C-7 and C-12 (see Figure 24). These were both found to resonate upfield of what
may be anticipated, at approximately 3.6-3.7 ppm. This indicated syn relative stereochemistry for
the reasons described above. The chemical shift of these protons was in very close agreement with
the H-7 and H-12 protons of the natural product isolaurepinnacin (14), which also has syn relative
stereochemistry across the ether oxygen. When these are compared to the chemical shifts for 7-
membered ring ethers with anti relative stereochemistry this assignment of stereochemistry based
on chemical shift becomes even more compelling.
As it is known that attack with inversion by the carbonate must have occurred at C-6, and the
initial epoxide is (6S,7R)-configured, then the stereochemistry of 250a at these positions must be
(6R,7R), as for compound 248a. With syn relative stereochemistry across the ether oxygen, C-12
must be (S)-configured. As attack by the epoxide will have happened at this centre with inver-
sion, the initial bromonium ion formed must have been (12R,13R)-configured, meaning the C-13
position must be (R). Therefore the overall absolute stereochemistry for compounds 250a and 289a
must be (6R,7R,12S,13R).
The 1H and 13C NMR spectra of compound 250a and isolaurepinnacin (14) show excellent
correlation between resonances that are common to both compounds, supporting the assignment
of 250a as comprising the core motif of isolaurepinnacin (14) (see Figure 24 and Table 13).
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Analysis of the COSY and HSQC NMR spectra of 250b and 289b revealed the same structural
connectivity as for 250a and 289a. The C-13 carbon had a typical chemical shift for bearing a bro-
mide and thus the bromide was assigned as being exocyclic, with C-12 being assigned as bearing
the ether oxygen (see Table 12). Again, hydrolysis of the cyclic carbonate revealed the C-6 position
to be part of the cyclic carbonate by shielding of the corresponding proton, confirming the for-
mation of a 6-membered carbonate and inherently the formation of a 7-membered medium-ring
ether.
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Figure 25: Comparison of the 1H NMR spectrum of carbonate 250b with that of the
structurally-related rogioloxepane A (15). Resonances for protons that are common to both
compounds are labelled.
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The ether protons at C-7 and C-12 were found to be downfield in 250b and 289b relative to 250a
and 289a, resonating at 4.0-4.3 ppm compared to 3.3-3.7 ppm. The shift of these ether protons is in
good agreement with the chemical shift of the C-7 and C-12 protons in the natural product rogi-
oloxepane A (15), which appear at 4.2-4.3 ppm (see Figure 25). The ether protons of rogioloxepane
A (15) have anti relative stereochemistry, which is consistent with us now assigning compounds
250b and 289b as having anti relative stereochemistry. As carbonates 250a and 250b have the same
core structural motif, they must arise from bromonium ion formation on opposite faces of the
C(12)-C(13) alkene. Therefore they will be diastereomeric at the C-12 and C-13 positions, so the
absolute stereochemistry of compounds 250b and 289b must be (6R,7R,12R,13S).
The 1H and 13C NMR spectra of compound 250b and rogioloxepane A (15) show excellent
correlation between resonances that are common to both compounds, supporting the assignment
of 250b as comprising the core motif of rogioloxepane A (15) (see Figure 25 and Table 13).
Carbonates 247a & 247b and Diols 290a & 290b
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As before, COSY NMR spectra were used to assign the protons of the carbonate-containing
compounds (247a and 247b) from H-15 through to H-4. This confirmed the position of the C(9)-
C(10) alkene. Correlation with the HSQC NMR spectra then allowed the chemical shifts of the
various carbon atoms to be assigned. It was found that the carbon atoms at C-12 had a chemical
shift of 56 ppm, whereas the C-13 carbon was downfield at 60 ppm. Therefore the comparatively
upfield C-12 carbon was assigned as bearing a bromide whereas the C-13 carbon was assigned as
bearing the ether oxygen. This meant that the bromide substituent must be endocyclic. As two
medium-ring ether compounds with endocyclic bromide substituents had been identified (248a
and 248b), these two compounds that also have endocyclic bromides must, by process of elimina-
tion, be 9-membered ring ethers 247a and 247b, which also incorporate 7-membered cyclic carbon-
ates.
As the 1H and 13C NMR spectra of 247a and 247b were markedly similar, as were those of 290a
and 290b, it was not possible to use difference in chemical shifts of the ether protons in order to
assign anti or syn relative stereochemistry across the ether oxygen. Therefore it was not possible
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to assign the absolute or relative stereochemistry specifically for either of the two diastereomers
(247a and 247b) that were isolated. However, as these compounds must contain a 7-membered
cyclic carbonate (vide supra), attack by the carbonate on the (6S,7R)-configured epoxide must result
in a (6S,7S)-configuration. Also, as the compounds must arise from bromonium ion formation
on opposite faces of the C(12)-C(13) alkene, they will be diastereomers of one another at the C-12
and C-13 positions. Therefore one compound will have the absolute configuration (6S,7S,12R,13S)
whereas the other will be (6S,7S,12S,13R).
The isolation of these carbonate-containing medium-ring ether compounds from Mixture A
accounted for five out of the eight compounds that we anticipated would be produced in this
brominative cyclisation reaction (c.f. Scheme 89). With the structures and stereochemistries of these
compounds elucidated, our attention focused on the isolation and identification of compounds
from Mixture B.
3.5.7 Successful Bromonium Ion-Assisted Epoxide Ring-Opening of 243 – Isolation and Struc-
tural Elucidation of Compounds From Mixture B
From observation of the crude 1H NMR spectrum of Mixture B it became apparent that it con-
tains one major alkene-containing compound, and this was found to decompose upon standing.
Therefore we decided to hydrolyse the carbonates as a mixture, using the same conditions as used
previously for the other carbonates, and then separate the resulting diols by preparative HPLC. In
this case the HPLC chromatogram was much cleaner than that of Mixture A, revealing that Mix-
ture B contained far fewer compounds. The two compounds highlighted on the chromatogram
in Figure 26 were isolated, and the structures of these two compounds were elucidated using the
same NMR techniques used previously:
Diol 288b
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The COSY and HSQC NMR spectra of compound 288b provided very similar information to
that of 248a and 288a, allowing us to establish the connectivity as being the same as these two
compounds. A chemical shift of approximately 55 ppm for the C-12 carbon again allowed us to
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Figure 26: HPLC chromatogram of the hydrolysed product of Mixture B.
assign the bromide as being at this position, and consequently endocyclic (See Table 12). Although
the carbonate-containing precursor to this compound was not isolated, the assignment of two other
medium-ring ethers with 7-membered carbonates and endocyclic bromides meant that compound
288b must have inherently arisen from the formation of a 6-membered carbonate. Consequently
the C-6 position must now bear a hydroxyl group, whilst the C-7 position is part of the medium-
ring ether, as for compound 288a.
As the carbonate-containing precursor to compound 288b must have formed from initial bromo-
nium ion formation on the opposite face of the C(12)-C(13) alkene to compound 248a, it should be
diastereomeric at the C-12 and C-13 positions, resulting in anti relative stereochemistry across the
ether oxygen. Using the anti vs syn 1H NMR correlation between the two ether protons, we antic-
ipated that the H-7 and H-13 protons in 288b should be downfield of those in 288a. Indeed, this
proves to be the case, with the ether protons in 288b being approximately 0.4-0.5 ppm downfield
of those in 288a. Therefore with the evidence for the structure and also the anti relative stereo-
chemistry, we can assign compound 288b as having an 8-membered ring-ether with an endocyclic
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bromide and a (6R,7R,12R,13S) absolute configuration.
Cyclopropane-Containing Diol 294
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From observation of the 1H NMR spectrum of compound 294 it is immediately obvious that
unlike the other compounds isolated this one does not contain an alkene. However, mass spec-
trometry confirmed that 294 has exactly the same mass as the medium-ring ether diols. Therefore
using the principle of double bond equivalents, 294 must contain a second ring in the absence of
an alkene.
As for the medium-ring ethers, the COSY NMR spectrum was utilised to assign the protons for
the H-4 to H-15 spin system. Correlation with the HSQC NMR spectrum allowed for the chemical
shifts of the corresponding carbon atoms to be assigned. The C-13 carbon had a chemical shift of
approximately 60 ppm whereas the C-12 carbon was downfield at approximately 75 ppm. There-
fore the C-13 carbon was assigned as being bromide-bearing whereas the C-12 carbon must bear
an oxygen substituent (See Table 12).
It was found that as well as coupling with the H-5 and H-7 proton, the H-6 proton also coupled
with another proton that appeared as a doublet in the 1H NMR spectrum. This must be an alcohol
proton and therefore the C-6 position bears a secondary alcohol. The C-7 carbon has a very similar
chemical shift to C-6 and C-12 and therefore is also evidently oxygen bearing. Consequently the
C-7 and C-12 carbons must be on either side of the ether oxygen, whilst the bromide substituent
at C-13 is exocyclic to the cyclic ether. An HMBC correlation between C-7 and H-12 confirmed the
presence of a cyclic ether and also the connectivity described above.
The COSY NMR spectrum shows that there is a very highly coupled spin system from H-9
through to H-11. As well as coupling with H-8, the H-9 proton (1.13 ppm) also couples with the
two H-10 protons (0.87 and 0.23 ppm), and H-11 (1.32 ppm); the H-10 protons couple with the H-9
and H-11 protons and the H-11 proton couples with the H-9 and H-10 protons, as well as H-12. The
highly coupled nature of this spin system along with the highly shielded nature of the 1H NMR
resonances is consistent with the presence of a cyclopropane at C(9)-C(10)-C(11). Considering this,
along with the presence of the ether oxygen between C-7 and C-12, means the compound must be
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a tetrahydropyran with a cyclopropane fused at C-9 and C-11 to form a bicyclic compound.
By consideration of the proposed mechanism (vide infra), compound 294 must arise by in-
tramolecular trapping of an intermediate oxonium ion by the tert-butyl carbonate at C-6. As the
initial epoxide is (6S,7R)-configured, the product of the reaction must be (6R,7R)-configured. All of
the steps in the proposed mechanism should occur stereospecifically and the relative configuration
at C-12 and C-13 should be set by the (E)-configuration of the initial alkene at this position. Also,
the H-9 and H-11 protons of the cyclopropane moiety must necessarily be on the same face of the
molecule. Although these constraints limit the number of potential diastereomers that 294 could
possibly be, the face of the C(12)-C(13) alkene that underwent initial bromonium ion formation
is unknown. The NOESY NMR spectrum of 294 revealed NOEs from H-7 to H-13 and also H-10
to H-12. This second correlation suggests that one of the H-10 protons is on the same face of the
molecule as H-12. This in turn would suggest that the H-12 proton is on the opposite face of the
molecule to the H-9 and H-11 protons. However, only a very weak NOE is observed between
H-7 and H-12 which is not sufficient to prove anti or syn relative stereochemistry across the ether
oxygen. Therefore the absolute configuration of compound 294 is unknown.
3.5.8 Successful Bromonium Ion-Assisted Epoxide Ring-Opening of 243 – Use of Diagnostic
13C NMR Shifts to Support Structural Assignments
In a similar way to the cyclooctene epoxide 131 model system (vide supra), upon assigning the
13C NMR spectra for the carbonate and diol compounds it became apparent that there are certain
trends in chemical shifts for the various structural features.
Table 12 shows that compounds exhibiting an endocyclic bromide were found to have a 13C
NMR shift of 55-58 ppm at C-12, whereas for an exocyclic bromide (C-13) the carbon resonated
at 62-63 ppm. Similarly, for a 6-membered carbonate the C-4 carbon had a chemical shift of ap-
proximately 67 ppm and the carbonyl carbon 149 ppm, whereas for a 7-membered carbonate the
C-4 carbon was comparatively shielded at 58 ppm and the carbonyl carbon deshielded, resonat-
ing at 154 ppm. These observed trends support the assigned structures, as similar sections of the
different compounds have comparable chemical shifts in their respective 13C NMR spectra.
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Table 12: Comparison of 13C NMR chemical shifts in the isolated medium-ring ether carbonates
and diols.
Carbonate CHBr CH2OC=O C=O Diol CHBr
O
Br
H
H
O O
O
248a
56.0 67.0 148.5 OBr
H
H
OH
288a
OH 55.7
O
Br
H H
O
O
O
250a
61.9 66.8 148.9 OBr
H H
OH
289a
OH 62.5
O
Br
H H
O
O
O
250b
62.8 66.8 148.5 OBr
H H
OH
289b
OH 62.8
O
Br
O
O
H H
O
247a or 247b
56.8 58.2 154.2
O
Br
H H
290a or 290b
OH
OH
57.7
O
Br
O
O
H H
O
247a or 247b
56.8 58.2 154.2
O
Br
H H
290a or 290b
OH
OH
57.8
O
Br
H
H
OH
288b
OH 55.2
O
Br
OH
OH
H
H
H
H
294
60.8
The observed pattern for the chemical shifts of the carbon atoms bearing bromides also holds
for the structurally-related natural products (Table 13). This further supports the structural assign-
ments that have been made for the isolated medium-ring ethers. Furthermore, Table 13 shows that
in a similar way to the 1H NMR spectra, comparison of all of the common resonances in the 13C
NMR spectra of medium-ring ether carbonates 247a, 247b, 248a, 250a and 250b with the related
natural products supports the structural assignments made previously.
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Table 13: 13C NMR comparison of the core motifs of the medium-ring ether carbonates with
structurally-related natural products (chemical shifts in ppm).
Carbon No. 248a 1a45 250a 1422 250b 1537 247a/b 247a/b 1221 1829
C-15 (CH3) 9.8 9.3 12.4 12.7 12.4 12.8 11.0 11.0 11.4 10.4
C-5, C-8, C-11, 22.7 25.8 23.4 28.0 23.3 28.4 30.4 30.4 23.2 29.0
C-14 (CH2)
a 26.0 29.7 26.5 32.7 28.3 31.1 31.6 31.3 26.8 31.6
28.7 32.3 31.9 33.8 30.2 32.6 35.1 35.2 34.7 32.1
32.3 33.8 34.2 37.6 30.5 34.9 36.1 36.2 39.2 35.6
C-6 (C−X) 80.2 74.0 N/Ab N/Ab N/Ab N/Ab 79.3 78.6 72.7 77.9
C-7 (C−X) 85.2 84.6c 79.6 77.0c 75.5 77.0 81.9 81.1 79.8 N/Ab
C-12 (C−X) 56.0 56.0 83.3 82.5c 77.9 77.0 56.8 56.8 52.8 56.8
C-13 (C−X) 81.1 81.4c 61.9 61.3 62.8 62.8 60.5 60.5 84.4 75.4
C-9, C-10 128.9 128.9 128.8 129.0 127.7 127.8 124.8 124.4 127.3 128.9
(C−C)a 129.3 129.2 129.1 129.2 127.8 128.2 129.6 130.0 129.3 130.7
a from the information available it was not possible to assign all of the resonances for the natu-
ral products, therefore each column is listed in order from lowest to highest chemical shift.
b different substituents are present on these carbons so the resonances are not comparable.
c it was not possible to assign this resonance with absolute certainty.
For carbonate 248a there is excellent agreement with the chemical shifts for laurencin (1a). The
alkene carbon resonances (C-9 and C-10) and three of the C-X carbon resonances (C-7, C-12 and
C-13) are within 0.6 ppm of those of the natural product. There is a slight discrepancy in the C-
6 chemical shifts, but this is likely due to the substituent at this position differing (ester in 1a,
carbonate in 248a).
The 13C NMR spectra for carbonates 250a and 250b also show excellent correlation with the
spectra of isolaurepinnacin (14) and rogioloxepane A (15), respectively. The C-9, C-10, C-12 and
C-13 resonances of the carbonates are all within 0.8 ppm of that reported for the corresponding
natural products. The C-7 carbon resonances have a slight discrepancy, with a difference of 2.6
ppm for carbonate 250a and 1.5 ppm for carbonate 250b. This could be due to the close proximity
of the different C-6 substituents.
Correlation of the 13C NMR chemical shifts of 9-membered ring diastereomers 247a and 247b
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with the structurally-related natural product itomanallene A (12) is not as good as the correlations
are for the six-membered carbonates. This is presumably due to the quite different bicyclic na-
ture of the two compounds compared to the natural product (247a and 247b being bicyclo[7.5.0]-
carbonates whereas itomanallene A (12) is a bicyclo[7.3.0]-ether). However, there is still good
correlation at the C-7, C-9 and C-10 positions, and relatively good correlation at the C-6 and C-12
positions. Furthermore, comparison of the 13C NMR chemical shifts of 247a and 247b with those of
obtusenyne (18), which is not bicyclic, also supports the proposal that the different types of bicyclic
compound are responsible for the differing chemical shifts. In the case of obtusenyne (18) there is
better correlation than itomanallene A (12) for the CH2 carbon resonances, the C-6 ether carbon
and also the C-12 bromide-bearing carbon, which at 56.8 ppm is identical to the C-12 carbon reso-
nances of 247a and 247b. Interestingly, the C-13 resonance in obtusenyne (18) (75.4 ppm) is a much
closer correlation to compounds 247a and 247b (60.5 ppm) than itomanallene A (12) (84.4 ppm),
even though the C(8)-C(15) structures in itomanallene A (12) and obtusenyne (18) are identical.
3.5.9 Successful Bromonium Ion-Assisted Epoxide Ring-Opening of 243 – Estimating Yields
and Investigating the Effect of Changing Conditions on the Biomimetic Brominative Cy-
clisation Reaction
Once all of the major compounds isolated from the biomimetic brominative cyclisation reaction
had their structures and stereochemistries assigned, it was then possible to estimate the yields of
each compound formed in the reaction. Estimated yields are reported instead of isolated yields as
it was not possible to isolate the entire quantity of each compound due to incomplete separation
of most of the compounds by HPLC (c.f. Figure 20).Therefore we considered that yields estimated
from the relevant NMR spectra would provide more accurate information about the system.
After column chromatography the masses of Mixtures A and B were recorded and 1H NMR
spectrum of each mixture was acquired. Figure 27 demonstrates how the alkene resonances for
each of the compounds within Mixture A could be integrated and then the relative integration of
each of these signals could be used in conjunction with the mass of the mixture to estimate the yield
of each compound. The same process could be used for Mixture B to provide estimated yields for
carbonates 248a and 287. Therefore overall we calculated the following yields for the carbonates:
248a, 4.1%; 250a, 1.4%; 250b, 1.2%; 247a and 247b, 1.8%; 248b, 3.5%; 287, 5.8%.
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Figure 27: 1H NMR spectrum of Mixture A.
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Table 14: Relative ratios of medium-ring ether carbonates 247a, 247b, 248a, 250a and 250b
formed at different temperatures and with various additives.
Temperature / ◦C Additive Time / h 248a 250a 250b 247a/b
0 4A˚ M.S. 1.5 54 13 23 10
0
4A˚ M.S. &
thioanisole
2.0 63 4 27 6
0 none 1.0 57 13 11 19
20 none 1.5 45 13 18 24
60 none 1.0 55 19 17 9
Now that we had a facile way to estimate the ratio of compounds formed in this reaction (i.e.
by integration of the 1H NMR spectra after column chromatography), we decided to investigate
the effect of changing conditions on the bromonium ion-assisted ring-opening of epoxide 243.
In particular we were interested in the effect of temperature on the relative formation of those
compounds with 6-membered carbonates, compared to those with 7-membered ones. We decided
to use the alkene-containing medium-ring ethers that are contained in Mixture A for our analysis,
and the results are summarised in Table 14.
Table 14 shows that in the main reported reaction, which was conducted at room temperature,
the ratio of carbonates 248a : 250a : 250b : 247a/b was 45 : 13 : 18 : 24. Interestingly, carbonate
248a is by far the most prevalent compound in this mixture, and it has the same core structure as
laurencin (1a), which was the first natural product of the family isolated. At other temperatures,
and with additives (thioanisole and 4A˚ M.S.) it was found that there were small changes to the
ratio, indicating the delicate balance of the system. In particular it is apparent that at the lower
temperature of 0 ◦C the ratio of compounds 247a and 247b, which contain 7-membered carbon-
ates, are found to decrease slightly. This is in accordance with the hypothesis made previously,
that at lower temperatures where kinetic products are favoured, compounds with 6-membered
carbonates should predominate.
Therefore, at the raised temperature of 60 ◦C it was anticipated that the ratio of 7-membered
carbonates 247a and 247b would increase. However, to our surprise the ratio actually decreased
from 24 at 20 ◦C, to 9. We considered that this may occur if the formation of these 7-membered
carbonates is reversible. To test this, Mixture A from the reaction conducted at room temperature
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was heated at 60 ◦C in nitromethane for 4 hours. After this time it was found that there was no
change in the ratio of the carbonates. Therefore the formation of all of isolated carbonates 247a,
247b, 248a, 250a and 250b must be irreversible.
3.5.10 Successful Bromonium Ion-Assisted Epoxide Ring-Opening of 243 – An Unexpected
Rearrangement Reaction
After the bromonium ion-assisted epoxide ring-opening reaction of 243 had been undertaken
it became apparent from the 1H NMR spectrum of the crude mixture prior to column chromatog-
raphy that the alkene resonances were under-integrating to a fairly large degree. Table 15 sum-
marises the relative integration of the alkene resonances, compared to the CHX and CH2/CH3
resonances, for triene 159, through epoxide 160 and Boc-protected 243, to the cyclised crude mix-
ture.
There is a slight under-integration of the alkene resonances for 159, 160 and 243. This is pre-
sumably due to a small amount of over-reduction in the hydrogenation of enediyne 158. However,
after the treatment of 243 with BDSB, the alkene resonances only integrate for 0.9 protons, whereas
the desired compounds contain 2 alkene protons. Therefore over 50% of the material from the
Table 15: Relative integrals for protons in the 1H NMR spectra of triene 159 through to the
bromonium ion-assisted epoxide ring-opening reaction.a
Compound CH−CH CHBr and CHO CH2 and CH3
(expected / actual) (expected / actual) (expected / actual)
OH
159
6 / 5.5 2 / 2.1 11 / 11.0
OH
O
160
4 / 3.4 4 / 4.0 11 / 11.0
OBoc
O
243
4 / 3.7 4 / 4.4 11 / 11.0b
Cyclised Compounds 2 / 0.9 6 / 4.8 11 / 11.0
(crude mixture)
a integrals for each compound are reported relative to the CH2 and CH3 signals, which have
been set to the figure that should be anticipated for each compound.
b excluding tBu group.
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reaction must be non-alkene containing (i.e. fully saturated) material. Initially we considered that
this may be due to over-bromination, or the formation of dimer-type species. However, mass spec-
trometry confirmed this not to be the case.
This loss of olefinic resonances may be partially explained by the isolation of cyclopropane-
containing tetrahydropyran 294. This structural motif is unique amongst reported natural prod-
ucts, and we believe it may constitute the core of an as yet undiscovered natural product from
Laurencia species. Our proposed mechanism for the formation of 287 is shown in Scheme 109.
After initial bromonium ion formation on the C(12)-C(13) alkene of 243 (295), nucleophilic at-
tack of the C(9)-C(10) alkene onto the adjacent bromonium ion would form cyclopropylalkyl carbo-
cation 296. This mode of attack of an alkene onto a nearby bromonium ion to form cyclopropanes
has precedent in the literature, albeit in conformationally constrained systems. For example, in
1980 Kawanisi reported that when diene 301 was treated with molecular bromine an interesting re-
arrangement reaction occurred to give three different compounds, two of which are cyclopropane-
containing (Scheme 110).147 This must occur via formation of a bromonium ion on one alkene,
followed by intramolecular attack by the well placed second alkene to give a cyclopropylalkyl car-
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Scheme 109: Proposed mechanism for the formation of cyclopropane-containing 287 upon
treatment of compound 243 with electrophilic bromine.
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Scheme 110: Example of cyclopropane formation during bromination of a 1,4-diene, where both
alkenes are (Z)-configured and 1,2-disubstituted.147
bocation. In the case of compounds 302 and 303, this carbocation is directly quenched by bromide,
with attack on either face giving the two diastereomers. Alternatively attack by bromide at the
cyclopropane, with collapse of the cyclopropane back to the alkene would furnish 304.
Simsek reported another interesting rearrangement reaction which furnished a cyclopropane-
containing compound (Scheme 111).148 It was found that when diene 305 was treated with molec-
ular bromine, four different compounds were formed, with 306 being the major one. Again, this
must form via bromonium ion formation on one alkene, intramolecular attack by the second to
form a carbocation, with subsequent quenching of this by bromide anion.
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Scheme 111: Example of cyclopropane formation during bromination of a 1,4-diene, where both
alkenes are (Z)-configured.148
In our system, after formation of the cyclopropylalkyl carbocation 296 it could undergo a re-
arrangement, via a cyclobutyl carbocation (297) to form 298. This interconversion between cy-
clopropylalkyl, cyclobutyl and allylic carbocations has been well documented, especially for the
C4H7+ system.149–151 Intermediate 298 can be represented as the bromonium ion resulting from
neighbouring group participation of the C-13 bromide (299) or as a cyclopropyl-stabilised carbo-
cation (298).
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This then leaves the epoxide oxygen well placed to undergo nucleophilic attack in an energeti-
cally favourable 6-exo manner onto the C-12 position of the bromonium ion, forming oxonium ion
300. The C(9)-C(10)-C(11) cyclopropane provides a favourable conformational constraint for this
reaction in the same way as the C(9)-C(10) alkene does in the medium-ring ether forming reac-
tion. The carbonate can then undergo a second favourable 6-exo cyclisation onto the C-6 position
of the oxonium ion. In the 1H NMR spectrum of Mixture B it is possible to observe two major
cyclopropane-containing compounds, in a ratio of 6.9 : 1.0. These may arise from bromonium ion
formation on opposite faces of the C(12)-C(13) alkene.
3.5.11 Successful Bromonium Ion-Assisted Epoxide Ring-Opening of 243 – A Summary
The treatment of Boc-protected epoxy-diene 243 with BDSB in nitromethane has resulted in the
formation of six different medium-ring ether compounds. This must have occurred via bromo-
nium ion-assisted epoxide ring-opening, where the tert-butyl carbonate moiety functioned as an
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Figure 28: Correlation of medium-ring ether diols with known natural products.
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intramolecular nucleophile to capture the intermediate oxonium ion species. The structures and
stereochemistries of the six medium-ring ether compounds have been elucidated using a range of
NMR experiments. The medium-ring ether compounds consist of three different structural motifs,
where there are two diastereomers of each motif. These diastereomers are epimeric at the C-12 and
C-13 positions, and this is due to indiscriminate bromonium ion formation on both faces of the
C(12)-C(13) alkene.
These medium-ring ethers represent the core motifs of five different natural products (Figure
28): compound 288a exhibits the same structural motif as laurencin (1a) and laureoxanyne (4);
289b has the same core as isoprelaurefucin (5); 290a has the core motif of isolaurallene (11); and
290b has the same motif as itomanallene A (12). Compounds with the same medium-ring ether
motif as prelaureatin (3) were not observed under the conditions. Any compound formed with the
prelaureatin motif would have to be a bicyclic compound, with an 8-membered ring ether fused to
a 7-membered carbonate. The formation of such a compound may be easily reversible, invoking
the principle of microscopic reversibility. Alternatively, the compound may be unable to form, or
may have formed and then gone on to produce other compounds in the reaction mixture, in the
same way as prelaureatin (3) itself undergoes a number of further reactions.
Scheme 112 summarises the successful key biomimetic reaction. The bromonium ion-assisted
epoxide ring-opening of 243 demonstrates the feasibility of our alternative unifying biogenesis for
the halogenated medium-ring ethers from Laurencia species. It also supports the proposal from our
biogenetic analysis that there are a number of undiscovered halogenated medium-ring ether natu-
ral products. Also, the isolation of a novel cyclopropane-containing tetrahydropyran 294 from the
reaction mixture suggests that natural products with this core structural motif will be discovered
in due course from Laurencia species.
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Scheme 112: Optimised procedure for the brominative cyclisation of 243 (percentage yields are
estimates based on the 1H NMR spectra of Mixtures A and B after column chromatography).
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3.6 Synthetic Studies Towards the C15 Enynes, (E)- and (Z)-127
Now that our proposed biogenesis for the medium-ring ethers from Laurencia species has been
validated, it would be interesting to investigate bromonium ion-assisted epoxide ring-opening of
the fully elaborated C15 epoxy-enynes, (E)- and (Z)-127.
Previous attempts in the group to form a similar compound have proven problematic due to
the presence of the β,γ-epoxide moiety.117 It was found that oxidation of the alcohol in the (Z,Z)-
configured epoxy-diene to the corresponding aldehyde 310 could be achieved successfully using a
Swern oxidation. However, very careful control of the conditions and temperature were required
for the reaction, it was not always reproducible, and treatment of the resulting aldehyde compound
with a range of phosphonium ylids was found to result in α-deprotonation and subsequent ring-
opening of the epoxide at the β-position to form α,β-unsaturated aldehyde 313 (Scheme 113).
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Scheme 113: Base-induced ring-opening of a β,γ-epoxy-aldehyde.
3.6.1 Synthesis of a Representative Model System for the C15 Epoxy-Enynes
It became apparent that deliberate epoxide ring-opening, followed by a Wittig-type olefina-
tion and subsequent reinstallation of the epoxide may provide a synthetic route to the C15 enynes.
This would avoid the problem of base-induced epoxide ring-opening observed during the Wittig
reactions. Scheme 114 summarises the proposed retrosynthesis of the C15 enynes 127 using this al-
ternative strategy. Disconnection of the C(6)-C(7) epoxide in epoxy-enyne 127 provides protected
chlorohydrin 314, which functions as a masked epoxide. The enyne can subsequently be discon-
nected to the corresponding aldehyde 315, which with adjustment of the C-4 oxidation level and
protecting group manipulation can be traced to chlorohydrin 316. Functional group interconver-
sion of this chlorohydrin reveals that it could arise from enantiopure epoxy-diene 160, which in
turn can be disconnected to triene 159. This triene can be prepared from (E)-2-penten-1-ol (154)
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Scheme 114: Proposed retrosynthesis of the fully elaborated C15 epoxy-enynes 127.
using the previously developed series of alkyne couplings and hydrogenation.
In a forward sense, once epoxy-diene 160 has been prepared, Lewis acid-promoted epoxide
ring-opening by chloride should provide chlorohydrin 316 with good regiocontrol.152 This method
has recently been used with good success by this group in work towards the biomimetic synthe-
sis of the obtusallene family of natural products (vide infra).102, 116 The regioselectivity observed
in these reactions is presumably due to initial chelation of the alcohol and epoxide oxygens by
the titanium, followed by selective SN2 attack by chloride at the C-7 position. Attack at C-7 re-
sults in the formation of six-membered chelate 317, which is favoured over the seven-membered
chelate which would result from attack at C-6, due to reasons of torsional strain and transannular
interactions (Scheme 115).153 Although this regioselectivity would be anticipated in the reaction
of epoxy-diene 160 with titanium(IV) isopropoxide and diethylamine hydrochloride, the ratio of
chlorohydrin regioisomers produced is of no consequence to the proposed synthesis. Both chloro-
hydrin regioisomers will produce the same epoxide stereoisomer upon ring-closure, due to both
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Scheme 115: Chelate-control in the regioselective ring-opening of β,γ epoxy-alcohols.
ring-opening and ring-closing of the epoxide occurring stereospecifically via SN2 mechanisms, re-
gardless of the initial position of attack.
Regioselective protection of the primary alcohol in chlorohydrin 316 and subsequent protec-
tion of the secondary alcohol will be followed by selective deprotection of the primary alcohol
protecting group. Oxidation of the primary alcohol to the corresponding aldehyde should provide
compound 315. This aldehyde-containing compound can then undergo olefination to install either
the (E)- or (Z)-configured enyne moiety.
Reaction of aldehyde 315 with the semi-stabilised phosphonium ylid derived from phospho-
nium salt 319 should provide (E)-enyne containing 314 with good selectivity. This ylid has been
successfully used in the synthesis of natural products from Laurencia species. For example, in
Masamune’s pioneering first synthesis of laurencin (1a), a yield of 94% for the desired (E)-enyne
was reported in the Wittig reaction using this phosphonium ylid.31 Burton also used the same
phosphonium salt in the total synthesis of the originally proposed structure of elatenyne, a halogen-
containing natural product from Laurencia majuscula.155, 156 The reaction gave good selectivity, with
the desired (E)-configured enyne being the favoured compound in a 7 : 1 ratio with the minor (Z)-
regioisomer. Previous work in this group has also demonstrated that the (E)-configured enyne
can be installed with good stereoselectivity. Aldehyde 318 was treated with the ylid derived from
phosphonium salt 319 to give a reasonable yield of enyne as a 19 : 1 mixture of stereoisomers, in
favour of the (E)-enyne 320 (Scheme 116).154
Although there is very good precedent for selective installation of an (E)-configured enyne, in-
corporation of a (Z)-configured enyne in a stereoselective fashion is less trivial. There are two main
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Scheme 116: Example of selective formation of an (E)-configured enyne.154
163
methodologies which have been utilised in the synthesis of medium-ring ether natural products
from Laurencia species, and both involve more than one step. In Crimmins’ synthesis of prelaure-
atin (3), (Z)-vinyl iodide 322 was formed via Stork-Zhao70 olefination of the corresponding alde-
hyde 321 (Scheme 117).39 A Sonogashira coupling of the vinyl iodide with trimethylsilyl-protected
acetylene provided the desired (Z)-configured enyne moiety 323. Crimmins also used this method-
ology of vinyl iodide formation and subsequent Sonogashira coupling in the synthesis of chloride-
containing rogioloxepane A (15)37 and obtusenyne (18).53
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Scheme 117: Crimmins’ method for installing the (Z)-configured enyne in prelaureatin (3).39
The other main methodology also utilises a Sonogashira coupling to install the alkyne portion,
although the vinyl halide is installed using a different method. In Murai’s synthesis of obtusenyne
(18), (Z)-vinyl bromide 326 was prepared selectively by Ueneshi debromination73 of the corre-
sponding 1,1-dibromoalkene 325, which in turn was formed via a Corey-Fuchs reaction of alde-
hyde 324 with an ylid derived from triphenylphosphine and carbon tetrabromide (Scheme 118).52
Murai also used this methodology in the synthesis of prelaureatin (3).157
Although these two methodologies give reasonable overall yields, it should be possible to se-
lectively install the (Z)-configured olefin in a single step using a Peterson-type olefination reac-
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Scheme 118: Murai’s method for installing the (Z)-configured enyne in obtusenyne (18).52
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Scheme 119: Proposed explanation for the observed stereoselectivity in the Peterson olefination
reaction.159
tion.66, 67, 158–160 This involves the reaction of an allenic-organometallic reagent 329 (formed from
metallation of silyl-containing propyne 328) with an aldehyde 330 (Scheme 119). The observed
stereoselectivity in the reaction is thought to be due to steric considerations in the addition of the
α-silyl carbanion to the aldehyde.159 The addition is believed to occur via a pericyclic process and
consequently the reaction could proceed either through transition state 331-A or 331-B. In tran-
sition state 331-B, the steric interaction between the R’ and SiR3 groups is increased relative to
transition state 331-A, and consequently the energy of the transition state will be higher. There-
fore under the kinetic conditions, reaction via the lower energy transition state 331-A is favoured,
selectively producing the (Z)-configured enyne 333 after elimination of a silanol. As the stereos-
electivity is due to this steric interaction, the size of the trialkylsilane substituent is important in
ensuring good levels of selectivity.
In Denmark’s synthesis of brasilenyne (338) (a non-bromine containing acetogenic natural prod-
uct isolated from the sea hare Aplysia brasiliana161) a Peterson-type olefination reaction was used to
install the (Z)-enyne with good stereoselectivity (Scheme 120).162 1,3-Bis(TIPS)propyne67 (43) was
metallated in situ at low temperature using n-butyllithium and this then underwent reaction with
aldehyde 336 to provide enyne-containing 337 in a very good 83% yield, with the selectivity 6 : 1
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Scheme 120: Peterson olefination using 1,3-bis(TIPS)propyne (43) in Denmark’s synthesis of
brasilenyne (338).162
in favour of the desired (Z)-stereoisomer.
Although this 1,3-bis(TIPS)propyne reagent (43) evidently provides good stereoselectivity, pre-
vious attempts in this group to prepare and isolate this compound have proven unsuccessful.163
Synthesis of the reagent was attempted by Bhuva using Corey’s reported procedure,67 with 1-
(TIPS)propyne (339) being treated sequentially with n-butyllithium and TMEDA, followed by
(TIPS)triflate (Scheme 121). It was found that although the desired 1,3-bis(TIPS)propyne (43)
reagent was formed in excellent yield, 13% of disiloxane 340 was also formed in the reaction.
Unfortunately these two compounds could not be separated even after repeated distillations.163
TIPS
1) nBuLi, TMEDA,
    THF / Et2O, !15°C, 2 h
2) TIPS-OTf
    !78°C " !40°C, 1 h TIPS
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TIPS O TIPS+
339 43
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85%
13%
Scheme 121: Formation of the inseparable disiloxane by-product 340 in the preparation of
1,3-bis(TIPS)propyne (43).163
After the unsuccessful attempts to prepare 1,3-bis(TIPS)propyne (43), Bhuva focused on the
use of 1,3-bis(TMS)propyne (341) instead, as this reagent should be easier to separate from the cor-
responding TMS-disiloxane by-product.163 The reagent was prepared according to Yamamoto’s
procedure159 and was successfully purified. Peterson-type olefination of heptanal using the lithi-
ated derivative of 1,3-bis(TMS)propyne was then undertaken, and it was found that the (Z)-enyne
was formed preferentially in a 2.6 : 1 ratio. The decreased stereoselectivity in comparison to the 1,3-
bis(TIPS)propyne reagent (43) was anticipated due to the presence of the less sterically bulky silyl
group. When this 1,3-bis(TMS)propyne reagent (341) was subsequently used in work towards the
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Scheme 122: Unsuccessful Peterson olefination of aldehyde 342 using 1,3-bis(TMS)propyne
(341).163
synthesis of the obtusallene family of natural products, it was found that there was no observation
of olefination of aldehyde 342 (Scheme 122).163
In 1984, Yamamoto reported that 3-(tert-butyldimethylsilyl)-1-trimethylsilylpropyne (344) gen-
erally gives excellent selectivity for the (Z)-configured enyne due to the steric bulk of the TBDMS
moiety.160 It was also reported that titanium rather than lithium-derived allenic-organometallic
reagents provide superior selectivity in these reactions. Firstly, this is thought to be due to the
larger metal cation promoting regioselective formation of the allenic-titanium derivative, as op-
posed to the acetylenic-titanium one. Also, it is thought that the allenic-titanium reagent contains
a tight metal-carbon bond and this encourages “a tight chelate transition state”.160 This is impor-
tant as it maximises the steric interaction of the R’ substituent of the aldehyde with the SiR3 moiety
of the allenic-titanium reagent, increasing the selectivity for transition state 331-A which provides
the desired (Z)-enyne (Scheme 119).
A Yamamoto-Peterson olefination reaction was used to selectively install a (Z)-enyne in Bur-
ton’s synthesis of the originally proposed structure of elatenyne, a bromine-containing natural
product from Laurencia species.156 Treatment of 344 with tert-butyllithium in the presence of tita-
nium(IV) isopropoxide at low temperature led to the formation of the allenic-titanium derivative in
situ. The reaction of this with aldehyde 345 provided an intermediate silanol, which was converted
to enyne 346 on the addition of a potassium base (Scheme 123). The (Z)-enyne was produced in
good yield and with excellent selectively, over 10 : 1 in favour of the desired stereoisomer. The
good yield and stereoselectivity observed in this reaction provides good precedent for the use
of a Yamamoto-Peterson olefination reaction to selectively install the (Z)-enyne of compound 314
(Scheme 114).
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Scheme 123: Yamamoto-Peterson olefination to selectively install the (Z)-enyne in Burton’s
synthesis of elatenyne.156
Once the (E)- and (Z)-enynes have been selectively installed to form protected chlorohydrins
(E)- and (Z)-314, TBAF-mediated cleavage of the alkynic trimethylsilyl moiety will be followed by
deprotection of the secondary alcohol substituent. Finally, treatment of the resulting compounds
with base should result in deprotonation of the secondary alcohol and subsequent SN2 attack of
the alkoxide onto the carbon-chloride bond. This will regenerate the desired epoxide moiety, and
complete the synthesis of the fully elaborated C15 (E)- and (Z)-configured epoxy-enynes 127.
Prior to any investigations using epoxy-diene 160, the feasibility of the proposed method of
enyne incorporation was investigated using a model system (Scheme 124). Treatment of (Z)-3-
hexen-1-ol (182) with mCPBA in dichloromethane yielded epoxide 183 in 87% yield. Titanium(IV)
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Scheme 124: First attempt at elaboration to an epoxy-enyne in a model system.
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isopropoxide-promoted ring-opening of the epoxide with diethylamine hydrochloride gave an
overall yield of 59%, with the ratio of chlorohydrin regioisomers being 7 : 1 in favour of the 3-
hydroxy-4-chloro-regioisomer 347. Protection of the primary alcohol as the TBDPS ether 348 was
achieved using TBDPS-Cl and imidazole, and this material was used directly without purification
in the acetylation of the secondary alcohol. Gratifyingly compound 349 was produced in 91% yield
over the two steps. Acetate incorporation proved the regiochemistry of the major isomer present,
as the COSY NMR spectrum revealed that the chemical shift of the H-3 proton increased from 4.0
ppm in chlorohydrin 348 to 5.4 ppm in chloroacetate 349. This is consistent for a proton attached
to a carbon that also bears an acetate group.
Deprotection of the primary silyl ether using acetic acid-buffered TBAF conditions furnished
compound 350 in 38% yield. Interestingly, it was found that under the mildly acidic conditions of
the chloroform NMR solvent, there was a rearrangement of the molecule to form the more stable
primary acetate 353, at the expense of the desired secondary acetate 350. This was observed by
loss of the secondary acetate proton signal at 5.4 ppm in the 1H NMR spectrum after a period
of 20 hours. Analysis of a range of NMR spectra demonstrated that there had been complete
conversion to a single carbonyl-containing compound, and mass spectrometry confirmed that the
compound had the same mass as the initial chloroacetate 350. This rearrangement presumably
occurs via initial 6-exo-trig attack of the primary alcohol onto the acid-activated carbonyl, with
overall nucleophilic acyl substitution (Scheme 125). As the Parikh-Doering oxidation is conducted
under basic conditions, it was considered that this observed rearrangement in the NMR solvent
should not be a concern in the next reaction of the synthesis.
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353
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352
Scheme 125: Rearrangement of chloroacetate 350 to form the more stable primary acetate.
Upon treatment of chloroacetate 350 with sulfur trioxide pyridine complex, DMSO and tri-
ethylamine it was found that the major product formed was compound 351, which contains the
α,β-unsaturated carbonyl moiety. This product was identified by 1H NMR spectroscopy, with the
aldehyde signal appearing as a doublet rather than a triplet or double doublet that would be antici-
pated for the desired product. The COSY NMR spectrum showed that the aldehyde signal couples
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with a proton that has a chemical shift in the alkene region, and this subsequently couples with an-
other proton that has a chemical shift in the same region of the spectrum. This connectivity and the
multiplicities of the signals are consistent with being an α,β-unsaturated carbonyl compound. This
presumably arose via oxidation of the primary alcohol to the corresponding aldehyde, followed by
base-mediated elimination of acetic acid in a mechanism similar to that shown for epoxide 310
(Scheme 113).
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Scheme 126: Example of the protection of a secondary alcohol as the corresponding PMB ether
under acid conditions.163
In order to avoid this undesired elimination it seemed apparent that the leaving group abil-
ity of the C-3 substituent had to be substantially reduced. Considering this, and the fact that it
would be necessary for selective deprotection of the primary alcohol silyl protecting group, pro-
tection of the secondary alcohol as an ether, in particular a p-methoxybenzyl ether, seemed to be
a particularly desirable route to pursue. Standard conditions for protection of alcohols as the cor-
responding PMB ethers generally involves deprotonation of the alcohol using sodium hydride,
followed by treatment with p-methoxybenzyl bromide.165, 166 There was a concern however, that
subjecting chlorohydrin 348 to such strongly basic conditions could result in elimination of HCl.
Previously in the group an alternative method for introduction of the PMB protecting group using
p-methoxybenzyltrichloroacetimidate (355) under acidic conditions has been used with reasonable
success (Scheme 126).163 This gave good precedent for the PMB protection of chlorohydrin 348
under acidic, rather than basic, conditions.
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Scheme 127: Preparation of p-methoxybenzyltrichloroacetimidate (355).164
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p-Methoxybenzyltrichloroacetimidate (355) was prepared in good yield and purity from the
reaction of 4-methoxybenzyl alcohol (357) with trichloroacetonitrile (358) under basic conditions
(Scheme 127).164 Alcohol 348 was then treated with p-methoxybenzyltrichloroacetimidate (355)
in the presence of PPTS163 (Scheme 128). After stirring for 3 days at room temperature it was
found that the reaction mixture comprised three components by TLC. The least polar component
was isolated by column chromatography and was found to contain a small amount of the desired
product by 1H NMR spectroscopy. However, one of the components was found to contain a large
amount of unreacted starting material.
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Conditions:
A) PPTS, CH2Cl2 / cyclohexane (1 / 1), r.t., 3 days            trace    
B) TfOH, Et2O, !15°C " r.t., 1.5 h                                          17%
Scheme 128: Attempted PMB protection using p-methoxybenzyltrichloroacetimidate (355) with
PPTS and triflic acid.
In an attempt to increase the conversion to the desired PMB protected 359, catalytic triflic
acid in diethyl ether167 was used instead of PPTS (Scheme 128). After stirring for 1.5 hours TLC
showed that the reaction mixture comprised a large number of components. Column chromatog-
raphy allowed separation of the desired PMB protected compound 359 in 17% yield. However,
this contained two inseparable impurities which appear to be p-methoxybenzyl alcohol (357) and
the ether which would arise from nucleophilic attack of this alcohol onto another molecule of p-
methoxybenzyltrichloroacetimidate (355).
As PMB protection under these acidic conditions had proven unsuccessful, it was considered
that conducting a similar reaction under neutral conditions should be beneficial. Dudley has re-
ported the preparation of a stable compound which can be used to protect both acid- and base-
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Scheme 129: Preparation of 2-(4-methoxybenzyloxy)-4-methylquinoline (361).168
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sensitive alcohols as the PMB ether upon treatment with methyl triflate.168 2-(4-Methoxybenzyloxy)
-4-methylquinoline (361) was prepared from p-methoxybenzyl alcohol (357) and 2-chlorolepidine
(360) in excellent yield and purity (Scheme 129). Alcohol 348 was subsequently treated with 2-(4-
methoxybenzyloxy)-4-methylquinoline (361) in the presence of methyl triflate and potassium car-
bonate (Scheme 130). After purification by column chromatography, the desired product 359 was
found to have been produced in reasonable quantity, although 1H NMR spectroscopy revealed the
same impurities as in the previous PMB protection using p-methoxybenzyltrichloroacetimidate
(355) and triflic acid.
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Scheme 130: PMB protection under neutral conditions using methyl triflate and
2-(4-methoxybenzyloxy)-4-methylquinoline (361).
PMB-protected 359 was used in the next step with a view to separate the impurities at a later
stage. TBDPS cleavage was achieved using the acetic acid buffered TBAF conditions to give the
desired compound 362 after purification by column chromatography (Scheme 131). Although it
was possible to separate alcohol 362 from the impurities of the previous reaction, the yield over
the two steps was just 13%. As PMB protection was providing poor yields of the desired product
with many side-products rendering purification difficult, it was considered that a different ether-
based protecting group should be sought.
The MOM protecting group was chosen as MOM-Cl is commercially available and can be used
with a reasonably weak base such as DIPEA to effect the desired transformation, as opposed to
sodium hydride which is required for the PMB protection of alcohols under basic conditions.
Therefore it was considered that TBDPS protected 348 should be stable to MOM protection, with-
OTBDPS
Cl OH
OH
Cl OPMB
1) 361, MeOTf, K2CO3, toluene
2) TBAF, AcOH, THF
348 362
13%
(over 2 steps)
Scheme 131: PMB protection and TBDPS cleavage to produce alcohol 362.
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out base-mediated elimination of HCl occurring. Gratifyingly, treatment of 348 with MOM-Cl and
DIPEA in dichloromethane provided MOM protected 363 in 96% yield after column chromatog-
raphy (Scheme 132). There was no observation of side-product formation as there was during the
attempted PMB protection.
OTBDPS
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Cl OMOM
MOM-Cl
DIPEA
CH2Cl2
40°C, 22 h348 363
96%
Scheme 132: Protection of the secondary alcohol in 348 as the MOM ether.
Once the secondary alcohol had successfully been protected as the MOM ether, removal of the
primary protecting group was required. Treatment with TBAF (which was buffered with acetic
acid to avoid HCl elimination) resulted in successful cleavage of the silyl-based group to pro-
vide alcohol 364 in 93% yield (Scheme 133). Subsequent oxidation of the primary alcohol to the
aldehyde oxidation level was then necessary to provide the precursor to olefination. Dess-Martin
oxidation of 364 gave clean conversion to the desired aldehyde 365 in 98% yield after work-up
(Scheme 134).
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93%
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0°C ! r.t., 16 h
Scheme 133: TBAF-mediated removal of the silyl protecting group in 363.
With aldehyde 365 now accessible in high yield and purity, a method for incorporating the
enyne functionality was then sought. The first olefination attempted was a Wittig-type reaction
with the ylid derived from phosphonium salt 319, in an effort to install the (E)-enyne selectively in
one step. Phosphonium salt 319 was prepared in 44% yield by stirring 3-bromo-1-(trimethylsilyl)-
1-propyne (366) with triphenylphosphine in toluene (Scheme 135). It was then treated with NaH-
MDS to generate the semi-stabilised ylid in situ. Aldehyde 365 was then added slowly at low
temperature and the mixture allowed to slowly warm to room temperature.
O
Cl OMOM
365
98%
OH
Cl OMOM
364
DMP
CH2Cl2
0°C ! r.t., 1.5 h
Scheme 134: Dess-Martin oxidation of the primary alcohol in 364.
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Scheme 135: Attempted Wittig-type olefination of aldehyde 365.
The mixture appeared to comprise three components by TLC, and these were separated by col-
umn chromatography. It was found that the component which eluted second was very volatile and
all of the mass was lost during rotary evaporation of the column solvent. 1H NMR spectroscopy
revealed that the other two components actually comprised a mixture of compounds. The least
polar component appeared to largely contain the desired product, due to the appearence of sig-
nals in the alkene region of the spectrum, which demonstrated the anticipated multiplicities and
coupling constants for an (E)-configured alkene. However, the product was contaminated with im-
purities that were inseparable by standard column chromatography, and overall this Wittig-type
olefination reaction appears to give a very poor yield of the desired compound, 367.
After the Wittig-type reaction had proven unsuccessful, a Yamamoto-Peterson olefination was
investigated instead for incorporation of the enyne functionality. TMS-TBDMS reagent 344 was
prepared by deprotonation of 1-(trimethylsilyl)propyne (368) using t-butyllithium, followed by
addition of TBDMS-Cl (Scheme 136). Reagent 344 was then treated with t-butyllithium at low
temperature, with subsequent addition of titanium(IV) isopropoxide to form the active allenic
organometallic reagent in situ. Aldehyde 365 was then added slowly at low temperature and
the reaction mixture was allowed to slowly warm to room temperature. The mixture was then
TMS
TBDMS
TMS
1) tBuLi, Et2O
    !5°C, 30 min
2) TBDMS-Cl
    !5°C " r.t., 18 h
368
344
70% TMS
Cl OMOM
O
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1) tBuLi, THF
    !78°C, 1 h
2) Ti(OiPr)4, THF
    !78°C, 15 min
3)
    THF
    !78°C " r.t., 1 h
4) HCl w/u
5) KHMDS, THF
    0°C " r.t., 45 min
369
trace
365
Scheme 136: Attempted Yamamoto-Peterson olefination of aldehyde 365.
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worked-up with aqueous HCl to form the intermediate silanol.
The product of this reaction was subsequently re-dissolved in THF and KHMDS was added
in order to effect elimination of the silanol to form the desired (Z)-enyne. TLC analysis showed
that the product mixture consisted of three components, which were separated by column chro-
matography. However, 1H NMR analysis revealed that each of these components again comprised
a mixture of compounds. The component that eluted second from the column appeared to contain
the desired compound, with similar signals in the 1H NMR spectrum to those described previously.
However, this component comprised only 10 mg, compared to 220 mg of aldehyde 365 which was
used in the reaction. Therefore, neither Yamamoto-Peterson olefination or a Wittig reaction using
phosphonium salt 319 is suitable for installing the desired enyne functionality into this system.
As these methods of installing the enyne directly had proven unsuccessful, it was considered
that a different approach whereby the enyne is installed over two or more steps should be inves-
tigated. In Kim’s synthesis of (+)-3-(E)- and (+)-3-(Z)-pinnatifidenyne (16), complementary meth-
ods were used to install the (E)- and (Z)-vinyl iodides selectively (Scheme 137).47 Stork-Zhao ole-
fination of aldehyde 370 provided (Z)-vinyl iodide 53 exclusively in excellent yield. Alternatively,
Takai olefination of 370 using iodoform and chromium(II) chloride furnished (E)-vinyl iodide 371
as the major product with good selectivity (E : Z = 8 : 1). Compounds 371 and 53 both underwent
Sonogashira coupling reactions with ethynyltrimethylsilane, to provide enynes 372 and 54 respec-
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Scheme 137: Complementary methods for installing (E)- and (Z)-vinyl iodides selectively in
Kim’s synthesis of the pinnatifidenynes ((E)- and (Z)-16).47
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Scheme 138: Takai’s proposed mechanism for (E)-vinyl iodide formation in the Takai olefination
reaction.72
tively. Removal of the TMS groups using TBAF provided the pinnatifidenyne natural products,
((E)- and (Z)-16).
The Takai olefination reaction was initially reported in 1986.72 In the reaction chromium(II)
chloride reacts with either iodoform or bromoform to generate the active organochromium species
375 in situ. This then reacts with an aldehyde to produce predominantly (E)-configured vinyl
iodides and bromides. Selectivities of up to 95 : 5, (E) : (Z) are reported for a range of aldehydes,
with the selectivity only decreasing significantly when α,β-unsaturated aldehydes are used.
In the reaction mechanism proposed by Takai, chromium first replaces two of the iodides on
iodoform, to form organochromium species 375 (Scheme 138), with the chromium being oxidised
from the +II to the +III oxidation state. This carbodianion species then reacts with the aldehyde,
presumably in a manner similar to that of 1,2-addition of a Grignard reagent to an aldehyde. It
is the arrangement of the molecule in the subsequent elimination reaction which is important in
providing the selectivity observed in the reaction. As can be seen in Newman projection 377, the
steric bulk of the alkyl and iodide substituents, and also the steric bulk of the two chromium groups
encourages an anti-arrangement for the elimination. This anti-elimination results in the formation
of an (E)-configured vinyl iodide.
I PPh3I
Cl OMOM
O
Cl OMOM
I
1) KHMDS, THF
    !78°C, 1 h
2) 
    THF
    !78°C, 1 h
365
379 380
Scheme 139: Attempted Stork-Zhao olefination of aldehyde 365.
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Scheme 140: Takai olefination of aldehyde 365 to form (E)-configured vinyl iodide 381 as the
major stereoisomer.
Attempted formation of the (Z)-configured vinyl iodide 380 by treatment of aldehyde 365 with
Stork’s phosphonium ylid70 (generated in situ by deprotonation of phosphonium salt 379) proved
unsuccessful (Scheme 139). This was as anticipated due to the poor conversion observed in the pre-
vious Wittig-type reaction. However, Takai olefination proved more successful, with vinyl iodide
381 being isolated in 54% yield after column chromatography (Scheme 140). The reaction gave a
reasonable level of stereoselectivity, with a 5 : 1 ratio in favour of the (E)-configured stereoisomer.
Cl OMOM
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I
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46%
Pd(PPh3)4, CuI
TMS H
Et2NH
r.t., 3.5 h
Cl OMOM
383
92%
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0°C ! r.t., 24 h
(E : Z = 5 : 1)
(E : Z = 5 : 1) (E : Z = 5 : 1)
Scheme 141: Sonogashira coupling of vinyl iodide 381 with ethynyltrimethylsilane, and
subsequent cleavage of the TMS moiety.
As the (E)- and (Z)-vinyl iodides were inseparable by standard column chromatography, they
were carried forward as a mixture, with a view to separate the two stereoisomers at a later stage
if possible. Sonogashira cross-coupling of vinyl iodide 381 with ethynyltrimethylsilane formed
TMS protected enyne 382 in 46% yield after chromatography (Scheme 141). This was followed by
removal of the TMS moiety using the acetic acid buffered TBAF conditions to furnish the desired
enyne 383 in 92% yield. This just left MOM deprotection and epoxide-formation to be achieved in
order to obtain the target compound.
Acid-mediated removal of the MOM protecting group in 383 was achieved by heating the com-
pound in ethanol at reflux in the presence of PPTS (Scheme 142). This provided the desired chloro-
Cl OMOM Cl OH
384
77%
PPTS
EtOH
90°C, 24 h383
(E : Z = 5 : 1)
(E : Z = 5 : 1)
Scheme 142: MOM deprotection to form enyne-containing chlorohydrin 384.
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hydrin 384 in good yield after column chromatography. Finally, treatment of the chlorohydrin with
base afforded the desired epoxy-enyne 385 in 87% yield after work-up, with no further purification
required (Scheme 143). Although it did not prove possible to separate the enyne stereoisomers by
column chromatography at any stage, the same ratio of E : Z achieved in the Takai reaction was
present in the target epoxy-enyne compound 385. Therefore undesirable enyne isomerisation did
not occur in any of the ensuing reactions.
Cl OH O
384 385
87%
(E : Z = 5 : 1)
K2CO3, MeOH
r.t., 4.5 h
(E : Z = 5 : 1)
Scheme 143: Base-mediated epoxide formation from chlorohydrin 384.
The successful synthetic sequence for formation of epoxy-enyne 385 is summarised in Scheme
144. The route involves masking the epoxide as MOM protected chlorohydrin 364, Dess-Martin
oxidation to form aldehyde 365, Takai olefination, followed by a Sonogashira coupling reaction to
form enyne 382, and finally re-introduction of the epoxide. The target epoxy-enyne compound 385
was prepared in 11 steps from commercially available (Z)-3-hexen-1-ol (182) and in an overall yield
of 7.6%. As methods have now been developed both for the formation of enantioenriched epoxy-
diene 160 and also to incorporate the enyne moiety, then the synthesis of the C15 epoxy-enyne 127
should now be possible.
178
OH OH
O
OH
OHCl
OTBDPS
OHCl
OTBDPS
OMOMCl
OH
OMOMCl
182 183 347
364 363 348
Ti(OiPr)4
NEt2H.HCl
CH2Cl2
r.t., 2.5 days
mCPBA
CH2Cl2
0°C, 2 h 87% 66%
(7 : 1 with minor regioisomer)
TBDPS-Cl
imidazole
THF
0°C ! r.t., 18 h
O
OMOMCl
365
OMOMCl
381
OMOMCl
382
OHCl
384
385
O
TMS
99%
MOM-Cl
DIPEA
CH2Cl2
40°C, 22 h
96%
TBAF
AcOH
THF
0°C ! r.t., 16 h
93%
DMP
CH2Cl2
0°C ! r.t., 1.5 h
98%
I
54%
77%
46%
OMOMCl
383
92%
CrCl2, CHI3
THF
0°C ! r.t., 3.5 h
TMS H
Pd(PPh3)4
CuI
Et2NH
r.t., 3.5 h
(E : Z = 5 : 1)
TBAF
AcOH
THF
0°C ! r.t., 24 h
PPTS
EtOH
90°C, 24 h
K2CO3
MeOH
r.t., 4.5 h
87%
(E : Z = 5 : 1)
Scheme 144: Summary showing the successful sequence for elaboration to an epoxy-enyne.
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4 Conclusion
The overall aim of this project was to provide experimental evidence to support the alternative
biogenesis laid out in the introduction, which postulates that the halogenated medium-ring ether
natural products from Laurencia species arise via bromonium ion-assisted epoxide ring-opening of
an enantiopure epoxide, where water or chloride functions as a nucleophile.
Initial model studies using cyclooctene epoxide 131 found that a range of different nucleophiles
can be incorporated in the bromonium ion-assisted epoxide ring-opening reaction to form bicyclo-
ethers 161 and 162, as well as epoxides 163 and 164 in some cases.131 Importantly, both chloride and
oxygen-based nucleophiles (water, alcohols, carboxylic acids) are effective. It was found that when
acid nucleophiles are used for the reaction, there is an interesting concentration affect whereby
increased dilution favours the formation of bicyclo-ethers 161 and 162 over epoxides 163 and 164.
Once this key bromonium ion-assisted epoxide ring-opening reaction had been developed to
incorporate the relevant nucleophiles in the model system, a suitable analogue of epoxy-enyne
127 had to be targeted. Epoxy-diene 160 was chosen as a suitable target and was prepared in
6 steps via alkyne coupling reactions, hydrogenation and asymmetric homoallylic epoxidation.
Although initial attempts to cyclise epoxy-diene 160 using water and acetate as intermolecular
nucleophiles proved unsuccessful, conversion into Boc-derivative 243 provided a more fruitful
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Figure 29: Summary of some of the key compounds in this work (X = O2CR, OR, OH, Cl, Br).
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approach. Our consideration that the tert-butyl carbonate moiety could function as a suitably
placed intramolecular nucleophile to trap an intermediate oxonium ion species was borne out
when upon treatment with a source of electrophilic bromine (BDSB), six out of the eight anticipated
bromine-containing medium-ring ether compounds were formed (247a, 247b, 248a, 248b, 250a and
250b).
These carbonate compounds, or the corresponding diols, could be separated by extensive col-
umn chromatography and preparative HPLC. A range of NMR techniques alongside comparison
with the NMR spectra of known natural products allowed for the structures and relative stere-
ochemistries of each compound to be assigned. The absolute stereochemistry could then be as-
signed for each compound by consideration of the absolute stereochemistry of the initial epoxide
243. The six compounds, comprised of 7-, 8- or 9-membered ring ethers, were identified as three
pairs of diastereomers, arising from bromonium ion formation on both faces of the C(12)-C(13)
alkene. Oxepine 250b represents the core motif of isoprelaurefucin (5), oxocine 248a exhibits the
core structure of laurencin (1a) and laureoxanyne (4), and oxonines 247a and 247b represent the
core motifs of isolaurallene (11) and itomanallene A (12), respectively.
The isolation of these medium-ring ether compounds firmly supports our proposed biogen-
esis as a real alternative to the long-standing Irie-Murai biogenesis. The biomimetic experiment
conducted demonstrates that the various medium-ring ether core motifs can be generated from a
single (6S,7R)-configured enantiopure epoxide, whereas previously different structural motifs had
been assumed to individually arise from either (6R,7R)- or (6S,7S)-configured laurediols (2a and
2b). Furthermore, this synthetic work in conjunction with the proposed biogenesis described pre-
viously indicates that there are possibly other halogenated medium-ring ether natural products
yet to be isolated from Laurencia species, including 12,13-epi-1b, 12,13-epi-3, 12,13-epi-13, 152, 12,13-
epi-152, 153 and 12,13-epi-153. As well as the six medium-ring ether compounds, a seventh major
compound was also identified in the reaction mixture. This compound is bromine-containing and
exhibits a tetrahydropyran fused to a cyclopropane. It is possible that natural products with this
motif will also be isolated from Laurencia species in the future.
Also, the fact that the medium-ring ether compounds were prepared in a biomimetic fashion
under laboratory conditions (i.e. non-enzymatic conditions) indicates that enzymatic control is
not required in the biogenesis of the natural products. The function of the bromoperoxidase en-
zyme could therefore just be to generate electrophilic bromine (presumably as HOBr and related
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species169, 170), which is then released into solution, going on to react with the C15 epoxy-enyne 127
which is also present, in a diastereoselective, non-regioselective, bromonium ion-assisted epoxide
ring-opening reaction.
Once the feasibility of our alternative biogenesis had been validated, we considered that it
would be interesting to be able to access the actual proposed biogenetic precursor, epoxy-enyne
127, in order to conduct chemical and enzymatic studies. In a similar system it had previously
been observed that undesirable epoxide ring-opening occurred during all attempts to incorporate
an enyne. Therefore an alternative method had to be developed in order to install the enyne adja-
cent to the epoxide. Epoxy-enyne 385 was chosen as a suitable fragment of 127, successfully being
prepared from epoxide 183 via stereospecific epoxide ring-opening, Takai olefination and Sono-
gashira coupling, followed by stereospecific ring-closure to re-form the epoxide. In future work,
this method of epoxy-enyne formation could now be applied to the synthesis of 127.
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Scheme 145: Snyder’s proposed alternative biogenesis.
As we approached the conclusion of this synthetic study into the biogenesis of the halogenated
medium-ring ether natural products via bromonium ion-assisted epoxide ring-opening, a different
alternative biogenesis was proposed by Snyder.171 He postulates that the natural products may
arise from initial cyclisation of one of the laurediol (2a or 2b) alcohols onto a bromonium ion at
C(9)-C(10). This would form a small cyclic ether (e.g. 386, Scheme 145), the oxygen of which could
undergo nucleophilic attack onto a bromonium ion at C(12)-C(13). The resulting oxonium ion (e.g.
387) could then undergo either intramolecular cyclisation, external nucleophilic attack, and / or
elimination to form various natural products.
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Part II
Towards the Total Synthesis of the Obtusallene Natural Products
183
1 Preface
The numbering for the obtusallene family of natural products and related compounds will be
in accordance with the system used for the medium-ring ethers in Part I of this thesis. This is
due to a previously proposed biogenesis for the obtusallene family in which Braddock invokes
epoxy-enyne compound 388 as a precursor (vide infra),172 and this compound is very similar to the
epoxy-enyne 127 which we have postulated for the biogenesis of the medium-ring ethers. This
will allow facile comparison between the structures reported and discussed, with those described
in the literature. It will also facilitate the mapping of intermediates onto the target macrocyclic
compounds, allowing clear discussion regarding transformations observed during reactions. Ex-
amples demonstrating the numbering scheme can be observed in Figure 30. The terminal carbon
atom of the enyne or bromoallene is denoted as C-1, with the carbon atoms being numbered se-
quentially along the carbon chain, up to C-15 for the terminal methyl substituent.
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Figure 30: Numbering scheme used for the obtusallene family of natural products, and all related
compounds in Part II of this thesis.
184
2 Introduction
In addition to the vast array of halogenated medium-ring ether natural products isolated from
Laurencia species, a family of halogen-containing macrocyclic C15 acetogenic natural products have
also been isolated from Laurencia species and organisms that feed on this red algae.
All members of this obtusallene family of natural products (shown in Figure 31) contain a 10-
or 11-membered macrocycle with an ether linkage. They all contain at least one bromine atom
and most also incorporate chlorine. The obtusallenes also characteristically exhibit a bromoallene
motif, apart from the recently isolated 402173 which contains an α,β-unsaturated methyl ester in its
place.
The first member of this family to be reported was isolated from the red alga Laurencia obtusa
in 1982 by Imre.174 Named obtusallene I (392), the structure of this compound was uncovered by
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Figure 31: Originally proposed structures for the obtusallene family of natural products.
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NMR spectroscopy and also X-ray crystallography, thus allowing all of the absolute and relative
stereochemistries to be unambiguously assigned. Obtusallene II (390) was also isolated by the
same group.174 The structure of this natural product was later confirmed by X-ray crystallography,
as was the structure of obtusallene III (394).175
In 1997 a related compound (395) was isolated and reported independently by two different
research groups. Ciavatta isolated the natural product from the digestive gland of the mollusc
Aplysia dactylomela and named it dactylallene.176 The structure was elucidated by NMR techniques
and also X-ray crystallography. Comparison of this compound with the structure of obtusallene II
(390) reveals that they are diastereomers, differing in the absolute stereochemistry at C-4 (S in 390
and R in 395) and also of the bromoallene moiety (R in 390 and S in 395). Guella independently
isolated this same compound from Laurencia obtusa and named it obtusallene IV.177
10-Bromo-obtusallene (393)178 and obtusallenes V-IX (391, 397-400)179 have also been isolated
from Laurencia obtusa. However, no crystallographic data has been reported for these compounds,
with assignments relying largely on NMR techniques. More recently, 12-epoxyobtusallene IV (396),
obtusallene X (401) and the ester-containing natural product 402 were reported by Souto.173 The
structure of 12-epoxyobtusallene IV (396) was confirmed by X-ray crystallography.
To date there have been no reported total syntheses of any of the obtusallene family of nat-
ural products. The varied complexity present in these structures with the different macrocyclic
motifs, stereo-defined bromoallene moieties, large number of stereogenic centres and their poly-
halogenated nature make them attractive, though challenging, synthetic targets.
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2.1 A Hypothesis Concerning the Biogenesis of all Members of the Obtusallene Fam-
ily of Natural Products
In 2006 Braddock proposed a hypothesis for the biogenesis of all known members of the ob-
tusallene family of natural products, whereby increases in structural complexity are introduced
by multiple halogenation events.172 An important intermediate in the biogenetic pathway to the
obtusallenes is proposed to be epoxide-containing 388 (Scheme 146), an analogous compound to
that which is proposed to be the biogenetic precursor to the Laurencia medium-ring ethers. How-
ever, in this case the C(12)-C(13) olefin is required to be (Z)-configured and the C(6)-C(7) epoxide
must have the opposite stereochemistry in order to achieve the correct absolute and relative stere-
ochemistries in the natural products.
Scheme 146 shows how regioselective and stereospecific nucleophilic ring-opening of epox-
ide 388 by chloride can form chlorohydrin 403. Electrophilic bromination of the C(9)-C(10) olefin
followed by 5-exo cyclisation of the C-6 alcohol onto the incipient bromonium ion in a diastereos-
elective manner forms tetrahydrofuran-containing 405 with all of the absolute and relative stereo-
chemistry set for the tetrahydrofuran core of obtusallenes II (390) and IV (397).
Further electrophilic bromination on the C(12)-C(13) olefin results in nucleophilic attack by the
tetrahydrofuran oxygen in a 6-endo manner to produce oxonium ion 407. This oxonium ion can
then undergo base-mediated fragmentation to form allylic bromide 408. Stereospecific SN2’ attack
by water produces cyclisation precursor 389 with loss of bromide. Finally, the formation of a third
bromonium ion on the enyne leads to macrobromoetherification, with attack of the C-14 alcohol
onto the C-4 position of the enyne forming the 11-membered macrocycle and bromoallene moiety
simultaneously. The two different diastereomers of obtusallenes II (390) and IV (395) will arise
from attack of the C-14 alcohol on different faces of the enyne.
With obtusallenes II (390) and IV (395) having been formed, 10-bromoobtusallene (393), ob-
tusallenes I (392), III (394) and V-IX (391, 397-400) can then arise from electrophilic bromination of
the C(12)-C(13) olefin of obtusallene II (390). However, at this stage some consideration is neces-
sary as to which face of the olefin undergoes bromonium ion formation and trapping.
187
OOH
Cl
O
HH
Br
Cl
O
HH
Br
Cl
H
H
Br
O
HH
Br
Cl
Br
O
HH
Br
Cl
OH
O
HH
Br
Cl
Br
OH
ClBr
Br
5-exo
Br
6-endo
B
OH2
O
HH
Br
Cl
OH
Br
Br
O
O
H H
Br
Cl
.
H
Br
H
H
O
O
H H
Br
Cl
.
H
H
Br
H
403
404
405
406
407
SN2'
408
389
409
Obtusallene II (390)
Obtusallene IV (395)
388
Cl
1
4
691215
1
4
6
91215
1
4
6
91215
1
4
69
12
15
1
4
69
12 15
1
4
69
12
15
1
4
69
12
15
1
4
69
12 15
14
69
12
15
1
4
69
12
15
1
4
69
12
15
Scheme 146: Proposed biogenesis of obtusallenes II and IV (390 and 395) from
epoxide-containing 388.172
Upon isolating obtusallene IV (395), Guella discovered that the compound exists as two slowly
interconverting conformers.177 This was evident from temperature-dependent signals in the NMR
spectra. At room temperature in CDCl3 broad signals were observed, which became sharper upon
decreasing the temperature. At −20 ◦C the slow exchange limit was reached and only a single
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Figure 32: Major 410 and minor 411 conformers of obtusallene IV (395) resulting from 180 ◦
flipping of the (E)-C(12)-C(13) olefin.177, 180
conformer was observed. Upon increasing the temperature to 50 ◦C, some signals were found to
sharpen, apart from those for the fragment C(11)-C(15). This led to the conclusion that there is
slow equilibration between two conformers at room temperature, which involves 180 ◦ flipping of
the (E)-C(12)-C(13) olefin (Figure 32).177
Re-examination of the NMR spectra of obtusallene II (390) revealed that there are also two
slowly interconverting conformers of this compound in a ratio of approximately 2 : 1 at −70 ◦C,
with the major one having the same olefin orientation as the minor conformer of obtusallene IV
(Figure 32).177 The minor conformer again arises from 180 ◦ flipping of the trans-alkene. Analysis
of the 1H NMR spectra at the fast and slow exchange limits reveal that there is also the presence of
two additional minor conformers. These are attributed to axial-equatorial interconversions of the
C-10 bromide substituent.177 However, these are comparatively fast exchange processes at room
temperature and do not result in flipping of the alkene, therefore they do not impact upon the
conversion of obtusallene II (390) into the other natural products. Similar conformational affects
have been observed for a number of other natural products from this family.177, 179
Analysis of the C-12 and C-13 stereochemistries of the obtusallenes (391-394, 397-400) that are
proposed to arise from obtusallene II (390) reveals that the exo-face of the major conformer of the
C(12)-C(13) olefin must undergo electrophilic bromination. Braddock proposes that after bromo-
nium ion formation on this alkene (412), nucleophilic attack by the well-positioned tetrahydrofu-
ran oxygen in an SN2 manner can occur in a 6-endo mode to form oxonium ion 413, or alternatively
5-exo to produce oxonium ion 421 (Scheme 147).172
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Scheme 147: Proposed biogenesis of 10-bromoobtusallene and obtusallenes I, III, V, VI, VII, VIII
and IX from obtusallene II (a originally proposed structure).172
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Base-mediated abstraction of one of the C-5 protons in tricyclic oxonium ion 413 results in
the formation of tetrahydropyran-containing 414, which can undergo HBr elimination at the C(9)-
C(10) position to form obtusallene I (392), with all of the correct absolute and relative stereochem-
istry. (Alternative elimination of HBr to form an enol ether at C(12)-C(13) is not possible as these
substituents do not have an antiperiplanar arrangement.) Further electrophilic bromination of this
newly formed alkene (415) and neighbouring group participation of the tetrahydropyran oxygen
results in the formation of oxonium ion 416. Elimination of the C-10 proton quenches the oxonium
ion and furnishes the natural product 10-bromoobtusallene (393).
Neighbouring group participation of the C-10 bromide in tricyclic oxonium ion 413 can pro-
vide bromonium ion 417. Stereospecific nucleophilic attack by oxygen at the C-10 position of the
bromonium ion forms a different tricyclic oxonium ion 418. This can undergo a similar fragmen-
tation pathway as oxonium ion 413 with base-mediated elimation of a proton at C-5 furnishing a
new tetrahydrofuran-containing compound 419. This tetrahydrofuran is well-positioned for SN2’
attack on the allylic chloride present in 419. A second stereospecific SN2’-like attack, this time by
water, at C-7 results in quenching of the incipient oxonium ion. Finally, nucleophilic substitution
of the two secondary bromide substituents present with inversion of stereochemistry provides the
reported structure of obtusallene III (394).
Alternatively, stereospecific attack by water at the C-6 position of oxonium ion 421 arising from
5-exo attack on bromonium ion 412, results in the formation of compound 422 (Scheme 147). This
compound is identical to obtusallene VII (391) in terms of the carbon skeleton and all relative
and absolute stereochemistries, apart from the fact that the chloride and bromide substituents are
interchanged. In the reported structure of obtusallene VII (391) bromide is present at C-7 and
chloride at C-13, whereas in compound 422 this is reversed.
Formation of an enol ether at C(9)-C(10) can occur by base-mediated elimination of HBr, which
is in an antiperiplanar arrangement. This enol ether undergoes either electrophilic bromination
or protonation, with participation of the tetrahydrofuran oxygen to form oxonium ion 423 (R =
H or Br). Subsequent 5-exo-trig attack by the C-6 alcohol onto the oxonium ion furnishes spiro-
ketal containing 424 and 425. Again, these compounds 424 and 425 have exactly the same carbon
framework and stereochemistry as some reported natural products, although in obtusallenes V
and VI (397 and 398) there is reported to be bromide at C-7 and chloride at C-13, whereas in
compounds 424 and 425 there is chloride at C-7 and bromide at C-13.
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Finally, hydrolysis of the spiro-ketal moiety in 424 and 425 and base-mediated elimination of
HCl from C(7)-C(8) produces compounds 427 and 428. These dihydrofuran-containing macrocy-
cles bear the same carbon framework as the reported structures of obtusallenes VIII and IX (399
and 400), and also bear the same halogen and oxygen substituents at the correct positions. How-
ever, the stereochemistry of the bromide-bearing carbon at C-13 is inverted in 427 and 428 relative
to that reported for obtusallenes VIII and IX (399 and 400).
This hypothesis by Braddock accounts for the biogenesis of all members of the obtusallene fam-
ily of natural products, as known in 2006.172 It correctly predicts the structures and all absolute
and relative stereochemistries of obtusallenes I-IV (390, 392, 394 and 395) and 10-bromoobtusallene
(393), four of which have had their structures unambiguously confirmed by X-ray crystallography.
The hypothesis also correctly predicts the carbon skeletons of obtusallenes V-IX (391 and 397-400)
as well as the vast majority of the substituents and stereochemistries. The reported structures of ob-
tusallenes V, VI and VII (397, 398 and 391) differ from the structures predicted in the analysis (424,
425 and 422) by placement of the halogen substituents, and the reported structures of obtusallenes
VIII and IX (399 and 400) differ from the predicted structures (427 and 428) by the stereochem-
istry present at C-13. However, the structure elucidation and stereochemical assignments for these
natural products relied on NMR spectroscopic techniques as opposed to X-ray crystallography.
Therefore some investigations were carried out within this group in order to probe the validity of
this hypothesis for the biogenesis, and also to determine whether some of the previously reported
structures should be re-assigned.102, 116, 181
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2.2 Model Studies to Support the Proposed Biogenesis of the Obtusallenes via Elec-
trophilic Bromination Events, and Structural Reassignment of Obtusallenes V, VI
and VII
Initial studies focused on a biomimetic synthesis of the tetrahydrofuran core of obtusallenes II
and IV (390 and 395).102 Bromoetherification precursor 429 was prepared via regioselective Sharp-
less asymmetric dihydroxylation of a doubly-skipped triene (not shown), to provide diol 429 in
28% yield and 93% e.e. This was then treated with 1.8 equivalents of TBCO to furnish two prod-
ucts in a 12 : 1 diastereomeric ratio (Scheme 148). The compounds could be separated by column
chromatography and the major diastereomer 430 proved to be crystalline after cleavage of the silyl
protecting group. X-ray crystallography showed that this major diastereomer does in fact exhibit
anti stereochemistry across the tetrahydrofuran oxygen, as is required for obtusallenes II and IV
(390 and 395).
With the successful preparation of des-chloro compound 430, a method for early chloride intro-
duction was targeted which should allow for the synthesis of the fully elaborated tetrahydrofuran
core of obtusallenes II and IV (390 and 395).102 A skipped-diene, which was to become chloro-
hydrin 431, was prepared by a double Wittig reaction of a bis-phosphonium salt with heptanal.
This provided the desired product in 96% yield and with good selectivity for the all cis isomer.
Monoepoxidation with mCPBA was followed by treatment with trimethylsilylchloride and triph-
enylphosphine. Quenching this reaction with TBAF provided a mixture of two chlorohydrin re-
gioisomers, which could be separated by careful column chromatography to provide the desired
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Scheme 148: A biomimetic synthesis of the tetrahydrofuran core present in obtusallenes II and IV
(390 and 395).102
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product 431. Subsequent treatment of this with TBCO in dichloromethane initiated bromoether-
ification, providing the desired anti product 432 as a single diastereomer and in a yield of 76%
(Scheme 148).102
With a method having been developed for the biomimetic synthesis of the fully elaborated
tetrahydrofuran core of obtusallenes II and IV (390 and 395), attention within the group turned to
investigating the proposed conversion of obtusallene II (390) into obtusallene VII (391), and indeed
to determine whether the structure of this natural product should be reassigned (from 391 to 422,
Scheme 147). Two model systems, 433 and 436, with the core structural motif of obtusallene II
(390) were prepared by initial biomimetic tetrahydrofuran formation and subsequent ring-closing
metathesis using Hoveyda-Grubbs I catalyst to construct the 11-membered macrocycles.116 Both
433 and 436 exhibit the same relative stereochemistries at C-6, C-7, C-9 and C-10 as obtusallene
II (390). They also both contain the required (E)-configured alkene at C(12)-C(13), as has been
confirmed by X-ray crystallography for both model macrocycles 433 and 436. Indeed, compari-
son of these X-ray crystal structures with that of obtusallene II (390) itself revealed them to have
essentially the same structure aside from a local change in conformation at C(14)-O-C(4)-C(5), pre-
sumably due to the absence of the bromoallene moiety in this portion of the molecule. This small
change in conformation was thought to be of little consequence for the purpose of investigating
the proposed interconversion.
Once chloride-containing macrocycle 433 had been prepared, it was subjected to the action of
NBS in deuterated chloroform with added water (Scheme 149).116 After 20 days the complex mix-
ture of products was separated by column chromatography and two compounds with obtusallene
VII-type structure were isolated, 434 and 435. It was found that bromide rather than the antici-
pated hydroxyl group was present at C-6, presumably due to the formation of molecular bromine
in situ by decomposition of NBS.
X-ray crystallography of both compounds revealed that 434 is a diastereomer of 435, differ-
ing in the stereochemistry at C-12 and C-13. This must arise from electrophilic bromination on
the exo faces of both alkene conformers. Although the yields of these two products was low (8%)
and bromide acted as a nucleophile at C-6 instead of water, compound 435 represents the core
structure of obtusallene VII with all of the relative stereochemistry correctly set. This compound
must arise from electrophilic bromination of the C(12)-C(13) alkene, 5-exo attack by the tetrahy-
drofuran oxygen at C-12 to form an oxonium ion, with subsequent fragmentation of the oxonium
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Scheme 149: Model studies investigating the postulated conversion of obtusallene II (390) into
obtusallene VII.116
ion by stereospecific attack by bromide at C-6. This is in line with the hypothesis proposed by
Braddock,172 and importantly the X-ray structure unambiguously places the chloride at C-7 and
the bromide at C-13, which supports a reassignment of the structure of obtusallene VII to 422 as
opposed to the initially reported 391.
Acetate-containing macrocycle 436 was also prepared in order to encourage conversion to the
obtusallene VII-type framework by neighbouring group participation of the acetate moiety.116
Treatment of 436 with NBS in dichloromethane resulted in the formation of compounds 437 and
438 after 4 days (Scheme 149). The compounds could be separated by column chromatography and
the structure of 437 was elucidated by X-ray crystallography. The structure of 438 was deduced
by converting both compounds to the corresponding bis-acetate and comparing the NMR spectra.
As the acetate is present at C-7 in 437 and C-6 in 438 the anticipated neighbouring group partici-
pation of the acetate moiety must have occurred. Therefore, after formation of the bromonium ion
and trapping in a 5-exo sense, the C-7 acetate must have undergone nucleophilic attack at the C-6
position of the oxonium ion, thereby ensuring an obtusallene VII-like motif. Adventitious water
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would have then quenched this charged intermediate to form 437 and 438. Although the macro-
cyclic skeleton produced is that of obtusallene VII, the stereochemistry at C-12 and C-13 is inverted
to that which is found in the natural product and evidently arises from electrophilic bromination
on the opposite face of the olefin to that required. However, this experiment still demonstrated the
validity of the proposed formation of obtusallene VII from obtusallene II (390).
In an effort to improve the yields and also the reaction times a further set of conditions were
investigated. Chloride-containing macrocycle 433 was treated with NBS in dichloromethane and
acetic acid was used as the nucleophile, with a catalytic quantity of TMG132 (Scheme 149).116 It was
found that two compounds, 439 and 440, could be isolated after column chromatography, in pleas-
ing yields of 30% and 13% respectively. It was found that compound 439 exhibits the macrocyclic
framework of obtusallene VII and contains halogen substituents at C-7, C-10 and C-13 and also an
oxygen-based substituent at C-6, as required in the natural product. Although it was not possi-
ble to assign the stereochemistry at C-12 and C-13, it is important to note that again, the chloride
substituent is present at C-7 and the bromide at C-13, in contrary to what was initially reported
as the structure for obtusallene VII (391).179 These successful bromonium ion-induced rearrange-
ments that place the bromide at C-13 instead of C-7 in accordance with Braddock’s hypothesis,172
prompted the reassignment of the structure of obtusallene VII from 391 to 422.116
Interestingly, the other compound 440 which was isolated from this third rearrangement reac-
tion (Scheme 149) represents a structural motif, which at the time, had not been observed in any
natural products isolated from Laurencia species. This compound must arise from 5-exo attack of
the tetrahydrofuran oxygen onto the C-12 position of an incipient bromonium ion, as in the case
of the formation of obtusallene VII-like 439. However, rather than nucleophilic attack by acetate
at the C-6 position of the oxonium ion, acetate instead undergoes stereospecific SN2 attack at C-9,
thus providing the bicyclic structure of 440. This compound has had its structure and all relative
stereochemistries confirmed by X-ray crystallography.
The isolation of this different structural motif prompted Braddock to propose that “it may rep-
resent the core of an as yet undiscovered natural product from Laurencia species.”116 Recently,
Souto reported the isolation of four new halogenated C15 acetogenins from Laurencia marilzae (Fig-
ure 33).180 Gratifyingly these compounds were found to have the same core structural motif as
compound 440. The isolation of these compounds strongly supports the hypothesis of how the
members of the obtusallene family of natural products arise.172
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Figure 33: The marilzabicycloallene family of natural products.180
Named marilzabicycloallene A-D (441-444), it was found that at the C-13 position there is either
a hydroxyl group or a chloride present, as opposed to the bromide found at this position in 440.
Souto proposes that this arises from epoxidation or chloronium ion formation on the C(12)-C(13)
alkene, instead of bromonium ion formation (Scheme 150).180 Epoxidation on the exo face of the
C(12)-C(13) olefin of the major conformer of obtusallene II (390) forms compound 445. This can un-
dergo 5-exo attack by the tetrahydrofuran oxygen to provide tricyclic oxonium ion 446, in an anal-
ogous way to the rearrangement to form obtusallene VII (422). Finally, stereospecific nucleophilic
attack by an oxygen-based nucleophile at C-9 results in fragmentation of the oxonium ion to form
marilzabicycloallene A (441) or marilzabicycloallene C (443). Alternatively, electrophilic chlorina-
tion on this same alkene conformer of obtusallene II (390) results in the formation of chloronium
ion 447. Attack in a 5-exo manner by the tetrahydrofuran oxygen provides oxonium ion 448, which
subsequently undergoes fragmentation by chloride attack at C-9, providing marilzabicycloallene
D (444).
Analysis of the stereochemistry of the bromoallene moiety and also the C-4 position of marilz-
abicycloallene B (442) reveals that it must arise from obtusallene IV (395). Epoxidation of the exo
face of the minor conformer of the C(12)-C(13) olefin forms compound 449 (Scheme 150). Again,
this can undergo 5-exo attack by the well-placed oxygen of the tetrahydrofuran to form tricyclic
oxonium ion 450. Finally, attack by water at C-9 in a stereospecific manner results in the formation
of marilzabicycloallene B (442). The structure of epoxide 449 looks remarkably similar to that of 12-
epoxyobtusallene IV (396), a natural product recently reported by the same research group (Figure
31).173 Analysis of the stereochemistry of the epoxide moiety and also that of the bromoallene motif
and C-4 position, reveals that 12-epoxyobtusallene IV (396) must arise from epoxidation of the exo
face of the C(12)-C(13) olefin of the major conformer of obtusallene IV (395).180 The recently dis-
covered natural product 402173 must arise from subsequent rearrangement of 12-epoxyobtusallene
IV (396) by virtue of the stereochemistry at the C-4 position and also the C(12)-C(13) epoxide being
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Scheme 150: Proposed biogenesis of the marilzabicycloallene family of natural products.180
identical (Scheme 151). Epoxide formation on the bromoallene of 12-epoxyobtusallene IV (396)
would provide 404, which after neighbouring group participation by the bromide would furnish
bromonium ion 454. This is then ready to undergo the key rearrangement, where a hydride mi-
grates from C-1 to C-2, with ring-opening of the bromonium ion, to form α,β-unsaturated 455.
Hydrolysis of the acid bromide followed by methylation of the resulting acid would furnish the
natural product, 402.
The only remaining natural product that has not had a biogenesis proposed for it is obtusal-
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lene X (401). This compound was also discovered by Souto173 and reported in 2011. Analysis of
the stereochemistry around the bromoallene motif reveals that obtusallene X (401) must arise from
obtusallene IV (395). It is possible to envisage two biogenetic routes to this natural product, one
involving electrophilic bromination and the other via 12-epoxyobtusallene IV (396) (Scheme 151).
The (12R,13R)-configuration of the natural product, along with the fact that the alkene present in
obtusallene IV (395) is trans reveals that obtusallene X (401) must be formed from a (12R,13R)-
configured epoxide or bromonium ion. Therefore either the C-12 or C-13 position must undergo
double inversion in order to preserve the (R,R)-stereochemistry. This precludes the formation of
the bromohydrin in obtusallene X (401) via direct opening of a bromonium ion with water. Pre-
sumably this method of bromohydrin formation could not occur anyway as the tetrahydrofuran
portion of the molecule would encumber backside attack onto a bromonium ion formed on the exo
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Scheme 151: Proposed biogenesis of 12-epoxyobtusallene IV (396),180 402 and obtusallene X (401)
from obtusallene IV (395).
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face of the C(12)-C(13) olefin.
However, after bromonium ion formation (451) on the exo face of the alkene of the major con-
former of obtusallene IV (395), the tetrahydrofuran oxygen could undergo nucleophilic attack at
C-13 in a 6-endo sense to provide tricyclic oxonium ion 452 (Scheme 151). Subsequent stereospecific
attack by water at C-13 would result in fragmentation of the oxonium ion to provide the required
(12R,13R)-bromohydrin of obtusallene X (401). Alternatively, 5-exo attack of the tetrahydrofuran
oxygen of 12-epoxyobtusallene IV (396) onto the C-12 position of the epoxide would produce tri-
cyclic oxonium ion 453. Subsequent SN2 attack by bromide at the C-12 position of the oxonium
ion would result in the formation of obtusallene X (401) with all of the relative stereochemistry
correctly set.
With this proposal for the biogenesis of these newly discovered natural products (398, 401
and 402) along with Souto’s proposed biogenesis for the recently reported marilzabicycloallenes
(441-444),180 and Braddock’s original proposal172 for the biogenesis of obtusallenes I-IX (390-400),
a consistent and tested102, 116 hypothesis for the biogenesis of all known members of the wider
obtusallene family of natural products has been described. All that remains is to address the dis-
crepancies between the reported structures of obtusallenes V, VI, VIII and IX (397, 398, 399 and
400) and the structures that are predicted by the proposed biogenesis (424, 425, 427 and 428).172
The reported structures of the natural products obtusallenes V and VI (397 and 398) place a
bromide substituent at C-7 and a chloride substituent at C-13. However, Braddock’s proposed bio-
genesis requires chloride to be present at C-7 and bromide at C-13.172 In 2008 Braddock and Rzepa
reported the use of GIAO-based density functional prediction to provide evidence to support the
reassignment of these structures.181 Calculated 13C NMR chemical shifts for all 15 carbon atoms in
the reported structure of obtusallene V (397) were compared to the reported values. It was found
that the calculated shifts were in good agreement with those reported, apart from at the C-7 and
C-13 positions. These were found to differ by approximately 12-13 ppm from the reported values.
When the same process was repeated for Braddock’s proposed structure for obtusallene V (424), it
was found that the discrepancy in chemical shift for these carbons decreased to approximately 0.5-
1.5 ppm. As it is these positions that bear the halogen substituents in question, this computational
study consequently provides strong evidence for the positioning of chloride at C-7 and bromide at
C-13, in line with Braddock’s proposed structure (424). The same affects were observed when the
reported (398) and proposed (425) structures for obtusallene VI were subjected to this computa-
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tional study.181 A sample of obtusallene V that had been donated to this group later proved to be
crystalline and gratifyingly X-ray crystallography confirmed the structure of the natural product
is that of 424, with the bromide and chloride substituents transposed.116
In the case of obtusallenes VIII and IX (399 and 400) it is just the stereochemistry at the C-13 po-
sition which differs from that predicted by Braddock’s hypothesis.172 In order to unambiguously
define the stereochemistry at this position, either X-ray crystallography or total synthesis of the
natural product would be required. However, with the model rearrangements,116 computational
studies,181 X-ray crystal structure of obtusallene V116 and the recent isolation of the marilzabicy-
cloallene natural products180 providing a great deal of evidence to support Braddock’s proposed
biogenesis,172 it may be anticipated with some confidence that the structures of obtusallenes VIII
and IX will be reassigned from 399 and 400, to 427 and 428 respectively, in the future.
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2.3 Initial Approach Towards the Total Synthesis of Obtusallenes II and IV
The first approach adopted by this group for the synthesis of obtusallenes II and IV (390 and
395) incorporated biomimetic steps for both the tetrahydrofuran and macrocycle formation.163 The
synthesis of macrobromoetherification precursor 474, which is summarised in Scheme 152, began
with commercially available trans-β-hydromuconic acid (456). Double esterification to dimethyl
ester 457 was followed by lithium aluminium hydride-mediated reduction to the corresponding
diol 458. After some optimisation, mono-silyl protection of diol 458 could be achieved in 45% yield
to furnish 459. The remaining alcohol was then oxidised to aldehyde 460 using the Dess-Martin
periodinane reagent and this underwent a Wittig olefination reaction with phosphorous ylid 461
to furnish doubly-skipped triene 462.
With this compound in hand, the next step was to be a regioselective Sharpless asymmetric
dihydroxylation to prepare diol 429. At the time there was no literature precedent for a regios-
elective dihydroxylation of a doubly-skipped triene.163 After some investigation Bhuva found
that a regioselective trans vs cis vs terminal Sharpless asymmetric dihydroxylation could indeed be
achieved, with preference for dihydroxylation of the trans-olefin.102, 163 Diol 429 was formed in
a modest yield of 28%, with the rest of the mass-balance from the reaction comprising mostly of
tetrols and hexols, as well as unreacted starting material.
Once this enantioenriched diol had been prepared, the stage was set for the first biomimetic
reaction. Treatment of 429 with TBCO in dichloromethane resulted in the desired diastereoselective
bromoetherification reaction, providing tetrahydrofuran 430 in 87% yield.102, 163 Acetylation of the
secondary alcohol to give 463 was followed by an (E)-selective cross metathesis with 3-buten-2-one
(464), catalysed by Hoveyda-Grubbs catalyst, to provide compound 465 in 81% yield.
Subsequent CBS asymmetric reduction of the carbonyl in α,β-unsaturated compound 465 was
achieved using borane and the chiral oxazaborolidine 466. After work-up with methanol this
formed alcohol-containing 467 in 83% yield and 78% d.e. PMB protection (468) using reagent
355, followed by TBDPS deprotection (469) and DMP-mediated oxidation of the resulting primary
alcohol furnished aldehyde 470. The enyne portion of the compound was then incorporated via
a Wittig reaction with phosphonium ylid 471 to produce 472 in 37% yield and with exclusive (E)-
stereochemistry. DDQ-mediated deprotection of the PMB group (473) and removal of the TMS
moiety using TBAF buffered with acetic acid resulted in the formation of macrobromoetherifica-
tion precursor 474.
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Scheme 152: First approach towards the total synthesis of obtusallenes II and IV (390 and 395),
with the preparation of macrobromoetherification precursor 474.163
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With macrobromoetherification precursor 474 in hand, Bhuva attempted to perform the de-
sired macrocyclisation (Scheme 153).163 Initially, TBCO was chosen as the source of electrophilic
bromine and the reaction was conducted in both deuterated chloroform and dichloromethane
(Conditions A and B). After 4 h at −60 ◦C, 3 h at −20 ◦C and 12 h at room temperature it was
found that no reaction had occurred and starting material 474 was exclusively recovered.
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Scheme 153: Attempted macrobromoetherification of compound 474.163
After TBCO had proven unsuccessful, the source of electrophilic bromine was changed to NBS.
NBS had proven to be much more successful than TBCO at encouraging bromoetherification in a
model enyne system.154, 163 NBS was added to 474 in deuterated chloroform at−60 ◦C and this was
then left at room temperature for 12 h (Condition C, Scheme 153). After this time Bhuva assessed
that approximately 80% of the starting material remained, but some had been converted to an
unidentified compound. Heating the reaction mixture at 60 ◦C for 7 h had no further affect, so a
further equivalent of NBS was added. After 2 days at room temperature it appeared that there had
been decomposition of the starting material.163
As macrocyclisation just in the presence of a source of electrophilic bromine had proven un-
successful, it was decided to use a metal-template in order to assist the desired macrobromoether-
ification. It was considered that this could bind to both the C-14 alcohol and the tetrahydrofuran
oxygen in order to place the molecule in a conformation that should encourage cyclisation. Sodium
triflate was chosen as a suitable reagent as the sodium cation should be of a convenient size for its
desired function, and importantly the triflate counterion is non-nucleophilic. NBS and sodium
triflate were added to 474 in deuterated chloroform at −60 ◦C and left for 2 h, followed by 3 h at
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−20 ◦C. There was no reaction after this time so the mixture was left at room temperature for 12 h.
It was found that the major component was the starting material 474, but interestingly the H-1
and H-3 protons under-integrated by approximately 20-25%. As it was the enyne protons that were
under-integrating, it appeared that there may have been bromoallene formation. Bhuva initially
suggested that the desired macrobromoetherification may be occurring, or alternatively the C-7
acetate moiety may be attacking the C-4 position of the brominated enyne in a favourable 5-exo-
trig manner.163 However, after closer inspection of the 1H NMR spectrum it was concluded that
none of the compounds in the reaction mixture was bromoallene-containing. Unfortunately there
was not enough material to acquire a 13C NMR spectrum of the reaction mixture, and due to lack
of material no further investigations into the macrobromoetherification reaction could be carried
out.
205
2.4 Second Approach Towards the Total Synthesis of Obtusallenes II and IV
As this initial attempt involving macrobromoetherification of 474 had proven unsuccessful, a
different approach towards the total synthesis of obtusallenes II and IV (390 and 395) was required.
Issues that needed to be addressed were the poor yield in the Sharpless asymmetric dihydroxyla-
tion reaction, the low yield of the Wittig reaction, and the nature of the C-7 substituent to ensure
that the acetate does not interfere with the macrocycle formation. There was also a desire to reduce
the number of protection and deprotection steps in order to render the route more efficient.153
It became apparent that an alkyne coupling strategy followed by hydrogenation may provide
a facile and efficient route to the skipped triene compound. Scheme 154 shows the final synthetic
route developed within this group by Solanki.153 Allyl bromide (477) was coupled with propargyl
alcohol (167) in the presence of copper iodide, sodium iodide and potassium carbonate, to furnish
enyne 478. The alcohol was then converted to the corresponding bromide 479 under Appel con-
ditions and subsequently underwent a second alkyne coupling reaction, this time with 3-butyn-
1-ol (171). Hydrogenation of enediyne 173 using palladium on barium sulfate, poisoned with
quinoline, furnished doubly-skipped triene 174 in good purity after silver-nitrate impregnated col-
umn chromatography. This compound then underwent a regioselective asymmetric homoallylic
epoxidation using one of Yamamoto’s reported ligands,121, 122 along with catalytic vanadium(V)
oxytriisopropoxide and CHP, to provide epoxy-diene 480 in 57% yield and 72% e.e.
As work conducted with a model system had revealed that early chloride introduction would
be possible without affecting the biomimetic tetrahydrofuran formation, this was pursued in the
actual system.102, 153 Consequently, epoxide 480 was subjected to Lewis acid-mediated chloride
ring-opening in a regioselective manner to form chlorohydrin 481, in a 5 : 1 ratio with the minor
6-chloro regioisomer. After protection of the primary alcohol as TBDPS ether 482, it was found that
the two chlorohydrin regioisomers were separable by column chromatography. Treatment of 482
with TBCO resulted in the desired biomimetic bromoetherification reaction occurring to provide
483 with the required diastereoselectivity and in a yield of 80%. This represents the fully elaborated
THF core of obtusallenes II and IV (390 and 395) with all relative and absolute stereochemistry
correctly set.116, 153 Subsequent TBDPS deprotection (484) using TBAF buffered with acetic acid163
was followed by DMP oxidation to give aldehyde 485.
206
Br
OH
OH Br
OH
OHOHOH
O
Cl
OH
OH
Cl
OH
OR
O
Cl
Br
H H
OR
O
Cl
Br
H H
OHO
Cl
Br
H H
OO
Cl
Br
H H
OMe
OMe
O
Cl
Br
H H
O
O
OH OH
O
Cl
Br
H H
CN
O
TMSO
O
Cl
Br
H H
CN
O
HO
O
Cl
Br
H H
CN
O
O
Si
O
O
H H
Br
Cl
CN
479478
167
477
171
173174480
R = TBDPS; 483R = TBDPS; 482481
484485486
487
490489
488
492
493
CuI, NaI
K2CO3
acetone
r.t., 20 h
CBr4, PPh3
CH2Cl2
CuI, NaI
K2CO3, DMF
r.t., 16 h
!20°C " r.t.
1 h
56%
(over 3 steps)
H2, quinoline
Pd-BaSO4
MeOH
r.t.
50%
V(O)(OiPr)3
199, CHP
toluene
57%
r.t., 72 h
N
N
OH
O
CAr3
OH
O
CAr3
Ar  =
199
Et2NH.HCl
Ti(OiPr)4, CH2Cl2
r.t., 72 h
TBDPS-Cl
imidazole
THF
0°C " r.t.
20 h
77%
(over 2 steps)
TBCO
CH2Cl2
!60°C " r.t.
20 h
80%
77%
TBAF, AcOH
THF, 22 h
0°C " r.t.
DMP
CH2Cl2
0°C " r.t.
16 h
HC(OMe)3
PTSA
CH2Cl2
0°C " r.t.
4 h
CSA, CH2Cl2
40°C, 20 h
67%
(over 3 steps)
TMS-CN
Me2AlCl
CH2Cl2
!78 " 40°C
20 h
TBAF, AcOH
THF
0°C, 1 h
50%
(over 2 steps)
Si
Cl
491
NEt3, DMAP
CH2Cl2
r.t., 21 h
72%
HGI
toluene
110°C, 18 h
28%
Scheme 154: Second approach towards the total synthesis of obtusallenes II and IV (390 and 395),
with the preparation of cyano-containing macrocycle 493.153
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The initial plan was to install the C(14)-C(15) portion of the molecule via a cross metathesis of
the terminal olefin of 483 with 1-butene. A biomimetic allylic oxidation mediated by electrophilic
bromine could then be used to incorporate the C-14 alcohol. After formation of the C(1)-C(4) enyne
moiety, this compound would then be used to investigate the biomimetic macrobromoetherifica-
tion reaction.153
Due to the low yielding nature of the Wittig reaction to install the enyne and the poor results
in the previous attempts at macrobromoetherification (vide supra), an alternative approach was
sought. After the success in forming the model macrocycles by ring-closing metathesis,116 this
method was pursued instead of macrobromoetherification.
One terminal olefin was already in place for the RCM reaction, but the other one still needed
to be incorporated, as well as the stereo-defined methyl substituent at C-14. Aldehyde 485 was
treated with trimethyl orthoformate and PTSA in dichloromethane to form dimethyl acetal 486.
Transacetalisation with diol 487182 formed acetal 488 in 67% yield from 484. Lewis acid-assisted
nucleophilic opening of the acetal by cyanide resulted in the formation of two diastereomers of
489, in a 2 : 1 ratio. The incorporation of the nitrile moiety was important as it was envisaged
that this would later allow for incorporation of the bromoallene motif. The two diastereomers of
489 formed are epimeric at C-4, in the same way as obtusallene II (390) and obtusallene IV (395)
are epimeric at C-4. Therefore one diastereomer of 489 could be elaborated to obtusallene II (390)
whilst the other could be elaborated to obtusallene IV (395).153
Compound 489 and the deprotected analogue 490 were both initially subjected to RCM condi-
tions. However, after treatment with Hoveyda-Grubbs I catalyst at reflux for 18 hours only cross
metathesis to form dimers was observed, with no formation of the desired macrocycle. Solanki
then chose to investigate the use of a relay-RCM reaction in order to overcome the unfavourable
entropy of the macrocycle formation.153 Described by Hoye in 2004,183 in a relay-RCM reaction an
additional unhindered olefin is incorporated into the molecule and situated 4-5 bonds away from
a sterically encumbered olefin that is required to undergo RCM. The ruthenium catalyst therefore
reacts firstly with this additional unhindered olefin and secondly with the nearby, more hindered,
olefin. This results in the loss of a 5- or 6-membered ring, but importantly places the ruthenium on
the hindered olefin which can then undergo a reaction with the third remaining olefin to form the
desired macrocycle.
Attempts to allylate the secondary alcohol in 490 were unsuccessful, but it was possible to in-
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corporate allylchlorodimethylsilane 491 to form relay-RCM precursor 492.153 Compound 492 was
heated at reflux in toluene overnight with a catalytic amount of Hoveyda-Grubbs I. Three com-
ponents were isolated by column chromatography after the reaction: two appeared to be cross
metathesis dimer products, whereas the third appeared promising for the desired macrocycle. The
1H NMR spectrum contained broad resonances which were in good agreement with those pub-
lished for obtusallene II (390) and HRMS confirmed the molecular formula for the desired macro-
cyclic compound 493. Finally, X-ray crystallography confirmed that the component was indeed
that of macrocycle 493. This confirmed all of the absolute and relative stereochemistry was as re-
quired for obtusallene II (390), and also confirmed the stereochemistry of the C(12)-C(13) olefin as
trans. Unfortunately, only 1.5 mg of compound 493 was prepared, and with no more late-stage
material available, a large-scale synthesis would have to be pursued in order to complete the total
synthesis of obtusallenes II (390) and IV (395).
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2.5 Current Approach Towards the Total Synthesis of Obtusallenes II and IV
After the previous success in this group of preparing macrocycle 493, it was decided that a
large-scale synthesis of obtusallenes II and IV (390 and 395) should be pursued. Yaqoob began
the synthesis with 100 mL of allyl bromide (477) and 60 mL of propargyl alcohol (167) and used
the same sequence of alkyne couplings as Solanki to produce enediyne 173 (Scheme 155).117 Pre-
viously, triene 174 had been prepared by hydrogenation of 173 using palladium on barium sul-
fate which was poisoned with quinoline. However, it was found that there was often some over-
hydrogenation under these conditions, with the terminal alkene being particularly susceptible to-
wards hydrogenation.153 Column chromatography using silver nitrate-impregnated silica gel was
required in order to separate any over- or under-reduced material from the desired triene 174.
Although this process worked well, it was found to be very laborious and it would not be very
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Scheme 155: Current approach towards the total synthesis of obtusallenes II and IV (390 and 395),
with the preparation of macrocycle 498.117
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amenable to large scale synthesis.
In order to overcome this difficulty, Yaqoob used a transfer hydrogenation protocol instead, to
selectively reduce the alkynes in 173.117 Treatment of 173 with pre-prepared zinc-copper couple in
iso-propanol and water as solvent furnished the desired triene 174 in 62% yield after 24 hours at
room temperature (Scheme 155). Although a large quantity of zinc-copper couple was required,
the reaction could be conducted on a multi-gram scale and there was excellent selectivity observed
for reduction of alkynes over alkenes.
The same procedures as Solanki153 were used in order to prepare aldehyde-containing 485.
At this stage the possibility of adopting a more concise route to the macrocyclic structures was
considered. If the C-14 methyl could be installed stereospecifically without having to use diol 487,
then it may be possible to have a terminal olefin to undergo RCM with the other terminal olefin,
as opposed to the disubstituted alkene in 489 or 490. If there was a terminal alkene at this position
then it would not be sterically encumbered in the way that the disubstituted alkene was proposed
to be,153 therefore there would be no need for the use of a relay-RCM reaction (vide supra).
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Scheme 156: Noyori’s method for preparing acetals under aprotic conditions.
The approach adopted involved modifying a procedure that was originally reported by Noy-
ori in 1980 for the formation of acetals under aprotic conditions.184 Noyori’s method uses catalytic
trimethylsilyl triflate to promote the reaction between a carbonyl compound 500 and an alkoxysi-
lane 501, to furnish the corresponding acetal 502 (Scheme 156). The high stability of the hexam-
ethylsiloxane (503) by-product is proposed to be the driving force for the reaction.
This method was adapted in order to incorporate cyanide instead of a second alcohol into the
system (Scheme 157). It was considered that the reaction of aldehyde 485 with enantiopure alcohol
(S)-494, trimethylsilyl triflate and trimethylsilyl cyanide should allow for a significant increase in
complexity in a single step (Scheme 155). Enantiopure alcohol (S)-494 would provide what would
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Scheme 157: An adaptation of Noyori’s method in order to incorporate cyanide.
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become the macrocycle ether oxygen, as well allowing for the incorporation of the important (S)-
configured C-14 methyl-bearing group. Also, the reaction would provide an alkyne which would
function as a handle for forming the macrocycle by RCM, as well as introducing a nitrile which
would function as a handle for incorporating the bromoallene. Importantly, it was envisaged that
the reaction should provide two diastereomers, 495 and 496, that are epimeric at the C-4 position,
allowing for the formation of both obtusallenes II and IV (390 and 395).
Aldehyde 485 was treated with (S)-(−)-3-butyn-2-ol (494) in the presence of trimethylsilyl tri-
flate, trimethylsilyl cyanide and a hindered base. After 24 hours of heating in dichloromethane at
reflux, the two enynes, 495 and 496, were isolated in an overall yield of 77% and in approximately 1
: 1 ratio. Importantly, as predicted, the two compounds are only epimeric at the nitrile substituent,
495 representing the required stereochemistry for obtusallene II (390), and 496 for obtusallene IV
(395). After some optimisation, it was found that palladium-catalysed hydrogenation of the alkyne
in 496, using benzene as the solvent could be achieved with good selectivity and in quantitative
yield. This formed compound 497 which contained two terminal olefins and was ready to undergo
the key macrocycle-forming step.
Initial attempts at RCM using the first generation of Hoveyda-Grubbs catalyst in toluene at re-
flux were found to be unsuccessful, with no product formation observed.117 Attention then turned
to the use of the Stewart-Grubbs catalyst (499) instead (Scheme 155). This metathesis catalyst has
been shown to be considerably more active than other commonly used catalysts.185 After some op-
timisation studies it was found that very dilute conditions were required, along with 30 mol% of
the catalyst and 24 h of heating at reflux in toluene. In order to avoid the formation of more dimeric
material upon concentrating the reaction mixture, an olefin metathesis catalyst scavenger186 was
added at the end of the reaction and left to heat at reflux for a further hour. Di(ethylene glycol)
vinyl ether was used for this purpose. The olefin undergoes metathesis with the ruthenium-based
catalyst and then the oxygen atoms coordinate to the ruthenium, effectively deactivating it. This
deactivated catalyst can then be removed from the reaction mixture by column chromatography.
If these optimised conditions are used for the RCM reaction of diene 497, it was found that
macrocycle 498 can be isolated in 33% yield after column chromatography. This yield is in accor-
dance with that observed for the RCM reactions of the model systems.116 Both cyano-containing
macrocycles 493 and 498 have proven crystalline and their structures have been fully elucidated
by X-ray crystallography. Figure 34 shows that compound 493 exhibits all of the absolute and rela-
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tive stereochemistries required for obtusallene II (390), whereas 498 represents the fully elaborated
core of obtusallene IV (395), with all of the required stereocentres correctly set. All that remains
is to install the bromoallene moieties into each compound, to complete the total synthesis of these
natural products.
Figure 34: X-ray crystallographic structures of cyano-containing macrocycles 493 (left) and 498
(right) with the relative and absolute stereochemistries correctly set for obtusallenes II and IV (390
and 395), respectively.
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2.6 Aims and Objectives
Now that a successful route has been established through to enyne diastereomers 495 and 496,
the first objective will be to prepare sufficient quantities of these compounds to allow for the com-
pletion of the total synthesis. Multi-gram quantities of enantioenriched epoxy-diene 480 have pre-
viously been prepared by a colleague, using the methodology described above. Therefore this
material can now be carried forward on a multi-gram scale, targeting gram quantities of epimers
495 and 496. Upon scaling of this route some procedures may require some optimisation. In par-
ticular, on grounds of safety it would be very desirable to reduce the number of equivalents of
trimethylsilylcyanide used in the cyanation reaction of aldehyde 485. There are currently 5 equiv-
alents used in this reaction, meaning that upon quenching the reaction on a large-scale, a large
quantity of hydrogen cyanide will be produced.
Once this sequence has been achieved, attention will turn to the key RCM reaction. Although
conditions have been optimised for the formation of macrocycle 498, there has been no attempt so
far at forming macrocycle epimer 493 from the diene epimer of 497. Although it may be anticipated
that the Stewart-Grubbs catalyst (499) will result in the production of 493 in a similar yield to 498,
the reaction of this other diastereomer may require some optimisation.
Once the two cyano-containing macrocycles 493 and 498 have been prepared, it should be pos-
sible to install the bromoallene motif using a similar method to that exhibited by Kim in his total
synthesis of itomanallene A (12).51 Treatment of aldehyde 506 with TMS-acetylene in the presence
of chlorotriisopropoxytitanium(IV) resulted in the formation of two diastereomers of compound
507 in a ratio of 4.7 : 1.0 (Scheme 158), with the selectivity observed being due to a Felkin-Ahn-
type model. Removal of the TMS group was achieved using TBAF (508) and this was followed
by trisylation of the secondary alcohol in order to convert it into a reasonable leaving group. Fi-
nally, copper-catalysed stereospecific SN2’ attack by bromide, furnished the bromoallene motif of
itomanallene A (12).
The proposed route to complete the total syntheses of obtusallenes II and IV (390 and 395) is
demonstrated for obtusallene IV (395) in Scheme 159. Firstly the nitrile in 498 will be reduced to the
corresponding aldehyde 510 using DIBAL-H. Once aldehyde 510 has been prepared it will undergo
a Grignard reaction with ethynylmagnesium bromide (511). This should form two diastereomers
of alcohol-containing 512, with the compound being epimeric at C-3. The use of this Grignard
reaction avoids the extra step of removing a TMS protecting group from the alkyne, which was a
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Scheme 158: Installation of the bromoallene in Kim’s total synthesis of Itomanallene A (12).51
feature of Kim’s synthesis of itomanallene A.51 Once the two epimers of 512 have been separated
they will both be trisylated on the C-3 alcohol substituent. The trisylated compound which exhibits
an (S)-configuration at C-3 (513) should provide the correct bromoallene stereochemistry upon
treatment with LiCuBr2, furnishing the complete structure of obtusallene IV (395).
This will constitute the first total synthesis of obtusallenes II and IV (390 and 395). Once these
two natural products have been prepared in an asymmetric fashion, the various proposed rear-
rangements can be investigated in an effort to synthesise the remaining members of the wider
obtusallene family of natural products.
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Scheme 159: Proposed synthetic route to complete the total synthesis of obtusallene IV (395).
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3 Results and Discussion
3.1 Chlorohydrin Formation and Biomimetic Bromoetherification to Provide the Core
Tetrahydrofuran of Obtusallenes II and IV
This work began with the regioselective nucleophilic ring-opening of enantioenriched epoxy-
diene 480, which had previously been prepared by a colleague. Using the reported procedure, 480
was treated with diethylamine hydrochloride and titanium(IV) iso-propoxide to produce insepa-
rable chlorohydrins 481 and 514 (Scheme 160).116
OH
O
OH
Cl OH
OH
HO Cl
+
480 481 514
Et2NH.HCl
Ti(OiPr)4
CH2Cl2
r.t., 6 days
4.5                             :                               1.0
5.96 g, 75%
6.50 g
OTBDPS
Cl OH
482
9.15 g, 71%
as a single regioisomer
(separable by column chromatography)
TBDPS-Cl
imidazole
0°C ! r.t.
20 h
Scheme 160: Gram-scale regioselective chloride ring-opening of epoxide 480 and TBDPS
protection of the primary alcohol.
This reaction was carried out on a multi-gram scale to provide the product in 75% yield and
with a ratio of 4.5 : 1.0 in favour of the desired regioisomer 481. Subsequent TBDPS protection of
the primary alcohol proceeded in 71% yield, furnishing 9 g of pre-cyclisation compound 482. At
this stage the two chlorohydrin regioisomers were separable by column chromatography, allowing
OH
Br
O
Br Br
Br Br
Br2
EtOH / AcOH
(1 / 1)
0°C, 1 h
515 TBCO (516)
15.0 g 22.3 g, 63%
Scheme 161: Preparation of gram quantities of the brominating reagent TBCO (516), from
4-bromophenol (515).
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for the isolation of pure 482.
The next step was the previously reported biomimetic bromoetherification reaction to form
the tetrahydrofuran core of obtusallenes II and IV (390 and 395).102, 116 TBCO (516), which was to
be used as the source of electrophilic bromine in this reaction, was freshly prepared by treating
4-bromophenol (515) with molecular bromine in ethanol and acetic acid (Scheme 161).187 This pro-
cedure was conducted on a multi-gram scale, providing 22 g of TBCO (516) in a 63% yield. Chloro-
hydrin 482 was then treated with 2.4 equivalents of this TBCO in an effort to form tetrahydrofuran-
containing 483 (vide supra). However, unfortunately it was found that there was over-bromination
of the compound to form a mixture of diastereomers of compound 517 (Scheme 162).
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Br
Br
H H
Cl
OTBDPS
OTBDPS
Cl OH TBCO (2.4 equiv)
CH2Cl2
!78°C " r.t.
40 h
482
517
Scheme 162: Overbromination resulting from the use of excess TBCO over an extended period.
This over-bromination has been observed previously by Solanki in the biomimetic bromoether-
ification of a similar chlorohydrin compound.153 In this case a debromination reaction was used to
successfully generate an alkene-containing compound. It was considered that this same method
could be used on compound 517. The TBDPS protecting group of 517 was firstly removed us-
ing TBAF and acetic acid (Scheme 163). The resulting tetrahydrofuran 518 was then treated with
a large excess of sodium iodide in acetone at reflux, using a method developed by Winstein in
1939.188
Unfortunately, in this case it was found that although there was some product formation ev-
ident by 1H NMR spectroscopy, there was approximately 50% of unidentified impurities also
formed in the reaction. These were inseparable by column chromatography, and furthermore the
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Scheme 163: TBDPS deprotection of overbrominated compound 517 and attempted elimination
to generate 484.
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yield in the reaction was very low, with just 21 mg recovered from 100 mg of 518. There are a
number of undesirable side reactions that can be envisaged in this reaction. For example, SN2
displacement of the C-7 chloride or C-12 bromide substituents by iodide could also occur. This
could potentially be followed by elimination of HI. Also, it is possible that the THF oxygen could
interfere with the desired reaction.
O
Br
Cl
H H
OTBDPSOTBDPS
Cl OH
482
483
TBCO (1.0 equiv)
1.79 g, 76%
CH2Cl2
!78°C " r.t., 40 h
2.00 g
Scheme 164: Successful bromoetherification of chlorohydrin 482 using 1 equivalent of TBCO.
Therefore it was decided that the initial reaction of chlorohydrin 482 with TBCO should be
repeated, this time using 1 equivalent of TBCO, as opposed to the 2.4 equivalents used previ-
ously. Gratifyingly this worked well, providing the desired product 483 in 76% yield, with no sign
of over-bromination (Scheme 164). This procedure could also be reliably scaled-up to use gram
quantities of 482, as long as the TBCO was freshly prepared and only 1 equivalent was used.
Once multi-gram quatities of tetrahydrofuran 483 had been successfully prepared, the next
step was deprotection of the TBDPS group. This was achieved using the acetic acid buffered TBAF
conditions described previously. The reaction proceeded to give the deprotected compound 484
in 87% yield (Scheme 165). Subsequent Dess-Martin periodinane oxidation of the alcohol in 484 to
furnish aldehyde 485 could also be achieved on a multi-gram scale, with quantities of up to 2.50 g
of 484 being converted into aldehyde 485 in quantitative yield. This aldehyde could then be used
without further purification in the subsequent cyanation reaction, to prepare epimeric enynes 495
and 496.
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0°C ! r.t., 18 h
Scheme 165: Deprotection of 483 and subsequent Dess-Martin oxidation of 484 to form aldehyde
485.
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3.2 Formation of Epimeric Cyclisation Precursors 497 and 534
Although epimeric compounds 495 and 496 have previously been prepared by a colleague (vide
supra), there was some concern about the large excess of trimethylsilyl cyanide used in the reaction.
Therefore it was desirable to try and decrease this if possible, ideally so that only one equivalent is
used.
O
Cl
Br
H H
O
O
519
Figure 35: Formation of acetal 519 as a side-product.
In previous reactions it was found that some of acetal 519 (Figure 35) was isolated as a side-
product in the reaction. Inspection of the conditions used revealed that two equivalents of the
expensive enantiopure alcohol (S)-494 had been used. Therefore it seems that cyanide has to com-
pete with a second molecule of alcohol (S)-494 in order to trap oxonium ion intermediate 522, to
form 495 and 496 instead of acetal 519 (Scheme 166). We reasoned that decreasing the number
of equivalents of (S)-494 from two to one, should result in an increase in the yield of the desired
products 495 and 496. Importantly, this should also allow for the quantity of trimethylsilyl cyanide
used in the reaction to be decreased.
It also seemed likely that the order of addition would be very important in this reaction. In
the reaction conducted previously (Scheme 155) aldehyde 485 was dissolved in dichloromethane
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Scheme 166: Proposed mechanism for the formation of 495 and 496 from aldehyde 485.
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and to this was added alcohol (S)-494, followed by trimethylsilyl triflate, 2,6-di-tert-butylpyridine
and finally trimethylsilyl cyanide. We considered that the order of addition should be altered
so that the alcohol (S)-494 is initially in solution, and to this is added 2,6-di-tert-butylpyridine (to
quench the triflic acid formed in the reaction), followed by trimethylsilyl triflate, then trimethylsilyl
cyanide and finally aldehyde 485. This would allow for the initial alkoxysilane to form, in line
with the procedure described by Noyori. Also, having the trimethylsilyl cyanide present before
the aldehyde should help to encourage trapping of the intermediate oxonium ion 522 by cyanide
instead of a second molecule of the alkoxysilane, to form compounds 495 and 496 instead of acetal
519 (Scheme 166).
O
OH
2,6-di-tert-butylpyridine
TMS-OTf
TMS-CN
523
1)
2)
3)
4)
(±)-494
OH
524
CNCH2Cl2
40°C, 42 h
Scheme 167: Initial attempt at decreasing the quantity of TMS-CN, using heptanal (523) as a test
substrate.
To test this postulate we decided to run concurrent investigations, one using heptanal (523)
and racemic alcohol (±)-494, and the other using aldehyde 485 and enantiopure alcohol (S)-494. In
each case the order of addition described above was adopted, and only 1 equivalent of alcohol and
1.5 equivalents of trimethylsilyl cyanide was used, instead of the 2 and 5 equivalents respectively,
used previously. Interestingly, instead of the desired compounds being produced, the reaction of
heptanal (523) with (±)-494 resulted in the formation of compound 524 (Scheme 167), and similarly,
the reaction of aldehyde 485 with alcohol (S)-494 provided compound 525 (Scheme 168).
These two compounds, 524 and 525, must arise from direct attack of cyanide anion onto either
OH
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3)
4)
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CH2Cl2
40°C, 42 h
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Br
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Scheme 168: Initial attempt at decreasing the quantity of TMS-CN, using aldehyde 485.
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O
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Scheme 169: Second attempt at decreasing the quantity of TMS-CN, allowing the initial
formation of acetal.
the aldehyde, or the activated aldehyde, preferentially to attack by alcohol 494. This raised the pos-
sibility that acetal 519 may need to be allowed to form initially and then this can subsequently go
on to produce the desired nitrile- and alkyne-containing products. Therefore we decided to mod-
ify the order of addition so that the aldehyde is added prior to the trimethylsilyl cyanide (Scheme
169). Also, as it now appears that the acetal has to be formed initially, the number of equiva-
lents of alcohol 494 had to be increased to 2. Corollary to this, the large excess of trimethylsilyl
cyanide is presumably therefore required to push the equilibrium towards the desired products.
Consequently, 5 equivalents of trimethylsilyl cyanide were used for this reaction, in line with that
previously reported. Again, heptanal (523) was used to investigate this alteration. Racemic alcohol
(±)-494 was dissolved in dichloromethane and 2,6-di-tert-butylpyridine was added, followed by
trimethylsilyl triflate. This was left to stir for 45 min to allow the corresponding alkoxysilane to
form. Heptanal (523) was subsequently added and this was stirred for a further hour to allow for
the formation of the acetal. Finally, trimethylsilyl cyanide was added and the reaction mixture was
heated at reflux for 42 h. After column chromatography two compounds were isolated in yields of
14% and 34%, which were found to be the two expected diastereomers, 526 and 527.
Following the success of this reaction using heptanal (523), the same conditions and order of
addition was applied to the reaction of aldehyde 485 with enantiopure alcohol (S)-494. There were
two major components visible by TLC and these were isolated by column chromatography. Al-
though each component was found to contain one of the desired compounds 495 and 496, there
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Figure 36: Target compounds 495 and 496 with their C-14 diastereomers, 528 and 529.
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was also an additional major compound present in each case. In the case of diastereomer 495
this amounted to 40%, whilst for diastereomer 496 the 1H NMR spectrum revealed the other com-
pound to be in a 1 : 1 ratio with the desired compound. Mass spectrometry of both components
revealed that there was no acetal present, with only the mass of the desired compounds observed.
This indicates that the other compounds must arise from epimerisation at C-14. Therefore these
additional compounds were assigned as C-4 epimers 528 and 529, which are diastereomers of the
desired compounds 495 and 496 (Figure 36).
OH
(S)-494
TfO TMS
OH
TMS
TMS OH
OH
TMS
(S)-530 531 (±)-530
Scheme 170: Proposed mechanism for the racemisation of alcohol (S)-494.
This must have occurred in the initial addition of trimethylsilyl triflate to enantiopure alcohol
(S)-494 (Scheme 170). Upon forming the trimethylsilyl derivative (S)-530, there could be epimeri-
sation at the stereocentre via stabilised carbocation 531, resulting in racemisation of the compound.
Overall this would provide four different diastereomers of the target compound, explaining the ob-
servation made in this reaction. In the case of the reaction of heptanal (523) shown in Scheme 169,
racemic alcohol (±)-494 was used instead of the enantiopure compound, and this epimerisation
was inconsequential to the outcome.
Assuming that this mode of racemisation is occurring, further changes were made to the order
of addition in the reaction of aldehyde 485, so it more closely resembles the initial conditions used
(Scheme 155). Aldehyde 485 was dissolved in dichloromethane and enantiopure alcohol (S)-494
was added, followed by 2,6-di-tert-butylpyridine and trimethylsilyl triflate. This would allow for
the alkoxysilane to quickly react with aldehyde 485 before it has the opportunity to racemise. Fi-
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Figure 37: Target compounds 495 and 496 and diastereomers 532 and 533, that arise from
aldehyde 485 not being enantiopure.
222
O
Br
H
Cl
H
O
OH
O
Br
H
Cl
H
O
CN
O
Br
H
Cl
H
O
CN
485
495 496
(S)-494
0.74 g, 23%
(over 2 steps)
1.31 g, 41%
(over 2 steps)
+
2,6-di-tert-butylpyridine
TMS-OTf
TMS-CN
1)
2)
3)
4)
CH2Cl2
40°C, 42 h
2.50 g
Scheme 171: Successful etherification/cyanation of aldehyde 485 and alcohol (S)-494.
nally trimethylsilyl cyanide was added and the reaction mixture was heated at reflux for 2 days.
The two components were separated by column chromatography and gratifyingly it was found
that both compounds 495 and 496 had been formed, with minimal signs of any other diastere-
omers. Each compound did appear to have approximately 5-10% of another diastereomer present,
however this is in line with the fact that the asymmetric epoxidation to form 480 was not com-
pletely selective, and consequently aldehyde 485 was not enantiopure. This results in the forma-
tion of diastereomers 532 and 533, in addition to 495 and 496 (Figure 37). It is interesting to note
that assuming these modifications have completely stopped the epimerisation from occurring, and
alcohol (S)-494 is now being introduced with complete enantiopurity, each diastereomer produced
in the reaction (495, 496, 532 and 533) will be single enantiomers.
It was found that using these conditions and the order of addition stated above, the reaction
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Scheme 172: Selective hydrogenation of the alkynes in 495 and 496 to produce the cyclisation
precursors.
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could be carried out on a gram-scale to produce 0.74 g of 495 and 1.31 g of 496, in an overall
yield of 64% from tetrahydrofuran-containing alcohol 484 (Scheme 171). The series of reactions
conducted in this study confirmed that 5 equivalents of trimethylsilyl cyanide and 2 equivalents
of enantiopure alcohol (S)-494 are required, in order for the reaction to proceed effectively and
efficiently.
Once compounds 495 and 496 had been prepared, each diastereomer was hydrogenated using
the conditions developed previously (Scheme 155) – palladium on barium sulfate, with quinoline
to poison the catalyst and benzene as the solvent (Scheme 172). In each case the alkyne was reduced
in good yield to chemoselectively provide the corresponding terminal alkene. The reactions could
be monitored by TLC and there was no observation of over-hydrogenation of either alkene present
in the products 534 and 497. These two epimeric cyclisation precursors were then ready to undergo
the key macrocycle-forming RCM reaction.
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3.3 Ring-Closing Metathesis to Form the 11-Membered Macrocycles of Obtusallenes
II and IV
The RCM of diene 497 has previously been optimised (Scheme 155), where it was found that
heating with 30 mol% of the Stewart-Grubbs catalyst (499) in toluene at reflux, under dilute condi-
tions, provided approximately 30-35% yield of the desired macrocycle 498. X-ray crystallography
of this compound confirmed the alkene as being (E)-configured, as well as confirming the relative
and absolute stereochemistries of all of the stereocentres in the molecule (Figure 34). Following
this, and using the conditions described, we have found that the reaction is indeed reproducible,
providing macrocycle 498 in a 29% yield (Scheme 173a).
However, RCM of diene diastereomer 534 has not previously been attempted. We considered
that using the same conditions with the Stewart-Grubbs catalyst (499) should provide the desired
macrocycle 493, which had been prepared previously by a different colleague, from a different
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Scheme 173: Diastereomer-dependent and catalyst-dependent effects in the RCM of (a) 497 and
(b) 534.
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Figure 38: Comparison of the coupling constants of (E)-alkene containing macrocycles 433 and
436, with macrocycle 535.
cyclisation precursor (vide supra). Therefore, diene 534 was heated at reflux in toluene for 20 h with
30 mol% of catalyst 499. After this time di(ethylene glycol) vinyl ether was added to deactivate the
metathesis catalyst, and after a further hour of heating the solvent was removed under reduced
pressure. There were two components observed by TLC and these were separated by column
chromatography. The least polar component was found to consist of a mixture of dimers. However,
the NMR spectra and mass spectrum of the more polar component confirmed the formation of a
macrocycle.
When the desired macrocycle diastereomer was prepared previously, the small quantities meant
that it was not possible to acquire a good quality 1H NMR spectrum. Therefore there was no NMR
spectra available with which to compare the product from the RCM of diene 534. Analysis of the
1H NMR spectrum revealed the alkene coupling constant to be 10.9 Hz, which would be consis-
tent for a (Z)-configured alkene (535) rather than the required (E)-alkene. Comparing this coupling
constant with the values for (E)-alkene containing macrocycles 433 and 436116 supported the con-
clusion that a (Z)-alkene had been produced in this reaction (Figure 38).
Therefore, although treating diene diastereomer 497 with Stewart-Grubbs catalyst (499) results
in the formation of an (E)-alkene in 29% yield, with no observation of the (Z)-stereoisomer (Scheme
173a), the use of identical conditions on diene diastereomer 534 furnishes (Z)-alkene containing 535
in 44% yield, with no observation of the (E)-stereoisomer (Scheme 173b, right). It is not immedi-
ately obvious why such a small change in the structure of a cyclisation precursor should have such
a drastic affect on the outcome of a metathesis reaction. We initially considered that perhaps the
thermodynamic product is different in each case – for diastereomer 497 the (E)-alkene containing
macrocycle 498 may be the thermodynamic product, whereas for diene 534 perhaps the thermo-
dynamic product is (Z)-macrocycle 535. From this, we considered that in the case of diene 534, the
desired (E)-macrocycle may be forming initially, and then upon continued heating this is gradually
converting to the thermodynamically stable 535. To test this hypothesis a reaction was conducted
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in the same manner as previously described, but the reaction was quenched after just 30 min of
heating, instead of 20 h. However, it was found that (Z)-alkene containing macrocycle 535 had
again been produced, in a comparable yield to the previous reaction, again with no observation of
the desired macrocycle 493.
In order for each epimer of the diene to form different geometries of alkene, presumably the
differently configured stereocentre at C-4 must alter the conformation one of the reaction inter-
mediates to a large extent. This would allow for two differently configured ruthenium metallacy-
clobutanes, 539 and 540, to form upon the [2 + 2] cycloaddition taking place between the ruthenium
carbene and the remaining terminal alkene of intermediate 538 (Scheme 174). Subsequent [2 + 2]
retro-cycloaddition of metallocycle 540 would provide macrocycle 498 with an (E)-alkene, whereas
for metallocycle 539 the (Z)-configured alkene of 535 would be produced. It has previously been
demonstrated by this group that the C-4 substituent can have a large impact upon the conforma-
tion of the molecule. It was found that when the X-ray crystal structure of model macrocycle 433
was superimposed on that of obtusallene II (390) there was a local conformation change at C(14)-
O-C(4)-C(5), whilst the remainder of the structure closely resembled that of the natural product.116
The only difference between the two compounds is that obtusallene II (390) has a bromoallene
substituent at C-4, whilst 433 has no substituent at this position. From this, it is possible to en-
visage that diene epimers 497 and 534, and the reaction intermediates in the RCM, could adopt
quite different conformations. This would then represent a rational explanation for the observed
stereoselectivity.
As the reaction with Stewart-Grubbs catalyst (499) had resulted in the undesired stereoiso-
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Scheme 174: Proposed explanation for the diastereomer-dependent RCM reaction.
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mer, it was decided to screen other metathesis catalysts to investigate whether a different catalyst
would provide the required (E)-alkene. Firstly, Hoveyda-Grubbs second-generation catalyst (537)
was used. As before, 30 mol% of the catalyst was used and the reaction mixture was conducted
under dilute condition in toluene and left to heat at reflux for 20 h. After column chromatography
it was found that the (Z)-configured alkene containing macrocycle 535 had again been produced,
with no observation of the (E)-macrocycle 493. However, when the first-generation version of
Hoveyda-Grubbs catalyst (536) was used, it was found that the 1H NMR spectrum of the more po-
lar component was markedly different from that of macrocycle 535. Whereas the NMR spectra of
535 had exhibited very defined resonances, the signals in the NMR spectra of this new compound
were mostly very broad, with hardly any splitting of the signals being discernible. Mass spectrom-
etry of this compound confirmed that it has the same mass as 535 and must contain a macrocycle.
As we had isolated the (Z)-macrocycle before, then by process of elimination this compound must
contain an (E)-alkene, and therefore be the desired compound 493.
The broadening of the signals present in the 1H NMR spectrum was similar to that observed for
macrocycle 498, although even more pronounced. This signal broadening was also observed in the
NMR spectra of obtusallenes II and IV (390 and 395), and was proposed to be due to interconver-
sion between two different conformers of the macrocycle, where ring-flipping of the C(12)-C(13)
alkene happens on the time-scale of the NMR spectrometer (vide supra). This could be overcome by
acquiring an NMR spectrum at 50 ◦C instead of room temperature. It is likely that if the compound
does contain an (E)-configured alkene, then this same interconversion between conformers could
be happening in the compound isolated from this reaction. We reasoned that acquiring an NMR
spectrum at 50 ◦C should result in sharpening of the signals, which would allow a value for the
alkene coupling constant to be uncovered. Figure 39 shows the two different NMR spectra, one
acquired at 20 ◦C and the other at 50 ◦C. The sharpening of the signals that was anticipated upon
warming the sample can be observed, and the coupling constant for the alkene is 14.0 Hz, which
is consistent with being an (E)-configured alkene.
Therefore, the compound isolated from the reaction of diene 534 with Hoveyda-Grubbs I (536)
has been assigned as (E)-macrocycle 493. The yield of this reaction at 11% was lower than the re-
action of diene 497 with Stewart-Grubbs catalyst (499). However, whereas in the reaction with
Stewart-Grubbs catalyst (499) the remaining material was a mixture of dimers, in the case of
Hoveyda-Grubbs I (536) most of the other material recovered was recyclable starting material 534.
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As with the observation that different diene epimers give different outcomes, it is not imme-
diately apparent why one catalyst should give exclusively (Z)-macrocycle 535, whilst another pro-
vides exclusively (E)-macrocycle 493. The only difference between the catalysts is that Stewart-
Grubbs (499) and Hoveyda-Grubbs II (537) contain an N-heterocyclic carbene ligand, whereas in
Hoveyda-Grubbs I (536) there is a phosphine ligand instead. The steric bulk of these ligands pre-
sumably either affects the alkene that the catalyst initially reacts with, or it affects the formation of
the ruthenium metallocycle intermediate that is formed, in a similar way to that shown in Scheme
174. However, regardless of the mechanism by which these compounds form, these studies have
developed methods to access both macrocycles 493 and 498, which are highly advanced interme-
diates in the total synthesis of obtusallenes II and IV (390 and 395).
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Figure 39: Comparison of 1H NMR spectra of macrocycle 493, acquired at 20 ◦C (top) and 50 ◦C
(bottom).
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4 Conclusion
The first main objective of this work has been achieved with the synthesis of gram quantities of
enyne epimers 495 and 496. The route to this required optimisation of the biomimetic bromoether-
ification reaction to form tetrahydrofuran 483. Previously an excess of TBCO had been used and
the reaction was not always reproducible. Now the reaction can be conducted reliably and repro-
ducibly on a multi-gram scale if just one equivalent of freshly prepared TBCO is used. This avoids
over-bromination, giving the desired compound in good purity.
Attempts to decrease the quantity of trimethylsilyl cyanide and enantiopure alcohol (S)-494 in
the cyanation reaction of aldehyde 485 gave insight into this novel reaction. It was found that the
order of addition in the reaction is critical in order to avoid racemisation of enantiopure alcohol (S)-
494. Also, the studies indicate that the reaction proceeds via the formation of acetal 519 (meaning
that two equivalents of (S)-494 are required), and this then goes on to form the desired nitrile
containing compounds 495 and 496 (where a large excess of trimethylsilyl cyanide is required to
push the equilibrium towards product).
Some interesting diastereomer-dependent and catalyst-dependent effects were observed in the
RCM of dienes 497 and 534. When the Stewart-Grubbs catalyst (499) was used, diene 497 gave
macrocycle 498, which contains an (E)-configured alkene, whilst the epimer of this compound,
diene 534, provided (Z)-alkene containing macrocycle 535. Furthermore, when catalysts with
an N-heterocyclic carbene-based ligand (499 and 537) were used to promote RCM of diene 534,
(Z)-macrocycle 535 was formed, whereas when Hoveyda-Grubbs I (536) was used instead, which
contains a phosphine ligand, (E)-macrocycle 493 was produced. Potential explanations for these
observations have also been proposed.
This work has expanded on previous studies conducted by colleagues and now provides access
to macrocycle epimers 493 and 498. Work to install the bromoallene moieties at C-4 (see Scheme
159) and therefore complete the total synthesis of obtusallenes II and IV (390 and 395) is currently
ongoing.
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Part III
Experimental
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1 General Experimental
Reagents: Pyridine was distilled from CaH2 and stored over 4A˚ molecular sieves. Quinoline was
dried over sodium sulfate and distilled from and stored over Zn dust. iPrMgCl in THF was titrated
against menthol (with phenanthroline as an indicator) prior to use. Copper(I) iodide was purified
by washing thoroughly with water and ethanol. NBS was purified by recrystallisation from wa-
ter. Thionyl chloride was purified by distillation under nitrogen prior to use. p-Toluenesulfonyl
chloride was recrystallised from CHCl3 and petroleum ether. Triethylamine was dried over CaSO4
prior to distillation under nitrogen, and was subsequently stored over 4A˚ molecular sieves. BDSB
was prepared according to the method of Snyder.144 TBCO was prepared according to the method
of Matveeva.187 DBTA was prepared according to the method of Frankland.130 Asymmetric epoxi-
dation ligand 199 was prepared according to the method of Yamamoto.122 All other reagents were
obtained from commercial sources and used as received.
Solvents: All reactions were performed in anhydrous solvents unless used in combination with
H2O. All solvents were distilled under nitrogen. HPLC grade CH2Cl2, THF, Et2O and toluene were
dried by passing through a column of alumina beads. Acetone was dried over CaSO4 and then
distilled. MeOH was used as received or dried over CaSO4 and then distilled. EtOH, MeCN and
glacial AcOH were used as received. Extraction solvents and chromatography eluents were used as
received. MeOH and CH2Cl2 were HiPerSolv grade, EtOH was AnalaR grade, and pentane, Et2O,
EtOAc and petroleum spirit 40− 60 ◦C were GPR grade. NO2Me was Chromasolv grade and was
dried by stirring over activated 4A˚ molecular sieves, decanted, and distilled. Cyclohexene and
benzene were purchased and used as received.
Experimental Techniques: Reactions were carried out in oven-dried glassware under an inert
atmosphere of nitrogen, unless otherwise stated. Air and moisture sensitive reagents were trans-
ferred by syringe. 4A˚ molecular sieves were prepared by repeatedly heating under vacuum and
flushing with nitrogen. Reaction temperatures other than room temperature were recorded as alu-
minum heating block, or bath temperatures. The phrase, removed / evaporated under reduced
pressure, or in vacuo, generally refers to rotary evaporation. Brine refers to a saturated aqueous
solution of NaCl. Column chromatography was performed on silica gel, particle size 33-70 µm,
or 40-63 µm. Analytical TLC was performed on Kieselgel 60 F254 pre-coated aluminium-backed
plates which were visualised by ultraviolet light (254 and 350 nm) and / or chemical staining
using potassium permanganate, an acidified solution of phosphomolybdic acid and cerium(IV)
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sulfate, or dinitrophenylhydrazine.
Characterisation: Fourier transform IR spectra were recorded using samples prepared as thin films
on NaCl or KBr plates, or neat using an ATR-IR spectrometer. 1H NMR spectra were recorded at
400 MHz or 500 MHz. 13C NMR spectra were recorded at 100 MHz or 125 MHz. Chemical shifts
(δ) are quoted in parts per million (ppm) and are referenced to the residual solvent peak. Coupling
constants (J) are quoted in Hertz (Hz). All NMR spectra were acquired at room temperature, unless
otherwise stated. Low resolution MS (EI, ESI, CI), GCMS, LCMS and HRMS were recorded by the
Imperial College Department of Chemistry Mass Spectrometry Service.
HPLC: Preparative HPLC was performed on a 25 cm x 10.0 mm SUPELCOSIL LC-Si HPLC column
with a particle size of 5 µm. Chiral analytical HPLC was performed on a 25 cm x 4.6 mm ChiralPak
AD or ODH column. All solvents for HPLC were HiPerSolv grade and used as received.
2 Naming of Compounds
All of the compounds in this experimental section are named and numbered according to IUPAC
recommendations on nomenclature, as opposed to the numbering system that has been used pre-
viously in this document.
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3 Procedures and Characterising Data for Compounds
(E)-1-Bromopent-2-ene189 (155)
Br
According to the methods of Palomo110 and Doyle Daves Jr.,111 a solution of bromine (20.5 g, 128
mmol, 1.1 equiv) in dichloromethane (40 mL) was added dropwise to a solution of triphenylphos-
phine (33.6 g, 128 mmol, 1.1 equiv) in dichloromethane (140 mL) at 0 ◦C. The orange-yellow triph-
enylphosphine dibromide suspension was stirred at 0 ◦C for 30 min. Pyridine (10.1 g, 128 mmol,
1.1 equiv) was subsequently added, followed by a solution of (E)-2-penten-1-ol (154) (10.0 g, 116
mmol, 1.0 equiv) in dichloromethane (60 mL). The reaction mixture was allowed to warm to room
temperature and stirred for 1.5 h. The mixture was washed with 1 M hydrochloric acid (2 x 100
mL) and the layers were separated. The aqueous portion was extracted with dichloromethane (2
x 50 mL) and the organics were combined and dried over sodium sulfate. The solvent and prod-
uct were distilled away from the triphenylphosphine oxide under reduced pressure, and collected
using a cold trap. The triphenylphosphine oxide was washed thoroughly with pentane, which
was combined with the solution of the product in dichloromethane. The solvent was carefully re-
moved by distillation, to provide the known product (E)-1-bromopent-2-ene (155) (14.0 g, 81%) as
a pale brown liquid, contaminated with approximately 3% of triphenylphosphine oxide and also
dichloromethane: R f 0.62 (petroleum spirit : ethyl acetate, 4 : 1); IR (neat) 2964, 2932, 1660, 1459,
1436, 1203, 962 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.88-5.81 (m, 1H, CHCH2CH3), 5.75-5.67 (m,
1H, CHCH2Br), 3.98 (d, J = 8.0 Hz, 2H, CH2Br), 2.15-2.08 (m, 2H, CH2CH3), 1.03 (t, J = 7.4 Hz,
3H, CH3);
13C NMR (100 MHz, CDCl3) δ 138.1 (1C, CHCH2CH3), 125.4 (1C, CHCH2Br), 33.4 (1C,
CH2Br), 25.1 (1C, CH2CH3), 13.0 (1C, CH3); MS (EI+) m/z 147 (M)+. The crude product was used
in the next step without further purification.
(E)-Oct-5-en-2-yn-1-ol115 (156)
OH
Using a modified method of Loreau,115 a solution of isopropylmagnesium chloride in THF (200 mL,
2.0 M, 397 mmol, 2.5 equiv) was added dropwise to a stirred solution of propargyl alcohol (12.0
mL, 206 mmol, 1.3 equiv) in THF (100 mL) at 0 ◦C. The reaction mixture was heated at 70 ◦C for
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1.5 h and subsequently cooled to 0 ◦C. Copper(I) chloride (3.14 g, 32 mmol, 0.2 equiv) was added,
followed by dropwise addition of a solution of (E)-1-bromopent-2-ene (155) (23.6 g, 159 mmol, 1.0
equiv) in diethyl ether (170 mL). The mixture was heated at 70 ◦C for 3 h, allowed to cool to room
temperature, and the mixture was washed with saturated ammonium chloride solution (2 x 200
mL). The aqueous was separated and extracted with ethyl acetate (4 x 150 mL). The organics were
combined, washed with brine (2 x 200 mL) and dried over sodium sulfate. After removal of the
solvent under reduced pressure, the residue was puried by column chromatography (petroleum
spirit : ethyl acetate, 4 : 1) to give the known product (E)-oct-5-en-2-yn-1-ol (156) (18.1 g, 92%) as
a pale yellow oil: R f 0.20 (petroleum spirit : ethyl acetate, 4 : 1); IR (neat) 3600-3050, 2964, 2873,
1463, 1373, 1009, 965 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.76-5.70 (m, 1H, CHCH2CH3), 5.45-5.38
(m, 1H, CH−CHCH2CH3), 4.31 (t, J = 2.2 Hz, 2H, CH2OH) 2.98-2.96 (m, 2H, CH2C−−CCH2OH),
2.10-2.03 (m, 2H, CH2CH3), 1.01 (t, J = 7.4 Hz, 3H, CH3);
13C NMR (100 MHz, CDCl3) δ 134.1 (1C,
CHCH2CH3), 122.6 (1C, CH−CHCH2CH3), 84.1 (1C, C−−C), 79.9 (1C, C−−C), 51.4 (1C, CH2OH), 25.3
(1C, CH2CH3), 22.0 (1C, CH2C−−CCH2OH), 13.5 (1C, CH3); MS (CI+, NH3) m/z 142 (M + NH4)+;
HRMS (CI+, NH3) m/z calcd for C8H16NO (M + NH4)+ 142.1232, found 142.1236.
(E)-1-Bromooct-5-en-2-yne109 (157)
Br
According to the method of Jeffery,190 carbon tetrabromide (58.3 g, 175 mmol, 1.2 equiv) was added
to a solution of (E)-oct-5-en-2-yn-1-ol (156) (18.1 g, 146 mmol, 1.0 equiv) in dichloromethane (500
mL) at−15 ◦C. A solution of triphenylphosphine (49.8 g, 190 mmol, 1.3 equiv) in dichloromethane
(200 mL) was added dropwise and the mixture was allowed to warm to room temperature and
stirred for 2 h. Petroleum spirit (400 mL) was added after the mixture had been concentrated to
approximately 100 mL, and the resulting mixture was cooled to −78 ◦C and filtered through a
short plug of silica to remove triphenylphosphine oxide and bromoform. The remaining solid was
washed with petroleum spirit (3 x 50 mL) and the solvent was removed under reduced pressure to
give the known product (E)-1-bromooct-5-en-2-yne (157) as a pale yellow oil, contaminated with
approximately 7% of bromoform: R f 0.55 (petroleum spirit : ethyl acetate, 4 : 1); IR (neat) 2963,
1459, 1419, 1208, 1143, 966 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.77-5.70 (m, 1H, CHCH2CH3), 5.43-
5.36 (m, 1H, CH−CHCH2CH3), 3.98 (t, J = 2.2 Hz, 2H, CH2Br), 3.00-2.98 (m, 2H, CH2C−−CCH2Br),
2.10-2.03 (m, 2H, CH2CH3), 1.01 (t, J = 7.4 Hz, 3H, CH3);
13C NMR (100 MHz, CDCl3) δ 134.3 (1C,
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CHCH2CH3), 122.2 (1C, CH−CHCH2CH3), 85.7 (1C, C−−C), 76.8 (1C, C−−C), 25.3 (1C, CH2CH3),
22.1 (1C, CH2C−−CCH2Br), 15.5 (1C, CH2Br), 13.5 (1C, CH3); MS (EI+) m/z 187 (M + H)+. The crude
product was used in the next step without further purification.
(E)-Dodec-9-ene-3,6-diyn-1-ol (158)
OH
According to the method of Villalva-Servin,114 a solution of 3-butyn-1-ol (11.0 mL, 146 mmol, 1.0
equiv) in acetone (500 mL) was added to a solution of (E)-1-bromooct-5-en-2-yne (157) (146 mmol,
1.0 equiv) in acetone (100 mL) at 0 ◦C. Potassium carbonate (40.3 g, 292 mmol, 2.0 equiv), sodium
iodide (43.8 g, 292 mmol, 2.0 equiv) and copper(I) iodide (27.7 g, 146 mmol, 1.0 equiv) were added
and the cloudy yellow mixture was heated at 70 ◦C for 22 h. The reaction mixture was subsequently
concentrated to approximately 100 mL and ethyl acetate (400 mL) was added. The mixture was
washed with ammonium chloride (2 x 200 mL) and water (2 x 200 mL). The aqueous washings were
combined and extracted with ethyl acetate (3 x 400 mL), after which the organics were combined,
dried over sodium sulfate and filtered. The solvent was removed under reduced pressure and the
product was puried by column chromatography (petroleum spirit : ethyl acetate, 4 : 1) to give
product 158 (10.0 g, 39% over 2 steps) as a yellow oil: R f 0.21 (petroleum spirit : ethyl acetate, 4
: 1); IR (neat) 3650-3100, 2963, 1670, 1419, 1314, 1041, 966 cm−1 ; 1H NMR (400 MHz, CDCl3) δ
5.75-5.66 (m, 1H, CHCH2CH3), 5.42-5.35 (m, 1H, CHCH2C−−C), 3.70 (t, J = 6.3 Hz, 2H, CH2OH),
3.18-3.14 (m, 2H, C−−CCH2C−−C), 2.90-2.88 (m, 2H, CHCH2C−−C), 2.47-2.43 (m, 2H, CH2CH2OH),
2.16 (br s, 1H, CH2OH), 2.07-2.00 (m, 2H, CH2CH3), 0.98 (t, J = 7.4 Hz, 3H, CH3);
13C NMR (100
MHz, CDCl3) δ 133.8 (1C, CHCH2CH3), 123.0 (1C, CHCH2C−−C), 78.4 (1C, C−−C), 76.9 (1C, C−−C),
76.7 (1C, C−−C), 75.7 (1C, C−−C), 61.1 (1C, CH2OH), 25.3 (1C, CH2CH3), 23.1 (1C, CH2CH2OH), 21.9
(1C, CHCH2C−−C), 13.5 (1C, CH3), 9.8 (1C, C−−CCH2C−−C); MS (CI+, NH3) m/z 194 (M + NH4)+;
HRMS (CI+, NH3) m/z calcd for C12H20NO (M + NH4)+ 194.1545, found 194.1539.
(3Z,6Z,9E)-Dodeca-3,6,9-trien-1-ol (159)
OH
Using a modified method of Yamada,191 5% Pd-BaSO4 (0.80 g) and quinoline (2.0 mL) were added
to a solution of (E)-dodec-9-ene-3,6-diyn-1-ol (158) (2.00 g, 11.4 mmol) in methanol / cyclohexene
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(1 / 1, 100 mL). The mixture was stirred vigorously and the reaction vessel was flushed with ni-
trogen, followed by hydrogen gas (using a balloon). The outlet was removed and a fresh balloon
of hydrogen was attached. After 2.5 h the reaction mixture was filtered through a short plug of sil-
ica and the solvent removed under reduced pressure. The crude mixture was subjected to column
chromatography (petroleum spirit : acetone, 4 : 1) to give product 159 (1.40 g, 68%) as a pale yellow
oil: R f 0.48 (petroleum spirit : acetone, 2 : 1); IR (neat) 3600-3020, 3013, 2962, 2933, 1647, 1439, 1396
cm−1; 1H NMR (400 MHz, CDCl3) δ 5.57-5.35 (m, 6H, CH−CH), 3.65 (t, J = 6.5 Hz, 2H, CH2OH),
2.86-2.82 (m, 2H, CHCH2CH), 2.79-2.75 (m, 2H, CHCH2CH), 2.39-2.33 (m, 2H, CH2CH2OH), 2.05-
1.90 (m, 3H, CH2CH3, OH), 0.99 (t, J = 3.8 Hz, 3H, CH3);
13C NMR (100 MHz, CDCl3) δ 132.5
(1C, CH−CH), 131.0 (1C, CH−CH), 128.3 (1C, CH−CH), 128.0 (1C, CH−CH), 126.9 (1C, CH−CH),
125.6 (1C, CH−CH), 62.1 (1C, CH2OH), 30.8 (1C, CH2CH2OH), 30.4 (1C, CHCH2CH), 25.6 (2C,
CHCH2CH, CH2CH3), 13.8 (1C, CH3); MS (CI+, NH3) m/z 198 (M + NH4)+; HRMS (CI+, NH3) m/z
calcd for C12H24NO (M + NH4)
+ 198.1858, found 198.1838.
(+)-N,N’-Dibenzyl-L-tartaric diamide130 (189)
N
H
O
OH
OH
H
N
O
Using a modified method of Frankland,130 benzylamine (204) (6.14 mL, 56.2 mmol, 2.0 equiv) was
added to a solution of (+)-dimethyl L-tartrate (203) (5.00 g, 28.1 mmol, 1.0 equiv) in methanol
(12.5 mL). The reaction mixture was heated at 70 ◦C for 2 h, and subsequently stirred for 14 h at
room temperature. The resulting white solid was filtered under reduced pressure, and washed
thoroughly with methanol to afford product 189 (6.20 g, 67%) as a white crystalline solid: m.p.
206− 208 ◦C (lit.130 199 ◦C); [α]21D +92.4 (c 1.30, DMSO); IR (neat) 3450-3100, 1624, 1539, 1455, 1279,
1243, 1093, 1066 cm−1; 1H NMR (400 MHz, DMSO−d6) δ 8.25 (t, J = 6.2 Hz, 2H, NH), 7.33-7.21
(m, 10H, ArH), 5.74 (d, J = 7.2 Hz, 2H, OH), 4.44-4.29 (m, 6H, CH2, CHOH);
13C NMR (100 MHz,
DMSO−d6) δ 172.7 (2C, C−O), 140.0 (2C, Ar), 128.6 (4C, Ar), 127.6 (4C, Ar), 127.0 (2C, Ar), 73.2
(2C, CHOH), 42.3 (2C, CH2); MS (ESI) m/z 329 (M + H)+; HRMS (ESI) m/z calcd for C18H21N2O4
(M + H)+ 329.1501, found 329.1511.
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Dimethyl (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate192 (211)
MeO
O
OMe
O
O O
According to the method of Taber,193 2,2-dimethoxypropane (210) (28 mL, 225 mmol, 3.0 equiv)
was added to a solution of (+)-dimethyl L-tartrate (203) (13.39 g, 75 mmol, 1.0 equiv) and PTSA (71
mg, 4 equiv, 0.5 mol%) in acetone (7 mL). After heating at 60 ◦C for 15 h the solvent was removed
under reduced pressure and the mixture was applied to column chromatography (petroleum spirit
: ethyl acetate, 2 : 1) to provide product 211 (7.56 g, 46%) as a colourless oil: [α]21D −47.7 (c 1.36,
MeOH); IR (neat) 2994, 2956, 1739, 1438, 1374, 1205, 1105 cm−1; 1H NMR (400 MHz, CDCl3) δ 4.84
(s, 2H, OCH), 3.86 (s, 6H, OCH3), 1.52 (s, 6H, OCCH3);
13C NMR (100 MHz, CDCl3) δ 170.1 (2C,
C−O), 113.9 (1C, OCCH3), 77.0 (2C, OCH), 52.9 (2C, OCH3), 26.3 (2C, OCCH3); MS (CI+, NH3) m/z
236 (M + NH4)
+; HRMS (CI+, NH3) m/z calcd for C9H15O6 (M + H)+ 219.0869, found 219.0866.
(4R,5R)-2,2-Dimethyl-1,3-dioxolane-4,5-dicarboxylic acid194 (212)
HO
O
OH
O
O O
Using a modified method of MacFarland,195 lithium hydroxide (6.82 g, 162 mmol, 2.5 equiv) was
added to a solution of dimethyl (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate (211) (14.16
g, 65 mmol, 1.0 equiv) in methanol (130 mL) at room temperature. After 20 h the white precipitate
was filtered and washed with diethyl ether (150 mL) to provide the dilithium salt (12.46 g, 95%) as
a white solid; 1H NMR (400 MHz, DMSO−d6) δ 3.98 (s, 2H, OCH), 1.29 (s, 6H, OCCH3); 13C NMR
(100 MHz, DMSO−d6) δ 173.9 (2C, C−O), 108.4 (1C, OCCH3), 79.1 (2C, OCH), 26.4 (2C, OCCH3).
Hydrochloric acid (10.17 mL, 2.0 equiv) was added to a vigorously stirred solution of the dilithium
salt in water (150 mL) at 0 ◦C. After 1 h the mixture was extracted with ethyl acetate (4 x 100
mL). The organics were washed with brine (100 mL), dried over sodium sulfate, filtered and the
solvent was removed under reduced pressure to give product 212 (8.82 g, 75%) as a white solid:
m.p. 92− 93 ◦C (lit.194 92 ◦C); [α]22D −45.2 (c 0.99, MeOH); IR (neat) 3300-2450, 1715, 1376, 1189
cm−1; 1H NMR (400 MHz, DMSO−d6) δ 4.67 (s, 2H, OCH), 1.39 (s, 6H, OCCH3); 13C NMR (100
MHz, CDCl3) δ 171.6 (2C, C−O), 112.8 (1C, OCCH3), 77.2 (2C, OCH), 26.9 (2C, OCCH3); MS (ESI)
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m/z 189 (M - H)−; HRMS (ESI) m/z calcd for C7H9O6 (M - H)− 189.0399, found 189.0399.
General Procedure for the Formation of Protected Tartramides
(R)-(+)-α-Methylbenzylamine ((R)-205), (S)-(−)-α-methylbenzylamine ((S)-205), benzhydrylamine
(208) or tritylamine (216) (2.2 equiv) was added to a solution of (4R,5R)-2,2-dimethyl-1,3-dioxolane-
4,5-dicarboxylic acid (212) (1.0 equiv, 0.15 M) in dichloromethane. The mixture was cooled to 0 ◦C
and DMAP (0.3 equiv) was added, followed by DCC (2.2 equiv). After heating at 45 ◦C for 18 h the
solvent was removed under reduced pressure, and the product subsequently purified by column
chromatography.
(4R,5R)-N,N’-Bis[(1R)-1-phenylethyl]-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxamide (213)
N
H
O
N
H
O
O O
Using 2.00 g of (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylic acid (212), product 213 (2.58 g,
62%) was isolated as a white solid after column chromatography (petroleum spirit : ethyl acetate,
1 : 1, to 1 : 2): m.p. 122− 124 ◦C; [α]21D +51.2 (c 1.00, CH2Cl2); IR (neat) 3500-3000, 1667, 1530, 1508,
1232, 1175, 1088 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.39-7.33 (m, 10H, ArH, NH), 7.31-7.26 (m, 2H,
ArH), 5.20 (dq, J = 7.8, 7.0 Hz, 2H, CHPh), 4.58 (s, 2H, CHO), 1.54 (d, J = 6.9 Hz, 6H, CHCH3), 1.51
(s, 6H, CCH3);
13C NMR (100 MHz, CDCl3) δ 168.7 (2C, C−O), 142.7 (2C, Ar), 128.8 (4C, Ar), 127.5
(2C, Ar), 126.1 (4C, Ar), 112.4 (1C, OCCH3), 77.3 (2C, CHO), 48.7 (2C, CHPh), 26.1 (2C, OCCH3),
22.2 (2C, CHCH3); MS (ESI) m/z 397 (M + H)+; HRMS (ESI) m/z calcd for C23H29N2O4 (M + H)+
397.2127, found 397.2129.
(4R,5R)-N,N’-Bis[(1S)-1-phenylethyl]-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxamide (214)
N
H
O
N
H
O
O O
Using 2.00 g of (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylic acid (212), product 214 (2.84 g,
76%) was isolated as a semi-solid after column chromatography (petroleum spirit : ethyl acetate,
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1 : 1): [α]21D −65.5 (c 0.85, CH2Cl2); IR (neat) 3550-2950, 1651, 1512, 1449, 1374, 1211, 1127, 1085
cm−1; 1H NMR (400 MHz, CDCl3) δ 7.38-7.25 (m, 12H, ArH, NH), 5.19 (dq, J = 8.0, 7.0 Hz, 2H,
CHPh), 4.56 (s, 2H, CHO), 1.54 (d, J = 7.0 Hz, 6H, CHCH3), 1.43 (s, 6H, CCH3);
13C NMR (100 MHz,
DMSO−d6) δ 168.3 (2C, C−O), 144.7 (2C, Ar), 128.7 (4C, Ar), 127.2 (2C, Ar), 126.5 (4C, Ar), 112.2
(1C, OCCH3), 78.0 (2C, CHO), 48.5 (2C, CHPh), 26.6 (2C, OCCH3), 22.8 (2C, CHCH3); MS (ESI) m/z
397 (M + H)+; HRMS (ESI) m/z calcd for C23H29N2O4 (M + H)+ 397.2127, found 397.2138.
(4R,5R)-N,N’-Bis(diphenylmethyl)-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxamide (215)
N
H
O
N
H
O
O O
Using 1.00 g of (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylic acid (212), product 215 (2.35
g, 86%) was isolated as a white crystalline solid after column chromatography (petroleum spirit :
ethyl acetate, 1 : 1): m.p. 47− 49 ◦C; [α]24D −16.0 (c 0.99, CH2Cl2); IR (neat) 3411, 3400-3200, 3061,
3029, 2987, 1667, 1494, 1448, 1374, 1241 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 8.8 Hz, 2H,
NH), 7.41-7.27 (m, 20H, ArH), 6.40 (d, J = 8.8 Hz, 2H, CHPh), 4.74 (s, 2H, CHO), 1.51 (s, 6H, CCH3);
13C NMR (100 MHz, CDCl3) δ 168.8 (2C, C−O), 141.2 (2C, Ar), 141.1 (2C, Ar), 128.8 (8C, Ar), 127.7
(2C, Ar), 127.6 (2C, Ar), 127.4 (8C, Ar), 112.7 (1C, OCCH3), 77.5 (2C, CHO), 56.5 (2C, CHPh), 26.2
(2C, CCH3); MS (ESI) m/z 521 (M + H)+; HRMS (ESI) m/z calcd for C33H33N2O4 (M + H)+ 521.2440,
found 521.2444.
(4R,5R)-N,N’-Bis-trityl-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxamide (217)
N
H
O
N
H
O
O O
Using 1.00 g of (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylic acid (212), product 217 (2.60
g, 73%) was isolated as a white crystalline solid after column chromatography (petroleum spirit :
ethyl acetate, 4 : 1, to 2 : 1): m.p. 77− 80 ◦C; [α]24D −1.3 (c 0.96, CH2Cl2); IR (neat) 1678, 1490, 1447,
1212, 1086 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.87 (s, 2H, NH), 7.34-7.16 (m, 30H, ArH), 4.66 (s,
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2H, CHO), 1.46 (s, 6H, CCH3);
13C NMR (100 MHz, CDCl3) δ 168.6 (2C, C−O), 144.3 (6C, Ar), 128.6
(12C, Ar), 128.0 (12C, Ar), 127.1 (6C, Ar), 113.0 (1C, OCCH3), 78.0 (2C, CHO), 70.4 (2C, CPh3), 26.4
(2C, CCH3); MS (ESI) m/z 673 (M + H)+; HRMS (ESI) m/z calcd for C45H41N2O4 (M + H)+ 673.3066,
found 673.3070.
General Procedure for Acetonide Cleavage in the Protected Tartramides
According to the method of Borner,196 trifluoroacetic acid (8.0 equiv) was added to a 0.1 M solution
of protected tartramide (1.0 equiv) in methanol / water (5 / 1 (213 and 214) or 10 / 1 (215 and 217)).
The reaction mixture was heated at 70 ◦C until no further change was observed by TLC (90 − 122
h), after which it was diluted with ethyl acetate and washed with sodium bicarbonate solution. The
aqueous was extracted thoroughly with ethyl acetate and the organics were combined and washed
with brine. The organics were dried over sodium sulfate, filtered, and the solvent was removed
under reduced pressure. The product was subsequently purified by column chromatography.
(2R,3R)-2,3-Dihydroxy-N,N’-bis[(1R)-1-phenylethyl]butanediamide (206)
N
H
O
OH
OH
H
N
O
Using 2.58 g of (4R,5R)-N,N’-bis[(1R)-1-phenylethyl]-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxami-
de (213), product 206 (1.39 g, 60%) was isolated as a white solid after column chromatography
(ethyl acetate : petroleum spirit, 6 : 1): m.p. 113− 115 ◦C (lit.197 130− 131 ◦C); [α]21D +130.6 (c 1.36,
DMSO); IR (neat) 3550-3000, 1647, 1519, 1138, 1062 cm−1; 1H NMR (400 MHz, DMSO−d6) δ 7.94
(d, J = 8.4 Hz, 2H, NH), 7.40-7.31 (m, 8H, ArH), 7.27-7.22 (m, 2H, ArH), 5.67 (d, J = 6.9 Hz, 2H, OH),
5.05-4.97 (m, 2H, CHCH3), 4.29 (d, J = 6.1 Hz, 2H, CHOH), 1.42 (d, J = 7.0 Hz, 6H, CH3);
13C NMR
(100 MHz, DMSO−d6) δ 171.5 (2C, C−O), 144.8 (2C, Ar), 128.7 (4C, Ar), 127.2 (2C, Ar), 126.6 (4C,
Ar), 73.1 (2C, CHOH), 48.2 (2C, CHCH3), 22.8 (2C, CH3); MS (CI+, NH3) m/z 357 (M + H)+; HRMS
(CI+, NH3) m/z calcd for C20H25N2O4 (M + H)+ 357.1814, found 357.1812.
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(2R,3R)-2,3-Dihydroxy-N,N’-bis[(1S)-1-phenylethyl]butanediamide (207)
N
H
O
H
N
O
OH
OH
Using 2.84 g of (4R,5R)-N,N’-bis[(1S)-1-phenylethyl]-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxamide
(214), product 207 (2.50 g, 81%) was isolated as a white solid after column chromatography (ethyl
acetate : petroleum spirit, 6 : 1, to 100 % ethyl acetate): m.p. 143− 145 ◦C (lit.197 144− 146 ◦C);
[α]21D +42.6 (c 1.24, DMSO); IR (neat) 3346, 3450-2900, 1639, 1529, 1445, 1137, 1076 cm
−1; 1H NMR
(400 MHz, DMSO−d6) δ 7.98 (d, J = 8.4 Hz, 2H, NH), 7.45-7.21 (m, 10H, ArH), 5.75 (d, J = 7.4 Hz,
2H, OH), 5.08-4.98 (m, 2H, CHCH3), 4.35 (d, J = 7.4 Hz, 2H, CHOH), 1.43 (d, J = 7.0 Hz, 6H, CH3);
13C NMR (100 MHz, DMSO−d6) δ 171.8 (2C, C−O), 144.7 (2C, Ar), 128.6 (4C, Ar), 127.0 (2C, Ar),
126.6 (4C, Ar), 73.3 (2C, CHOH), 48.2 (2C, CHCH3), 22.9 (2C, CH3); MS (CI+, NH3) m/z 357 (M +
H)+; HRMS (CI+, NH3) m/z calcd for C20H25N2O4 (M + H)+ 357.1814, found 357.1829.
(2R,3R)-N,N’-Bis(diphenylmethyl)-2,3-dihydroxybutanediamide (209)
N
H
O
OH
OH
H
N
O
Using 2.35 g of (4R,5R)-N,N’-bis(diphenylmethyl)-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxamide
(215), product 209 (1.60 g, 74%) was isolated as a white solid after column chromatography (petrole
um spirit : ethyl acetate, 2 : 1, to 1 : 2): m.p. 160− 162 ◦C; [α]21D +74.1 (c 1.02, DMSO); IR (neat)
3450-3050, 1625, 1535, 1115, 1074 cm−1; 1H NMR (400 MHz, DMSO−d6) δ 8.26 (d, J = 8.7 Hz, 2H,
NH), 7.38-7.23 (m, 20H, ArH), 6.18 (d, J = 8.7 Hz, 2H, CHPh2), 5.94 (d, J = 7.5 Hz, 2H, OH), 4.41 (d,
J = 7.4 Hz, 2H, CHOH); 13C NMR (100 MHz, DMSO−d6) δ 171.6 (2C, C−O), 142.7 (4C, Ar), 129.0
(4C, Ar), 128.7 (4C, Ar), 127.9 (4C, Ar), 127.7 (4C, Ar), 127.4 (4C, Ar), 73.4 (2C, CHOH), 56.4 (2C,
CHPh2); MS (CI+, NH3) m/z 498 (M + NH4)+; HRMS (ESI) m/z calcd for C30H29N2O4 (M + H)+
481.2127, found 481.2128.
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(2R,3R)-N,N’-Bis-trityl-2,3-dihydroxybutanediamide198 (218)
N
H
O
OH
OH
O
H
N
Using 2.60 g of (4R,5R)-N,N’-bis-trityl-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxamide (217), prod-
uct 218 (0.31 g, 13%) was isolated as a white solid after column chromatography (petroleum spirit :
ethyl acetate, 2 : 1, to 1 : 2): m.p. 249− 252 ◦C (lit.198 278− 279 ◦C); IR (neat) 3403, 3350-3000, 1686,
1489, 1445, 1021 cm−1; 1H NMR (400 MHz, CD3CN) δ 8.17 (s, 2H, NH), 7.37-7.22 (m, 30H, ArH),
4.41 (d, J = 7.4 Hz, 2H, CHOH), 4.35 (d, J = 7.6 Hz, 2H, CHOH); 13C NMR (100 MHz, CD3CN) δ
170.6 (2C, C−O), 144.8 (6C, Ar), 128.6 (12C, Ar), 127.9 (12C, Ar), 127.0 (6C, Ar), 73.0 (2C, CHOH),
69.8 (1C, CPh3); MS (ESI) m/z 655 (M + Na)+; HRMS (ESI) m/z calcd for C42H37N2O4 (M + H)+
633.2753, found 633.2765. An optical rotation was not recorded due to poor solubility.
(2R,3R)-2,3-Dihydroxy-N,N’-bis(naphthalen-1-ylmethyl)butanediamide (220)
N
H
O
OH
OH
H
N
O
Using a modified method of Frankland,130 1-naphthylmethylamine (219) (1.65 mL, 11.2 mmol, 2.0
equiv) was added to a solution of (+)-dimethyl L-tartrate (203) (1.00 g, 5.6 mmol, 1.0 equiv) in
methanol (2.5 mL). The reaction mixture was stirred at room temperature for 18 h and was subse-
quently filtered under reduced pressure, washing thoroughly with methanol, to provide product
220 (1.51 g, 63%) as a white solid which required no further purification: m.p. 231− 234 ◦C; [α]21D
+80.6 (c 1.25, DMSO); IR (neat) 3550-3000, 3271, 1685, 1630, 1618, 1535, 1431, 1284, 1127, 1085, 1026
cm−1; 1H NMR (400 MHz, DMSO−d6) δ 8.32 (app. t, J = 6.0 Hz, 2H, NH), 8.14 (d, J = 7.8 Hz, 2H,
ArH), 7.98-7.94 (m, 2H, ArH), 7.84 (d, J = 8.1 Hz, 2H, ArH), 7.61-7.52 (m, 6H, ArH), 7.49-7.43 (m,
2H, ArH), 5.87 (d, J = 7.3 Hz, 2H, OH), 4.89-4.77 (m, 4H, CH2Ar), 4.45 (d, J = 7.2 Hz, 2H, CHOH);
13C NMR (100 MHz, DMSO−d6) δ 172.7 (2C, C−O), 134.9 (2C, Ar), 133.6 (2C, Ar), 131.2 (2C, Ar),
128.9 (2C, Ar), 127.7 (2C, Ar), 126.7 (2C, Ar), 126.2 (2C, Ar), 125.9 (2C, Ar), 125.3 (2C, Ar), 123.8
(2C, Ar), 73.4 (2C, CHOH), 40.4 (2C, CH2Ar); MS (ESI) m/z 429 (M + H)+; HRMS (ESI) m/z calcd for
C26H25N2O4 (M + H)+ 429.1814, found 429.1819.
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(3S,4R)-Epoxyhexan-1-ol199 (183)
OH
O
Racemic Epoxidation: According to the method of Muller,129 mCPBA (5.18 g, 30.0 mmol, 1.5 equiv)
was added to a solution of (Z)-3-hexen-1-ol (182) (2.00 g, 20.0 mmol, 1.0 equiv) in dichloromethane
(150 mL) at 0 ◦C. The reaction mixture was allowed to stir at 0 ◦C for 2 h. Saturated aqueous sodium
sulfite (100 mL) was added and the mixture was stirred for a further 15 min. The aqueous layer was
separated and extracted with ethyl acetate (3 x 80 mL). The organics were combined, washed with
saturated aqueous sodium bicarbonate (200 mL) and brine (200 mL), dried over sodium sulfate
and filtered. The solvent was removed under reduced pressure and the mixture was purified by
column chromatography (diethyl ether : petroleum spirit, 2 : 1, to 5 : 1) to give product 183 (2.02 g,
87%) as a colourless oil: IR (neat) 3550-2950, 2970, 2878, 1467, 1391, 1054 cm−1; 1H NMR (400 MHz,
CDCl3) δ 3.95-3.82 (m, 2H, CH2OH), 3.13 (dt, J = 8.0, 4.5 Hz, 1H, OCH), 2.94 (td, J = 6.4, 4.3 Hz, 1H,
OCH), 1.99-1.50 (m, 4H, CH2CH3, CH2CH2OH), 1.07 (t, J = 7.6 Hz, 3H, CH3);
13C NMR (100 MHz,
CDCl3) δ 60.7 (1C, OCH), 57.9 (1C, CH2OH), 55.2 (1C, OCH), 30.4 (1C, CH2), 21.2 (1C, CH2), 10.5
(1C, CH3); MS (CI+, NH3) m/z 134 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for C6H16NO2 (M +
NH4)
+ 134.1181, found 134.1180.
Asymmetric Epoxidation Using Titanium(IV) iso-Propoxide: Using a modified method of Jami-
son,107 ligand 189 or 203 (1.25 equiv) was added to a solution of titanium(IV) iso-propoxide (1.00
equiv) in dichloromethane at 0 ◦C. After stirring for 1.5 h at 0 ◦C, TBHP (1.25 equiv) was added
and the mixture was stirred for a further 1 h. A solution of (Z)-3-hexen-1-ol (182) (1.00 equiv) in
dichloromethane was added to produce an overall concentration of 0.17 M. The reaction mixture
was stirred at 0 ◦C for 40 h, after which it was allowed to warm to room temperature and TBHP
(1.25 equiv) was added, stirring at room temperature for a further 24 h. Sodium hydroxide and
brine were added and stirred for 30 min. The mixture was subsequently filtered through a plug
of silica, eluting with diethyl ether. The organics were washed with aqueous sodium thiosulfate,
dried over sodium sulfate and filtered. The solvent was removed under reduced pressure and
the product purified by column chromatography. The product had spectroscopic data consistent
with that above. For full details on number of equivalents of reagents used, temperatures, reaction
times and conversions, see Table 7 (page 87).
Asymmetric Epoxidation Using Vanadium(V) Oxytriisopropoxide: According to the method of
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Yamamoto,121 a solution of bishydroxamic acid 199 (42 mg, 0.04 mmol, 0.02 equiv) in toluene (0.2
mL) was added to a solution of vanadium(V) oxytriisopropoxide (4.9 mg, 0.02 mmol, 0.01 equiv) in
toluene (0.2 mL) at room temperature. The red-brown mixture was stirred at room temperature for
7 h, after which cumene hydroperoxide (0.50 mL) and a solution of (Z)-3-hexen-1-ol (182) (200 mg,
2.0 mmol, 1.0 equiv) in toluene (0.2 mL) was added and stirred for 136 h. Aqueous sodium sulfite
(5 mL) was added and stirred for 30 min. The aqueous was extracted with diethyl ether (2 x 5 mL)
and the organics were combined, dried over sodium sulfate and filtered. The solvent was removed
under reduced pressure and the product purified by column chromatography. The product had
spectroscopic data consistent with that above. For full details on number of equivalents of reagents
used, temperatures, reaction times and conversions, see Table 7 (page 87).
Asymmetric Epoxidation Using Zirconium(IV) tert-Butoxide: According to the method of On-
aka,128 zirconium(IV) tert-butoxide (0.20 equiv or 0.40 equiv) was added to a solution of tartramide
ligand (189, 206, 207, 209, 218 or 220) (0.22 equiv or 0.60 equiv) in dichloromethane at room tem-
perature. The mixture was stirred for 1-2 h in the presence of activated 4A˚ molecular sieves, and
subsequently cooled to the required temperature. Cumene hydroperoxide (2.0 equiv) and a solu-
tion of (Z)-3-hexen-1-ol (182) (1.0 equiv) in dichloromethane was added dropwise to produce an
overall concentration of 0.13 M. The reaction mixture was stirred at the requisite temperature and
monitored by TLC. Saturated aqueous sodium bisulfite and diethyl ether were added and stirred
for 30 min whilst warming to room temperature. Sodium sulfate and silica were added and stirred
for a further 30 min. The mixture was filtered through a plug of silica, eluting with diethyl ether.
The solvent was subsequently removed under reduced pressure and the product purified by col-
umn chromatography. The product had spectroscopic data consistent with that above. For full
details on number of equivalents of reagents used, temperatures, reaction times and conversions,
see Table 7 (page 87).
(3S,4R)-Epoxyhexan-1-yl trityl ether129 (202)
OCPh3
O
According to the method of Muller,129 triethylamine (0.12 mL, 0.86 mmol, 2.0 equiv) and trityl
chloride (131 mg, 0.47 mmol, 1.1 equiv) were added to a solution of (3S,4R)-epoxyhexan-1-ol (183)
(50 mg, 0.43 mmol, 1.0 equiv) in dichloromethane (3 mL), and stirred for 6 h at room tempera-
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ture. The solvent was removed under reduced pressure and the mixture was purified by column
chromatography (petroleum spirit : diethyl ether, 5 : 1) to give product 202 (136 mg, 89% [esti-
mated from 1H NMR spectrum]) as a colourless oil: IR (neat) 2968, 2876, 1489, 1448, 1182, 1071
cm−1; 1H NMR (400 MHz, CDCl3) δ 7.50-7.45 (m, 6H, ArH), 7.37-7.22 (m, 9H, ArH), 3.29 (t, J =
6.7 Hz, 2H, CH2OCPh3), 3.17-3.13 (m, 1H, OCH), 2.93 (td, J = 6.1, 4.3 Hz, 1H, OCH), 1.94-1.78
(m, 2H, CH2CH2OCPh3), 1.63-1.48 (m, 2H, CH2CH3), 1.05 (t, J = 7.5 Hz, 3H, CH3);
13C NMR (100
MHz, CDCl3) δ 144.2 (3C, Ar), 128.7 (6C, Ar), 127.8 (6C, Ar), 127.0 (3C, Ar), 86.7 (1C, OCPh3), 61.2
(1C, OCH), 58.2 (1C, CH2OCPh3), 55.0 (1C, OCH), 28.7 (1C, CH2), 21.2 (1C, CH2), 10.6 (1C, CH3);
MS (ESI) m/z 381 (M + Na)+; HRMS (ESI) m/z calcd for C25H26O2Na (M + Na)+ 381.1831, found
381.1831; HPLC (OD-H), n-hexane : i-propanol = 99 : 1, wavelength = 254 nm, flow rate = 0.50 mL
/ min, Rt = 13.1 min (3S,4R), Rt = 14.2 min (3R,4S).
(3R,4S,6Z,9E)-3,4-Epoxydodeca-6,9-dien-1-ol (160)
OH
O
Racemic Epoxidation: According to the method of Mihelich,120 TBHP (0.36 mL) was added drop-
wise to a solution of (3Z,6Z,9E)-dodeca-3,6,9-trien-1-ol 159 (129 mg, 0.72 mmol, 1.0 equiv) and
vanadyl acetylacetonate (10 mg, 0.04 mmol, 5 mol %) in dichloromethane (10 mL) at 0 ◦C. The mix-
ture was stirred at room temperature for 16 h after which it was diluted with dichloromethane (10
mL) and washed with 10% w/w sodium sulfite (10 mL). The layers were separated and the aque-
ous portion was extracted with diethyl ether (2 x 10 mL). The organics were combined, washed
with brine (20 mL) and dried over sodium sulfate. The crude mixture was purified by column chro-
matography to give product 160 (68 mg, 48 %) as an oil: R f 0.19 (petroleum spirit : ethyl acetate, 2 :
1); IR (neat) 3600-3050, 3010, 2964, 2930, 2874, 1455, 1385 cm−1; 1H NMR (400MHz; CDCl3) δ 5.62-
5.38 (m, 4H, CH−), 3.94-3.85 (m, 2H, CH2OH), 3.17-3.12 (m, 1H, OCH), 3.05-3.00 (m, 1H, OCH),
2.81-2.77 (m, 2H, CHCH2CH), 2.47-2.24 (m, 2H, CH2CHO), 2.07-2.00 (m, 2H, CH2CH3), 1.97-1.73
(m, 2H, OCHCH2CH2OH), 1.01-0.98 (m, 3H, CH3);
13C NMR (100 MHz; CDCl3) δ 132.9 (1C, CH=),
130.8 (1C, CH=), 126.6 (1C, CH=), 124.1 (1C, CH=), 60.8 (1C, CH2OH), 56.0 (1C, CH2CHO), 55.0
(1C, OCHCH2CH2OH), 30.6 (1C, CHCH2CH), 30.5 (1C, CH2CH2OH), 26.3 (1C, CHCH2CHO), 25.5
(1C, CH2CH3), 13.8 (1C, CH3); MS (CI+, NH3) 214 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for
C12H24NO2 (M + NH4)
+ 214.1807, found 214.1803.
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Asymmetric Epoxidation: Using a modified method of Onaka,128 zirconium(IV) t-butoxide (1.58
mL, 10.2 mmol, 0.40 equiv) was added to (2R,3R)-N,N’-dibenzyl-2,3-dihydroxybutanediamide (189)
(2.01 g, 6.1 mmol, 0.60 equiv) and activated 4A˚ molecular sieves (1.03 g) in dichloromethane (75
mL) at room temperature. The mixture was stirred for 2 h after which it was cooled to −40 ◦C.
CHP (3.77 mL) was added dropwise, followed by dropwise addition of a solution of (3Z,6Z,9E)-
dodeca-3,6,9-trien-1-ol (159) (1.84 g, 10.2 mmol, 1.0 equiv) in dichloromethane (5 mL). After 20 h
CHP (1.80 mL) was added and after a further 24 h aqueous sodium sulfite (10 mL) and diethyl
ether (100 mL) were added and the reaction mixture was allowed to warm to room temperature.
Sodium sulfate (40.0 g) and silica (4.0 g) were added and the mixture was stirred for 30 min before
passing through a plug of silica, eluting with ethyl acetate (200 mL). The solvent was removed un-
der reduced pressure and the crude mixture was subjected to column chromatography (petroleum
spirit : ethyl acetate, 2 : 1), providing product 160 (1.64 g, 82%) as a colourless oil: [α]20D −8.9 (c
0.87, CH2Cl2) [when trityl derivative 221 recorded an e.r. of 78 : 22, (3S,4R) : (3R,4S) - see below];
all other data was identical with that reported above.
(3S,4R,6Z,9E)-3,4-Epoxydodeca-6,9-dien-1-yl trityl ether (221)
OCPh3
O
According to the method of Muller,129 triethylamine (0.07 mL, 0.51 mmol, 2.0 equiv) and trityl
chloride (78 mg, 0.28 mmol, 1.1 equiv) were added to a solution of (3S,4R,6Z,9E)-3,4-epoxydodeca-
6,9-dien-1-ol (160) (50 mg, 0.24 mmol, 1.0 equiv) in dichloromethane (2.5 mL) at room temperature.
The mixture was stirred for 18 h after which it was diluted with dichloromethane (15 mL) and
washed with water (15 mL). The aqueous was extracted with dichloromethane (3 x 15 mL) and
the combined organics were washed with brine (20 mL). The organics were dried over sodium
sulfate, filtered and the solvent was removed under reduced pressure. The crude mixture was
subjected to column chromatography (petroleum spirit : ethyl acetate, 20 : 1) to provide product
221 (82 mg, 73%) as a colourless oil: R f 0.38 (petroleum spirit : ethyl acetate, 10 : 1); [α]20D −0.9 (c
0.98, CH2Cl2); IR (neat) 3063, 3026, 2963, 2926, 2875, 1490, 1447, 1068 cm−1; 1H NMR (400 MHz,
CDCl3) δ 7.53-7.48 (m, 6H, ArH), 7.38-7.32 (m, 6H, ArH), 7.31-7.26 (m, 3H, ArH), 5.62-5.37 (m, 4H,
CH−CH), 3.33 (t, J = 6.5 Hz, 2H, CH2OCPh3), 3.20-3.15 (m, 1H, OCH), 3.01 (td, J = 6.4, 4.3 Hz, 1H,
OCH), 2.79 (app t, J = 6.3 Hz, 2H, C−CHCH2CH−C), 2.45-2.37 (m, 1H, OCHCH2), 2.30-2.22 (m,
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1H, OCHCH2), 2.10-2.01 (m, 2H, CH2CH3), 1.98-1.81 (m, 2H, OCHCH2CH2), 1.01 (t, J = 7.4 Hz, 3H,
CH3);
13C NMR (100 MHz, CDCl3) δ 144.2 (3C, Ar), 132.8 (1C, CH−CH), 130.6 (1C, CH−CH), 128.7
(6C, Ar), 127.8 (6C, Ar), 127.0 (3C, Ar), 126.7 (1C, CH−CH), 124.5 (1C, CH−CH), 86.8 (1C, CPh3),
61.1 (1C, CH2OCPh3), 56.4 (1C, OCH), 54.9 (1C, OCH), 30.6 (1C, CH−CHCH2CH−CH), 28.7 (1C,
OCHCH2CH2), 26.3 (1C, OCHCH2CH−CH), 25.6 (1C, CH2CH3), 13.9 (1C, CH3); MS (ESI) m/z 461
(M + Na)+; HRMS (ESI) m/z calcd for C31H34O2Na (M + Na)+ 461.2457, found 461.2451; HPLC
(ChiralPak AD), n-hexane : i-propanol = 99.75 : 0.25, wavelength = 200 nm, injection volume = 10
µL, flow rate = 0.25 mL / min, Rt = 105.7 min (3S,4R), Rt = 93.9 min (3R,4S), e.r. = 78 : 22, (3S,4R) :
(3R,4S).
Procedure for Dilution Studies Using 9-Oxabicyclo[6.1.0]non-4-ene (131), where Ac-
etate was the Nucleophile131
To a solution of 9-oxabicyclo[6.1.0]non-4-ene (131) (50 mg, 0.4 mmol, 1.0 equiv) in dichloromethane
(1.6 mL: 0.25 M; 16 mL: 0.025 M; 160 mL: 0.0025 M) was added NBS (72 mg, 0.4 mmol, 1.0 equiv)
in a single portion, along with 1 drop of TMG. Acetic acid (24 mg, 0.4 mmol, 1.0 equiv) was added
and the reaction mixture was stirred at room temperature for 2.5 h (with the exception of the reac-
tion conducted at 0.0025 M, which was stirred for 3 days). After this time the reaction mixture was
washed with 10% w/w sodium sulfite (8 mL), dried over sodium sulfate and the solvent was re-
moved in vacuo. The product distribution was estimated by 1H NMR analysis of the crude reaction
mixture directly after work-up. For information regarding experimental procedures to prepare
pure samples of compounds 161-164 (Nu = Ac), and also for characterising data, see Appendix II
(from page 320).
[Also see Appendix II (from page 320) for experimental procedures and characterising data for the
other compounds discussed in Section 3.3 (pages 97–101).]
Procedure for the Treatment of (3R*,4S*,6Z,9E)-3,4-Epoxydodeca-6,9-dien-1-ol (160) with
NBS and Water
TMG (23 mg, 0.2 mmol, 5 mol %) and NBS (0.65 g, 3.7 mmol, 1.0 equiv) were added to a stirred
solution of (3R*,4S*,6Z,9E)-3,4-epoxydodeca-6,9-dien-1-ol 160 (0.72 g, 3.7 mmol, 1.0 equiv) in water
(370 mL). The mixture was stirred at room temperature for 3 days and the products were extracted
with ethyl acetate (3 x 100 mL). The organics were combined and washed with 10% w/w sodium
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sulfite (2 x 100 mL) and brine (100 mL). The organics were dried over sodium sulfate, and the
solvent was removed under reduced pressure to give a colourless oil. Separation of products and
purification was achieved by column chromatography (petroleum spirit : ethyl acetate, 2 : 1, to 100
% ethyl acetate) and HPLC (n-hexane / i-propanol) where appropriate.
(3R*,4S*,6Z,9S*,10R*)-9-Bromo-3,4-epoxydodec-6-ene-1,10-diol and (3R*,4S*,6Z,9R*,10S*)-9-Bro
mo-3,4-epoxydodec-6-ene-1,10-diol (224)
Br
OH
O
OH
Diastereomer 1: Isolated as a single diastereomer, with the overall relative stereochemistry unas-
signed: 32 mg, 3.0% as a colourless oil; IR (KBr) 3700-3100, 2967, 2880, 1643, 1438, 1385 cm−1; 1H
NMR (400 MHz, CDCl3) δ 5.75-5.64 (m, 2H, CH−CH), 4.16-4.07 (m, 1H, CHBr), 3.93-3.83 (m, 2H,
CH2OH), 3.67 (ddd, J = 8.8, 5.8, 3.3 Hz, 1H, CHOH), 3.18 (dt, J = 7.6, 4.6 Hz, 1H, OCHCH2CH2OH),
3.07 (dt, J = 7.0, 5.0 Hz, 1H, C−CHCH2CHO), 2.86-2.76 (m, 1H, CH2CHBr), 2.63-2.57 (m, 1H,
CH2CHBr), 2.45-2.37 (m, 1H, C−CHCH2CHO), 2.33-2.26 (m, 1H, C−CHCH2CHO), 1.98-1.89 (m,
1H, OCHCH2CH2OH), 1.84-1.69 (m, 2H, OCHCH2CH2OH, CH2CH3), 1.62-1.51 (m, 1H, CH2CH3),
1.02 (t, J = 7.4 Hz, 3H, CH3);
13C NMR (100 MHz, CDCl3) δ 128.3 (1C, C−C), 126.9 (1C, C−C),
75.0 (1C, CHOH), 60.6 (1C, CHBr), 60.5 (1C, CH2OH), 56.1 (1C, OCH), 55.7 (1C, OCH), 31.3 (1C,
CH2CHBr), 30.6 (1C, CH2CH2OH), 26.8 (1C, CH2CH3), 26.7 (1C, CH2CHO), 10.1 (1C, CH3); MS
(CI+, NH3) 310 (M + NH4)
+; HRMS (CI+, NH3) m/z calcd for C12H25NO379Br (M + NH4)+ 310.1018,
found 310.1018; HPLC (n-hexane : i-propanol, 95 : 5), 4.00 mL / min, 240 nm, Rt 22.5 min.
Diastereomer 2: Isolated as a single diastereomer, with the overall relative stereochemistry unas-
signed: 55 mg, 5.1% as a colourless oil; IR (KBr) 3750-3100, 2978, 2818, 1641, 1421, 1265 cm−1; 1H
NMR (400 MHz, CDCl3) δ 5.69-5.60 (m, 2H, CH−CH), 4.16-4.10 (m, 1H, CHBr), 3.93-3.81 (m, 2H,
CH2OH), 3.70 (dt, J = 8.8, 3.9 Hz, 1H, CHOH), 3.13 (dt, J = 7.7, 4.4 Hz, 1H, OCHCH2CH2OH),
3.03 (dt, J = 6.4, 4.4 Hz, 1H, C−CHCH2CHO), 2.73-2.61 (m, 2H, CH2CHOH), 2.45-2.27 (m, 2H,
C−CHCH2CHO), 1.98-1.87 (m, 1H, CH2CH2OH), 1.81-1.54 (m, 3H, CH2CH2OH, CH2CH3), 1.03
(t, J = 7.4, 3H, CH3);
13C NMR (100 MHz, CDCl3) δ 129.0 (1C, C−C), 126.7 (1C, C−C), 76.1 (1C,
CHOH), 62.0 (1C, CHBr), 60.6 (1C, CH2OH), 55.9 (1C, OCH), 55.2 (1C, OCH), 31.4 (1C, CH2CHBr),
30.6 (1C, CH2CH2OH), 26.7 (1C, CH2CH3), 26.6 (1C, CH2CHO), 10.3 (1C, CH3); MS (CI+, NH3)
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310 (M + NH4)
+; HRMS (CI+, NH3) m/z calcd for C12H25NO379Br (M + NH4)+ 310.1018, found
310.1021; HPLC (n-hexane : i-propanol, 95 : 5), 4.00 mL / min, 240 nm, Rt 24.5 min.
(3R*,4S*,6Z,9S*,10R*)-10-Bromo-3,4-epoxydodec-6-ene-1,9-diol and (3R*,4S*,6Z,9R*,10S*)-10-Bro
mo-3,4-epoxydodec-6-ene-1,9-diol (225)
OH
Br
O
OH
Diastereomer 1: Isolated as a single diastereomer, with the overall relative stereochemistry unas-
signed: 10 mg, 0.9% as a colourless oil; IR (KBr) 3700-3050, 2850, 2770, 1642, 1404 cm−1; 1H NMR
(400 MHz, CDCl3) δ 5.75-5.63 (m, 2H, CH−CH), 4.07 (ddd, J = 9.7, 5.0, 3.4 Hz, 1H, CHBr), 3.95-3.79
(m, 3H, CHOH, CH2OH), 3.18-3.14 (m, 1H, OCHCH2CH2OH), 3.09-3.04 (m, 1H, C−CHCH2CHO),
2.52-2.31 (m, 4H, CH2CHOH, C−CHCH2CHO), 2.04-1.76 (m, 4H, CH2CH3, CH2CH2OH), 1.12 (t,
J = 7.3 Hz, 3H, CH3);
13C NMR (100 MHz, CDCl3) δ 127.6 (1C, C−C), 127.4 (1C, C−C), 74.0 (1C,
CHOH), 64.7 (1C, CHBr), 60.5 (1C, CH2OH), 56.0 (1C, OCHCH2C−C), 55.6 (1C, OCHCH2CH2OH),
31.8 (1C, CH2CHOH), 30.6 (1C, CH2CH2OH), 27.0 (1C, CH2CH3), 26.5 (1C, CH2CHO), 12.5 (1C,
CH3); MS (CI+, NH3) 310 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for C12H25NO379Br (M + H)+
293.0752, found 293.0750; HPLC (n-hexane : i-propanol, 95 : 5), 4.00 mL / min, 240 nm, Rt 27.5
min.
Diastereomer 2: Isolated as a single diastereomer, with the overall relative stereochemistry unas-
signed: 8 mg, 0.7% as a colourless oil; IR (KBr) 3700-3050, 2850, 2771, 1642, 1402 cm−1; 1H NMR
(400 MHz, CDCl3) δ 5.77-5.63 (m, 2H, CH−CH), 4.12-4.05 (m, 1H, CHBr), 3.96-3.85 (m, 2H, CH2OH),
3.74 (dt, J = 8.2, 4.4 Hz, 1H, CHOH), 3.20 (dt, J = 7.8, 4.5 Hz, 1H, OCHCH2CH2OH), 3.10-3.05 (m,
1H, C−CHCH2CHO), 2.51-2.29 (m, 4H, CH2CHOH, C−CHCH2CHO), 2.02-1.65 (m, 5H, CH2CH3,
CH2CH2OH, OH), 1.12 (t, J = 7.2 Hz, 3H, CH3) ;
13C NMR (100 MHz, CDCl3) δ 127.9 (1C, C−C),
127.6 (1C, C−C), 73.6 (1C, CHOH), 65.1 (1C, CHBr), 60.6 (1C, CH2OH), 56.0 (2C, OCHCH2C−,
OCHCH2CH2OH), 31.9 (1C, CH2CHOH), 30.7 (1C, CH2CH2OH), 27.3 (1C, CH2CH3), 26.2 (1C,
CH2CHO), 12.5 (1C, CH3); MS (CI+, NH3) 310 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for
C12H25NO379Br (M + H)+ 293.0752, found 293.0766; HPLC (n-hexane : i-propanol, 95 : 5), 4.00
mL / min, 240 nm, Rt 28.5 min.
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(3R*,4S*,6Z,9R*,10S*)-9,10-Dibromo-3,4-epoxydodec-6-en-1-ol and (3R*,4S*,6Z,9S*,10R*)-9,10-D
ibromo-3,4-epoxydodec-6-en-1-ol (228)
OH
OBr
Br
Isolated as a mixture of two diastereomers (it was not possible to estimate the ratio from the
1H NMR spectrum): 10 mg, 0.9% as a colourless oil; IR (KBr) 3650-3050, 1717, 1350, 1054 cm−1;
1H NMR (400 MHz, CDCl3) δ 5.73-5.66 (m, 4H, CH−CH), 4.26-4.14 (m, 4H, CHBr), 3.96-3.85 (m,
4H, CH2OH), 3.16 (dt, J = 7.8, 4.5 Hz, 2H, OCHCH2CH2OH), 3.08-2.97 (m, 4H, C−CHCH2CHO,
CHCH2CHBr), 2.92-2.84 (m, 2H, C−CHCH2CHBr), 2.51-2.21 (m, 6H, C−CHCH2CHO, CH2CH3),
2.07-1.90 (m, 4H, CH2CH3, CH2CH2OH), 1.83-1.55 (m, 4H, CH2CH2OH, OH), 1.12 (t, J = 7.2 Hz, 6H,
CH3);
13C NMR (100 MHz, CDCl3) δ 127.7 (1C, C−C), 127.6 (1C, C−C), 127.4 (1C, C−C), 127.3 (1C,
C−C), 60.7 (2C, CH2OH, CHBrCH2CH3), 60.6 (1C, C−CHCH2CHBr), 60.4 (1C, C−CHCH2CHBr),
57.5 (1C, OCH), 57.3 (1C, OCH), 55.9 (1C, OCHCH2CH2OH), 55.8 (1C, OCHCH2CH2OH), 55.1 (1C,
OCHCH2CH2OH), 55.0 (1C, OCHCH2CH2OH), 35.2 (1C, C−CHCH2CHBr), 35.1 (1C, C−CHCH2C
HBr), 30.6 (1C CH2CH2OH), 30.5 (1C CH2CH2OH), 30.3 (2C, CH2CH3), 29.7 (2C, C−CHCH2CHO),
11.1 (2C, CH3); MS (CI+, NH3) 372 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for C12H24NO279Br2
(M + NH4)
+ 372.0174, found 372.0157; HPLC (n-hexane : i-propanol, 98.5 : 1.5), 3.50 mL / min, 206
nm, Rt 40.5 min.
(3R*,4S*,6R*)-6-Bromo-6-[(2R*,4S*,5R*)-4-bromo-5-ethyltetrahydrofuran-2-yl]-3,4-epoxy-hexan-
1-ol, (3R*,4S*,6R*)-6-Bromo-6-[(2R*,4R*,5S*)-4-bromo-5-ethyltetrahydrofuran-2-yl]-3,4-epoxyhe
xan-1-ol, (3R*,4S*,6S*)-6-Bromo-6-[(2S*,4S*,5R*)-4-bromo-5-ethyltetrahydrofuran-2-yl]-3,4-epox
yhexan-1-ol and (3R*,4S*,6S*)-6-Bromo-6-[(2S*,4R*,5S*)-4-bromo-5-ethyltetrahydrofuran-2-yl]-3,
4-epoxyhexan-1-ol (229)
O
Br
H H
Br
OH
O
O
Br
H H
Br
OH
O
Diastereomers 1 and 2: Isolated as a mixture of two diastereomers in a ratio of 1.2 : 1.0 (found
by integration of the signals at 4.36 and 4.27 ppm): 15 mg, 1.1% as a colourless oil; IR (KBr)
3600-3100, 2974, 1715, 1640, 1445, 1379, 1098, 948 cm−1; 1H NMR (400 MHz, CDCl3) δ 4.40-4.36
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(m, 1H, OCHCHBr), 4.31-4.27 (m, 1H, OCHCHBr), 4.25-4.18 (m, 2H, OCHCHBr), 4.08-4.04 (m,
4H, CH3CH2CHO, OCHCHBr), 3.94-3.84 (m, 4H, CH2OH), 3.29-3.19 (m, 3H, OCHCH2CH2OH,
CHBrCH2CHO), 3.18-3.14 (m, 1H, OCHCH2CH2OH), 2.53-2.46 (m, 2H, CHBrCH2), 2.40-2.19 (m,
4H, CHBrCH2CHO, CHBrCH2), 2.08-2.02 (m, 2H, CHBrCH2CHO), 1.98-1.57 (m, 8H, CH2CH3,
CH2CH2OH), 1.03 (t, J = 7.4 Hz, 6H, CH3);
13C NMR (100 MHz, CDCl3) δ 88.7 (1C, OCHCHBr), 88.6
(1C, OCHCHBr), 79.9 (1C, OCHCH2), 79.0 (1C, OCHCH2), 60.5 (1C, CH2OH), 60.4 (1C, CH2OH),
55.6 (1C, OCHCH2), 55.1 (1C, OCHCH2), 54.9 (1C, OCHCH2), 54.8 (1C, OCHCH2), 54.6 (1C, CHBr),
53.2 (1C, CHBr), 48.3 (1C, OCHCHBr), 48.2 (1C, OCHCHBr), 40.4 (1C, CHBrCH2 ), 40.2 (1C, CHBrC
H2), 34.0 (1C, CH2CHO), 33.7 (1C, CH2CHO), 31.0 (1C, CH2CH2OH), 30.6 (1C, CH2CH2OH), 26.4
(1C, CH2CH3), 26.3 (1C, CH2CH3), 10.0 (1C, CH3), 9.9 (1C, CH3); MS (CI+, NH3) 370 (M + H)+;
HRMS (CI+, NH3) m/z calcd for C12H21O379Br2 (M + H)+ 370.9857, found 370.9860.
Diastereomers 3 and 4: Isolated as a mixture of two diastereomers (it was not possible to esti-
mate the ratio from the 1H NMR spectrum): 16 mg, 1.2% as a colourless oil; IR (KBr) 3600-3050,
2969, 2916, 1712, 1641, 1379, 1260, 1051 cm−1; 1H NMR (400 MHz, CDCl3) δ 4.27-4.21 (m, 3H,
OCHCH2CHBr, OCHCHBr), 4.18-4.12 (m, 1H, OCHCHBr), 4.07-4.01 (m, 2H, CH2CHCHBr), 3.94-
3.86 (m, 6H, OCHCHBr, CH2OH), 3.30-3.25 (m, 2H, OCHCH2CHBr), 3.24-3.20 (m, 1H, OCH), 3.18-
3.13 (m, 1H, OCHCH2CH2OH), 2.76-2.68 (m, 2H, CH2CHCHBr), 2.40-2.19 (m, 4H, CH2CHCHBr,
OCHCH2CHBr), 2.12-2.05 (m, 2H, OCHCH2CHBr), 1.99-1.50 (m, 8H, CH2CH2OH, CH2CH3), 1.03
(t, J = 7.4 Hz, 6H, CH3); 13C NMR (100 MHz, CDCl3) δ 87.4 (1C, CH3CH2CHCHBr), 87.3 (1C,
CH2CHCHBr), 79.5 (1C, OCHCHBr), 79.1 (1C, OCHCHBr), 60.6 (1C, CH2OH), 60.4 (1C, CH2OH),
55.6 (1C, OCHCH2), 55.1 (1C, OCHCH2), 54.9 (1C, OCHCH2), 54.8 (1C, OCHCH2), 54.5 (1C, OCH
CH2CHBr), 53.4 (1C, OCHCH2CHBr), 46.7 (1C, OCHCHBr), 46.5 (1C, OCHCHBr), 40.4 (1C, CH2CH
CHBr), 40.2 (1C, CH2CHCHBr), 33.4 (1C, OCHCH2CHBr), 33.1 (1C, OCHCH2CHBr), 31.0 (1C,
CH2CH2OH), 30.6 (1C, CH2CH2OH), 25.3 (1C, CH2CH3), 25.2 (1C, CH2CH3), 9.9 (1C, CH3), 9.8
(1C, CH3); MS (CI+, NH3) 370 (M + H)+; HRMS (CI+, NH3) m/z calcd for C12H21O379Br2 (M + H)+
370.9857, found 370.9867.
Procedure for the Treatment of (3R*,4S*,6Z,9E)-3,4-Epoxydodeca-6,9-dien-1-ol (160) with
NBS and Water in THF
TMG (12 mg, 0.1 mmol, 5 mol %) and NBS (0.44 g, 2.5 mmol, 1 equiv) were both added to a solution
of (3R*,4S*,6Z,9E)-3,4-epoxydodeca-6,9-dien-1-ol 160 (0.50 g, 2.5 mmol, 1.0 equiv) in THF (250 mL)
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at room temperature. A mixture of water (45 mg, 2.5 mmol, 1.0 equiv) in THF (10 mL) was added
by syringe pump over a period of 25 h and the mixture was stirred for 3 days, after which a further
mixture of water (45 mg, 2.5 mmol, 1.0 equiv) in THF (10 mL) was added by syringe pump over
a period of 25 h. After a further 24 h at room temperature, the reaction mixture was washed
with 10% w/w sodium sulfite (100 mL) and brine (100 mL). The organics were dried over sodium
sulfate, filtered and the solvent was subsequently evaporated under reduced pressure. Separation
of products and purification was achieved by column chromatography (petroleum spirit : ethyl
acetate, 3 : 1, to 1 : 1) and HPLC (n-hexane / i-propanol) where appropriate. (3R*,4S*,6Z,9E)-3,4-
epoxydodeca-6,9-dien-1-ol 160 (140 mg, 28% [estimated from 1H NMR spectrum]) was recovered
and dibromides 228 (100 mg, 11% [estimated from 1H NMR spectrum]) were produced, along with
four other compounds:
(2R*)-2-[(3S*,4R*,6Z,9E)-3,4-Epoxydodeca-6,9-dien-1-yloxy]tetrahydrofuran and (2S*)-2-[(3S*,4R
*,6Z,9E)-3,4-Epoxydodeca-6,9-dien-1-yloxy]tetrahydrofuran (232)
O
O O
H
Isolated as a mixture of two diastereomers (it was not possible to estimate the ratio from the 1H
NMR spectrum): 160 mg, 24% as a colourless oil; IR (KBr) 3650-3050, 2965, 1636, 1456, 1348, 1186,
1093, 1038, 970 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.60-5.35 (m, 8H, CH−CH), 5.17-5.14 (m, 2H,
OCHO), 3.94-3.82 (m, 6H, OCHCH2CH2O, CH2OCHO), 3.60-3.52 (m, 2H, CH2OCHO), 3.10-2.94
(m, 4H, OCHCH2CH−, OCHCH2CH2O), 2.79-2.71 (m, 4H, CH−CHCH2CH =), 2.44-2.18 (m, 4H,
OCHCH2CH−), 2.07-1.73 (m, 16H, CH2CH3, OCHCH2CH2O, OCHCH2, OCHCH2CH2), 0.98 (t, J
= 7.4 Hz, 6H, CH3);
13C NMR (100 MHz, CDCl3) δ 132.8 (2C, CH−), 130.6 (2C, CH−), 126.7 (2C,
CH−), 124.4 (2C, CH−), 104.0 (1C, OCHO), 103.8 (1C, OCHO), 66.9 (2C, OCHCH2CH2O), 64.3 (2C,
CH2OCHO), 56.3 (1C, OCHCH2CH−), 56.2 (1C, OCHCH2CH−), 54.8 (2C, OCHCH2CH2O), 32.3
(2C, OCHCH2), 30.6 (2C, CH−CHCH2CH−), 28.5 (2C, OCHCH2CH2O), 26.3 (2C, OCHCH2CH−),
25.5 (2C, CH2CH3), 23.5 (2C, OCHCH2CH2), 13.8 (2C, CH3); MS (CI+, NH3) 284 (M + NH4)+;
HRMS (CI+, NH3) m/z calcd for C16H27O3 (M + H)+ 267.1960, found 267.1953.
254
γ-Butyrolactone200 (234)
O
O
160 mg (estimated from 1H NMR spectrum): 1H NMR200 (400 MHz, CDCl3) δ 4.37 (t, J = 7.0 Hz,
2H, CH2C−O), 2.51 (t, J = 8.2 Hz, 2H, CH2O), 2.32-2.24 (m, 2H, CH2); 13C NMR (100 MHz, CDCl3)
δ 177.7 (1C, C−O), 68.5 (1C, CH2C−O), 27.8 (1C, CH2O), 22.2 (1C, CH2).
1-(Tetrahydrofuran-2-yl)pyrrolidine-2,5-dione (233)
O
N
O
O
20 mg (estimated from 1H NMR spectrum): IR (KBr) 3600-2950, 1640, 1376 cm−1; 1H NMR (400
MHz, CDCl3) δ 5.90 (dd, J = 7.9, 5.0 Hz, 1H, CHCN), 4.18 (dd, J = 14.6, 7.8 Hz, 1H, CH2O), 3.95 (td,
J = 7.8, 4.5 Hz, 1H, CH2O), 2.70 (s, 4H, CH2C−O), 2.50-2.40 (m, 1H, CH2CHN), 2.39-2.28 (m, 1H,
CH2CH2O), 2.26-2.16 (m, 1H, CH2CHN), 2.05-1.93 (m, 1H, CH2CH2O);
13C NMR (100 MHz, CDCl3)
δ 176.8 (2C, C−O), 81.6 (1C, CHN), 70.2 (1C, CH2O), 28.5 (1C, CH2CHN), 28.2 (2C, CH2C−O), 26.1
(1C, CH2CH2O); MS (CI+, NH3) 187 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for C8H12NO3 (M
+ H)+ 170.0817, found 170.0817; HPLC (n-hexane : i-propanol, 98.5 : 1.5), 3.50 mL / min, 206 nm,
Rt 53.5 min.
Procedure for the Treatment of (3R*,4S*,6Z,9E)-3,4-Epoxydodeca-6,9-dien-1-ol (160) with
NBS and Acetic Acid in Dichloromethane
NBS (392 mg, 2.2 mmol, 1.0 equiv) and TMG (12 mg, 0.1 mmol, 5 mol%) were added to a solution of
(3R*,4S*,6Z,9E)-3,4-epoxydodeca-6,9-dien-1-ol 160 (430 mg, 2.2 mmol, 1.0 equiv) in dichloromethane
(210 mL) at room temperature. A mixture of acetic acid (132 mg, 2.2 mmol, 1.0 equiv) in dichlorom-
ethane (10 mL) was added dropwise via a syringe pump over a period of 25 h and stirred for a fur-
ther 4 days. A further mixture of acetic acid (132 mg, 2.2 mmol, 1.0 equiv) in dichloromethane (10
mL) was added over a period of 25 h using a syringe pump. After 24 h the mixture was washed
with 10% w/w sodium sulfite (100 mL) and brine (100 mL). The aqueous portions were extracted
with dichloromethane (50 mL) and then the organics were combined, dried over sodium sulfate,
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filtered and the solvent was subsequently evaporated under reduced pressure. Separation of prod-
ucts and purification was achieved by column chromatography (petroleum spirit : ethyl acetate, 4
: 1, to 100 % ethyl acetate). (3R*,4S*,6Z,9E)-3,4-Epoxydodeca-6,9-dien-1-ol 160 (120 mg, 19% [es-
timated from 1H NMR spectrum]) was recovered and dibromides 228 (58 mg, 7%) were isolated,
along with twelve other compounds:
(3R*,4S*,6Z,9S*,10R*)-9-Acetoxy-10-bromo-3,4-epoxydodec-6-en-1-ol, (3R*,4S*,6Z,9R*,10S*)-9-A
cetoxy-10-bromo-3,4-epoxydodec-6-en-1-ol, (3R*,4S*,6Z,9S*,10R*)-10-Acetoxy-9-bromo-3,4-epox
ydodec-6-en-1-ol and (3R*,4S*,6Z,9R*,10S*)-10-Acetoxy-9-bromo-3,4-epoxydodec-6-en-1-ol (237
and 238)
Br
OAc O
OH
OAc
Br O
OH
Isolated as a mixture of four compounds (two regioisomers, each comprising of two diastere-
omers – it was not possible to estimate the ratio from the 1H NMR spectrum): 133 mg, 18% as
a colourless oil: IR (neat) 2971, 2931, 1739, 1712, 1437, 1372, 1229, 1044, 1023 cm−1; 1H NMR
(400 MHz, CDCl3) δ 5.63-5.49 (m, 8H, CH−CH), 5.05-5.00 (m, 2H, CHOAc), 4.96-4.90 (m, 2H,
CH3CH2CHOAc), 4.13-4.07 (m, 2H, CH−CHCH2CHBr), 4.06-3.99 (m, 2H, CHBr), 3.91-3.80 (m, 8H,
CH2OH), 3.14-3.09 (m, 4H, OCHCH2CH2OH), 3.03-2.96 (m, 4H, OCHCH2CH−CH), 2.64-2.48 (m,
8H, CH−CHCH2CHOAc, CH−CHCH2CHBr), 2.40-2.21 (m, 8H, OCHCH2CH−CH), 2.11 (s, 6H,
COCH3), 2.07 (s, 6H, COCH3), 1.95-1.84 (m, 4H, OCHCH2CH2OH), 1.81-1.67 (m, 12H, CH2CH2OH,
CH2CH3), 1.06 (t, J = 7.2 Hz, 6H, CH2CH3), 0.93 (t, J = 7.5 Hz, 6H, CH2CH3);
13C NMR (100
MHz, CDCl3) δ 170.6 (2C, C−O), 170.3 (2C, C−O), 128.3 (1C, C−C), 128.2 (1C, C−C), 127.6 (2C,
C−C), 127.0 (1C, C−C), 126.9 (1C, C−C), 126.3 (2C, C−C), 76.7 (2C, CH3CH2CHOAc), 75.0 (2C,
CH−CHCH2CHOAc), 60.4 (4C, CH2OH), 58.9 (2C, CH3CH2CHBr), 55.9 (1C, OCHCH2CH−CH),
55.8 (3C, CH2CHBr, OCHCH2CH−CH), 55.7 (1C, OCHCH2CH−CH), 55.6 (1C, OCHCH2CH−CH),
55.0 (4C, OCHCH2CH2OH), 32.5 (2C, CH−CHCH2CHOAc) 30.7 (1C, OCHCH2CH2OH), 30.6 (1C,
CH2CH2OH), 29.5 (2C, CH2CHBr), 27.6 (2C, OCHCH2CH2OH), 26.6 (2C, OCHCH2CH−CH), 26.5
(2C, OCHCH2), 24.2 (4C, CH2CH3), 21.0 (4C, COCH3), 12.2 (2C, CH2CH3), 9.6 (2C, CH2CH3); MS
(CI+, NH3) 352 (M + NH4)
+; HRMS (CI+, NH3) m/z calcd for C14H24O479Br (M + H)+ 335.0858,
found 335.0856.
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(3R*,4S*,6S*,7S*,9E)-7-Acetoxy-6-bromo-3,4-epoxydodec-9-en-1-ol, (3R*,4S*,6R*,7R*,9E)-7-Aceto
xy-6-bromo-3,4-epoxydodec-9-en-1-ol, (3R*,4S*,6S *,7S*,9E)-6-Acetoxy-7-bromo-3,4-epoxydodec-
9-en-1-ol and (3R*,4S*,6R*,7R*,9E)-6-Acetoxy-7-bromo-3,4-epoxydodec-9-en-1-ol (239 and 240)
O
OH
O
OH
AcO Br Br OAc
Isolated as a mixture of four compounds (two regioisomers, each comprising of two diastereomers
– it was not possible to estimate the ratio from the 1H NMR spectrum): 4% (estimated from 1H
NMR spectrum); 1H NMR (400 MHz, CDCl3) δ 5.82-5.37 (m, 8H, CH−CH), 5.31-4.97 (m, 4H,
CHOAc), 4.41-4.36 (m, 2H, CHBr), 4.25-4.19 (m, 2H, CHBr), 3.95-3.83 (m, 8H, CH2OH), 3.21-2.97
(m, 8H, CHO), 2.96-1.30 (m, 16H, CH2CH3, CH2CHBr, CH2CHOAc), 2.20 (s, 12H, C−OCH3), 1.00
(t, J = 7.5 Hz, 6H, CH2CH3), 0.91 (t, J = 7.4 Hz, 6H, CH2CH3); HPLC (n-hexane : i-propanol, 98.5 :
1.5), 3.50 mL / min, 203 nm, Rt 26.0 min.
(3R*,4S*,10R*)-10-Bromo-3,4-epoxydodeca-6,8-dien-1-ol and (3R*,4S*,10S*)-10-Bromo-3,4-epoxy
dodeca-6,8-dien-1-ol (241)
Br O
OH
Isolated as a mixture of two diastereomers (it was not possible to estimate the ratio from the 1H
NMR spectrum): 2% (estimated from 1H NMR spectrum); 1H NMR (400 MHz, CDCl3) δ 6.48 (m,
2H, CHBrCH−CH), 6.19 (m, 2H, CH−CHCH2), 5.73-5.64 (m, 2H, CHBrCH−CH), 5.52-5.45 (m, 2H,
CH−CHCH2), 4.31-4.16 (m, 2H, CHBr), 3.97-3.84 (m, 4H, CH2OH), 3.19-3.01 (m, 4H, CHO), 2.64-
1.67 (m, 12H, CH2CH3, CH2CHO, CH2CH2OH), 1.09 (t, J = 7.2 Hz, 6H, CH3); HPLC (n-hexane :
i-propanol, 98.5 : 1.5), 3.5 mL / min, 203 nm, Rt 30.0 min.
(3R*,4S*,6R*)-6-Bromo-3,4-epoxydodeca-7,9-dien-1-ol and (3R*,4S*,6S*)-6-Bromo-3,4-epoxydode
ca-7,9-dien-1-ol (242)
Br
OH
O
Isolated as a mixture of two diastereomers (it was not possible to estimate the ratio from the 1H
NMR spectrum): 2% (estimated from 1H NMR spectrum); 1H NMR (400 MHz, CDCl3) δ 6.32-6.21
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(m, 2H, CH−CHCHBr), 6.11-6.00 (m, 2H, CH2CH−CH), 5.83-5.76 (m, 2H, CH2CH−CH), 5.59 (dd,
J = 14.9, 8.1 Hz, 2H, CH−CHCHBr), 4.60-4.51 (m, 2H, CHBr), 3.98-3.80 (m, 4H, CH2OH), 3.20-3.08
(m, 4H, CHO), 2.20-2.09 (m, 4H, CH2CH3), 2.03-1.70 (m, 8H, CH2CHO), 1.01 (t, J = 7.4 Hz, 6H,
CH3); HPLC (n-hexane : i-propanol, 98.5 : 1.5), 3.5 mL / min, 203 nm, Rt 23.5 min.
tert-Butyl (3R*,4S*)-epoxyhexan-1-yl carbonate (268)
OBoc
O
According to the method of Jamison,107 1-methylimidazole (0.74 mL, 9.3 mmol, 1.35 equiv) and
di-t-butyl dicarbonate (2.14 mL, 9.3 mmol, 1.35 equiv) were added dropwise and sequentially to
a solution of (3R*,4S*)-epoxyhexan-1-ol (183) (0.80 g, 6.9 mmol, 1.0 equiv) in toluene (25 mL) at
0 ◦C. The reaction mixture was stirred for 5 h at room temperature and the solvent was removed
under reduced pressure. The mixture was purified by column chromatography (petroleum spirit :
ethyl acetate, 6 : 1) to give product 268 (0.57 g, 38%) as a colourless oil: IR (neat) 2975, 1738, 1458,
1369, 1275, 1252, 1158 cm−1; 1H NMR (400 MHz, CDCl3) δ 4.26-4.22 (m, 2H, CH2OC−O), 3.09-3.03
(m, 1H, CHO), 2.92 (td, J = 6.3, 4.3 Hz, 1H, CHO), 1.99-1.80 (m, 2H, CH2), 1.61-1.46 (m, 11H, CH2,
CCH3), 1.06 (t, J = 7.5 Hz, 3H, CH2CH3);
13C NMR (100 MHz, CDCl3) δ 153.4 (1C, C−O), 82.1 (1C,
CCH3), 64.3 (1C, CH2OC−O), 58.1 (1C, CHO), 54.1 (1C, CHO), 27.8 (3C, CCH3), 27.5 (1C, CH2),
21.1 (1C, CH2), 10.5 (1C, CH2CH3); MS (CI+, NH3) m/z 234 (M + NH4)+; HRMS (CI+, NH3) m/z
calcd for C11H24NO4 (M + NH4)
+ 234.1705, found 234.1704.
(4R*,5R*)-4-Ethyl-5-(2-hydroxyethyl)-1,3-dioxolan-2-one (279)
OH
OO
O
According to the method of McDonald,201 boron trifluoride diethyl etherate (0.15 mL, 1.02 mmol,
1.1 equiv) was added dropwise to a solution of tert-butyl (3R*,4S*)-epoxyhexan-1-yl carbonate
(268) (200 mg, 0.93 mmol, 1.0 equiv) in dichloromethane (20 mL) at −40 ◦C. The reaction mix-
ture was stirred for 40 min and then sodium bicarbonate solution (20 mL) was added, with stirring
at room temperature for 15 min. Dichloromethane (20 mL) and water (20 mL) were added, the
organics were separated and the aqueous was extracted with ethyl acetate (3 x 30 mL). The or-
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ganics were combined, washed with brine (60 mL) and dried over sodium sulfate. The solvent
was removed under reduced pressure, and the mixture was purified by column chromatography
(ethyl acetate : petroleum spirit, 2 : 1) to give product 279 (74 mg, 50%) as a colourless oil: IR
(neat) 3600-3150, 1773, 1463, 1375, 1178, 1048 cm−1; 1H NMR (400 MHz, CDCl3) δ 4.57-4.51 (m,
1H, CHOC−O), 4.35 (dd, J = 12.6, 6.3 Hz, 1H, CHOC−O), 3.89-3.85 (m, 2H, CH2OH), 2.06-1.92 (m,
2H, CH2CH2OH), 1.85-1.76 (m, 2H, CH2CH3), 1.07 (t, J = 7.4 Hz, 3H, CH3);
13C NMR (100 MHz,
CDCl3) δ 154.7 (1C, C−O), 83.3 (1C, CHOC−O), 79.0 (1C, CHOC−O), 58.2 (1C, CH2OH), 36.3 (1C,
CH2CH2OH), 26.6 (1C, CH2CH3), 8.8 (1C, CH3); MS (CI+, NH3) m/z 178 (M + NH4)+; HRMS (CI+,
NH3) m/z calcd for C7H16NO4 (M + NH4)+ 178.1079, found 178.1078.
2-[(4R*,5R*)-5-Ethyl-2-oxo-1,3-dioxolan-4-yl]ethyl acetate (277)
OAc
OO
O
According to the method of Milton-Smith,202 a solution of acetyl chloride (27 mg, 0.34 mmol, 1.5
equiv) in toluene (0.3 mL) was added to a solution of (4R*,5R*)-4-ethyl-5-(2-hydroxyethyl)-1,3-
dioxolan-2-one (279) (36 mg, 0.23 mmol, 1.0 equiv) and pyridine (46 mg, 0.58 mmol, 2.5 equiv)
in toluene (0.3 mL) at 0 ◦C. The reaction mixture was stirred at room temperature for 2 h and
directly applied to column chromatography (petroleum spirit : ethyl acetate, 2 : 1, to 1 : 1) to give
product 277 (38 mg, 83%) as a colourless oil: IR (neat) 2972, 1791, 1735, 1462, 1369, 1231, 1180, 1039
cm−1; 1H NMR (400 MHz, CDCl3) δ 4.43-4.38 (m, 1H, CHOC−O), 4.32-4.25 (m, 2H, CHOC−O,
CH2OAc), 4.22-4.15 (m, 1H, CH2OAc), 2.13-2.00 (m, 5H, CH2CH2OAc, OCH3), 1.85-1.74 (m, 2H,
CH2CH3), 1.04 (t, J = 7.4 Hz, 3H, CH2CH3);
13C NMR (100 MHz, CDCl3) δ 170.7 (1C, C−OCH3),
154.2 (1C, CHOC−O), 82.9 (1C, CHOC−O), 78.5 (1C, CHOC−O), 59.8 (1C, CH2OAc), 33.0 (1C,
CH2CH2OAc), 26.7 (1C, CH2CH3), 20.8 (1C, C−OCH3), 8.8 (1C, CH2CH3); MS (CI+, NH3) m/z 220
(M + NH4)
+; HRMS (CI+, NH3) m/z calcd for C9H18NO5 (M + NH4)+ 220.1185, found 220.1195.
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(4R*,5R*)-4-(2-Bromoethyl)-5-ethyl-1,3-dioxolan-2-one (278)
Br
OO
O
According to the method of Jeffery,190 carbon tetrabromide (252 mg, 0.76 mmol, 1.2 equiv) was
added to a solution of (4R*,5R*)-4-ethyl-5-(2-hydroxyethyl)-1,3-dioxolan-2-one (279) (100 mg, 0.63
mmol, 1.0 equiv) in dichloromethane (1.5 mL) at −10 ◦C. A solution of triphenylphosphine (215
mg, 0.82 mmol, 1.3 equiv) in dichloromethane (1.0 mL) was added dropwise and the reaction
mixture was allowed to warm to room temperature, stirring for 45 min. The solvent was re-
moved under reduced pressure and the mixture immediately subjected to column chromatogra-
phy (petroleum spirit : ethyl acetate, 2 : 1) to give product 278 (129 mg, 92%) as a colourless oil: IR
(neat) 2973, 2941, 1789, 1462, 1369, 1258, 1183, 1157, 1044 cm−1; 1H NMR (400 MHz, CDCl3) δ 4.55
(ddd, J = 9.5, 6.3, 3.4 Hz, 1H, CHOC−O), 4.27 (dd, J = 12.6, 6.3 Hz, 1H, CHOC−O), 3.58-3.53 (m, 2H,
CH2Br), 2.41-2.31 (m, 1H, CH2CH2Br), 2.21-2.11 (m, 1H, CH2CH2Br), 1.88-1.77 (m, 2H, CH2CH3),
1.08 (t, J = 7.5 Hz, 3H, CH3);
13C NMR (100 MHz, CDCl3) δ 154.1 (1C, C−O), 82.6 (1C, CHOC−O),
79.0 (1C, CHOC−O), 36.7 (1C, CH2CH2Br), 27.4 (1C, CH2Br), 26.7 (1C, CH2CH3), 8.7 (1C, CH3);
MS (CI+, NH3) m/z 240 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for C7H15NO379Br (M + NH4)+
240.0235, found 240.0242.
tert-Butyl (3R,4S,6Z,9E)-3,4-epoxydodeca-6,9-dienyl carbonate (243)
O
O O
O
Triethylamine (3.83 mL, 27.7 mmol, 2.0 equiv) and DMAP (337 mg, 2.8 mmol, 0.2 equiv) were
added to a solution of (3R,4S,6Z,9E)-3,4-epoxydodeca-6,9-dien-1-ol (160) (2.71 g, 13.8 mmol, 1.0
equiv) in toluene (50 mL) at 0 ◦C. Di-t-butyl dicarbonate (4.28 mL, 18.7 mmol, 1.35 equiv) was
added dropwise and the reaction mixture was allowed to warm to room temperature. After stirring
at room temperature for 16 h, the solvent was removed under reduced pressure and the mixture
was immediately subjected to column chromatography (petroleum spirit : ethyl acetate, 9 : 1),
to give product 243 (2.30 g, 56%) as a colourless oil: R f 0.59 (petroleum spirit : ethyl acetate, 2 :
1); [α]20D −3.8 (c 1.05, CH2Cl2); IR (neat) 2973, 1739, 1457, 1395, 1370, 1276, 1252, 1159, 1102, 967
cm−1; 1H NMR (400 MHz, CDCl3) δ 5.62-5.35 (m, 4H, CH−CH), 4.31-4.23 (m, 2H, CH2OC−O),
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3.12-3.05 (m, 1H, OCH), 3.00 (td, J = 6.4, 4.1 Hz, 1H, OCH), 2.81-2.74 (m, 2H, CHCH2CH), 2.45-
2.35 (m, 1H, CH2CHO), 2.29-2.19 (m, 1H, CH2CHO), 2.08-1.81 (m, 4H, OCHCH2, CH2CH3), 1.51
(s, 9H, C(CH3)3), 0.98 (t, J = 7.5 Hz, 3H, CH2CH3);
13C NMR (100 MHz, CDCl3) δ 153.4 (1C, C−O),
132.9 (1C, C−C), 130.8 (1C, C−C), 126.6 (1C, C−C), 124.1 (1C, C−C), 82.2 (1C, CCH3), 64.3 (1C,
CH2OBoc), 56.2 (1C, OCH), 54.0 (1C, OCH), 30.6 (1C, C−CCH2C−C), 27.8 (3C, CCH3), 27.6 (1C,
OCHCH2), 26.1 (1C, CH2CH2OBoc), 25.6 (1C, CH2CH3), 13.8 (1C, CH2CH3); MS (CI+, NH3) m/z 314
(M + NH4)
+; HRMS (CI+, NH3) m/z calcd for C17H32NO4 (M + NH4)+ 314.2331, found 314.2323.
Bis(3R,4S,6Z,9E)-3,4-epoxydodeca-6,9-dienyl carbonate (284)
O
O O
O O
This side product was isolated as a pale yellow oil (0.93 g, 32%); R f 0.49 (petroleum spirit : ethyl
acetate, 2 : 1): [α]20D −6.4 (c 1.57, CH2Cl2); IR (neat) 2963, 1745, 1461, 1403, 1251, 966 cm−1; 1H NMR
(400 MHz, CDCl3) δ 5.62-5.35 (m, 8H, CH−CH), 4.38-4.31 (m, 4H, CH2OC−O), 3.08 (dt, J = 7.1, 4.5
Hz, 2H, OCH), 3.01 (td, J = 6.4, 4.2 Hz, 2H, OCH), 2.80-2.74 (m, 4H, CHCH2CH), 2.46-2.37 (m, 2H,
CH2CHO), 2.28-2.19 (m, 2H, CH2CHO), 2.06-1.97 (m, 6H, OCHCH2, CH2CH3), 1.93-1.84 (m, 2H,
OCHCH2), 0.98 (t, J = 7.4 Hz, 6H, CH3);
13C NMR (100 MHz, CDCl3) δ 155.0 (1C, C−O), 132.9 (2C,
C−C), 130.9 (2C, C−C), 126.6 (2C, C−C), 124.0 (2C, C−C), 65.4 (2C, CH2OC−O), 56.2 (2C, OCH),
53.8 (2C, OCH), 31.4 (2C, C−CCH2C−C), 27.5 (2C, OCHCH2), 26.1 (1C, CH2CH2OC−O), 25.5 (2C,
CH2CH3), 13.8 (2C, CH2CH3); MS (CI+, NH3) m/z 436 (M + NH4)+; HRMS (CI+, NH3) m/z calcd
for C25H42NO5 (M + NH4)
+ 436.3063, found 436.3056.
Procedure for the Treatment of tert-Butyl (3R*,4S*,6Z,9E)-3,4-epoxydodeca-6,9-dienyl
carbonate (243) with NBS in HFIP
According to the method of Jamison,107 HFIP (16 mL) was stirred with 4A˚ molecular sieves (2.43 g)
at room temperature for 30 min. tert-Butyl (3R*,4S*,6Z,9E)-3,4-epoxydodeca-6,9-dienyl carbonate
243 (200 mg, 0.67 mmol, 1.0 equiv) in HFIP (3.5 mL) was added and the flask was cooled to 0 ◦C.
NBS (119 mg, 0.67 mmol, 1.0 equiv) was added in one portion with vigorous stirring in the absence
of light, and after 1 h the reaction mixture was diluted with ethyl acetate (60 mL) and filtered. The
organics were washed with 10% w/w sodium sulfite (50 mL), water (50 mL) and brine (50 mL).
The aqueous was extracted with ethyl acetate (3 x 50 mL) and the organics were combined, dried
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over sodium sulfate, filtered, and the solvent was removed under reduced pressure to furnish a
yellow oil. Components were separated by column chromatography.
Bromodiethylsulfonium bromopentachloroantimonate
According to the method of Snyder,144 diethylsulfide (0.59 mL, 5.50 mmol, 1.1 equiv) was added
dropwise to a solution of bromine (0.26 mL, 5.00 mmol, 1.0 equiv) in 1,2-dichloroethane (15 mL) at
−42 ◦C. Antimony pentachloride (6.0 mL, 6.00 mmol, 1.2 equiv) was added dropwise and after stir-
ring for 30 min at −42 ◦C, the reaction mixture was slowly warmed to 40 ◦C. The solvent was de-
canted from the solid after cooling to −18 ◦C, and the solid was rinsed with cold dichloromethane
(3 x 1 mL) to give the product (2.72 g, 99%) as an orange crystalline solid.
Procedure for Cyclisation of tert-Butyl (3R,4S,6Z,9E)-epoxydodeca-6,9-dienyl carbonate
(243) and Subsequent Carbonate Hydrolysis
According to the method of Snyder,144 a solution of BDSB (885 mg, 1.61 mmol, 1.0 equiv) in ni-
tromethane (1 mL) was added rapidly to a solution of tert-butyl (3R,4S,6Z,9E)-epoxydodeca-6,9-
dienyl carbonate (243) (477 mg, 1.61 mmol, 1.0 equiv) in nitromethane (80 mL) at room tempera-
ture. After 1 h the reaction mixture was diluted with ethyl acetate (200 mL) and washed with a
mixture of sodium sulfite (100 mL) and sodium bicarbonate (100 mL). The layers were separated
and the aqueous was extracted with ethyl acetate (4 x 100 mL). The organics were then combined,
washed with brine (200 mL), dried over sodium sulfate, filtered and the solvent was removed un-
der reduced pressure. The crude mixture was subjected to column chromatography (petroleum
spirit : ethyl acetate, 3 : 1 to 1 : 2) to give two components, firstly Mixture A (105 mg) as a pale
yellow oil and secondly Mixture B (91 mg) as a colourless oil.
Mixture A: R f 0.35 (ethyl acetate : petroleum spirit, 3 : 1). Analysis of the 1H NMR spectrum
provides the following estimated yields from tert-butyl (3R,4S,6Z,9E)-epoxydodeca-6,9-dienyl car-
bonate 243: 248a (21 mg, 4.1%), 250a (7 mg, 1.4%), 250b (6 mg, 1.2%), 247a and 247b (9 mg, 1.8%).
These compounds were separated by preparative HPLC:
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(4R)-4-[(2R,4Z,7S,8R)-7-Bromo-8-ethyl-3,6,7,8-tetrahydro-2H-oxocin-2-yl]-1,3-dioxan-2-one (248a)
O
Br
O
O
OH
H
The product was isolated as a colourless oil (containing 12% of compound 250b, found by relative
integration of the resonance at 5.95 ppm with the resonance at 5.74 ppm): [α]26D +20.0 (c 1.20,
CH2Cl2); IR (neat) 2967, 2923, 1748, 1449, 1408, 1248, 1192, 1124, 1093 cm−1; 1H NMR (400 MHz,
CDCl3) δ 6.03-5.91 (m, 2H, CH−CH), 4.55 (dt, J = 11.1, 3.7 Hz, 1H, HCOC−O), 4.52-4.35 (m, 2H,
H2COC−O), 4.04 (dt, J = 9.9, 3.4 Hz, 1H, CHBr), 3.51-3.45 (m, 2H, OCH), 3.17 (ddd, J = 14.1, 8.5,
3.6 Hz, 1H, CH2CHBr), 2.60-2.46 (m, 2H, CH2CHBr, CH2CH−CH), 2.23-2.13 (m, 2H, CH2CH−CH,
CH2CH2O), 2.09-1.97 (m, 2H, CH2CH2O, CH2CH3), 1.56-1.49 (m, 1H, CH2CH3), 0.99 (t, J = 7.4
Hz, 3H, CH3);
13C NMR (100 MHz, CDCl3) δ 148.5 (1C, C−O), 129.3 (1C, C−C), 128.9 (1C, C−C),
85.2 (1C, CH−CHCH2CHO), 81.1 (1C, CHBrCHO), 80.2 (1C, CHOC−O), 67.0 (1C, CH2OC−O),
56.0 (1C, CHBr), 32.3 (1C, CH2CHBr), 28.7 (1C, CH−CHCH2CHO), 26.0 (1C, CH2CH3), 22.7 (1C,
CH2CH2O), 9.8 (1C, CH3); MS (CI+, NH3) m/z 336 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for
C13H23NO479Br (M + NH4)
+ 336.0810, found 336.0807; HPLC (n-hexane : i-propanol, 94 : 6), 1.05
mL / min, 203 nm, Rt 148 min.
(4R)-4-(2R,7S)-7-[(1R)-1-Bromopropyl]-2,3,6,7-tetrahydrooxepin-2-yl-1,3-dioxan-2-one (250a)
O
H H
Br
O O
O
The product was isolated as a colourless oil (containing 27% of an unidentified saturated com-
pound, found by relative integration of the resonance at 3.70 ppm with the resonance at 3.65 ppm):
[α]23D +22.6 (c 0.30, CH2Cl2); IR (neat) 2970, 2931, 1747, 1407, 1251, 1192, 1124 cm
−1; 1H NMR (400
MHz, CDCl3) δ 5.83-5.80 (m, 2H, CH−CH), 4.55-4.46 (m, 2H, CHOC−O, CH2OC−O), 4.39-4.32 (m,
1H, CH2OC−O), 3.96-3.90 (m, 1H, CHBr), 3.65 (ddd, J = 9.9, 4.5, 2.0 Hz, 1H, CHBrCHO), 3.59 (ddd,
J = 10.7, 3.4, 1.6 Hz, 1H, CH−CHCH2CHO), 2.65-2.56 (m, 1H, CH−CHCH2), 2.52-2.30 (m, 2H,
CH−CHCH2), 2.29-2.24 (m, 2H, CH−CHCH2, CH2CH2OC−O), 2.09-1.72 (m, 3H, CH2CH2OC−O,
CH2CH3), 1.06 (t, J = 7.2 Hz, 3H, CH3);
13C NMR (125 MHz, CDCl3) δ 148.9 (1C, C−O), 129.1 (1C,
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C−C), 128.8 (1C, C−C), 83.3 (1C, CHBrCHO), 80.6 (1C, CHOC−O), 79.6 (1C, CH−CHCH2CHO),
66.8 (1C, CH2OC−O), 61.9 (1C, CHBr), 34.2 (1C, CH−CHCH2), 31.9 (1C, CH−CHCH2), 26.5 (1C,
CH2), 23.4 (1C, CH2), 12.4 (1C, CH3); MS (CI+, NH3) m/z 336 (M + NH4)+; HRMS (CI+, NH3) m/z
calcd for C13H23NO479Br (M + NH4)
+ 336.0810, found 336.0811; HPLC (n-hexane : i-propanol, 94 :
6), 1.50 mL / min, 203 nm, Rt 140 min.
(4R)-4-(2R,7R)-7-[(1S)-1-Bromopropyl]-2,3,6,7-tetrahydrooxepin-2-yl-1,3-dioxan-2-one (250b)
O
Br
H H
O O
O
The product was isolated as a colourless oil (containing 9% of 248a and 20% of 250a, found by
relative integration of the resonance at 5.95 ppm with the resonance at 5.76 ppm and the reso-
nance at 5.74 ppm): [α]26D −9.0 (c 0.20, CH2Cl2); IR (neat) 2925, 2857, 1748, 1410, 1249, 1191, 1119
cm−1; 1H NMR (400 MHz, CDCl3) δ 5.73-5.70 (m, 2H, CH−CH), 4.54 (ddd, J = 10.8, 5.0, 3.4 Hz,
1H, CH2OC−O), 4.46 (ddd, J = 10.2, 4.3, 2.5 Hz, 1H, CHOC−O), 4.35 (td, J = 11.1, 3.6 Hz, 1H,
CH2OC−O), 4.28 (dt, J = 11.7, 1.8 Hz, 1H, CH−CHCH2CHO), 4.22 (ddd, J = 10.5, 4.3, 1.7 Hz,
1H, CHBrCHO), 4.03 (dt, J = 9.7, 4.0 Hz, 1H, CHBr), 2.85-2.78 (m, 1H, CH−CHCH2), 2.67-2.54
(m, 1H, CH−CHCH2), 2.38-2.17 (m, 3H, CH−CHCH2, CH−CHCH2, CH2CH2O), 2.09-2.01 (m, 1H,
CH2CH2O), 1.93-1.72 (m, 2H, CH2CH3), 1.10 (t, J = 7.2 Hz, 3H, CH3);
13C NMR (100 MHz, CDCl3)
δ 148.5 (1C, C−O), 127.8 (1C, C−C), 127.7 (1C, C−C), 80.9 (1C, CHOC−O), 77.9 (1C, CHBrCHO),
75.5 (1C, CH−CHCH2CHO), 66.8 (1C, CH2OC−O), 62.8 (1C, CHBr), 30.5 (1C, CH−CHCH2), 30.2
(1C, CH−CHCH2), 28.3 (1C, CH2CH3), 23.3 (1C, CH2CH2O), 12.4 (1C, CH3); MS (CI+, NH3) m/z
336 (M + NH4)
+; HRMS (CI+, NH3) m/z calcd for C13H23NO479Br (M + NH4)+ 336.0810, found
336.0807; HPLC (n-hexane : i-propanol, 94 : 6), 1.50 mL / min, 203 nm, Rt 145 min.
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(5aS,7R,8S,10Z,12aS)-8-Bromo-7-ethyl-4,5,5a,7,8,9,12,12a-octahydro[1,3]dioxepino[5,4-b]oxonin-
2-one (247a) and (5aS,7S,8R,10Z,12aS)-8-Bromo-7-ethyl-4,5,5a,7,8,9,12,12a-octahydro[1,3]dioxepi
no[5,4-b]oxonin-2-one (247b)
O
Br
H
O
Br
H
O
O
O
O
H H
O O
Diastereomer 1: The product was isolated as a colourless oil (containing 16% of an unidentified
compound, found by relative integration of the resonance at 4.40 ppm with the resonance at 4.50
ppm): [α]26D +15.0 (c 0.20, CH2Cl2); IR (neat) 2925, 1790, 1171, 1055 cm
−1; 1H NMR (500 MHz,
CDCl3) δ 5.84-5.75 (m, 1H, CH−CH), 5.69-5.61 (m, 1H, CH−CH), 4.62-4.46 (m, 2H, CH2CHO,
CHOC−O), 4.26-4.20 (m, 1H, CHBr), 4.19-4.13 (m, 1H, CHBrCHO), 3.92-3.84 (m, 2H, CH2OC−O),
3.04-2.84 (m, 2H, CH2CH−CH), 2.71-2.55 (m, 2H, CH2CH−CH), 2.33-2.20 (m, 1H, CH2CH3), 2.09-
1.94 (m, 3H, CH2CH3, CH2CH2O), 1.12 (t, J = 7.1 Hz, 3H, CH3);
13C NMR (125 MHz, CDCl3) δ
154.2 (1C, C−O), 129.6 (1C, C−C), 124.8 (1C, C−C), 81.9 (1C, CH−CHCH2CHO), 79.3 (1C, OCH),
60.5 (1C, OCHCHBr), 58.2 (1C, CH2OC−O), 56.8 (1C, CHBr), 36.1 (1C, CH2CH2OC−O), 35.1 (1C,
CH−CHCH2CHBr), 31.6 (1C, CH−CHCH2CHO), 30.4 (1C, CH2CH3), 11.0 (1C, CH3); MS (ESI) m/z
319 (M + H)+; HPLC (n-hexane : i-propanol, 94 : 6), 1.50 mL / min, 203 nm, Rt 97 min. It was not
possible to obtain high resolution mass spectrometry data for this compound using either CI or
ESI modes of ionisation.
Diastereomer 2: The product was isolated as a colourless oil (containing ca. 20% of Diastereomer
1, found by relative integration of the alkene resonances in the 13C NMR spectrum): [α]24D +18.5
(c 0.20, CH2Cl2); IR (neat) 2968, 1793, 1385, 1174, 1054 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.85-
5.77 (m, 1H, CH−CH), 5.69-5.61 (m, 1H, CH−CH), 4.64-4.57 (m, 1H, CH2CHO), 4.53-4.47 (m, 1H,
CHOC−O), 4.27-4.21 (m, 1H, CHBr), 4.20-4.14 (m, 1H, CHBrCHO), 3.93-3.84 (m, 2H, CH2OC−O),
3.05-2.84 (m, 2H, CH2CH−CH), 2.31-2.24 (m, 1H, CH2CH3), 2.06-1.94 (m, 3H, CH2CH3, CH2CH2O),
1.12 (t, J = 7.2 Hz, 3H, CH3);
13C NMR (100 MHz, CDCl3) δ 154.2 (1C, C−O), 130.0 (1C, C−C),
124.4 (1C, C−C), 81.1 (1C, CH−CHCH2CHO), 78.6 (1C, OCH), 60.5 (1C, OCHCHBr), 58.2 (1C,
CH2OC−O), 56.8 (1C, CHBr), 36.2 (1C, CH2CH2OC−O), 35.2 (1C, CH−CHCH2CHBr), 31.3 (1C,
CH−CHCH2CHO), 30.4 (1C, CH2CH3), 11.0 (1C, CH3); MS (ESI) m/z 319 (M + H)+; HPLC (n-
hexane : i-propanol, 94 : 6), 1.50 mL / min, 203 nm, Rt 102 min. It was not possible to obtain high
resolution mass spectrometry data for this compound using either CI or ESI modes of ionisation.
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Mixture B: R f 0.29 (ethyl acetate : petroleum spirit, 3 : 1). Analysis of the 1H NMR spectrum
provides the following estimated yields from tert-butyl (3R,4S,6Z,9E)-epoxydodeca-6,9-dienyl car-
bonate 243: 248b (18 mg, 3.5%) and 287 (30 mg, 5.8%). This mixture of carbonates was subjected to
basic hydrolysis:
Sodium hydroxide (171 mg, 4.28 mmol. 15.0 equiv) was added to a solution of Mixture B (91 mg,
0.29 mmol, 1.0 equiv) in methanol at room temperature. After 2 h ammonium chloride (136 mg,
2.54 mmol, 9.0 equiv) was added and stirred for an additional 10 min. The crude mixture was fil-
tered through a plug of silica, eluting with diethyl ether (100 mL) and the solvent was subsequently
evaporated under reduced pressure to provide Mixture C (75 mg) as a colourless oil.
Mixture C: R f 0.31 (ethyl acetate : petroleum spirit, 3 : 1). These compounds were separated by
preparative HPLC:
(1R)-1-[(2R,4Z,7R,8S)-7-Bromo-8-ethyl-3,6,7,8-tetrahydro-2H-oxocin-2-yl]propane-1,3-diol (288b)
O
Br
H
H
OH
OH
The product was isolated as a colourless oil (containing 7% of an unidentified compound, found
by relative integration of the resonance at 4.26 ppm with the resonance at 4.20 ppm): [α]26D −25.5 (c
1.00, CH2Cl2); IR (neat) 3600-3050, 2933, 1457, 1386, 1152, 1046 cm−1; 1H NMR (400 MHz, CDCl3)
δ 5.81-5.71 (m, 2H, CH−CH), 4.16 (ddd, J = 10.0, 7.5, 2.9 Hz, 1H, CHBr), 3.97 (ddd, J = 9.8, 6.7, 3.2
Hz, 1H, CHOCHBr), 3.93-3.81 (m, 4H, CHOH, CHOHCHO, CH2OH), 3.13-3.05 (m, 1H, CHBrCH2),
2.83 (br s, 1H, OH), 2.74-2.65 (m, 1H, CHBrCH2), 2.57 (br s, 1H, OH), 2.44-2.29 (m, 2H, CH2CHO),
2.05-1.94 (m, 1H, CH2CH3), 1.93-1.82 (m, 1H, CH2CH3), 1.81-1.67 (m, 2H, CH2CH2OH), 1.02 (t, J =
7.4 Hz, 3H, CH3);
13C NMR (100 MHz, CDCl3) δ 128.1 (1C, CH−CH), 127.7 (1C, CH−CH), 78.3 (1C,
CHO), 77.7 (1C, CHO), 73.0 (1C, CHOH), 61.1 (1C, CH2OH), 55.2 (1C, CHBr), 35.3 (1C, CHBrCH2),
34.9 (1C, CH2CH2OH), 29.8 (1C, CH2CHO), 26.2 (1C, CH2CH3), 9.0 (1C, CH3); MS (CI+, NH3) m/z
310 (M + NH4)
+; HRMS (CI+, NH3) m/z calcd for C12H22O379Br (M + H)+ 293.0752, found 293.0742;
HPLC (n-hexane : i-propanol, 94 : 6), 4.00 mL / min, 203 nm, Rt 48 min.
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1-[2-(1-Bromopropyl)-3-oxabicyclo[4.1.0]hept-4-yl]propane-1,3-diol (294)
O
H
H
Br
H H
OH
OH
The product was isolated as a colourless oil (comprises of three diastereomers in a ratio of approx-
imately 30:4:1, found by relative integration of the resonance at 0.25 ppm with the resonance at
0.40 ppm and the resonance at 0.30 ppm – the following resonances given are for the major di-
astereomer): [α]26D +7.7 (c 1.90, CH2Cl2); IR (neat) 3600-3000, 2928, 1460, 1066 cm
−1; 1H NMR (400
MHz, CDCl3) δ 4.29 (td, J = 8.8, 3.1 Hz, 1H, CHBr), 3.93 (dd, J = 8.8, 2.1 Hz, 1H, CHBrCHO), 3.85
(app t, J = 5.1 Hz, 2H, CH2OH), 3.53 (ddd, J = 12.7, 6.4, 2.1 Hz, 1H, CHOH), 3.31 (ddd, J = 11.3,
6.5, 4.5 Hz, 1H, CHOCHOH), 2.81 (d, J = 2.4 Hz, 1H, CHOH), 2.66 (br s, 1H, CH2OH), 2.19-2.05 (m,
1H, CH2CH3), 1.98-1.83 (m, 2H, CH2CH3, CH2CHO), 1.75-1.64 (m, 2H, CH2CH2OH), 1.38-1.27 (m,
2H, CH2CHO, CHCHO), 1.16-1.08 (m, 4H, CHCH2CHO, CH3), 0.90-0.81 (m, 1H, CHCH2CH), 0.39
(dd, J = 10.7, 5.3 Hz, 1H, CHCH2CH);
13C NMR (100 MHz, CDCl3) δ 75.4 (1C, CHBrCHO), 74.6
(1C, CHOH), 70.9 (1C, CHOCHOH), 61.1 (1C, CH2OH), 60.8 (1C, CHBr), 34.0 (1C, CH2CH2OH),
27.5 (1C, CH2CH3), 24.8 (1C, CH2CHO), 11.8 (1C, CHCH2CH), 11.3 (1C, CH3), 11.2 (1C, CHCHO),
7.0 (1C, CHCH2CHO); MS (CI+, NH3) m/z 310 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for
C12H22O379Br (M + H)+ 293.0752, found 293.0739; HPLC (n-hexane : i-propanol, 94 : 6), 4.00 mL /
min, 203 nm, Rt 42 min.
General Procedure for the Hydrolysis of the Cyclic Carbonates Isolated from Mixture A
Sodium hydroxide (15.0 equiv) was added to a solution of carbonate 248a, 250a, 250b, 247a or 247b
(1.0 equiv) in methanol (42 mM) at room temperature. After stirring for 2 h ammonium chloride
(9.0 equiv) was added and stirred for a further 10 min. The mixture was filtered through a plug
of silica, eluting with diethyl ether, and the solvent was subsequently removed under reduced
pressure to provide the product 288a, 289a, 289b, 290a or 290b, respectively in quantitative yield.
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(1R)-1-[(2R,4Z,7S,8R)-7-Bromo-8-ethyl-3,6,7,8-tetrahydro-2H-oxocin-2-yl]propane-1,3-diol (288a)
O
Br
OHH
H
OH
The product was isolated as a colourless oil (containing 12% of 289b, in accordance with what
was found for compound 248a): [α]28D +11.0 (c 1.20, CH2Cl2); IR (neat) 3650-3050, 2922, 1649, 1447,
1055 cm−1; 1H NMR (400 MHz, CDCl3) δ 6.02-5.89 (m, 2H, CH−CH), 4.10 (dt, J = 9.9, 3.4 Hz,
1H, CHBr), 3.92-3.84 (m, 2H, CH2OH), 3.79-3.73 (m, 1H, CHOH), 3.58-3.53 (m, 1H, CHBrCHO),
3.29-3.15 (m, 2H, CHOCHOH, C−CCH2CHBr), 2.92 (d, J = 2.9 Hz, 1H, CHOH), 2.56-2.48 (m, 1H,
C−CCH2CHBr), 2.44-2.35 (m, 1H, C−CCH2CHO), 2.22-2.13 (m, 1H, C−CCH2CHO), 2.10-1.98 (m,
1H, CH2CH3), 1.82-1.75 (m, 2H, CH2CH2OH), 1.69-1.59 (m, 1H, CH2CH3), 1.01 (t, J = 7.5 Hz, 3H,
CH3);
13C NMR (100 MHz, CDCl3) δ 129.4 (1C, C−C), 128.8 (1C, C−C), 84.6 (1C, C−CCH2CHO),
83.9 (1C, CHBrCHO), 74.3 (1C, CHOH), 61.4 (1C, CH2OH), 55.7 (1C, CHBr), 34.9 (1C, CH2CH2OH),
32.3 (1C, C−CCH2CHBr), 30.4 (1C, C−CCH2CHO), 25.8 (1C, CH2CH3), 9.3 (1C, CH3); MS (CI+,
NH3) m/z 310 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for C12H22O379Br (M + H)+ 293.0752,
found 293.0745.
(1R)-1-(2R,7S)-7-[(1R)-1-Bromopropyl]-2,3,6,7-tetrahydrooxepin-2-ylpropane-1,3-diol (289a)
O
H H
Br
OH
OH
The product was isolated as a colourless oil (containing 27% of an unidentified saturated com-
pound, in accordance with what was found for compound 250a): [α]28D +43.0 (c 0.20, CH2Cl2);
IR (neat) 3600-3050, 2929, 1667, 1423, 1260, 1059cm−1; 1H NMR (400 MHz, CDCl3) δ 5.80-5.76
(m, 2H, CH−CH), 4.01-3.95 (m, 1H, CHBr), 3.88-3.83 (m, 2H, CH2OH), 3.79-3.70 (m, 2H, CHOH,
CHBrCHO), 3.38-3.30 (m, 1H, CHO), 2.61-2.57 (m, 1H, C−CHCH2), 2.54-2.46 (m, 1H, C−CHCH2),
2.37-2.25 (m, 2H, C−CHCH2), 2.00-1.78 (m, 2H, CH2CH3), 1.76-1.70 (m, 2H, CH2CH2OH), 1.08
(t, J = 7.2 Hz, 3H, CH3);
13C NMR (125 MHz, CDCl3) δ 128.8 (1C, C−C), 128.4 (1C, C−C), 83.9
(1C, CHOCHOH), 83.0 (1C, CHO), 74.6 (1C, CHO), 62.5 (1C, CHBr), 61.2 (1C, CH2OH), 34.7 (1C,
CH2CH2OH), 34.2 (1C, CH2CHOCHOH), 32.8 (1C, CH2CHOCHBr), 26.4 (1C, CH2CH3), 12.6 (1C,
CH3); MS (CI+, NH3) m/z 310 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for C12H25NO379Br (M +
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NH4)
+ 310.1018, found 310.1021.
(1R)-1-(2R,7R)-7-[(1S)-1-Bromopropyl]-2,3,6,7-tetrahydrooxepin-2-ylpropane-1,3-diol (289b)
O
Br
H H
OH
OH
The product was isolated as a white solid (containing 9% of 288a and 20% of 289a, in accordance
with what was found for compound 250b): [α]28D −10.0 (c 0.01, CH2Cl2); IR (neat) 3650-3000, 2926,
1639, 1455, 1055 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.78-5.68 (m, 2H, CH−CH), 4.30-4.24 (m, 1H,
CHBrCHO), 4.10-3.97 (m, 2H, CHBr, CHOCHOH), 3.91-3.84 (m, 2H, CH2OH), 3.83-3.75 (m, 1H,
CHOH), 2.93 (d, J = 4.5 Hz, 1H, CHOH), 2.74-2.64 (m, 1H, C−CCH2), 2.57-2.53 (m, 1H, C−CCH2),
2.36-2.20 (m, 2H, C−CCH2), 1.98-1.65 (m, 4H, CH2CH2OH, CH2CH3), 1.10 (t, J = 7.2 Hz, 3H, CH3);
13C NMR (100 MHz, CDCl3) δ 128.2 (1C, C−C), 127.6 (1C, C−C), 78.0 (1C, CHBrCHO), 77.9 (1C,
CHOCHOH), 74.2 (1C, CHOH), 62.8 (1C, CHBr), 61.2 (1C, CH2OH), 35.1 (1C, CH2CH2OH), 31.2
(1C, CH2CHOCHOH), 31.0 (1C, CH2CHOCHBr), 27.4 (1C, CH2CH3), 12.6 (1C, CH3); MS (CI+,
NH3) m/z 310 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for C12H25NO379Br (M + NH4)+ 310.1018,
found 310.1021. Due to small quantities of material it was not possible to obtain a melting point
for this compound.
(2S,3S,5Z,8S,9R)-8-Bromo-9-ethyl-2-(2-hydroxyethyl)-2,3,4,7,8,9-hexahydrooxonin-3-ol (290a) and
(2S,3S,5Z,8R,9S)-8-Bromo-9-ethyl-2-(2-hydroxyethyl)-2,3,4,7,8,9-hexahydrooxonin-3-ol (290b)
O
Br
OH
HH
O
Br
OH
HH
OH OH
Diastereomers 1: The product was isolated as a off-white solid (containing 16% of an uniden-
tified compound, in accordance with what was found for Diastereomer 1 of compound 247a or
247b): [α]28D +1.0 (c 0.02, CH2Cl2); IR (neat) 3650-3000, 2923, 1642, 1457, 1262, 1057 cm
−1; 1H NMR
(400 MHz, CDCl3) δ 5.72-5.65 (m, 2H, CH−CH), 4.22 (td, J = 8.8, 3.4 Hz, 1H, CHBr), 4.17-4.12
(m, 1H, CHBrCHO), 3.93-3.86 (m, 2H, CH2OH), 3.80-3.72 (m, 1H, CHOHCHO), 3.60-3.53 (m, 1H,
CHOH), 3.02-2.79 (m, 2H, C−CHCH2), 2.40-1.92 (m, 4H, C−CHCH2, CH2CH3), 1.85-1.72 (m, 2H,
CH2CH2OH), 1.08 (t, J = 7.2 Hz, 3H, CH3);
13C NMR (100 MHz, CDCl3) δ 128.7 (1C, C−C), 127.9
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(1C, C−C), 73.9 (1C, CHOH), 73.5 (1C, CHOHCHO), 61.2 (1C, CH2OH), 60.6 (1C, CHBrCHO), 57.7
(1C, CHBr), 35.2 (1C, CH2CH2OH), 35.0 (1C, C−CCH2CHBr), 32.1 (1C, C−CCH2CHOH), 30.3 (1C,
CH2CH3), 11.1 (1C, CH3); MS (CI+, NH3) m/z 310 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for
C12H25NO379Br (M + NH4)
+ 310.1018, found 310.1018. Due to small quantities of material it was
not possible to obtain a melting point for this compound.
Diastereomer 2: The product was isolated as a white solid (containing 21% of Diastereomer 1,
in accordance with what was found for Diastereomer 2 of compound 247a or 247b): [α]28D −1.0
(c 0.01, CH2Cl2); IR (neat) 3600-3050, 2928, 1671, 1458, 1061 cm−1; 1H NMR (500 MHz, CDCl3)
δ 5.73-5.67 (m, 2H, CH−CH), 4.27-4.22 (m, 1H, CHBr), 4.21-4.16 (m, 1H, CHBrCHO), 3.97-3.87
(m, 2H, CH2OH), 3.83-3.76 (m, 1H, CHOHCHO), 3.64-3.57 (m, 1H, CHOH), 3.04-2.83 (m, 2H,
CH−CHCH2), 2.45-1.95 (m, 4H, CH−CHCH2, CH2CH3), 1.92-1.75 (m, 2H, CH2CH2OH), 1.11 (t,
J = 7.2 Hz, 3H, CH3);
13C NMR (125 MHz, CDCl3) δ 128.5 (1C, C−C), 128.1 (1C, C−C), 73.9 (1C,
CHOH), 73.5 (1C, CHOHCHO), 61.1 (1C, CH2OH), 60.6 (1C, CHBrCHO), 57.8 (1C, CHBr), 35.2 (1C,
CH2CH2OH), 35.1 (1C, C−CCH2CHBr), 32.1 (1C, C−CCH2CHOH), 30.3 (1C, CH2CH3), 11.1 (1C,
CH3); MS (CI+, NH3) m/z 310 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for C12H25NO379Br (M +
NH4)
+ 310.1018, found 310.1021. Due to small quantities of material it was not possible to obtain
a melting point for this compound.
(3R*,4R*)-4-Chlorohexane-1,3-diol203 (347)
OH
Cl OH
According to the method of Braddock,116 titanium(IV) isopropoxide (7.69 mL, 26 mmol, 6.0 equiv)
and diethylamine hydrochloride (9.81 g, 90 mmol, 20.0 equiv) were added to a solution of (3R*,4S*)-
epoxyhexan-1-ol (183) (0.50 g, 4.3 mmol, 1.0 equiv) in dichloromethane (300 mL) at room tempera-
ture. After 2.5 days saturated tartaric acid (150 mL) was added and stirred for 10 min. The mixture
was filtered through a plug of silica, eluting with dichloromethane (500 mL). The solvent was re-
moved under reduced pressure, and the aqueous diluted with water (300 mL). The aqueous was
extracted with ethyl acetate (3 x 250 mL), and the combined organics were washed with potassium
hydrogen carbonate (150 mL) and brine (150 mL). The organics were dried over sodium sulfate, fil-
tered and the solvent was removed under reduced pressure. The mixture was purified by column
chromatography (ethyl acetate : petroleum spirit, 4 : 1) to give product 347 (389 mg, 59%) as a pale
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yellow oil: IR (neat) 3600-3000, 2973, 2957, 2883, 1460, 1429, 1331, 1132, 1054 cm−1; 1H NMR (400
MHz, CDCl3) δ 4.00-3.81 (m, 4H, CHOH, CH2OH, CHCl), 2.46 (br s, 2H, OH), 1.99-1.76 (m, 4H,
CH2CH3, CH2CH2OH), 1.10 (t, J = 7.3 Hz, 3H, CH3);
13C NMR (100 MHz, CDCl3) δ 73.3 (1C, CH),
70.6 (1C, CH), 60.8 (1C, CH2OH), 35.9 (1C, CH2), 27.6 (1C, CH2), 11.2 (1C, CH3); MS (CI+, NH3)
m/z 170 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for C6H17NO235Cl (M + NH4)+ 170.0948, found
170.0951. The following additional signals were also observed in the 13C NMR spectrum for the
minor regioisomer: δ 75.4 (1C, CHOH), 64.6 (1C, CHCl), 59.3 (1C, CH2OH), 37.8 (1C, CH2CH2OH),
27.6 (1C, CH2CH3), 10.1 (1C, CH3).
(3R*,4R*)-1-(tert-Butyldiphenylsilanyloxy)-4-chloro-hexan-3-ol (348)
OTBDPS
Cl OH
According to the method of Braddock,116 imidazole (408 mg, 6.0 mmol, 2.4 equiv) and TBDPS-Cl
(0.65 mL, 2.5 mmol, 1.0 equiv) were added to a solution of (3R*,4R*)-4-chlorohexane-1,3-diol (347)
(380 mg, 2.5 mmol, 1.0 equiv) in THF (15 mL) at 0 ◦C. The reaction mixture was stirred for 18 h at
room temperature, and subsequently purified by applying the reaction mixture to a plug of silica,
eluting with ethyl acetate. The solvent was removed under reduced pressure, and product 348
was isolated as a colourless oil which was used in the next reaction without further purification:
IR (neat) 3600-3200, 2931, 2857, 1472, 1427, 1106 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.72-7.68 (m,
4H, ArH), 7.48-7.40 (m, 6H, ArH), 4.08-4.02 (m, 1H, CHOH), 3.96-3.83 (m, 3H, CHCl, CH2OSi), 2.83
(d, J = 5.3 Hz, 1H, CHOH), 2.04-1.75 (m, 4H, CH2CH2OSi, CH2CH3), 1.12-1.07 (m, 12H, CH2CH3,
CH3);
13C NMR (100 MHz, CDCl3) δ 135.6 (4C, Ar), 129.8 (2C, Ar), 127.8 (4C, Ar), 127.7 (2C, Ar),
72.5 (1C, CHOH), 69.9 (1C, CHCl), 62.1 (1C, CH2OSi), 36.1 (1C, CH2CH2OSi), 27.6 (1C, CH2CH3),
26.8 (3C, CCH3), 19.1 (1C, CCH3), 11.4 (1C, CH2CH3); MS (CI+, NH3) m/z 408 (M + NH4)+; HRMS
(CI+, NH3) m/z calcd for C22H32O2Si35Cl (M + H)+ 391.1860, found 391.1859.
(3R*,4R*)-1-(tert-Butyldiphenylsilanyloxy)-4-chlorohexan-3-yl acetate (349)
OTBDPS
Cl OAc
According to the method of Milton-Smith,202 a solution of pyridine (0.51 mL, 6.3 mmol, 2.5 equiv)
in toluene (2.5 mL), followed by a solution of acetyl chloride (0.27 mL, 3.8 mmol, 1.5 equiv) in
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toluene (2.5 mL), was added dropwise to a solution of (3R*,4R*)-1-(tert-butyldiphenylsilanyloxy)-
4-chloro-hexan-3-ol (348) (0.98 g, 2.5 mmol, 1.0 equiv) in toluene (25 mL) at 0 ◦C. The reaction
mixture was stirred at room temperature for 22 h, after which the solvent was removed under
reduced pressure. The mixture was immediately subjected to column chromatography (petroleum
spirit : diethyl ether, 20 : 1) to provide product 349 (976 mg, 91% [over 2 steps]) as a colourless
oil: IR (neat) 2931, 2857, 1742, 1427, 1227, 1106 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.71-7.66 (m,
4H, ArH), 7.47-7.38 (m, 6H, ArH), 5.37 (ddd, J = 8.1, 4.8, 3.4 Hz, 1H, CHOAc), 3.97 (dt, J = 9.1, 3.9
Hz, 1H, CHCl), 3.74-3.69 (m, 2H, CH2OSi), 2.09-2.00 (m, 4H, CH2CH2OSi, OC−OCH3), 1.97-1.66
(m, 3H, CH2CH2OSi, CH2CH3), 1.11-1.05 (m, 12H, CCH3, CH2CH3);
13C NMR (100 MHz, CDCl3) δ
170.3 (1C, C−O), 135.6 (6C, Ar), 129.7 (2C, Ar), 127.7 (4C, Ar), 72.3 (1C, CHOAc), 65.5 (1C, CHCl),
60.0 (1C, CH2OSi), 34.0 (1C, CH2CH2OSi), 27.7 (1C, CH2CH3), 26.8 (3C, CCH3), 20.9 (1C, OCOCH3),
19.1 (1C, CCH3), 11.3 (1C, CH2CH3); MS (CI+, NH3) m/z 450 (M + NH4)+; HRMS (ESI) m/z calcd
for C24H34O3Si
35Cl (M + H)+ 433.1966, found 433.1957.
(3R*,4R*)-4-Chloro-1-hydroxyhexan-3-yl acetate (350)
OH
Cl OAc
According to the method of Braddock,116 acetic acid (0.07 mL, 1.2 mmol, 5.0 equiv) and TBAF in
THF (1.0 M, 0.73 mL, 0.7 mmol, 3.0 equiv) were added sequentially and dropwise to a solution of
(3R*,4R*)-1-(tert-butyldiphenylsilanyloxy)-4-chlorohexan-3-yl acetate (349) (100 mg, 0.23 mmol, 1.0
equiv) in THF (7 mL) at 0 ◦C. The reaction mixture was allowed to warm to room temperature and
stirred for 2.5 h. Acetic acid (0.07 mL, 1.2 mmol, 5.0 equiv) was added and the reaction mixture
was cooled to 0 ◦C. TBAF in THF (1.0 M, 0.73 mL, 0.7 mmol, 3.0 equiv) was added dropwise
and the reaction mixture was allowed to warm to room temperature, stirring for 16 h. The reaction
mixture was diluted with diethyl ether (25 mL) and washed with potassium carbonate (25 mL). The
aqueous was extracted with diethyl ether (3 x 25 mL) and the combined organics were washed with
brine (50 mL) and dried over sodium sulfate. The solvent was removed under reduced pressure
and the mixture was applied to column chromatography (petroleum spirit : ethyl acetate, 1 : 1) to
provide product 350 (17 mg, 38%) as a colourless oil: IR (neat) 3600-3100, 2966, 2938, 2881, 1738,
1461, 1372, 1228, 1047 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.28 (dt, J = 9.1, 3.9 Hz, 1H, CHOAc),
3.92 (dt, J = 9.2, 4.0 Hz, 1H, CHCl), 3.73 (dt, J = 11.5, 4.9 Hz, 1H, CH2OH), 3.58 (ddd, J = 13.5, 8.8,
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5.0 Hz, 1H, CH2OH), 2.17 (s, 3H, C−OCH3), 2.00-1.69 (m, 4H, CH2CH2OH, CH2CH3), 1.08 (t, J =
7.3 Hz, 3H, CH2CH3);
13C NMR (100 MHz, CDCl3) δ 171.6 (1C, C−O), 76.5 (1C, CHOAc), 65.8 (1C,
CHCl), 58.4 (1C, CH2OH), 34.8 (1C, CH2CH2OH), 27.9 (1C, CH2CH3), 20.9 (1C, C−OCH3), 11.2 (1C,
CH2CH3); MS (CI+, NH3) m/z 212 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for C8H19NO335Cl (M
+ NH4)
+ 212.1053, found 212.1059.
4-Chlorohex-2-enal (351)
O
Cl
According to the method of Solanki,153 DMSO (0.06 mL, 0.83 mmol, 5.5 equiv) and triethylamine
(0.11 mL, 0.78 mmol, 5.2 equiv) were added to a solution of (3R*,4R*)-4-chloro-1-hydroxyhexan-3-
yl acetate (350) (30 mg, 0.15 mmol, 1.0 equiv) in dichloromethane (0.2 mL) at room temperature.
The mixture was cooled to 0 ◦C and sulfur trioxide pyridine complex (37 mg, 0.23 mmol, 1.5 equiv)
was added in one portion. The mixture was stirred for 1 h at 0 ◦C and for 3 h at room temperature.
Diethyl ether (20 mL) was added and the mixture was washed with water (20 mL). The aqueous
was extracted with diethyl ether (3 x 20 mL) and the combined organics were washed with water (3
x 40 mL) and brine (40 mL). The organics were dried over sodium sulfate, filtered and the solvent
was removed under reduced pressure to give product 351 (25% conversion [estimated from 1H
NMR spectrum]) as a yellow oil: 1H NMR (400 MHz, CDCl3) δ 9.63 (d, J = 7.7 Hz, 1H, CHO),
6.78 (dd, J = 15.6, 7.5 Hz, 1H, CH−CHCHO), 6.28 (ddd, J = 15.6, 7.7, 0.9 Hz, 1H, CH−CHCHO),
4.57-4.49 (m, 1H, CHCl), 2.10-1.75 (m, 2H, CH2CH3), 1.00-0.98 (m, 3H, CH3).
4-Methoxybenzyl 2,2,2-trichloroethanimidoate164 (355)
MeO
O CCl3
NH
According to the method of Patil,164 50% aqueous potassium hydroxide (10 mL) was added to a so-
lution of p-methoxybenzyl alcohol (357) (0.90 mL, 7.2 mmol, 1.0 equiv) in dichloromethane (10 mL)
at room temperature. Tetrabutylammonium hydrogen sulfate (15 mg) was added and the mixture
was cooled to −12 ◦C. Trichloroacetonitrile (358) (0.87 mL, 8.7 mmol, 1.2 equiv) was added drop-
wise and the mixture was stirred for 30 min at −12 ◦C and 30 min at room temperature. The layers
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were separated and the aqueous was extracted with dichloromethane (2 x 10 mL). The combined
organics were dried over sodium sulfate, filtered and two-thirds of the solvent was removed under
reduced pressure. The mixture was filtered through a silica plug eluting with dichloromethane (20
mL), and the solvent was removed under reduced pressure to provide product 355 as a colourless
oil which was sufficiently pure to use in the next reaction: IR (neat) 3339, 1955, 2837, 1739, 1661,
1613, 1514, 1300, 1245, 1175, 1071 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.36 (br s, 1H, NH), 7.41 (d, J
= 8.7 Hz, 2H, ArH), 6.94 (d, J = 8.7 Hz, 2H, ArH), 5.30 (s, 2H, CH2O), 3.84 (s, 3H, OCH3);
13C NMR
(100 MHz, CDCl3) δ 162.6 (1C, C−NH), 159.7 (1C, Ar), 129.7 (2C, Ar), 127.5 (1C, Ar), 113.9 (2C, Ar),
91.6 (1C, CCl3), 70.7 (1C, CH2O), 55.3 (1C, OCH3); MS (ESI) m/z 305 (M + Na+).
2-[(4-Methoxybenzyl)oxy]-4-methylquinoline168 (361)
N
Me
O
MeO
According to the method of Dudley,168 toluene (4 mL) was added to 2-chlorolepidine (360) (300 mg,
1.7 mmol, 1.0 equiv), ground potassium hydroxide (375 mg, 6.7 mmol, 4.0 equiv) and 18-crown-6
(27 mg, 0.1 mmol, 0.06 equiv) at room temperature. p-Methoxybenzyl alcohol (357) (0.27 mL, 2.2
mmol, 1.3 equiv) was added and the reaction mixture was heated at reflux for 1 h, with azeotropic
removal of water using a Dean-Stark trap. After cooling to room temperature, the mixture was
diluted with ethyl acetate (10 mL) and washed with water (5 mL), followed by brine (10 mL). The
organics were dried over sodium sulfate, filtered and the solvent was removed under reduced
pressure. The mixture was applied to column chromatography (petroleum spirit : ethyl acetate,
20 : 1) to give product 361 (433 mg, 92%) as a colourless oil: IR (neat) 1608, 1572, 1513, 1463, 1395,
1327, 1244, 1172, 1129, 1036 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.91 (dd, J = 8.2, 1.3 Hz, 2H, ArH),
7.68-7.63 (m, 1H, ArH), 7.51-7.47 (m, 2H, ArH), 7.46-7.41 (m, 1H, ArH), 6.97-6.93 (m, 2H, ArH), 6.83
(d, J = 0.8 Hz, 1H, ArH), 5.50 (s, 2H, OCH2Ar), 3.85 (s, 3H, OCH3), 2.65 (d, J = 0.9 Hz, 3H, ArCH3);
13C NMR (100 MHz, CDCl3) δ 161.8 (Ar), 159.4 (Ar), 146.8 (Ar), 146.5 (Ar), 130.1 (Ar), 129.6 (Ar),
129.2 (Ar), 127.8 (Ar), 125.5 (Ar), 123.8 (Ar), 123.7 (Ar), 113.9 (Ar), 113.3 (Ar), 67.2 (1C, OCH2Ar),
55.3 (1C, OCH3), 18.7 (1C, ArCH3); MS (CI+, NH3) m/z 280 (M + H)+; HRMS (ESI) m/z calcd for
C18H18NO2 (M + H)
+ 280.1331, found 280.1338.
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1-(([(3R*,4R*)-1-(tert-Butyldiphenylsilanyloxy)-4-chlorohexan-3-yl]oxy)methyl)-4-meth
oxybenzene (359)
OTBDPS
Cl OPMB
According to the method of Dudley,168 potassium carbonate (141 mg, 1.02 mmol, 2.0 equiv) was
added to a solution of (3R*,4R*)-1-(tert-butyldiphenylsilanyloxy)-4-chloro-hexan-3-ol (348) (200
mg, 0.51 mmol, 1.0 equiv) and 2-[(4-methoxybenzyl)oxy]-4-methylquinoline (361) (285 mg, 1.02
mmol, 2.0 equiv) in toluene (5 mL) at room temperature. The reaction mixture was cooled to 0 ◦C
and methyl triflate (0.12 mL, 1.02 mmol, 2.0 equiv) was added dropwise. The mixture was al-
lowed to warm to room temperature and stirred for 18 h. Ethyl acetate (10 mL) and water (10
mL) were added to the mixture, and the organics were separated and washed with brine (20 mL).
The organics were dried over sodium sulfate, filtered and the solvent was removed under reduced
pressure. The mixture was subjected to column chromatography (petroleum spirit : ethyl acetate,
20 : 1) to provide product 359 (164 mg [contaminated with a small quantity of some unidentified
compounds]) as a colourless oil: 1H NMR (400 MHz, CDCl3) δ 7.74-7.67 (m, 4H, ArH), 7.49-7.38
(m, 6H, ArH), 7.23 (d, J = 8.6 Hz, 2H, ArH), 6.86 (d, J = 8.5 Hz, 2H, ArH), 4.56 (d, J = 11.2 Hz, 1H,
OCH2Ar), 4.51 (d, J = 11.1 Hz, 1H, OCH2Ar), 3.97-3.75 (m, 7H, CHCl, CHOPMB, CH2OTBDPS,
ArOCH3), 2.06-1.63 (m, 4H, CH2CH3, CH2CH2OTBDPS), 1.12-1.03 (m, 12H, CH2CH3, CCH3);
13C
NMR (100 MHz, CDCl3) δ 159.3 (1C, Ar), 135.6 (4C, Ar), 133.8 (2C, Ar), 133.7 (2C, Ar), 129.7 (2C,
Ar), 129.5 (2C, Ar), 127.7 (4C, Ar), 113.8 (1C, Ar), 77.9 (1C, CHOPMB), 72.4 (1C, OCH2Ar), 65.9 (1C,
CHCl), 60.3 (1C, CH2OTBDPS), 55.3 (1C, OCH3), 33.1 (1C, CH2), 26.9 (3C, CCH3), 26.5 (1C, CH2),
19.2 (1C, CCH3), 11.6 (1C, CH2CH3); MS (CI+, NH3) m/z 528 (M + NH4)+; HRMS (ESI) m/z calcd
for C30H43NO3Si
35Cl (M + H)+ 528.2701, found 528.2701.
(3R*,4R*)-4-Chloro-3-[(4-methoxybenzyl)oxy]hexan-1-ol (362)
OH
Cl OPMB
According to the method of Braddock,116 acetic acid (0.09 mL, 1.56 mmol, 5.0 equiv) and TBAF in
THF (1.0 M, 0.91 mL, 0.93 mmol, 3.0 equiv) were added sequentially and dropwise to a solution of
1-(([(3R*,4R*)-1-(tert-butyldiphenylsilanyloxy)-4-chlorohexan-3-yl]oxy)methyl)-4-methoxybenzene
(359) (160 mg, 0.31 mmol, 1.0 equiv) in THF (10 mL) at 0 ◦C. The reaction mixture was stirred at
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0 ◦C for 1 h and at room temperature for 2 h. Acetic acid (0.09 mL, 1.56 mmol, 5.0 equiv) was added
and the reaction mixture was cooled to 0 ◦C. TBAF in THF (1.0 M, 0.91 mL, 0.93 mmol, 3.0 equiv)
was added dropwise and the reaction mixture was allowed to warm to room temperature, stirring
for 16 h. The reaction mixture was diluted with ethyl acetate (25 mL) and washed with potassium
carbonate (25 mL). The aqueous was extracted with ethyl acetate (3 x 25 mL) and the combined or-
ganics were washed with brine (25 mL) and dried over sodium sulfate. The solvent was removed
under reduced pressure and the mixture was applied to column chromatography (petroleum spirit
: ethyl acetate, 2 : 1) to provide product 362 (18 mg, 13% [over 2 steps]) as a colourless oil: 1H
NMR (400 MHz, CDCl3) δ 7.32-7.28 (m, 2H, ArH), 6.93-6.90 (m, 2H, ArH), 4.64 (d, J = 11.2 Hz,
1H, OCH2Ar), 4.54 (d, J = 11.2 Hz, 1H, OCH2Ar), 3.99 (dt, J = 10.5, 3.5 Hz, 1H, CHCl), 3.86-3.81
(m, 4H, CHOPMB, ArOCH3), 3.77-3.73 (m, 2H, CH2OH), 2.04-1.90 (m, 2H, CH2CH2OH, CH2CH3),
1.85-1.76 (m, 1H, CH2CH2OH), 1.72-1.60 (m, 1H, CH2CH3), 1.08 (t, J = 7.2 Hz, 3H, CH2CH3);
13C
NMR (100 MHz, CDCl3) δ 159.5 (1C, Ar), 130.0 (1C, Ar), 129.7 (2C, Ar), 114.0 (2C, Ar), 80.0 (1C,
CHOPMB), 72.4 (1C, OCH2Ar), 65.0 (1C, CHCl), 60.4 (1C, CH2OH), 55.3 (1C, ArOCH3), 32.2 (1C,
CH2CH2OH), 25.8 (1C, CH2CH3), 11.7 (1C, CH2CH3); MS (CI+, NH3) m/z 290 (M + NH4)+; HRMS
(CI+, NH3) m/z calcd for C14H25NO335Cl (M + NH3)+ 290.1523, found 290.1536.
(3R*,4R*)-1-(tert-Butyldiphenylsilanyloxy)-4-chloro-3-(methoxymethoxy) hexane (363)
OTBDPS
Cl OMOM
According to the method of Thomas,204 N,N-diisopropylethylamine (0.30 mL, 1.74 mmol, 2.0 equiv)
was added to a solution of (3R*,4R*)-1-(tert-butyldiphenylsilanyloxy)-4-chloro-hexan-3-ol (348) (340
mg, 0.87 mmol, 1.0 equiv) in dichloromethane (4 mL) at room temperature. Chloromethyl methyl
ether (0.17 mL, 2.17 mmol, 2.5 equiv) was added dropwise and the reaction mixture was heated at
40 ◦C for 15 h. The organics were diluted with dichloromethane (15 mL) and washed with water
(3 x 10 mL) and brine (10 mL) and dried over sodium sulfate. After filtration, the solvent was re-
moved under reduced pressure and the mixture subjected to column chromatography (petroleum
spirit : ethyl acetate, 15 : 1) to provide product 363 (307 mg, 81%) as a colourless oil: IR (neat)
2931, 2857, 1472, 1427, 1153, 1104, 1035 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.71-7.67 (m, 4H, ArH),
7.48-7.39 (m, 6H, ArH), 4.71 (d, J = 6.9 Hz, 1H, OCH2O), 4.66 (d, J = 6.9 Hz, 1H, OCH2O), 4.03-
3.96 (m, 2H, CHCl, CHOMOM), 3.82-3.77 (m, 2H, CH2OSi), 3.37 (s, 3H, OCH3), 2.09-1.99 (m, 1H,
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CH2CH2OSi), 1.98-1.90 (m, 1H, CH2CH3), 1.81-1.66 (m, 2H, CH2CH2OSi, CH2CH3), 1.12-1.06 (m,
12H, CH2CH3, CCH3);
13C NMR (100 MHz, CDCl3) δ 135.6 (4C, Ar), 133.7 (2C, Ar), 129.7 (2C, Ar),
127.7 (4C, Ar), 97.0 (1C, OCH2O), 77.8 (1C, CHOMOM), 66.2 (1C, CHCl), 60.3 (1C, CH2OSi), 55.8
(1C, OCH3), 33.3 (1C, CH2CH2OSi), 26.9 (3C, CCH3), 26.5 (1C, CCH3), 19.2 (1C, CH2CH3), 11.7 (1C,
CH2CH3); MS (CI+, NH3) m/z 452 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for C24H36O3Si35Cl
(M + H)+ 435.2122, found 435.2134.
(3R*,4R*)-4-Chloro-3-(methoxymethoxy)hexan-1-ol (364)
OH
Cl OMOM
According to the method of Braddock,116 acetic acid (0.20 mL, 3.45 mmol, 5.0 equiv) and TBAF (2.00
mL, 2.07 mmol, 3.0 equiv) were added dropwise to a solution of (3R*,4R*)-1-(tert-butyldiphenylsila
nyloxy)-4-chloro-3-(methoxymethoxy)hexane (363) (300 mg, 0.69 mmol, 1.0 equiv) in THF (21 mL)
at 0 ◦C. The reaction mixture was stirred at 0 ◦C for 45 min and subsequently allowed to warm to
room temperature, stirring for 2 h. Acetic acid (0.20 mL, 3.45 mmol, 5.0 equiv) was added and the
reaction mixture was cooled to 0 ◦C. TBAF (2.00 mL, 2.07 mmol, 3.0 equiv) was added dropwise
and the mixture was allowed to warm to room temperature, stirring for 16 h. The mixture was
diluted with ethyl acetate (40 mL) and washed with sodium bicarbonate (40 mL). The aqueous
was extracted with ethyl acetate (3 x 40 mL) and the organics were combined, washed with brine
(60 mL) and dried over sodium sulfate. The solvent was removed under reduced pressure and
the mixture was subjected to column chromatography (ethyl acetate : petroleum spirit, 4 : 1) to
give product 364 (99 mg, 73%) as a colourless oil: IR (neat) 3550-3050, 2936, 1461, 1381, 1150, 1099,
1027, 915 cm−1; 1H NMR (400 MHz, CDCl3) δ 4.78 (d, J = 6.9 Hz, 1H, OCH2O), 4.76 (d, J = 6.7
Hz, 1H, OCH2O), 3.99-3.91 (m, 2H, CHCl, CHOMOM), 3.85-3.76 (m, 2H, CH2OH), 3.46 (s, 3H,
OCH3), 2.21 (t, J = 5.9 Hz, 1H, CH2OH), 2.06-1.92 (m, 2H, CH2CH2OH, CH2CH3), 1.85-1.76 (m, 1H,
CH2CH2OH), 1.75-1.66 (m, 1H, CH2CH3), 1.11 (t, J = 7.3 Hz, 3H, CH2CH3);
13C NMR (100 MHz,
CDCl3) δ 97.7 (1C, OCH2O), 82.3 (1C, CHOMOM), 66.4 (1C, CHCl), 59.5 (1C, CH2OH), 56.1 (1C,
OCH3), 33.2 (1C, CH2CH2OH), 26.3 (1C, CH2CH3), 11.5 (1C, CH2CH3); MS (CI+, NH3) m/z 214 (M
+ NH4)
+; HRMS (CI+, NH3) m/z calcd for C8H21NO335Cl (M + NH3)+ 214.1210, found 214.1215.
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(3R*,4R*)-4-Chloro-3-(methoxymethoxy)hexanal (365)
O
Cl OMOM
According to the method of Solanki,153 DMP (308 mg, 0.72 mmol, 1.5 equiv) was added to a so-
lution of (3R*,4R*)-4-chloro-3-(methoxymethoxy)hexan-1-ol (364) (95 mg, 0.48 mmol, 1.0 equiv) in
dichloromethane (0.5 mL) at 0 ◦C. The reaction mixture was allowed to warm to room temperature
and stirred for 1.5 h. The mixture was diluted with diethyl ether (5 mL) and sodium bicarbonate
(5 mL) was added. After stirring vigorously for 30 min the aqueous was separated and extracted
with diethyl ether (4 x 5 mL). The organics were combined and washed with sodium bicarbonate
(15 mL), water (15 mL) and brine (15 mL). The organics were dried over sodium sulfate and the
solvent was removed under reduced pressure to provide product 365 (80 mg, 85%) as a colourless
oil, which could be used in the next reaction without further purification: IR (neat) 2940, 1725,
1462, 1383, 1151, 1100, 1024 cm−1; 1H NMR (400 MHz, CDCl3) δ 9.83 (dd, J = 2.3, 0.7 Hz, 1H, CHO),
4.76 (d, J = 7.1 Hz, 1H, OCH2O), 4.71 (d, J = 7.0 Hz, 1H, OCH2O), 4.35 (dt, J = 7.9, 3.8 Hz, 1H,
CHOMOM), 4.01 (dt, J = 10.3, 3.4 Hz, 1H, CHCl), 3.38 (s, 3H, OCH3), 2.95 (dd, J = 4.4, 0.8 Hz, 1H,
CH2CHO), 2.90 (dd, J = 3.9, 0.8 Hz, 1H, CH2CHO), 2.06-1.95 (m, 1H, CH2CH3), 1.72-1.60 (m, 1H,
CH2CH3), 1.11 (t, J = 7.3 Hz, 3H, CH2CH3);
13C NMR (100 MHz, CDCl3) δ 200.1 (1C, CHO), 97.1
(1C, OCH2O), 75.6 (1C, CHOMOM), 65.3 (1C, CHCl), 55.9 (1C, OCH3), 45.0 (1C, CH2CHO), 26.1
(1C, CH2CH3), 11.6 (1C, CH2CH3); MS (CI+, NH3) m/z 212 (M + NH4)+; HRMS (CI+, NH3) m/z
calcd for C8H19NO3
35Cl (M + NH3)+ 212.1053, found 212.1055.
(1E,4R*,5R*)-5-Chloro-1-iodo-4-(methoxymethoxy)hept-1-ene (381)
Cl OMOM
I
According to the method of Kim,47 a solution of (3R*,4R*)-4-chloro-3-(methoxymethoxy)hexanal
(365) (100 mg, 0.52 mmol, 1.0 equiv) and iodoform (406 mg, 1.03 mmol, 2.0 equiv) in THF (10 mL)
was added to a suspension of chromium(II) chloride (380 mg, 3.09 mmol, 6.0 equiv) in THF (40
mL) at 0 ◦C. The mixture was allowed to warm to room temperature and after 3.5 h the organics
were washed with water (50 mL), sodium thiosulfate (50 mL) and brine (50 mL). The organics
were dried over sodium sulfate, filtered, and the solvent was removed under reduced pressure.
The crude mixture was subjected to column chromatography (petroleum spirit : diethyl ether, 20
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: 1, to 10 : 1) to give product 381 (89 mg, 54%) as a colourless oil: IR (neat) 2944, 2891, 1606, 1147,
1098, 1029 cm−1; 1H NMR (400 MHz, CDCl3) δ 6.55 (dt, J = 14.5, 7.4 Hz, 1H, CH−CHI), 6.23 (dt, J
= 14.4, 1.3 Hz, 1H, CH−CHI), 4.71 (s, 2H, OCH2O), 3.90 (dt, J = 10.0, 3.5 Hz, 1H, CHCl), 3.77 (ddd,
J = 8.7, 5.3, 3.5 Hz, 1H, CHOMOM), 3.43 (s, 3H, OCH3), 2.62-2.51 (m, 1H, CH2CH−CHI), 2.42-2.33
(m, 1H, CH2CH−CHI), 1.98-1.88 (m, 1H, CH2CH3), 1.81-1.68 (m, 1H, CH2CH3), 1.10 (t, J = 7.3 Hz,
3H, CH2CH3);
13C NMR (100 MHz, CDCl3) δ 141.9 (1C, CH−CHI), 96.6 (1C, OCH2O), 78.7 (1C,
CHOMOM), 77.9 (1C, CH−CHI), 65.5 (1C, CHCl), 56.0 (1C, OCH3), 37.4 (1C, CH2CH−CHI), 26.6
(1C, CH2CH3), 11.5 (1C, CH2CH3); MS (CI+, NH3) m/z 336 (M + NH4)+; HRMS (CI+, NH3) m/z
calcd for C9H20NO235ClI (M + NH3)+ 336.0227, found 336.0217.
(3E,6R*,7R*)-7-Chloro-6-(methoxymethoxy)-1-trimethylsilanylnon-3-en-1-yne (382)
Cl OMOM TMS
According to the method of Kim,47 ethynyltrimethylsilane (0.11 mL, 0.80 mmol, 3.0 equiv) was
added to copper(I) iodide (10 mg, 0.053 mmol, 0.2 equiv) in diethylamine (4 mL) at room tem-
perature and stirred for 10 min. This was added to a solution of (1E,4R*,5R*)-5-chloro-1-iodo-4-
(methoxymethoxy)hept-1-ene (381) (85 mg, 0.27 mmol, 1.0 equiv) and Pd(PPh3)4 (31 mg, 0.027
mmol, 0.1 equiv) in diethylamine (4 mL), which had previously been stirred for 10 min in the
dark at room temperature. The reaction mixture was stirred in the dark for 3.5 h and then the
solvent was removed under reduced pressure and the mixture immediately subjected to column
chromatography (petroleum spirit : diethyl ether, 20 : 1) to give product 382 (34 mg, 44%) as a pale
yellow oil: IR (neat) 2958, 2170, 1461, 1249, 1151, 1083, 1034, 910 cm−1; 1H NMR (400 MHz, CDCl3)
δ 6.17 (dt, J = 15.9, 7.5 Hz, 1H, CH−CHC−−C), 5.65 (d, J = 16.0 Hz, 1H, CH−CHC−−C), 4.73 (d, J =
7.1 Hz, 1H, OCH2O), 4.69 (d, J = 7.2 Hz, 1H, OCH2O), 3.89 (dt, J = 9.8, 3.6 Hz, 1H, CHCl), 3.74 (td, J
= 6.6, 3.4 Hz, 1H, CHOMOM), 3.41 (s, 3H, OCH3), 2.65-2.56 (m, 1H, CH2CHOMOM), 2.47-2.38 (m,
1H, CH2CHOMOM), 1.95-1.86 (m, 1H, CH2CH3), 1.83-1.71 (m, 1H, CH2CH3), 1.08 (t, J = 7.3 Hz, 3H,
CH2CH3), 0.20 (s, 9H, SiCH3);
13C NMR (100 MHz, CDCl3) δ 140.6 (1C, CH−CHC−−C), 113.0 (1C,
CH−CHC−−C), 103.5 (1C, C−−C), 96.5 (1C, OCH2O), 93.8 (1C, C−−C), 79.2 (1C, CHOMOM), 65.8 (1C,
CHCl), 55.9 (1C, OCH3), 34.7 (1C, CH2CHOMOM), 26.9 (1C, CH2CH3), 11.5 (1C, CH2CH3), 0.2 (3C,
SiCH3); MS (CI+, NH3) m/z 306 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for C14H29NO235ClSi (M
+ NH3)+ 306.1656, found 306.1662.
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(3E,6R*,7R*)-7-Chloro-6-(methoxymethoxy)non-3-en-1-yne (383)
Cl OMOM
According to the method of Braddock,116 acetic acid (0.21 mL, 3.62 mmol, 10.0 equiv) and TBAF
(3.09 mL, 2.17 mmol, 6.0 equiv) were added dropwise to a solution of (3E,6R*,7R*)-7-chloro-6-
(methoxymethoxy)-1-trimethylsilanylnon-3-en-1-yne (382) (100 mg, 0.35 mmol, 1.0 equiv) in THF
(6 mL) at 0 ◦C. The reaction mixture was allowed to warm to room temperature and stirred for 2
h. Acetic acid (0.21 mL, 3.62 mmol, 10.0 equiv) was added at room temperature and TBAF (3.09
mL, 2.17 mmol, 6.0 equiv) was subsequently added at 0 ◦C. After stirring for a further 4 h at room
temperature a final portion of acetic acid (0.21 mL, 3.62 mmol, 10.0 equiv) was added, followed by
TBAF (3.09 mL, 2.17 mmol, 6.0 equiv) at 0 ◦C. The reaction mixture was stirred at room tempera-
ture for 20 h and was subsequently diluted with ethyl acetate (50 mL) and washed with sodium
bicarbonate (100 mL). The aqueous was extracted with ethyl acetate (3 x 50 mL) and the combined
organics were washed with brine (100 mL), dried over sodium sulfate and the solvent was re-
moved under reduced pressure. The mixture was purified by column chromatography (petroleum
spirit : diethyl ether, 9 : 1) to give product 383 (69 mg, 92%) as a pale yellow oil: IR (neat) 3295,
2934, 1461, 1213, 1150, 1099, 1032, 917 cm−1; 1H NMR (400 MHz, CDCl3) δ 6.24 (dt, J = 16.0, 7.4
Hz, 1H, CH−CHC−−C), 5.66-5.59 (m, 1H, CH−CHC−−C), 4.74-4.70 (m, 2H, OCH2O), 3.90 (dt, J =
9.9, 3.5 Hz, 1H, CHCl), 3.77 (ddd, J = 8.9, 5.6, 3.4 Hz, 1H, CHOMOM), 3.43 (s, 3H, OCH3), 2.86
(d, J = 2.1 Hz, 1H, C−−CH), 2.67-2.59 (m, 1H, CH2CHOMOM), 2.49-2.41 (m, 1H, CH2CHOMOM),
1.98-1.88 (m, 1H, CH2CH3), 1.82-1.70 (m, 1H, CH2CH3), 1.10 (t, J = 7.3 Hz, 3H, CH2CH3);
13C NMR
(100 MHz, CDCl3) δ 141.6 (1C, CH−CHC−−C), 111.8 (1C, CH−CHC−−C), 96.6 (1C, OCH2O), 82.0
(1C, C−−CH), 79.3 (1C, CHOMOM), 76.6 (1C, C−−CH), 65.7 (1C, CHCl), 56.0 (1C, OCH3), 34.6 (1C,
CH2CHOMOM), 26.7 (1C, CH2CH3), 11.5 (1C, CH2CH3); MS (CI+, NH3) m/z 234 (M + NH4)+;
HRMS (CI+, NH3) m/z calcd for C11H21NO235Cl (M + NH3)+ 234.1261, found 234.1268.
(3R*,4R*,6E)-3-Chloronon-6-en-8-yn-4-ol (384)
Cl OH
Using a modified method of Krishna,205 PPTS (23 mg, 0.09 mmol, 0.3 equiv) was added to a so-
lution of (3E,6R*,7R*)-7-chloro-6-(methoxymethoxy)non-3-en-1-yne (383) (65 mg, 0.30 mmol, 1.0
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equiv) in ethanol (5 mL) and heated at 110 ◦C for 3.5 h. A further portion of PPTS (64 mg, 0.25
mmol, 0.8 equiv) was added and the mixture was heated at 110 ◦C for 2 h, followed by 18 h at
90 ◦C. The solvent was removed under reduced pressure and the mixture directly applied to col-
umn chromatography (petroleum spirit : diethyl ether, 9 : 1, to 4 : 1) to give product 384 (40 mg,
77%) as a colourless oil: IR (neat) 3650-3050, 3293, 2971, 2936, 1459, 1435, 1382, 1294, 1107, 1046
cm−1; 1H NMR (400 MHz, CDCl3) δ 6.28 (dt, J = 15.9, 7.4 Hz, 1H, CH−CHC−−C), 5.63 (ddd, J =
15.8, 3.4, 1.6 Hz, 1H, CH−CHC−−C), 3.88 (ddd, J = 8.6, 5.1, 3.5 Hz, 1H, CHCl), 3.77 (ddd, J = 14.1,
6.6, 3.5 Hz, 1H, CHOH), 2.87 (d, J = 2.3 Hz, 1H, C−−CH), 2.47 (app t, J = 7.2 Hz, 2H, CH2CHOH),
1.98 (d, J = 7.8 Hz, 1H, CHOH), 1.94-1.84 (m, 2H, CH2CH3), 1.09 (t, J = 7.3 Hz, 3H, CH2CH3);
13C
NMR (100 MHz, CDCl3) δ 141.1 (1C, CH−CHC−−C), 112.0 (1C, CH−CHC−−C), 81.9 (1C, C−−CH),
77.2 (1C, C−−CH), 72.7 (1C, CHOH), 69.5 (1C, CHCl), 38.3 (1C, CH2CHOH), 28.1 (1C, CH2CH3), 11.3
(1C, CH2CH3); MS (CI+, NH3) m/z 190 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for C9H17NO35Cl
(M + NH3)+ 190.0999, found 190.1005.
(3R*,4S*,6E)-3,4-Epoxynon-6-en-8-yne (385)
O
Potassium carbonate (152 mg, 1.53 mmol, 4.0 equiv) was added to a solution of (3R*,4R*,6E)-3-
chloronon-6-en-8-yn-4-ol (384) (66 mg, 0.38 mmol, 1.0 equiv) in methanol (3.5 mL) at room temper-
ature. The white suspension was stirred for 4.5 h and subsequently diluted with water (25 mL). The
aqueous was extracted with diethyl ether (3 x 25 mL) and the organics dried over sodium sulfate.
The organics were filtered and the solvent removed under reduced pressure to give product 385 (45
mg, 87%) as a colourless oil which did not require further purification: IR (neat) 3288, 2971, 1457,
1384, 957, 924 cm−1; 1H NMR (400 MHz, CDCl3) δ 6.30 (dt, J = 16.0, 6.9 Hz, 1H, CH−CHC−−C),
5.64 (ddd, J = 16.0, 3.6, 1.8 Hz, 1H, CH−CHC−−C), 3.03 (td, J = 6.3, 4.3 Hz, 1H, OCH), 2.95 (td, J =
6.3, 4.4 Hz, 1H, OCH), 2.87 (d, J = 2.0 Hz, 1H, C−−CH), 2.49-2.40 (m, 1H, CH2CHO), 2.38-2.28 (m,
1H, CH2CHO), 1.37-1.22 (m, 2H, CH2CH3), 1.08 (t, J = 7.5 Hz, 3H, CH2CH3);
13C NMR (100 MHz,
CDCl3) δ 141.0 (1C, CH−CHC−−C), 111.1 (1C, CH−CHC−−C), 81.9 (1C, C−−CH), 76.8 (1C, C−−CH),
58.1 (1C, OCH), 55.3 (1C, OCH), 31.5 (1C, CH2CHO), 21.0 (1C, CH2CH3), 10.6 (1C, CH2CH3); MS
(CI+, NH3) m/z 154 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for C9H16NO (M + NH3)+ 154.1232,
found 154.1225. The following additional signals were also observed in the 13C NMR spectrum
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for the minor (6Z)-stereoisomer: δ 140.1 (1C, CH−CHC−−C), 110.6 (1C, CH−CHC−−C), 82.3 (1C,
C−−CH), 77.3 (1C, C−−CH), 58.3 (1C, OCH), 55.6 (1C, OCH), 21.1 (1C, CH2CH3).
(3R,4R,6Z)-4-Chlorodeca-6,9-diene-1,3-diol (481)
Cl OH
OH
According to the method of Braddock,116 diethylamine hydrochloride (20.8 g, 189 mmol, 5.3 equiv)
and titanium(IV) isopropoxide (15.8 mL, 54 mmol, 1.5 equiv) were added to a solution of (3R,4S,6Z)-
3,4-epoxydeca-6,9-dien-1-ol (480) (6.0 g, 36 mmol, 1.0 equiv) in dichloromethane (720 mL) at room
temperature. After stirring for 5 days saturated tartaric acid (800 mL) was added and the pre-
cipitate was filtered off using a sinter and washed thoroughly with dichloromethane (300 mL).
The aqueous was extracted with dichloromethane (3 x 200 mL) and the combined organics were
washed with sodium bicarbonate (400 mL) and brine (400 mL). The organics were dried over
sodium sulfate, filtered and the solvent was removed under reduced pressure. The crude mix-
ture was subjected to column chromatography (petroleum spirit : ethyl acetate, 2 : 1) to provide
an inseparable mixture of the two chlorohydrin regioisomers 481 and 508 (5.2 g, 71%) in a 5 : 1
ratio, as a colourless oil (data given is for the major regioisomer): R f 0.21 (petroleum spirit : ethyl
acetate, 1 : 1); [α]21D +9.4 (c 0.55, CH2Cl2); IR (neat) 3650-3100, 3079, 3013, 2925, 1638, 1423, 1375,
1254, 1047 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.91-5.80 (m, 1H, CH2−CH), 5.68-5.49 (m, 2H,
CH−CH), 5.13-5.01 (m, 2H, CH2−CH), 4.03-3.82 (m, 4H, CHCl, CHOH, CH2OH), 2.92-2.85 (m, 2H,
C−CCH2C−C), 2.76-2.56 (m, 2H, CHClCH2), 1.97-1.76 (m, 2H, CH2CH2OH); 13C NMR (100 MHz,
CDCl3) δ 136.3 (1C, CH2−CH), 130.3 (1C, CH−CH), 125.7 (1C, CH−CH), 115.1 (1C, CH2−CH),
72.6 (1C, CHOH), 67.7 (1C, CHCl), 60.8 (1C, CH2OH), 36.2 (1C, CH2CH2OH), 32.5 (1C, CHClCH2),
31.7 (1C, C−CCH2C−C); MS (CI+, NH3) m/z 222 (M + NH4)+; HRMS (CI+, NH3) m/z calcd for
C10H21NO2Cl (M + NH4)
+ 222.1261, found 222.1262.
(3R,4R,6Z)-1-(tert-Butyldiphenylsilanyloxy)-4-chlorodeca-6,9-dien-3-ol (482)
Cl OH
OTBDPS
According to the method of Braddock,116 imidazole (4.14 g, 61 mmol, 2.4 equiv) and TBDPS-Cl
(6.58 mL, 25 mmol, 1.0 equiv) were added sequentially to a solution of (3R,4R,6Z)-4-chlorodeca-
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6,9-diene-1,3-diol (481) (5.20 g, 25 mmol, 1.0 equiv) in THF (180 mL) at 0 ◦C. The reaction mixture
was allowed to warm to room temperature and stirred for 18 h. The mixture was diluted with
ethyl acetate (600 mL) and washed with water (500 mL) and brine (500 mL). The organics were
dried over sodium sulfate, filtered and the solvent was removed under reduced pressure. The
crude mixture was subjected to column chromatography (petroleum spirit : ethyl acetate, 20 : 1) to
provide product 482 (8.29 g, 74%) as a colourless oil: R f 0.46 (petroleum spirit : ethyl acetate, 9 : 1);
[α]23D +6.1 (c 0.95, CH2Cl2); IR (neat) 3650-3400, 2931, 2858, 1638, 1589, 1471, 1427, 1241, 1189 cm
−1;
1H NMR (400 MHz, CDCl3) δ 7.73-7.68 (m, 4H, ArH), 7.50-7.41 (m, 6H, ArH), 5.86 (ddt, J = 17.0,
10.2, 6.1 Hz, 1H, CH2−CH), 5.67-5.52 (m, 2H, CH−CH), 5.13-5.01 (m, 2H, CH2−CH), 4.11-4.05 (m,
1H, CHOH), 3.99-3.82 (m, 3H, CHCl, CH2OTBDPS), 2.89 (app t, J = 6.5 Hz, 2H, CH2−CHCH2),
2.81 (d, J = 5.6 Hz, 1H, CHOH), 2.79-2.71 (m, 1H, CHClCH2), 2.65-2.56 (m, 1H, CHClCH2), 1.98-
1.88 (m, 1H, CHOHCH2), 1.82-1.74 (m, 1H, CHOHCH2), 1.09 (s, 9H, CCH3);
13C NMR (100 MHz,
CDCl3) δ 136.5 (1C, CH2−CH), 135.6 (4C, Ar), 133.1 (2C, Ar), 130.1 (1C, CH−CH), 129.9 (2C, Ar),
127.8 (4C, Ar), 126.1 (1C, CH−CH), 115.0 (1C, CH−CH), 71.8 (1C, CHOH), 67.0 (1C, CHCl), 62.0
(1C, CH2OTBDPS), 36.4 (1C, CHOHCH2), 32.5 (1C, CHClCH2), 31.7 (1C, CH2−CHCH2), 26.8 (3C,
CCH3), 19.1 (1C, CCH3); MS (CI+, NH3) m/z 443 (M + H)+; HRMS (CI+, NH3) m/z calcd for
C26H36O2SiCl (M + H)+ 443.2173, found 443.2171.
2,4,4,6-Tetrabromo-2,5-cyclohexadienone (516)
O
Br Br
Br Br
According to the method of Matveeva,187 bromine (14 mL, 270 mmol, 3 equiv) was added dropwise
to a solution of 4-bromophenol (515) (15 g, 90 mmol, 1 equiv) in ethanol (45 mL) and acetic acid
(45 mL) at 0 ◦C. After 1 h a solution of sodium bicarbonate (21 g) in water (180 mL) was added
dropwise at 0 ◦C to form a yellow-orange precipitate. The product was filtered under reduced
pressure and washed thoroughly with water and n-hexane. The crude product was recrystallised
from chloroform to provide product 516 (22 g, 63%) as a yellow crystalline solid: IR (neat) 1678,
1582, 1311, 900 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.81 (s, 2H); 13C NMR (100 MHz, CDCl3) δ
169.7 (1C, C−O, 147.8 (2C, CH), 119.8 (2C, CBr), 43.8 (1C, CBr2); MS (CI+, NH3) m/z 428 (M +
NH4)
+; HRMS (CI+, NH3) m/z calcd for C6H6NO79Br4 (M + NH4)+ 423.7183, found 423.7176.
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(2R,3R,5S)-5-((S)-1-Bromobut-3-enyl)-2-(2-(tert-butyldiphenylsilyloxy)ethyl)-3-chlorote
trahydrofuran (483)
O
Br
Cl
H H
OTBDPS
According to the method of Braddock,116 TBCO (1.11 g, 2.7 mmol, 1.2 equiv) was added to a so-
lution of (3R,4R,6Z)-1-(tert-butyldiphenylsilanyloxy)-4-chlorodeca-6,9-dien-3-ol (482) (1.00 g, 2.3
mmol, 1.0 equiv) in dichloromethane (60 mL) at −78 ◦C. The reaction mixture was left to warm
slowly to room temperature and stirred for a period of 18 h. The mixture was subsequently di-
luted with ethyl acetate (100 mL) and washed with sodium bicarbonate (50 mL) and brine (50 mL).
The organics were dried over sodium sulfate, filtered and the solvent was removed under reduced
pressure. The crude mixture was purified by column chromatography (petroleum spirit : ethyl
acetate, 25 : 1) to provide product 483 (1.06 g, 90%) as a pale yellow-brown oil: R f 0.51 (petroleum
spirit : ethyl acetate, 9 : 1); [α]23D −1.5 (c 0.52, CH2Cl2); IR (neat) 3072, 2959, 2933, 2860, 1474, 1430,
1109, 1090 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.77-7.70 (m, 4H, ArH), 7.51-7.41 (m, 6H, ArH), 5.99-
5.88 (m, 1H, CH2−CH), 5.25-5.18 (m, 2H, CH2−CH), 4.54-4.44 (m, 3H, CHO, CHCl), 4.08 (ddd, J
= 8.5, 5.7, 3.0 Hz, 1H, CHBr), 3.95-3.77 (m, 2H, CH2OTBDPS), 2.83-2.76 (m, 2H, CH2CHBr), 2.58
(ddd, J = 14.0, 9.6, 4.9 Hz, 1H, CH2CHCl), 2.40 (dd, J = 13.8, 6.5 Hz, 1H, CH2CHCl), 2.12-1.95 (m,
2H, CH2CH2OTBDPS), 1.11 (s, 9H, CCH3);
13C NMR (100 MHz, CDCl3) δ 135.6 (4C, Ar), 134.9 (1C,
CH2−CH), 133.6 (2C, Ar), 129.7 (2C, Ar), 127.7 (4C, Ar), 118.1 (1C, CH2−CH), 80.3 (1C, CHO), 78.4
(1C, CHO), 63.3 (1C, CHCl), 60.7 (1C, CH2OTBDPS), 58.2 (1C, CHBr), 41.2 (1C, CH2CHCl), 39.9 (1C,
CH2CHBr), 34.4 (1C, CH2CH2OTBDPS), 26.9 (3C, CCH3), 19.2 (1C, CCH3); MS (CI+, NH3) m/z 540
(M + NH4)
+; HRMS (ESI) m/z calcd for C26H35O2Si35Cl79Br (M + H)+ 521.1278, found 521.1282.
2-((2R,3R,5S)-5-[(1S)-1-Bromobut-3-en-1-yl]-3-chlorotetrahydrofuran-2-yl)ethanol (484)
O
Br
Cl
H H
OH
According to the method of Braddock,116 TBAF (1.0 M in THF, 25.6 mL, 26.1 mmol, 3.0 equiv) was
added dropwise to a solution of acetic acid (2.4 mL, 43.5 mmol, 5.0 equiv) and (2R,3R,5S)-5-((S)-1-
bromobut-3-enyl)-2-(2-(tert-butyldiphenylsilyloxy)ethyl)-3-chlorotetrahydrofuran (483) (4.52 g, 8.7
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mmol, 1.0 equiv) in THF (270 mL) at 0 ◦C. The reaction mixture was stirred at 0 ◦C for 1 h and at
room temperature for 3 h. A further portion of acetic acid (2.4 mL, 43.5 mmol, 5.0 equiv) was added
and additional TBAF (1.0 M in THF, 25.6 mL, 26.1 mmol, 3.0 equiv) was added after cooling to 0 ◦C.
The reaction mixture was left to slowly warm to room temperature over a period of 18 h. It was
diluted with ethyl acetate (500 mL) and washed with sodium bicarbonate (250 mL). The aqueous
was extracted with ethyl acetate (3 x 200 mL) and the organics were subsequently combined and
washed with brine (400 mL) and dried over sodium sulfate. The solvent was removed under
reduced pressure and the crude mixture purified by column chromatography (petroleum spirit :
ethyl acetate, 2 : 1) to provide product 484 (1.97 g, 80%) as a pale yellow oil: R f 0.38 (petroleum
spirit : ethyl acetate, 1 : 1); [α]28D +2.3 (c 0.84, CH2Cl2); IR (neat) 3600-3100, 2874, 1642, 1434, 1310,
1044 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.94-5.82 (m, 1H, CH2−CH), 5.22-5.15 (m, 2H, CH2−CH),
4.56 (app t, J = 3.7 Hz, 1H, CHCl), 4.47 (ddd, J = 9.5, 6.2, 3.2 Hz, 1H, CHBrCHO), 4.38 (ddd, J =
8.0, 5.0, 3.0 Hz, 1H, CHClCHO), 4.04 (ddd, J = 8.5, 5.1, 3.3 Hz, 1H, CHBr), 3.82 (t, J = 5.9 Hz, 2H,
CH2OH), 2.77-2.70 (m, 2H, CH2CHBr), 2.54 (ddd, J = 14.1, 9.6, 4.9 Hz, 1H, CH2CHCl), 2.42-2.36 (m,
1H, CH2CHCl), 2.22 (br s, 1H, OH), 2.13-2.03 (m, 1H, CH2CH2OH), 1.93-1.84 (m, 1H, CH2CH2OH);
13C NMR (100 MHz, CDCl3) δ 134.6 (1C, CH2−CH), 118.2 (1C, CH2−CH), 81.9 (1C, CHClCHO),
78.8 (CHBrCHO), 63.0 (1C, CHCl), 60.6 (1C, CH2OH), 58.0 (1C, CHBr), 41.0 (1C, CH2CHCl), 40.1
(1C, CH2CHBr), 34.0 (1C, CH2CH2OH); MS (CI+, NH3) m/z 300 (M + NH4)+; HRMS (ESI) m/z calcd
for C10H17O2
35Cl79Br (M + H)+ 283.0100, found 283.0093.
2-Hydroxyoctanenitrile (524)
OH
CN
2,6-Di-tert-butylpyridine (0.42 mL, 1.9 mmol, 1.1 equiv) was added to a solution of 3-butyn-2-ol
((±)-494) (123 mg, 1.8 mmol, 1.0 equiv) in dichloromethane (7 mL) at room temperature. This was
followed by the addition of trimethylsilyl triflate (0.38 mL, 2.1 mmol, 1.2 equiv), then trimethylsilyl
cyanide (0.33 mL, 1.6 mmol, 1.5 equiv) and finally a solution of heptanal (523) (200 mg, 1.8 mmol,
1.0 equiv) in dichloromethane (1 mL). The reaction mixture was heated at 40 ◦C for 18 hours, after
which it was diluted with dichloromethane (40 mL) and the reaction quenched by the addition of
water (40 mL). The layers were separated and the organics were dried over sodium sulfate. After
filtration the solvent was removed under reduced pressure and the crude mixture subjected to
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column chromatography (petroleum spirit : ethyl acetate, 9 : 1), providing product 524 as a pale
yellow oil: R f 0.36 (petroleum spirit : ethyl acetate, 4 : 1); 1H NMR (400 MHz, CDCl3) δ 4.51 (dd, J
= 12.9, 6.4 Hz, 1H, CHOH), 2.48 (d, J = 6.1 Hz, 1H, OH), 1.92-1.84 (m, 2H, CH2), 1.58-1.49 (m, 2H,
CH2), 1.42-1.28 (m, 6H, CH2), 0.93 (t, J = 6.9 Hz, 3H, CH3); MS (CI
+, NH3) m/z 159 (M + NH4)+.
(2R*)-2-[(2R*)-But-3-yn-2-yloxy]octanenitrile (526) and (2R*)-2-[(2S*)-But-3-yn-2-yloxy]
octanenitrile (527)
O
CN
O
CN
2,6-Di-tert-butylpyridine (0.42 mL, 1.93 mmol, 1.1 equiv) was added to a solution of 3-butyn-
2-ol ((±)-494) (246 mg, 3.51 mmol, 2.0 equiv) in dichloromethane (7 mL) at room temperature.
Trimethylsilyl triflate (0.38 mL, 2.10 mmol, 1.2 equiv) was added and the mixture was stirred for
45 min. A solution of heptanal (523) (200 mg, 1.75 mmol, 1.0 equiv) in dichloromethane (1 mL)
was then added and the mixture was stirred for a further hour. Finally trimethylsilyl cyanide (1.10
mL, 8.75 mmol, 5.0 equiv) was added and the reaction mixture was heated at 40 ◦C for 20 hours.
The mixture was then diluted with dichloromethane (40 mL) and the reaction quenched by the
addition of water (40 mL). The layers were separated and the organics were washed with brine (40
mL), dried over sodium sulfate, filtered and the solvent was subsequently removed under reduced
pressure. The mixture was then subjected to column chromatography (petroleum spirit : ethyl ac-
etate, 35 : 1) to provide two diastereomers (526 and 527), where the relative stereochemistry is
undefined.
Diastereomer 1 – Isolated as a colourless oil (46 mg, 14%): R f 0.45 (petroleum spirit : ethyl acetate,
20 : 1); IR (neat) 3300, 2955, 2929, 2859, 1456, 1376, 1326, 1253, 1228, 1096 cm−1; 1H NMR (400 MHz,
CDCl3) δ 4.55 (t, J = 6.6 Hz, 1H, CHCN), 4.49 (qd, J = 6.5, 2.0 Hz, 1H, CHCH3), 2.53 (d, J = 2.0 Hz,
1H, C−−CH), 1.92-1.84 (m, 2H, CH2CHCN), 1.52 (d, J = 6.6 Hz, 3H, CHCH3), 1.42-1.28 (m, 8H, CH2),
0.95-0.89 (m, 3H, CH2CH3);
13C NMR (100 MHz, CDCl3) δ 118.3 (1C, CN), 81.7 (1C, C−−CH), 74.7
(1C, C−−CH), 66.3 (1C, CHCN), 64.8 (1C, CHCH3), 34.8 (1C, CH2), 31.5 (1C, CH2), 28.6 (1C, CH2),
24.6 (1C, CH2), 22.6 (1C, CH2), 21.7 (1C, CHCH3), 14.1 (1C, CH2CH3); MS (CI+, NH3) m/z 211 (M +
NH4)
+; HRMS (CI+) m/z calcd for C12H23N2O (M + NH4)+ 211.1811, found 211.1810.
Diastereomer 2: – Isolated as a colourless oil (116 mg, 34%): R f 0.30 (petroleum spirit : ethyl
acetate, 20 : 1); IR (neat) 3292, 2955, 2929, 2860, 1456, 1375, 1217, 1095 cm−1; 1H NMR (400 MHz,
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CDCl3) δ 4.42 (qd, J = 6.5, 2.1 Hz, 1H, CHCH3), 4.34 (t, J = 6.6 Hz, 1H, CHCN), 2.60 (d, J = 2.0 Hz,
C−−CH), 1.90-1.83 (m, 2H, CH2CHCN), 1.56-1.47 (m, 5H, CHCH3, CH2), 1.41-1.29 (m, 6H, CH2),
0.94-0.89 (m, 3H, CH2CH3);
13C NMR (100 MHz, CDCl3) δ 118.9 (1C, CN), 81.7 (1C, C−−CH), 75.1
(1C, C−−CH), 66.4 (1C, CHCN), 66.1 (1C, CHCH3), 33.7 (1C, CH2), 31.5 (1C, CH2), 28.6 (1C, CH2),
24.6 (1C, CH2), 22.5 (1C, CH2), 21.7 (1C, CHCH3), 14.0 (1C, CH2CH3); MS (CI+, NH3) m/z 211 (M +
NH4)
+; HRMS (CI+) m/z calcd for C12H23N2O (M + NH4)+ 211.1811, found 211.1812.
Procedure for the Oxidation of 2-((2R,3R,5S)-5-[(1S)-1-Bromobut-3-en-1-yl]-3-chlorotetr
ahydrofuran-2-yl)ethanol (484) and Subsequent Formation of Compounds 495 and 496
DMP (5.60 g, 13.2 mmol, 1.5 equiv) was added to a solution of 2-((2R,3R,5S)-5-[(1S)-1-bromobut-3-
en-1-yl]-3-chlorotetrahydrofuran-2-yl)ethanol (484) (2.50 g, 8.8 mmol, 1.0 equiv) in dichlorometha-
ne (35 mL) at 0 ◦C. The reaction mixture was allowed to warm to room temperature and was stirred
for 2 h, after which diethyl ether (150 mL) and aqueous sodium bicarbonate (150 mL) was added.
This was stirred vigorously for 30 min after which the layers were separated and the aqueous
was extracted with diethyl ether (3 x 150 mL). The combined organics were washed with aqueous
sodium bicarbonate (150 mL), water (150 mL) and brine (150 mL), dried over sodium sulfate, fil-
tered, and the solvent was removed under reduced pressure to provide 485 as a colourless oil. This
aldehyde was used crude in the next step without further purification. A solution of (S)-3-butyn-
2-ol ((S)-494) (1.24 g, 17.7 mmol, 2.0 equiv) in dichloromethane (5 mL) was added to a solution of
aldehyde 485 in dichloromethane (45 mL) at 0 ◦C. 2,6-Di-tert-butylpyridine (2.14 mL, 9.8 mmol, 1.1
equiv) was added, followed by dropwise addition of trimethylsilyl triflate (1.92 mL, 10.6 mmol,
1.2 equiv) and finally dropwise addition of trimethylsilyl cyanide (5.55 mL, 44.4 mmol, 5.0 equiv).
The reaction mixture was stirred at 0 ◦C for 1 h, followed by 65 h at 40 ◦C. After this time it was ap-
parent from TLC that the reaction had not gone to completion. Additional trimethylsilyl cyanide
(2.22 mL, 17.8 mmol, 2.0 equiv) was added and the mixture was heated at 40 ◦C for a further 24 h.
The reaction mixture was diluted with dichloromethane (100 mL), water (100 mL) was added and
this was stirred vigorously for 20 min. The layers were separated and the organics were washed
with water (100 mL). The combined aqueous portions were then extracted with dichloromethane
(4 x 100 mL), after which the organics were combined, washed with brine (200 mL), dried over
sodium sulfate, filtered and the solvent was subsequently removed under reduced pressure. The
diastereomers were then separated by column chromatography (petroleum spirit : ethyl acetate,
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25 : 1, to 5 : 1).
(2S)-3-(2R,3R,5S)-5-[(1S)-1-Bromobut-3-en-1-yl]-3-chlorotetrahydrofuran-2-yl-2-[(2S)-but-3-yn-2-
yloxy]propanenitrile (495)
O
Cl
Br
O
CNH H
Compound 495 (0.74 g, 23%) was isolated as a colourless oil: R f 0.42 (petroleum spirit : ethyl
acetate, 9 : 1); [α]28D −13.3 (c 0.42, CH2Cl2); IR (neat) 3296, 2992, 2945, 2116, 1645, 1439, 1375, 1217,
1095 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.90 (ddt, J = 17.0, 10.2, 6.8 Hz, 1H, CH−CH2), 5.24-
5.16 (m, 2H, CH−CH2), 4.76 (t, J = 7.0 Hz, 1H, CHCN), 4.61-4.58 (m, 1H, CHCl), 4.56-4.42 (m,
3H, CHOCHBr, CHOCHCl, CHCH3), 4.05 (ddd, J = 8.5, 5.8, 3.0 Hz, 1H, CHBr), 2.79-2.73 (m, 2H,
CH2CHBr), 2.65-2.56 (m, 2H, CH2CHCl, C−−CH), 2.47-2.38 (m, 2H, CH2CHCl, CH2CHCN), 2.21
(ddd, J = 13.9, 7.2, 5.7 Hz, 1H, CH2CHCN), 1.53 (d, J = 6.5 Hz, 3H, CHCH3);
13C NMR (100 MHz,
CDCl3) δ 134.7 (1C, CH−CH2), 118.2 (1C, CH−CH2), 117.6 (1C, CN), 81.4 (1C, C−−CH), 78.8 (1C,
CHOCHBr), 78.7 (1C, CHOCHCl), 75.1 (1C, C−−CH), 65.0 (1C, CHCH3), 64.0 (1C, CHCN), 62.1 (1C,
CHCl), 57.4 (1C, CHBr), 40.9 (1C, CH2CHCl), 39.9 (1C, CH2CHBr), 35.4 (1C, CH2CHCN), 21.7 (1C,
CH3); MS (CI+, NH3) m/z 379 (M + NH4)+; HRMS (ESI+) m/z calcd for C15H23N2O235Cl79Br (M +
NH4)
+ 377.0631, found 377.0635.
(2R)-3-(2R,3R,5S)-5-[(1S)-1-Bromobut-3-en-1-yl]-3-chlorotetrahydrofuran-2-yl-2-[(2S)-but-3-yn-2-
yloxy]propanenitrile (496)
O
Cl
Br
O
CNH H
Compound 496 (1.31 g, 41%) was isolated as a colourless oil: R f 0.33 (petroleum spirit : ethyl ac-
etate, 9 : 1); [α]28D +2.1 (c 0.60, CH2Cl2); IR (neat) 3298, 2986, 2935, 1645, 1439, 1312, 1267, 1217, 1094
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cm−1; 1H NMR (400 MHz, CDCl3) δ 5.94-5.83 (m, 1H, CH−CH2), 5.24-5.17 (m, 2H, CH−CH2), 4.61-
4.37 (m, 5H, CHCN, CHCl, CHCH3, CHOCHBr, CHOCHCl), 4.03 (td, J = 6.9, 2.6 Hz, 1H, CHBr),
2.78-2.73 (m, 2H, CH2CHBr), 2.66-2.58 (m, 2H, C−−CH, CH2CHCl), 2.45-2.39 (m, 1H, CH2CHCl),
2.32-2.14 (m, 2H, CH2CHCN), 1.54 (d, J = 6.6 Hz, 3H, CH3);
13C NMR (100 MHz, CDCl3) δ 134.6
(1C, CH−CH2), 118.7 (1C, CN), 118.4 (1C, CH−CH2), 81.6 (1C, C−−CH), 78.8 (1C, CHOCHBr), 78.4
(1C, CHOCHCl), 75.3 (1C, C−−CH), 67.3 (1C, CHCH3), 63.4 (1C, CHCN), 62.3 (1C, CHCl), 58.3 (1C,
CHBr), 41.6 (1C, CH2CHCl), 40.7 (1C, CH2CHBr), 36.7 (1C, CH2CHCN), 21.7 (1C, CH3); MS (CI+,
NH3) m/z 379 (M + NH4)+; HRMS (ESI+) m/z calcd for C15H23N2O235Cl79Br (M + NH4)+ 377.0631,
found 377.0633.
(2S)-3-(2R,3R,5S)-5-[(1S)-1-Bromobut-3-en-1-yl]-3-chlorotetrahydrofuran-2-yl-2-[(2S)-bu
t-3-en-2-yloxy]propanenitrile (534)
O
Br
H H
Cl
O
CN
Pd-BaSO4 (105 mg, 0.3 equiv) and quinoline (0.2 mL) were added to a solution of (2S)-3-(2R,3R,5S)-
5-[(1S)-1-bromobut-3-en-1-yl]-3-chlorotetrahydrofuran-2-yl-2-[(2S)-but-3-yn-2-yloxy]propanenitri
le (495) (350 mg, 1.0 equiv) in benzene (25 mL) at room temperature. The flask was flushed with
nitrogen, followed by hydrogen gas. The reaction mixture was stirred vigorously under a hydro-
gen atmosphere for 30 min, after which it was filtered through a plug of silica, eluting with ethyl
acetate. The solvent was removed under reduced pressure and the crude mixture subjected to col-
umn chromatography (petroleum spirit : ethyl acetate, 10 : 1) to provide product 534 (325 mg, 92%)
as a colourless oil: [α]28D −37.5 (c 0.37, CH2Cl2); IR (neat) 2980, 1646, 1433, 1375, 1244, 1088 cm−1;
1H NMR (400 MHz, CDCl3) δ 5.97-5.84 (m, 1H, CH−CH2), 5.72-5.60 (m, 1H, CH−CH2), 5.42-5.32
(m, 2H, CH−CH2), 5.25-5.17 (m, 2H, CH−CH2), 4.58-4.39 (m, 4H, CHOCHCl, CHCl, CHOCHBr,
CHCN), 4.23-4.15 (m, 1H, CHCH3), 4.07-4.02 (m, 1H, CHBr), 2.85-2.72 (m, 2H, CH2CHBr), 2.65-2.56
(m, 1H, CH2), 2.48-2.39 (m, 1H, CH2), 2.38-2.29 (m, 1H, CH2), 2.24-2.15 (m, 1H, CH2), 1.34 (d, J = 6.3
Hz, 3H, CH3);
13C NMR (100 MHz, CDCl3) δ 137.5 (1C, CH−CH2), 134.7 (1C, CH−CH2), 119.3 (2C,
CN, CH−CH2), 118.2 (1C, CH−CH2), 78.9 (1C, CHO), 78.8 (1C, CHO), 77.2 (1C, CHCH3), 63.4 (1C,
CHCN), 62.4 (1C, CHCl), 57.4 (1C, CHBr), 40.9 (1C, CH2), 39.9 (1C, CH2CHBr), 35.6 (1C, CH2), 21.3
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(1C, CH3); MS (CI+, NH3) m/z 379 (M + NH4)+; HRMS (CI+) m/z calcd for C15H25N2O235Cl79Br (M
+ NH4)
+ 379.0788, found 379.0789.
(1R,3R,5S,6Z,9S,10S,12R)-9-Bromo-12-chloro-5-methyl-4,13-dioxabicyclo[8.2.1]tridec-6-e
ne-3-carbonitrile (535)
O
Br
H H
Cl
O CN
Stewart-Grubbs catalyst (499) (39 mg, 0.07 mmol, 0.3 equiv) was added to a solution of (2S)-3-
(2R,3R,5S)-5-[(1S)-1-bromobut-3-en-1-yl]-3-chlorotetrahydrofuran-2-yl-2-[(2S)-but-3-en-2-yloxy]pr
opanenitrile (534) (82 mg, 0.23 mmol, 1.0 equiv) in toluene (600 mL) and heated at 110 ◦C for 0.5
h. Di(ethylene glycol) vinyl ether (0.02 mL, 0.14 mmol, 0.6 equiv) was added and the heating
was continued for 1 h, after which the reaction mixture was allowed to cool to room temperature
and the solvent removed under reduced pressure. The crude mixture was subjected to column
chromatography (petroleum spirit : ethyl acetate, 20 : 1, to 9 : 1, to 4 : 1), providing the title com-
pound 535 (33 mg, 44%) as a white solid: R f 0.29 (petroleum spirit : ethyl acetate, 9 : 1); m.p.
133− 135 ◦C; [α]28D +8.0 (c 0.44, CH2Cl2); IR (neat) 2971, 2934, 2899, 1660, 1447, 1378, 1292, 1270,
1072 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.61 (dd, J = 10.9, 9.3 Hz, 1H, CH−CHCHO), 5.54 (td, J =
10.4, 6.0 Hz, 1H, CH−CHCHO), 4.63 (dq, J = 8.9, 6.1 Hz, OCHCH3), 4.54-4.46 (m, 1H, OCHCHCl),
4.45-4.41 (m, 1H, CHCl), 4.40-4.34 (m, 1H, OCHCHBr), 4.25 (d, J = 9.2 Hz, CHCN), 4.01 (ddd, J
= 12.6, 3.7, 1.5 Hz, 1H, CHBr), 3.18 (ddd, J = 12.8, 12.8, 10.5 Hz, 1H, CH2CHBr), 2.64-2.55 (m,
2H, CH2CHBr, CH2CHCl), 2.40 (ddd, J = 15.3, 11.3, 9.4 Hz, 1H, CH2CHCN), 2.17-2.07 (m, 2H,
CH2CHCl, CH2CHCN), 1.41 (d, J = 6.2 Hz, 3H, CH3);
13C NMR (100 MHz, CDCl3) δ 135.4 (1C,
CH−CHCHO), 128.4 (1C, CH−CHCHO), 119.6 (1C, CN), 77.8 (1C, CHOCHCl), 73.6 (1C, CHCH3),
73.5 (1C, CHOCHBr), 65.0 (1C, CHCN), 55.6 (1C, CHCl), 53.9 (1C, CHBr), 38.2 (1C, CH2CHCl), 35.4
(1C, CH2CHCN), 35.0 (1C, CH2CHBr), 19.8 (1C, CH3); MS (CI+, NH3) m/z 351 (M + NH4)+; HRMS
(ESI+) m/z calcd for C13H18NO235Cl79Br (M + H)+ 334.0209, found 334.0202.
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(1R,3S,5S,6E,9S,10S,12R)-9-Bromo-12-chloro-5-methyl-4,13-dioxabicyclo[8.2.1]tridec-6-e
ne-3-carbonitrile (493)
O
O
Br
H H
Cl
CN
Hoveyda-Grubbs I catalyst (536) (41 mg, 0.07 mmol, 0.3 equiv) was added to a solution of (2S)-3-
(2R,3R,5S)-5-[(1S)-1-bromobut-3-en-1-yl]-3-chlorotetrahydrofuran-2-yl-2-[(2S)-but-3-en-2-yloxy]pr
opanenitrile (534) (82 mg, 0.23 mmol, 1.0 equiv) in toluene (600 mL) and heated at 110 ◦C for 19
h. Di(ethylene glycol) vinyl ether (0.02 mL, 0.14 mmol, 0.6 equiv) was added and the heating was
continued for 1 h, after which the reaction mixture was allowed to cool to room temperature and
the solvent removed under reduced pressure. The crude mixture was subjected to column chro-
matography (petroleum spirit : ethyl acetate, 9 : 1), providing the title compound 493 (8 mg, 11%)
as a green solid: R f 0.20 (petroleum spirit : ethyl acetate, 9 : 1); m.p. 136− 140 ◦C; [α]28D +6.2 (c 0.64,
CH2Cl2); IR (neat) 2979, 2929, 1443, 1378, 1311, 1268, 1088 cm−1; 1H NMR (500 MHz, CDCl3, 50 ◦C)
δ 5.95 (dt, J = 14.0, 7.0 Hz, 1H, CH2CH−CH), 5.60-5.52 (br m, 1H, CH2CH−CH), 4.52 (app t, J = 5.6
Hz, 1H, CHCl), 4.48 (t, J = 4.8 Hz, 1H, CHCN), 4.41 (td, J = 5.0, 2.3 Hz, 1H, CHBr),4.27-4.15 (br m,
2H, CHOCHCl, CHOCHBr), 4.02 (dq, J = 8.7, 6.4 Hz, 1H, CHCH3), 2.82-2.72 (br m, 2H, CH2CHBr),
2.42 (ddd, J = 13.8, 9.5, 6.6 Hz, 1H, CH2CHCl), 2.28-2.21 (m, 2H, CH2CHCl, CH2CHCN), 2.18-
2.12 (m, 1H, CH2CHCN), 1.34 (d, J = 6.4 Hz, 3H, CH3);
13C NMR (100 MHz, CDCl3) δ 134.3 (1C,
CH−CHCHCH3), 130.0 (1C, CH−CHCHCH3), 119.4 (1C, CN), 78.8 (1C, CHCH3), 77.0 (1C, CHO),
76.7 (1C, CHO), 66.7 (1C, CHCN), 59.1 (1C, CHCl), 51.3 (1C, CHBr), 40.9 (1C, CH2CHCl), 38.4 (1C,
CH2CHBr), 35.5 (1C, CH2CHCN), 21.1 (1C, CH3); MS (CI+, NH3) m/z 334 (M + H)+; HRMS (CI+)
m/z calcd for C13H18NO235Cl79Br (M + H)+ 334.0209, found 334.0210.
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(2R)-3-(2R,3R,5S)-5-[(1S)-1-Bromobut-3-en-1-yl]-3-chlorotetrahydrofuran-2-yl-2-[(2S)-bu
t-3-en-2-yloxy]propanenitrile (497)
O
Br
H H
Cl
O
CN
Pd-BaSO4 (196 mg, 0.3 equiv) was added to a solution of (2R)-3-(2R,3R,5S)-5-[(1S)-1-bromobut-
3-en-1-yl]-3-chlorotetrahydrofuran-2-yl-2-[(2S)-but-3-yn-2-yloxy]propanenitrile (496) (653 mg, 1.0
equiv) in benzene (50 mL) at room temperature, followed by quinoline (0.4 mL). The flask was
flushed with nitrogen, followed by hydrogen gas. The reaction mixture was stirred vigorously
under a hydrogen atmosphere for 1.5 h, after which it was filtered through a plug of silica, elut-
ing with ethyl acetate. The solvent was removed under reduced pressure and the crude mixture
subjected to column chromatography (petroleum spirit : ethyl acetate, 10 : 1) to provide product
497 (428 mg, 65%) as a colourless oil: R f 0.53 (petroleum spirit : acetone, 3 : 1); [α]26D +33.3 (c 0.30,
CH2Cl2); IR (neat) 2980, 2875, 1643, 1314, 1087 cm−1; 1H NMR (400 MHz, CDCl3) δ 5.97-5.84 (m,
2H, CH−CH2), 5.38-5.17 (m, 4H, CH−CH2), 4.54-4.51 (m, 1H, CHCl), 4.48-4.39 (m, 3H, CHBrCHO,
CHClCHO, CHCN), 4.17 (dq, J = 13.5, 6.3 Hz, 1H, CHCH3), 4.03 (td, J = 7.2, 2.6 Hz, 1H, CHBr),
2.79-2.74 (m, 2H, CH2CHBr), 2.63 (ddd, J = 14.1, 9.5, 5.0 Hz, 1H, CH2CHCl), 2.43 (ddd, J = 14.3,
6.4, 0.6 Hz, 1H, CH2CHCl), 2.30-2.22 (m, 1H, CH2CHCN), 2.20-2.12 (m, 1H, CH2CHCN), 1.34 (d,
J = 6.3 Hz, 3H, CH3);
13C NMR (100 MHz, CDCl3) δ 138.7 (1C, CH−CH2), 134.5 (1C, CH−CH2),
119.3 (1C, CN), 118.3 (1C, CH−CH2), 117.5 (1C, CH−CH2), 79.0 (1C, CHCH3), 78.9 (1C, CHO),
78.4 (1C, CHO), 63.4 (1C, CHCN), 62.4 (1C, CHCl), 58.2 (1C, CHBr), 41.6 (1C, CH2CHBr), 40.7 (1C,
CH2CHCl), 36.8 (1C, CH2CHCN), 20.2 (1C, CH3); MS (CI+, NH3) m/z 379 (M + NH4)+; HRMS
(CI+) m/z calcd for C15H25N2O235Cl79Br (M + NH4)+ 379.0788, found 379.0789.
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(1R,3R,5S,6E,9S,10S,12R)-9-Bromo-12-chloro-5-methyl-4,13-dioxabicyclo[8.2.1]tridec-6-e
ne-3-carbonitrile (498)
O
O
Br
H H
Cl
CN
Stewart-Grubbs catalyst (499) (41 mg, 0.08 mmol, 0.3 equiv) was added to a solution of (2R)-3-
(2R,3R,5S)-5-[(1S)-1-bromobut-3-en-1-yl]-3-chlorotetrahydrofuran-2-yl-2-[(2S)-but-3-en-2-yloxy]pr
opanenitrile (497) (86 mg, 0.24 mmol, 1.0 equiv) in toluene (600 mL) and heated at 110 ◦C for 16 h.
Di(ethylene glycol) vinyl ether (0.02 mL, 0.14 mmol, 0.6 equiv) was added and the heating was con-
tinued for 1 h, after which the reaction mixture was allowed to cool to room temperature and the
solvent removed under reduced pressure. The crude mixture was subjected to column chromatog-
raphy (petroleum spirit : ethyl acetate, 20 : 1, to 9 : 1), providing the title compound 498 (23 mg,
29%) as a white crystalline solid: R f 0.15 (petroleum spirit : ethyl acetate, 9 : 1); m.p. 144 ◦C; [α]18D
+18.4 (c 0.46, CH2Cl2); IR (neat) 2932, 2253, 1665, 1449, 1386, 1091, 1060 cm−1; 1H NMR (400 MHz,
CDCl3) δ 5.94-5.80 (br m, 1H, CH−CHCHCH3), 5.76-5.62 (br m, 1H, CH−CHCHCH3), 4.75 (dt, J =
8.1, 5.4 Hz, 1H, CHOCHBr), 4.56-4.47 (m, 2H, CHCH3, CHBr), 4.43 (app br s, 1H, CHCl), 4.39-4.34
(br m, 1H, CHCN), 3.92-3.83 (app br s, 1H, CHOCHCl), 2.92 (br m, 1H, CH2CHBr), 2.60-2.35 (br m,
3H, CH2CHBr, CH2CHCl), 1.98-1.93 (m, 2H, CH2CHCN), 1.45 (d, J = 7.0 Hz, 3H, CH3);
13C NMR
(100 MHz, CDCl3) δ 129.7 (1C, CH−CHCHCH3), 126.7 (1C, CH−CHCHCH3), 119.6 (1C, CN), 78.3
(1C, CHOCHBr), 75.3 (1C, CHOCHCl), 71.8 (1C, CHCH3), 61.4 (1C, CHCl), 56.5 (1C, CHCN), 49.2
(1C, CHBr), 38.8 (1C, CH2CHCl), 37.6 (1C, CH2CHBr), 36.3 (1C, CH2CHCN), 13.5 (1C, CH3); MS
(CI+, NH3) m/z 334 (M + H)+; HRMS (CI+) m/z calcd for C13H18NO235Cl79Br (M + H)+ 334.0209,
found 334.0212.
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Appendices
I – 2D NMR Spectra of Isolated Medium-Ring Ether Compounds
The 2D NMR spectra (COSY, HSQC, HMBC, NOESY) in this appendix are provided in support of
the assignments made for carbonates 247a, 247b, 248a, 250a and 250b, and diols 288a, 288b, 289a,
289b, 290a, 290b and 294. All 1H NMR spectra were acquired at either 400 MHz or 500 MHz, and
all DEPT-135 NMR spectra were acquired at either 100 MHz or 125 MHz.
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Figure 40: COSY NMR spectrum of carbonate 248a.
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Figure 41: HSQC NMR spectrum of carbonate 248a.
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Figure 42: COSY NMR spectrum of carbonate 250a.
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Figure 43: HSQC NMR spectrum of carbonate 250a.
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Figure 44: HMBC NMR spectrum of carbonate 250a.
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Figure 45: COSY NMR spectrum of carbonate 250b.
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Figure 46: HSQC NMR spectrum of carbonate 250b.
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Figure 47: COSY NMR spectrum of carbonate diastereomer 1, either 247a or 247b.
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Figure 48: HSQC NMR spectrum of carbonate diastereomer 1, either 247a or 247b.
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Figure 49: COSY NMR spectrum of carbonate diastereomer 2, either 247a or 247b.
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Figure 50: HSQC NMR spectrum of carbonate diastereomer 2, either 247a or 247b.
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Figure 51: COSY NMR spectrum of diol 288a.
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Figure 52: HSQC NMR spectrum of diol 288a.
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Figure 53: HMBC NMR spectrum of diol 288a.
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Figure 54: NOESY NMR spectrum of diol 288a.
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Figure 55: COSY NMR spectrum of diol 288b.
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Figure 56: HSQC NMR spectrum of diol 288b.
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Figure 57: COSY NMR spectrum of diol 289a.
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Figure 58: HSQC NMR spectrum of diol 289a.
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Figure 59: COSY NMR spectrum of diol 289b.
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Figure 60: HSQC NMR spectrum of diol 289b.
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Figure 61: COSY NMR spectrum of diol diastereomer 1, either 290a or 290b.
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Figure 62: HSQC NMR spectrum of diol diastereomer 1, either 290a or 290b.
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Figure 63: COSY NMR spectrum of diol diastereomer 2, either 290a or 290b.
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Figure 64: HSQC NMR spectrum of diol diastereomer 2, either 290a or 290b.
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Figure 65: COSY NMR spectrum of cyclopropane 294.
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Figure 66: HSQC NMR spectrum of cyclopropane 294.
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Figure 67: HMBC NMR spectrum of cyclopropane 294.
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Figure 68: NOESY NMR spectrum of cyclopropane 294.
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Abstract
9-Oxabicyclo[6.1.0]non-4-ene (1) undergoes intramolecular bromonium ion-assisted epox-
ide ring-opening using N-bromosuccinimide via a presumed oxonium ion that is subject to
stereospecific, nonregioselective capture with added external nucleophiles producing novel bi-
cyclo[4.2.1] and bicyclo[3.3.1] ethers. Carboxylic acids (as catalyzed by tetramethylguanidine),
alcohols, water, and halides can all function as effective nucleophiles. Stereospecific direct
opening of the bromonium ion with carboxylic acids was found to be a competing process
where high dilution disfavors this pathway. Halogen-induced isotopic 13C NMR shifts (∆δ CBr
1.3-1.9 ppb; ∆δ CCl 8.6-8.7 ppb) were found to be most useful in unambiguously identifying
halogen-bearing carbons, and correlation of these 13C NMR shifts allowed ready assignment of
diastereomeric structures. The structure of adducts 6b, 6c, 7b, 7c, 7d, and 8a-d were all eluci-
dated by X-ray crystallography.
O
Br
X
O
Br X
+O
X = O2CR, OR, OH
O
Br
X
NO O
Br
H X
up to 96% yield
11 examples
320
DOI: 10.1021/jo101617h Published on Web 11/29/2010 J. Org. Chem. 2011, 76, 97–104 97
r 2010 American Chemical Society
pubs.acs.org/joc
Intramolecular Bromonium Ion Assisted Epoxide Ring-Opening: Capture
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9-Oxabicyclo[6.1.0]non-4-ene (1) undergoes intramolecular bromonium ion-assisted epoxide ring-
opening using N-bromosuccinimide via a presumed oxonium ion that is subject to stereospecific,
nonregioselective capture with added external nucleophiles producing novel bicyclo[4.2.1] and bicyclo-
[3.3.1] ethers. Carboxylic acids (as catalyzed by tetramethylguanidine), alcohols, water, and halides
can all function as effective nucleophiles. Stereospecific direct opening of the bromonium ion with
carboxylic acids was found to be a competing process where high dilution disfavors this pathway.
Halogen-induced isotopic 13CNMRshifts (ΔδCBr 1.3-1.9 ppb;ΔδCCl 8.6-8.7 ppb) were found to
bemost useful in unambiguously identifying halogen-bearing carbons, and correlation of these 13CNMR
shifts allowed ready assignment of diastereomeric structures. The structure of adducts 6b, 6c, 7b, 7c,
7d, and 8a-d were all elucidated by X-ray crystallography.
Introduction
The formation of a bromonium ion1-8 by the action of
electrophilic bromine on an alkene followed by stereospecific
trapping by a nucleophile to give a 1,2-addition product is a
fundamental reaction in organic chemistry.9 In 1985, a further
reactivity mode was reported whereby in the reaction of an
epoxyalkenewithmolecular bromine, intramolecular trapping
of the bromonium ion by the epoxide oxygen occurred, and a
presumed resultant oxonium ion was captured by the neces-
sarily present bromide anion (Scheme 1, case a).10a Although
mixtures of ethereal dibromide products were produced by
nonregioselective ring-openings, only those diastereomers of
stereospecific backside opening of the bromonium ion by the
epoxide oxygen and subsequent stereospecific backside at-
tack on the resultant oxonium ion were formed. The same
authors later reported that the intermolecular reaction of
alkenes and epoxides with molecular bromine could proceed
along the same pathway with the same stereochemical out-
come (Scheme 1, case a).10b
More recently, bothMcDonald11 andJamison12havedemon-
strated the use of electrophilic bromine sources (bromonium
(1) For a review see: Ruasse,M.-F.Acc. Chem. Res. 1990, 23, 87–93. and
references cited therein.
(2) The 3-membered cyclic bromonium ionwas first suggested byRoberts
and Kimball: Roberts, I.; Kimball, G. E. J. Am. Chem. Soc. 1937, 59, 947–
948.
(3) For evidence that the bromonium ion is cyclic and symmetrical see:
Winstein, S.; Lucas, H. J. J. Am. Chem. Soc. 1939, 61, 2845–2848.
(4) For the observation of bromonium ions byNMR see: (a) Olah, G. A.;
Bollinger, J.M.; Brinich, J. J. Am. Chem. Soc. 1968, 90, 2587–2594. (b) Olah,
G. A.; Bollinger, J. M. J. Am. Chem. Soc. 1968, 90, 6082–6086.
(5) For the first isolable bromonium ion see: Strating, J.; Wieringa, J. H.;
Wynberg, H. J. Chem. Soc., Chem. Commun. 1969, 907–908.
(6) ForX-raycharacterisationof stablebromoniumions see: (a)Slebocka-Tilk,
H.; Ball, R. G.; Brown, R. S. J. Am. Chem. Soc. 1985, 107, 4504–4508. (b) Bennet,
A. J.; Brown, R. S.; McClung, R. E. D.; Klobukowski, M.; Aarts, G. H. M.;
Santarsiero, B. D.; Bellucci, G.; Bianchini, R. J. Am. Chem. Soc. 1991, 113, 8532–
8535. (c) Brown, R. S.; Nagorski, R.W.; Bennet, A. J.; McClung, R. E. D.; Aarts,
G.H.M.;Klobukowski,M.;McDonald, R.; Santarsiero, B.D. J. Am.Chem. Soc.
1994, 116, 2448–2456. (d) Brown, R. S. Acc. Chem. Res. 1997, 30, 131–137.
(7) For the first generation and trapping of enantiomerically pure bro-
monium ions see: Braddock, D. C.; Hermitage, S. A.; Kwok, L.; Pouwer, R.;
Redmond, J. M.; White, A. J. P. Chem. Commun. 2009, 1082–1084.
(8) On the absolute configurational stability of bromonium ions in the
presence of alkenes see: Denmark, S. E.; Burk, M. T.; Hoover, A. J. J. Am.
Chem. Soc. 2010, 132, 1232–1233.
(9) Olah, G. A.; Laali, K. K.; Wang, Q.; Prakash, G. K. S. Onium Ions;
John Wiley & Sons: New York, 1998.
(10) (a)Davies, S.G.; Polywka,M.E.C.; Thomas, S. E.Tetrahedron Lett.
1985, 26, 1461–1464. (b) Davies, S. G.; Polywka, M. E. C.; Thomas, S. E.
J. Chem. Soc., Perkin Trans. 1 1986, 1277–1282.
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di-sym-collidine perchlorate and NBS, respectively) to effect
spectacular intramolecular bromonium ion assisted epoxide
ring-openings, to construct complex (poly)cyclic ether com-
pounds, where the final cyclization is terminated by an intra-
molecularly positioned nucleophile (Scheme 1, case b). In
these systems, the regioselectivity of ring-closure was effec-
tively controlled by the substitution pattern of the substrate,
and stereospecific ring-openings occurred, although the bromo-
nium ion formation was not face selective. The latter work
allowed for the total synthesis of ent-dioxepandehydrothyr-
siferol and demonstrated the feasibility of this route as a
biogenetic pathway in Laurencia species. To date, however,
there have been no reports on intramolecular bromonium
ion-assisted epoxide ring-opening with an added external
nucleophile (Scheme 1, case c).13 Such a method should
provide additional flexibility in building (poly)cyclic ether com-
pounds with different functional groups. However, in such
systems there is an additional inherent selectivity question;
whether the added external nucleophile will attack directly
the bromonium ion of the original olefin or whether the for-
mation of an oxonium ion followed by its trapping will pre-
dominate. Herein we report the first examples of intramolec-
ular bromonium ion assisted epoxide ring-expansions with
trapping of the presumed resultant oxonium ion14 by added
external nucleophiles. In particular, we report that the use of
water15 as the solvent (and nucleophile) gives rise to exclusive
trapping of the oxonium ion in preference to the original
bromonium ion.
Results and Discussion
We selected 9-oxabicyclo[6.1.0]non-4-ene (1)10a as a sui-
table alkene epoxide substrate and N-bromosuccinimide
(NBS) as the source of electrophilic bromine. A carboxylic
acid was selected as a suitable nucleophile which can provide
a proton to produce succinimide as the neutral byproduct.
However, initial experiments with alkene epoxide 1 and
NBS, with acetic acid as the added nucleophile, in dichlor-
omethane, failed to give any reaction. To our delight, the
addition of catalytic quantities (1 mol%) of tetramethylgua-
nidine (TMG)16 led to rapid reaction giving the previously
unreported [4.2.1]bicycloether 2 and [3.3.1]bicycloether 3 (as
an inseparable 1:1 mixture, 43%) and novel bromoacetates 4
(13%) and 5 (26%) after purification by column chroma-
tography (Scheme 2). The identities and stereochemistries of
these diastereomeric compounds with identical molecular for-
mulas were unambiguously proven by a combination of X-ray
crystallography, NMR methods, and correlation by inter-
conversion (vide infra). In the reaction itself, a bromonium
ionA can evidently be trapped intramolecularly by the epoxide
to give an oxonium ion B. This can only occur when the
bromonium ion and epoxide are on opposite faces (where
presumably the bromonium ion can be formed reversibly on
either face of the alkene). The oxonium ion B can in turn be
trappedwith an added external nucleophile (acetate) giving 2
and 3. A control experiment without NBS showed that the
epoxide is not ring-opened by acetic acid under these condi-
tions. A further possible isomer could possibly be envisioned
by opening of the oxonium ion B R-to the carbon bearing
bromine. This would lead to a syn-bromocarboxylate (not
shown) by double inversion at this center. Such a compound
was not detected in this or any other series. This implies that
the bromine is an effective steric shield for ring-opening of
the oxonium ion at this position. Alternatively, the bromo-
nium ion A can be directly trapped by acetate giving bro-
moacetates 4 and 5 with the epoxide left intact. In this
SCHEME 1. Generalized Modes of Intramolecular Bromonium
Ion-Assisted Epoxide Ring-Openings
SCHEME 2. Bromoether Formation by Capture with an Added
Nucleophile
(11) Bravo, F.; McDonald, F. E.; Neiwert, W. A.; Hardcastle, K. I. Org.
Lett. 2004, 6, 4487–4489.
(12) Tanuwidjaja, J.; Ng, S.-S.; Jamison, T. F. J. Am. Chem. Soc. 2009,
131, 12084–12085.
(13) (a) For the intramolecular capture of a bromonium ion with the
oxygen of a THF and opening of the oxonium ion with an external
nucleophile see: Braddock, D. C.; Millan, S.; Perez-Fuertes, Y.; Pouwer,
R. H.; Sheppard, R. N.; Solanki, S.; White, A. J. P. J. Org. Chem. 2009, 74,
1835–1841 and references cited therein. An electrophilic aminoalkoxylation
of olefins featuring the intermolecular capture of a bromonium ion by an
epoxide followed by capture of the oxonium intermolecularly by an amine
has been reported: (b) Zhou, L.; Tan, C. K.; Zhou, J.; Yeung, Y.-Y. J. Am.
Chem. Soc. 2010, 132, 10245–10247.
(14) For a report of an extraordinarily stable oxonium ion see: Mascal,
M.; Hafezi, N.; Meher, N. K.; Fettinger, J. C. J. Am. Chem. Soc. 2008, 130,
13532–13533.
(15) For the use of water as solvent for promoting endoselective epoxide-
opening cascades see: (a)Morten,C. J.; Jamison, T. F. J. Am. Chem. Soc. 2009,
131, 6678–6679. (b) Byers, J. A.; Jamison, T. F. J. Am. Chem. Soc. 2009, 131,
6383–6385. (c) Vilotijevic, I.; Jamison, T. F. Science 2007, 317, 1189–1192.
(16) For the use of TMG as a catalyst for bromolactonisation and
intermolecular bromoacetoxylation see: Ahmad, S. M.; Braddock, D. C.;
Cansell, G.; Hermitage, S. A. Tetrahedron Lett. 2007, 48, 915–918.
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eventuality, the external nucleophile can trap the bromonium
ion regardless of which face it has been formed giving rise to
two bromoacetate epoxide diastereoisomers. The relative
stereochemistries of the products show that both bromo-
nium and oxonium ion trapping are stereospecific (albeit not
regioselective) giving a total of only four possible products.
In an effort to further favor the formation of bromoethers
2 and 3 over bromoacetates 4 and 5, we explored the effect of
concentrationon the reaction. Inspectionof the results (Table 1)
show amarked concentration dependence on the relative ratios
of bicyclo ethers 2 and 3 versus bromoacetates 4 and 5, with
the former being favored at high dilution.17
A series of other carboxylic acids as added external nucleo-
philes were then utilized (Table 2). Thus benzoic acid, p-
nitrobenzoic acid and 2,3,4,5-tetrafluorobenzoic acid as
added nucleophiles under the optimized conditions shown
gave bicycloethers 6a-c and 7a-c along with the bromoa-
cetates 8a-c and 9a-c (entries 1-5) respectively. A con-
centration effect is again in operation (entry 1 vs entry 2
and entry 4 vs entry 5) and the use of more dilute solutions
(entries 2 and 5) provided the bicycloethers as the major
products of these reactions in high yields. The relative ratio
of all the bicycloethers was approximately unity in these
cases, indicating indiscriminate attack at either position of
oxonium ion B by the nucleophile. The benzoate ethers 6a
and 7a were formed as an inseparable mixture, while the p-
nitrobenzoate ethers 6b and 7b, and the tetrafluorobenzo-
ate ethers 6c and 7c could be separated by column chro-
matography and by HPLC respectively. Chloride could be
incorporated to give 6d and 7d in excellent yield by the use
of TMSCl and catalytic TMG in CH2Cl2 (entry 6). Alter-
natively the use of LiCl in wet CH3CN gave the same
bicyclic ethers along with small quantities of bromochlor-
ide epoxides 8d and 9d (entry 7). In both cases the yield of
the bicyclic ethers 6d and 7d is good even in relatively con-
centrated solution, but there is no marked preference for one
ring systemover the other.Alcohols (MeOH,EtOH) could be
utilized as nucleophiles by the action ofNBS in the alcohol as
solvent (entries 8,9) (the use of added methanol in dichlor-
omethane gave only poor conversions and gave rise to dibro-
mide side-products) to give bicycloethers 6e and 7e, and 6f
and 7f respectively, both as inseparable mixtures. Trace quan-
tities of epoxides from direct opening of the bromonium ion
by methanol were apparent, but in insufficient quantities to
be isolated and fully characterized. In these cases there is a
slight preference (2-3:1) for the [3.3.1]bicycloether as the
major diastereoisomer. The use of water as solvent produced
ether products 6g and 7g18 exclusively in excellent yields,
regardless of the concentration (entries 10,11,12), again with
a slight preference (ca. 3:1) for the [3.3.1]bicycloether as the
major diastereoisomer. Finally, we prepared the known
dibromides 6h and 7h as an inseparablemixture by the action
of molecular bromine on epoxyalkene 1 in carbon tetrachlo
ride (entry 13).10a These experiments show that the intramole-
cular bromonium ion assisted epoxide ring-opening is a favor-
able and high-yielding process that can occur with a variety
of added external nucleophiles (carboxylic acids, alcohols,
water and halides). In polar solvents (which also function as
the nucleophile) this process is highly favored over direct
attack of the nucleophile on the bromonium ion.Under these
conditions the [3.3.1]bicycloether is the slightly preferred
diastereoisomer. In chlorinated solvents the intramolecular
bromonium ion assisted epoxide ring-opening with carboxylic
acids as addednucleophiles canbe rendered favorable in dilute
solution.
Both bicycloethers in the p-nitro- (6b, 7b) and tetrafluoro-
(6c, 7c) benzoate series were crystalline and their structures
were solved by X-ray crystallography (Figure 1, 6b and 7b.
For 6c and 7c see the Supporting Information). Chloride 7d
could be obtained byHPLC separation, andwas also crystal-
line, and was also confirmed as the [3.3.1]bicycloether by
X-ray crystallography (see the Supporting Information).19
These structures confirm the expected anti relationship between
both the bromide and ether oxygen and the anti relationship
between the ether oxygen and the benzoate group, showing
that bromonium ion opening by the epoxide, and subsequent
oxonium ion opening are completely stereospecific. The tetra-
fluorobenzoate ethers 6c and 7cwere hydrolyzed under basic
conditions to the alcohols 6g and 7g respectively (thus con-
firming the latter’s structures). Individual samples of authen-
tic acetates 2 and 3, benzoates 6a and 7a andmethyl ethers 6e
and 7e (thus confirming their structures), were then prepared
by standard methods from the free alcohols 6g and 7g
by acetylation, benzoylation andmethylation respectively
(see Supporting Information). With the stereochemistry all
secured for all the novel bicyclic ethers bar 6d, 6f, and 7f, inspec-
tion of all the 13C NMR spectra reveals a strong correlation
for the [4.2.1] ethers where the carbon bearing the bromine
TABLE 1. Concentration Dependent Product Distribution
entrya [1] mol dm-3 % conversionb 2 þ 3: 4 þ 5b
1 0.25 99 30:70
2 0.025 95 55:45
3 0.0025 63 80:20
4 0.00025 72c 85:15
aAll reactions performed with 1.0 equivalent of NBS, 15 μL of TMG
and 1.0 equivalent of AcOH for 2.5 h at rt (see Supporting Information).
bAs determined by inspection of the 1H NMR spectrum of the crude
reactionmixture (see Supporting Information). cAfter a reaction time of
72 h.
(17) This effect is not easy to rationalize.Assuming that the attackof acetate
is the rate-determining step (and irreversible) then the product distribution
should remain unchanged with changing concentration. Oxonium ion B or
bromonium ion A could not be observed by 1H NMR monitoring of the
reaction mixtures indicating that neither intermediate accumulates. The posi-
tion of the expected rapid equilibrium between A and B is expected also to be
concentration independent. One referee helpfully suggested that “If one makes
the alternative assumption that bromonium ionA andoxonium ionB are not in
rapid equilibrium, then the product distribution is the result of the relative rates
of formationofB versus external nucleophilic attackonA.Higher dilution then
favors the intramolecular attack to form B, which may then react with the
added nucleophile at its leisure.”
(18) These alcohols have been reported previously as a 7:1 inseparable
mixture, by bromination of an epoxydiol: Takahashi, A.; Aso, M.; Tanaka,
M.; Suemune, H. Tetrahedron 2000, 56, 1999–2006.
(19) The X-ray data is unable to distinguish between the mixed halogen
species and a mixture of the dibromo and dichloro species for 7d (see
Supporting Information for a full discussion). However, there is no doubt
that this is the mixed bicyclo[3.3.1]bromochloride: the 13C NMR spectrum
has 8 different 13CNMR resonances with the resonance at 50.3 ppm showing
a distinctive bromine isotope effect (Δδ [C79Br,C81Br] = 1.8 ppb) and the
resonance at 57.6 ppm showing a distinctive chlorine isotope effect (Δδ
[C35Cl,C37Cl] = 8.7 ppb). See also ref 20. The mass spectrum also shows the
distinctive isotope pattern for amonochloromonobromide [m/z=242 (24%),
240 (100%), 238 (76%): Mþ.].
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atom resonates invariantly in the region 54 ( 1 ppm. The
same resonance is seen at 50.5( 1 ppm for the [3.3.1]bicyclic
compounds. For a given substituent, the difference between
these chemical shifts is Δδ g 3 ppm, thus providing a quick
and convenientmethod for identification of the different ring
systems (Table 3). Chloride 6d and ethyl ethers 6f and 7fwere
then assigned on the basis of their bromine-bearing carbon
resonances at 53.4, 54.7, and 51.4 ppm respectively. The
known dibromides10a 6h (53.4 ppm) and 7h (50.4 ppm) were
also found to conform to this model. Moreover, bromide-
induced isotopic NMR shifts were most useful in unambigu-
ously identifying these carbons as the bromide bearing ones
(Figure 2, see also Supporting Information).20
The bromoepoxides 8a, 8b, 8c and 8d21 were also unam-
biguously identified by X-ray crystallography (Figure 3a-d).
Evidently, bromonium ions have been trappeddirectly by the
nucleophile to give an anti arrangement of functional groupsby
stereospecific ring-opening. The diastereomeric epoxide pro-
ducts 9a-9dmust come from ring-opening of the bromonium
ionwhen formed on the other face of the olefin. Interestingly,
bromotetrafluorobenzoate epoxide 9c proved to be unstable
on standing, and produced 6c, 7c, 8c (and 9c) in ratios com-
parable to those observed in the reaction detailed in Table 2,
entry 5. This can be rationalized by invoking bromonium ion
formation in 9c by neighboring group participation of the
FIGURE 1. (a) Molecular structure of 6b. (b) Molecular structure
of 7b.
TABLE 2. Bromonium Ion-Assisted Epoxide Ring-Opening of 1 with Added External Nucleophile
entry nucleophile (equiv) solvent additive T (h) [C] 6a 7a 8 9 total yield
1b PhCO2H (1.1) CH2Cl2 1mol%TMG 6 0.22M 6a and 7a
c (50%) 0.9: 1d 8a (22%) 9a (8%) 80%
2b PhCO2H (1.1) CH2Cl2 1mol%TMG 6 0.0025M 6a and 7a
c (81%) 1: 0.9 d 8a (2%) 9a (2%) 85%
3b 4-NO2PhCO2H (1.1) CH2Cl2 1mol%TMG 3 0.0026M 6b (41%) 7b (42%) 8b (11%) 9b (4%) 98%
4b 2,3,4,5-F4-PhCO2H (1.1) CH2Cl2 1mol%TMG 6 0.25M 6c and 7cc (33%) 0.6: 1d 8c (4%) 9c (2%) 39%
5b 2,3,4,5-F4-PhCO2H (1.1) CH2Cl2 1mol%TMG 3 0.0042M 6c (22%)e 7c (22%)e 8c (10%) 9c (4%) 58%
6f TMSCl (1.1) CH2Cl2 1mol%TMG 4 0.08M 6d and 7d
c (90%) 1.4: 1d 8d (0%) 9d (0%) 90%
7f LiCl (15) MeCN - 1 0.22M 6d and 7dc (86%) 1.2: 1d 8d and 9db (8%) 9: 1 94%
8f MeOH MeOH - 6.5g 0.25M 6e and 7ec (52%) 1: 2.1d,h - - 58%
9f EtOH EtOH - 9.5 0.25M 6f and 7fc (51%) 1: 3.2d - - 51%
10f H2O H2O - 2.5 0.25M 6g and 7gd (84%) 1: 3.2d - - 84%
11f H2O H2O - 2.5 0.025M 6g and 7gc (96%) 1: 3.0d - - 96%
12f H2O H2O - 2.5 0.0025M 6g and 7gc (86%) 1: 3.2d - - 86%
13f Br2 CCl4 - 3 0.2M 6h and 7hc (48%) 1: 1d - - 48%
aCompounds 6a-h and 7a-h were found to be indefinitely stable at room temperature in chlorinated solvents. Thus under the conditions of the
reaction no isomerization between the two is occurring, and the product ratios reflect the kinetic product distribution and not an equilibrium position.
bTwo equivalents of NBS. cProducts were inseparable by flash column chromatography. dRatio determined by 1H NMR spectroscopy. eIsolated yield
afterHPLC separation. fNBS (1.0-1.3 equiv). gTheuse of catalytic quantities of TMGresulted in the reaction going to completion in 4 h, but the isolated
yield of 6e and 7e was reduced at 43% (1: 2.8). hAverage of two runs after chromatography.
(20) (a) For bromine-induced isotopic shifts see: Raynes, W. T.; Sergeyev,
N.M.; Sandor, P.;Grayson,M.Magn. Reson. Chem. 1997, 35, 141–143. (b)For
chlorine-induced isotopic shifts see: Sergeyev, N.M.; Sergeyeva, N.D.; Raynes,
W. T. J. Magn. Reson, Ser. A 1995, 115, 174–182. (c) For the use of these
methods to distinguish bromochloride regioisomers after opening of a bromo-
nium ion with chloride see ref 7. (d) For the use of these methods in natural
product structure elucidation see ref 13 and references cited therein.
(21) Modeling of the disorder in the X-ray crystal structure of 8d means
that for 88%of themolecules in the crystal the bromide is on the same side of
the ring as the epoxide oxygen, whilst in the remaining 12% it is the chloride
that is the same side as the oxygen (i.e., the minor diastereoisomer 9d). This is
consistent with the ratio of the diastereoisomers (9:1) observed as an
inseparable mixture by 1H NMR and implies cocrystallisation.
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bromine and loss of tetrafluorobenzoate. The resultant bromo-
nium ion A (c.f. Scheme 2) can now be trapped by the
epoxide and the oxonium ion B trapped by the earlier
expelled tetrafluorobenzoate anion. The formation of 8c also
implies concomitant reversible loss of electrophilic bromine
from the bromonium ion to the bulk medium8 and return to
the other face of the alkene and recapture by tetrafluoro-
benzoate. To the best of our knowledge the spontaneous for-
mation of a bromonium ion by NGP of bromide on a suitably
positioned leaving group is unprecedented, and this observa-
tionmay be useful in designing further systems for the gener-
ation of enantiopure bromonium ions starting from enantio-
pure bromohydrins.7 It also implicitly confirms the expected
anti relationship between the bromine and tetrafluorobenzo-
ate group in 9c. Bromoacetate epoxides 4 and 5were assigned
by comparison of the 13C NMR spectral data for the
bromine-bearing carbons (Table 4) with those of esters 8a-c
and 9a-c respectively. Here again, the bromide-induced
isotopic NMR shifts were most useful in unambiguously
identifying these carbons as the bromide bearing ones (see
Supporting Information).20
Bromotetrafluorobenzoate epoxide 9c was saponified
to give the known syn-diepoxide 10 (Scheme 3).22,23 This
unambiguously confirms the assigned stereochemistry for
9c, and by analogy the stereochemistries of 5 and 9a-b.
Finally, we recognized that a peracid epoxidation of
inexpensive 1,5-cyclooctadiene (11) would deliver epoxyalk-
ene 1 and produce a stoichiometric quantity of carboxylic
acid as side-product. This carboxylic acid could subsequently
also function as an in situ external added nucleophile in the
presence of a suitable electrophilic bromine source, to provide
bicyclo[4.2.1] and bicyclo[3.3.1]ethers, thereby constructing
products with four stereocenters with complete control of
relative stereochemistry in one-pot and with good atom
TABLE 3. Correlation of 13C NMR Chemical Shifts for the Carbon-
Bearing Bromine for 2, 3, 6a-h, and 7a-ha
aAll spectra were recorded in CDCl3.
FIGURE 2. Bromide-induced isotopic shift for the CBr resonance
of 3 at 50.6 ppm (125 MHz, CDCl3).
FIGURE 3. (a)Molecular structure of one (8a-I) of the two crystal-
lographically independent CS-symmetric molecules present in the
crystals of 8a (see Supporting Information). (b)Molecular structure
of 8b. (c) Molecular structure of 8c. (d) Molecular structure of the
CS-symmetric species 8d (see Supporting Information).
TABLE 4. Correlation of 13C NMR Chemical Shifts for the Carbon-
Bearing Bromine for 4, 5, 8a-c, and 9a-ca
aAll spectra were recorded in CDCl3.
(22) Rudolph, J.; Reddy, K. L.; Chiang, J. P.; Sharpless, K. B. J. Am.
Chem. Soc. 1997, 119, 6189–6190.
(23) Saponification of bromobenzoate 8c under the same conditions led
to the formation of the expected diastereomeric epoxide and competitive
formation of alcohols 6g and 7g. The pre-existing epoxide evidently suffers
intramolecular nucleophilic attack by the alkoxide generated from collapse
of the tetrahedral intermediate during BAc2 ester hydrolysis.
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efficiency.We recognized thatwe could run this reaction in a
one-pot stepwise fashion, with dilution after complete epox-
idation, followed by addition of NBS and TMG. Alter-
natively, all the reagents could be added at t=0, where the
epoxide would be expected to be consumed as it was pro-
duced. In the event, both approaches (see Supporting In-
formation for full information) were successively realized
using mCPBA, NBS and TMG (Scheme 4) to give meta-
chlorobenzoate ethers 12 (δC [CBr] 53.5 ppm) and 13 (δC
[CBr] 50.4 ppm).
Conclusion
In conclusion, we have extended the intramolecular bromo-
nium ion-assisted epoxide ring-opening method first reported
by Davies and Thomas, and more recently by Jamison and
McDonald, to allow the incorporation of an added external
nucleophile. In exploring such systems there is an additional
inherent selectivity question;whether the added external
nucleophile will attack directly the bromonium ion of the
original olefin or whether the formation of an oxonium ion
followed by its trapping will predominate. Using NBS and a
catalytic quantity of TMG allowed the use of aliphatic and
aromatic carboxylic acids to function as nucleophiles as
desired,with the trapping of the presumedoxonium ion favored
at high dilution. Alcohols and water could also function as the
nucleophile when used directly as solvents (in conjunction with
NBS) to trap the presumed oxonium in high yield regardless
of the concentration.Halides (usingTMSCl,LiCl orBr2) could
also be incorporated in high yields. These results demon-
strate that the intramolecular bromonium ion-assisted ep-
oxide ring-opening is a favorable and high-yielding process
that can occur with a variety of added external nucleophiles.
This pathway can be favored over direct attack of the exter-
nal nucleophile on the bromonium ion. However, the regio-
chemistry of the nucleophilic capture on the oxonium ion is
not highly selective and remains essentially unperturbed by
the nature of the solvent or of the nucleophile. Finally, we
have also demonstrated herein the value of halide-induced
isotopic NMR shifts in unambiguously identifying chloride
and bromide-bearing carbons, thus aiding structure elucida-
tion in general.
Experimental Section
Representative Procedure for Bromonium Ion-Assisted Epox-
ide Ring-Opening with Acetic Acid as the Added External Nu-
cleophile. To a solution of epoxyalkene 1 (100 mg, 0.80 mmol)
in CH2Cl2 (3.6 mL) was added TMG (0.92 mg, 0.008 mmol,
1 mol %), acetic acid (0.05 mL, 1.6 mmol) and NBS (286 mg,
1.6 mmol). Themixture was stirred for 1 h at room temperature,
diluted with CH2Cl2 (20 mL) and quenched with an aqueous
solution of Na2SO3 (10%, 20 mL). The organic layer was dried
over MgSO4 and the solvent was evaporated in vacuo to afford
the crude material. Column chromatography eluting with pe-
troleum ether/EtOAc (9:1 to 8:2) afforded first a 1:1 mixture
of the two cyclic ethers 2 and 3 (90 mg, 43%), second, epoxide
5 (27 mg, 13%) and third, epoxide 4 (54 mg, 26%). Authentic
samples of 2 and 3 were prepared from alcohols 6g and 7g
respectively (see Supporting Information).24
(1R*,2R*,5S*,6S*)-5-Bromo-9-oxabicyclo[4.2.1]nonan-2-yl
Acetate (2). Colorless oil: Rf (PE/EtOAc 8:2) 0.36; IR (neat)
1734 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.15 (ddd, J= 3.8,
4.9, 7.4, 1H), 4.74-4.65 (m, 1H), 4.62 (ddd, J = 2.9, 4.6, 7.5,
1H), 4.20 (ddd, J = 4.9, 7.6, 9.7, 1H), 2.32-2.23 (m, 1H),
2.20-2.09 (m, 3H), 2.08 (s, 3H), 2.07-1.89 (m, 3H), 1.83-1.74
(m, 1H); 13C NMR (100MHz, CDCl3) δ 170.2, 82.7, 78.3, 73.3,
53.7, 29.8, 29.3, 26.1, 25.9, 21.1; MS (CIþ, NH3) m/z 282, 280
(MþNH4)þ; HRMS (CIþ, NH3)m/z calcd for C10H19NO379Br
(M þ NH4)þ 280.0548, found 280.0552.
(1R*,2R*,5R*,6R*)-6-Bromo-9-oxabicyclo[3.3.1]nonan-2-yl
Acetate (3). Colorless oil: Rf (PE/EtOAc 8:2) 0.36; IR (neat)
1735 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.12 (dt, J = 6.0,
11.8, 1H), 4.45 (dt, J = 5.6, 12.7, 1H), 3.96 (dt, J = 5.5, 10.7,
2H), 2.54-2.44 (m, 1H), 2.38 (ddd, J = 6.4, 12.9, 19.6, 1H),
2.29-2.20 (m, 1H), 2.07 (s, 3H), 2.10-1.85 (m, 5H); 13C NMR
(100 MHz, CDCl3) δ 170.1, 70.3, 69.7, 66.5, 50.6, 31.1, 25.6,
25.1, 23.1, 21.2; MS (CIþ, NH3) m/z 282, 280 (M þ NH4)þ;
HRMS (CIþ, NH3)m/z calcd for C10H19NO3
79Br (MþNH4)þ
280.0548, found 280.0552.
(1S*,4S*,5S*,8R*)-5-Bromo-9-oxabicyclo[6.1.0]nonan-4-yl
Acetate (4). Colorless oil: Rf (PE/EtOAc 9:1) 0.14; IR (neat)
1737 cm-1; 1HNMR (400MHz, CDCl3) δ 5.24 (dt, J=3.8, 8.4,
1H), 4.61 (ddd, J = 3.4, 6.8, 8.4, 1H), 3.04-2.95 (m, 2H),
2.32-2.14 (m, 5H), 2.08 (s, 3H), 1.96-1.79 (m, 1H), 1.76-1.58
(m, 2H); 13C NMR (100MHz, CDCl3) δ 169.6, 73.1, 55.4, 55.2,
51.0, 29.6, 28.6, 24.1, 23.5, 21.1;MS (CIþ, NH3)m/z 282, 280 (M
þNH4)þ; HRMS (CIþ, NH3)m/z calcd for C10H16O379Br (Mþ
H)þ 263.0283, found 263.0284.
(1S*,4R*,5R*,8R*)-5-Bromo-9-oxabicyclo[6.1.0]nonan-4-yl
Acetate (5). Colorless oil: Rf (PE/EtOAc 9:1) 0.18; IR (neat)
1737 cm-1; 1HNMR (400MHz, CDCl3) δ 5.24 (td, J=3.4, 9.1,
1H), 4.42 (ddd, J=4.0, 4.9, 8.9, 1H), 3.17 (dt, J=4.3, 7.3, 1H),
3.10 (dt, J = 4.5, 9.6, 1H), 2.50-2.34 (m, 2H), 2.29-2.14 (m,
3H), 2.11 (s, 3H), 1.91-1.73 (m,2H), 1.62-1.46 (m,1H); 13CNMR
(100 MHz, CDCl3) δ 169.9, 73.2, 55.5, 54.6, 53.7, 31.8, 27.9,
25.2, 23.3, 21.0; MS (CIþ, NH3) m/z 282, 280 (M þ NH4)þ;
HRMS (CIþ, NH3) m/z calcd for C10H16O3
79Br (M þ H)þ
263.0283, found 263.0285.
Benzoic Acid.Following the representative procedure (above)
using benzoic acid as the added external nucleophile according
to the conditions recorded in Table 2, entry 2. The crudemixture
was purified by column chromatography elutingwith petroleum
ether/EtOAc (9:1 to 8:2) to give first, an inseparablemixture of the
cyclic ether benzoates 6a and 7a, second epoxide 8a, and third,
epoxide 9a. Authentic samples of 6a and 7awere prepared from
alcohols 6g and 7g respectively (see Supporting Information).24
SCHEME 3. Saponification to Epoxide 10
SCHEME 4. One-Pot Epoxidation-Bromination
(24) Tetrafluorobenzoates 6c and 7c could be separated by HPLC and
individually saponified to give pure samples of each of alcohols 6g and 7g
(see Supporting Information).
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(1R*,2R*,5S*,6S*)-5-Bromo-9-oxabicyclo[4.2.1]nonan-2-yl
Benzoate (6a). Colorless oil: Rf (PE/EtOAc 9:1) 0.72; IR (neat)
1713 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.08-8.03 (m, 2H),
7.63-7.59 (m, 1H), 7.50-7.47 (m, 2H), 5.46-5.42 (m, 1H),
4.85-4.80 (m, 1H), 4.69-4.65 (m, 1H), 4.26 (dt, J= 5.0, 10.0,
1H), 2.37-1.91 (m, 8H); 13C NMR (100 MHz, CDCl3) δ 165.6,
133.2, 130.0, 129.6, 128.5, 82.9, 78.4, 73.8, 53.6, 29.8, 29.5, 26.5,
25.8; MS (CIþ, NH3) m/z 344, 342 (M þ NH4)þ; HRMS (CIþ,
NH3) m/z calcd for C15H21NO3
79Br (M þ NH4)þ 342.0705,
found 342.0706.
(1R*,2R*,5R*,6R*)-6-Bromo-9-oxabicyclo[3.3.1]nonan-2-yl
Benzoate (7a). Colorless oil: Rf (PE/EtOAc 9:1) 0.73; IR (neat)
1712 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.12-8.00 (m, 2H),
7.60 (app t, J= 7.4, 1H), 7.48 (app t, J= 7.7, 2H), 5.48-5.35
(m, 1H), 4.51 (dt, J=5.6, 12.7, 1H), 4.17-4.12 (m, 1H), 4.02 (app t,
J=4.9, 1H), 2.63-2.44 (m, 2H), 2.38-2.27 (m, 1H), 2.25-2.02
(m, 5H); 13C NMR (100 MHz, CDCl3) δ 165.6, 133.2, 130.0,
129.6, 128.5, 70.7, 69.8, 66.7, 50.6, 31.2, 25.9, 25.2, 23.2; MS
(CIþ, NH3) m/z 344, 342 (M þNH4)þ; HRMS (CIþ, NH3) m/z
calcd for C15H18O3
79Br (M þ H)þ 325.0439, found 325.0439.
(1S*,4S*,5S*,8R*)-5-Bromo-9-oxabicyclo[6.1.0]nonan-4-yl
Benzoate (8a).White solid: mp 113-115 C; Rf (PE/EtOAc 9:1)
0.20; IR (neat) 1704 cm-1; 1HNMR (400MHz, CDCl3) δ 8.06-
8.00 (m, 2H), 7.65-7.57 (m, 1H), 7.51-7.45 (m, 2H), 5.59 (ddd,
J=3.3, 4.2, 7.9, 1H), 4.82 (ddd, J=3.2, 6.1, 8.9, 1H), 3.21 (dt,
J=4.0, 9.8, 1H), 3.15 (dt, J=4.3, 9.9, 1H), 2.43 (ddd, J=4.4,
8.7, 15.8, 1H), 2.32-2.17 (m, 3H), 2.16-1.96 (m, 2H), 1.85-1.68
(m, 2H); 13C NMR (100 MHz, CDCl3) δ 165.2, 133.5, 129.6,
128.7, 73.5, 55.6, 55.5, 50.6, 29.0, 28.6, 23.8, 23.6; MS (CIþ,
NH3) m/z 344, 342 (M þ NH4)þ; HRMS (CIþ, NH3) m/z calcd
for C15H18O3
79Br (M þ H)þ 325.0439, found 325.0445.
(1S*,4R*,5R*,8R*)-5-Bromo-9-oxabicyclo[6.1.0]nonan-4-yl
Benzoate (9a). White solid: mp 73-74 C; Rf (PE/EtOAc 9:1)
0.16; IR (neat) 1711 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.06
(dd, J = 1.2, 8.3, 2H), 7.64-7.58 (m, 1H), 7.50-7.45 (m, 2H),
5.52 (td, J= 3.2, 8.6, 1H), 4.64 (dt, J= 4.4, 8.7, 1H), 3.23 (dt,
J=4.2, 8.0, 1H), 3.17 (dt, J=4.6, 9.4, 1H), 2.56-2.35 (m, 3H),
2.34-2.22 (m, 2H), 2.07-1.96 (m, 1H), 1.91-1.80 (m, 1H),
1.74-1.63 (m, 1H); 13CNMR(100MHz, CDCl3) δ 165.4, 133.5,
129.7, 128.5, 73.7, 55.7, 54.8, 52.5, 31.6, 27.7, 25.2, 23.2; MS
(CIþ, NH3) m/z 344, 342 (M þNH4)þ; HRMS (CIþ, NH3) m/z
calcd for C15H18O3
79Br (M þ H)þ 325.0439, found 325.0439.
p-Nitrobenzoic Acid. Following the representative procedure
(above) using p-nitrobenzoic acid as the added external nucleo-
phile according to the conditions recorded in Table 2, entry 3.
The crude mixture was purified by column chromatography
eluting with petroleum ether/EtOAc (9:1 to 8:2) to give first
[3.3.1]bicycloether 4-nitrobenzoate 7b, second, [4.2.1]bicycloether
4-nitrobenzoate 6b, third epoxide 8b, and fourth, epoxide 9b.
(1R*,2R*,5S*,6S*)-5-Bromo-9-oxabicyclo[4.2.1]nonan-2-yl
4-Nitrobenzoate (6b).White solid: mp 85 C;Rf (PE/EtOAc 8:2)
0.43; IR (neat) 1720 cm-1; 1H NMR (400 MHz, CDCl3) δ
8.38-8.30 (m, 2H), 8.26-8.18 (m, 2H), 5.47 (ddd, J= 3.9, 4.5,
7.8, 1H), 4.84 (td, J=2.8, 8.5, 1H), 4.69 (ddd, J=2.5, 4.8, 7.5,
1H), 4.31-4.22 (m, 1H), 2.41-2.32 (m, 1H), 2.29-2.22 (m, 3H),
2.48-2.03 (m, 3H), 2.02-1.93 (m, 1H); 13C NMR (125 MHz,
CDCl3) δ 163.7, 150.6, 135.3, 130.7, 123.6, 82.8, 78.1, 75.0, 53.2,
29.8, 29.3, 26.4, 25.9;MS (CIþ, NH3)m/z 389, 387 (MþNH4)þ;
HRMS (CIþ, NH3) m/z calcd for C15H20N2O5
79Br (M þ H)þ
387.0556, found 387.0558.
(1R*,2R*,5R*,6R*)-6-Bromo-9-oxabicyclo[3.3.1]nonan-2-yl
4-Nitrobenzoate (7b). White solid: mp 116 C; Rf (PE/EtOAc
8:2) 0.47; IR (neat) 1720 cm-1; 1H NMR (400 MHz, CDCl3) δ
8.37-8.29 (m, 2H), 8.26-8.18 (m, 2H), 5.44 (dt, J= 5.9, 10.5,
1H), 4.50 (dt, J= 5.6, 11.8, 1H), 4.16 (app t, J= 5.7, 1H), 4.03
(app t, J = 5.0, 1H), 2.66-2.57 (m, 1H), 2.55-2.43 (m, 1H),
2.39-2.30 (m, 1H), 2.29-2.05 (m, 5H); 13C NMR (125 MHz,
CDCl3) δ 163.7, 150.7, 135.3, 130.7, 123.6, 72.0, 69.8, 66.4, 50.1,
31.1, 25.8, 25.1, 23.1;MS (CIþ, NH3)m/z 389, 387 (MþNH4)þ;
HRMS (CIþ, NH3)m/z calcd for C15H20N2O5
79Br (MþNH4)þ
387.0569, found 387.0566.
(1S*,4S*,5S*,8R*)-5-Bromo-9-oxabicyclo[6.1.0]nonan-4-yl
4-Nitrobenzoate (8b). White solid: mp 150 C; Rf (PE/EtOAc
8:2) 0.33; IR (neat) 1708 cm-1; 1H NMR (400 MHz, CDCl3) δ
8.37-8.31 (m, 2H), 8.25-8.20 (m, 2H), 5.56 (dt, J = 3.9, 8.2,
1H), 4.83-4.70 (m, 1H), 3.18 (dt, J=4.2, 9.1, 1H), 3.12 (dt, J=
4.2, 10.0, 1H), 2.43 (ddd, J= 4.3, 8.9, 15.7, 1H), 2.34-2.14 (m,
4H), 2.10-1.98 (m, 1H), 1.88-1.69 (m, 2H); 13C NMR (100
MHz, CDCl3) δ 163.4, 150.8, 135.0, 130.7, 123.8, 75.0, 55.2,
55.1, 50.5, 29.9, 28.8, 24.2, 23.5; MS (CIþ, NH3) m/z 389, 387
(MþNH4)þ; HRMS (CIþ, NH3) m/z calcd for C15H20N2O579Br
(M þ H)þ 387.0556, found 387.0570.
(1S*,4R*,5R*,8R*)-5-Bromo-9-oxabicyclo[6.1.0]nonan-4-yl
4-Nitrobenzoate (9b). White solid: mp 105 C; Rf (PE/EtOAc
8:2) 0.25; IR (neat) 1710 cm-1; 1H NMR (400 MHz, CDCl3) δ
8.37-8.30 (m, 2H), 8.27-8.21 (m, 2H), 5.51 (td, J = 3.4, 9.3,
1H), 4.55 (ddd, J = 3.8, 5.2, 9.0, 1H), 3.23 (dt, J = 4.3, 8.5,
1H), 3.17 (dt, J= 4.6, 9.8, 1H), 2.57-2.43 (m, 2H), 2.42-2.21
(m, 3H), 2.10-1.95 (m, 1H), 1.93-1.82 (m, 1H), 1.73-1.59 (m,
1H); 13C NMR (100 MHz, CDCl3) δ 163.6, 150.7, 135.2, 130.9,
123.7, 74.9, 55.3, 54.6, 53.5, 32.1, 28.2, 25.3, 23.4; MS (CIþ,
NH3) m/z 389, 387 (M þ NH4)þ; HRMS (CIþ, NH3)
m/z calcd for C15H20N2O5
79Br (M þ H)þ 387.0556, found
387.0558.
2,3,4,5-Tetrafluorobenzoic Acid.Following the representative
procedure (above) using 2,3,4,5-tetrafluorobenzoic acid as the
added external nucleophile according to the conditions recorded
inTable 2, entry 5.The crudemixturewaspurifiedby columnchro-
matography eluting with petroleum ether/EtOAc (9:1 to 8:2) to
give first, a 1:1 mixture of bicycloethers 6c and 7c, second,
epoxide 8c and third, epoxide 9c. The tetrafluorobenzoates 6c
and 7cwere separated using HPLC on a 25 cm Supelcosil LC-Si
column (ID 21.2 mm), eluting with n-Hexane/EtOAc (90:10),
flow rate 9 mLmin-1, detecting at 254 nm.Rt 7c 14.8 min,Rt 6c
16.8 min.
(1R*,2R*,5S*,6S*)-5-Bromo-9-oxabicyclo[4.2.1]nonan-2-yl
2,3,4,5-Tetrafluorobenzoate (6c).White solid: mp 80 C;Rf (PE/
EtOAc 9:1) 0.33; IR (neat) 1716 cm-1; 1H NMR (400 MHz,
CDCl3) δ 7.66-7.58 (m, 1H), 5.45 (dt, J = 4.2, 7.4, 1H), 4.78
(td, J=2.9, 7.8, 1H), 4.67 (ddd, J=7.6, 4.8, 2.6, 1H), 4.25-4.20
(m, 1H), 2.42-1.89 (m, 8H); 13C NMR (125 MHz, CDCl3)
161.4, 147.9 (dd, J = 264, 13), 146.5 (dd, J = 238, 11), 143.7
(dt, J= 261, 12), 141.5 (dt, J=259, 14), 114.7 (brm), 113.2 (dd,
J=21, 3), 83.0, 78.0, 75.6, 53.2, 29.7, 29.4, 26.6, 25.8;MS (CIþ,
NH3) m/z 416, 414 (M þ NH4)þ; HRMS (CIþ, NH3) m/z calcd
for C15H17NO3F4
79Br (M þ NH4)þ 414.0328, found 414.0328.
(1R*,2R*,5R*,6R*)-6-Bromo-9-oxabicyclo[3.3.1]nonan-2-yl
2,3,4,5-Tetrafluorobenzoate (7c).White solid: mp 38-40 C; Rf
(PE/EtOAc 9:1) 0.33; IR (neat) 1715 cm-1; 1HNMR (400MHz,
CDCl3) δ 7.66-7.56 (m, 1H), 5.45-5.35 (m, 1H), 4.49 (dt, J =
5.5, 12.7, 1H), 4.13-4.08 (m, 1H), 4.00 (app t, J = 5.1,
1H), 2.62-2.53 (m, 1H), 2.50-2.40 (m, 1H), 2.36-2.28 (m,
1H), 2.25-2.15 (m, 1H), 2.15-2.02 (m, 4H); 13C NMR
(125 MHz, CDCl3) δ 161.3, 147.6 (dd, J= 260, 10), 146.5 (dd,
J = 249, 12), 143.5 (dt, J = 274, 16), 141.5 (dt, J = 255, 14),
114.7 (br m), 113.2 (dd, J = 21, 3), 72.4, 71.6, 69.8, 66.4, 50.2,
31.0, 25.7, 25.1, 23.1;MS (CIþ, NH3)m/z 416, 414 (MþNH4)þ;
HRMS (CIþ, NH3) m/z calcd for C15H17NO3F4
79Br (M þ
NH4)
þ 414.0328, found 414.0331.
(1S*,4S*,5S*,8R*)-5-Bromo-9-oxabicyclo[6.1.0]nonan-4-yl
2,3,4,5-Tetrafluorobenzoate (8c).White solid: mp 45 C;Rf (PE/
EtOAc 9:1) 0.21; IR (neat) 1716 cm-1; 1H NMR (400 MHz,
CDCl3) δ 7.64 (tdd, J=2.5, 6.0, 10.4, 1H), 5.57 (dt, J=3.7, 8.4,
1H), 4.81-4.63 (m, 1H), 3.13-3.04 (m, 2H), 2.44-2.36
(m, 1H), 2.33-2.08 (m, 4H), 2.08-1.92 (m, 1H), 1.85-1.63
(m, 2H); 13CNMR (100MHz, CDCl3) δ 147.7 (dd, J=263, 12),
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146.5 (dd, J= 250, 10), 143.7 (dt, J= 262, 13), 141.3 (dt, J=
256, 13), 114.2 (brm), 113.4 (dd, J=21,1), 75.5, 55.4, 55.0, 50.3,
29.5, 28.6, 24.1, 23.4;MS (CIþ, NH3)m/z 416, 414 (MþNH4)þ;
HRMS (CIþ, NH3) m/z calcd for C15H14O3F4
79Br (M þ H)þ
397.0062, found 397.0063.
(1S*,4R*,5R*,8R*)-5-Bromo-9-oxabicyclo[6.1.0]nonan-4-yl
2,3,4,5-Tetrafluorobenzoate (9c). Colorless oil: Rf (PE/EtOAc
9:1) 0.18; IR (neat) 1728 cm-1; 1H NMR (400 MHz, CDCl3) δ
7.71-7.59 (m, 1H), 5.52 (td, J=3.2, 8.8, 1H), 4.56 (dt, J=4.4,
8.8, 1H), 3.21 (dt, J= 4.3, 7.4, 1H), 3.15 (dt, J= 4.7, 9.8, 1H),
2.56-2.21 (m, 5H), 2.07-1.98 (m, 1H), 1.91-1.79 (m, 1H),
1.72-1.58 (m, 1H); 13CNMR (100MHz, CDCl3) δ 160.9, 148.0
(dd, J=261, 9), 146.4 (dd, J= 226, 9), 144.0 (dt, J=227, 24),
141.3 (dt, J = 237, 14), 114.4 (m), 113.3 (dd, J = 21, 2), 75.3,
55.5, 54.6, 52.5, 31.7, 29.7, 27.7, 25.0, 23.2; MS (CIþ, NH3) m/z
399, 397 (MþH)þ; HRMS (CIþ, NH3)m/z calcd for C15H14O3-
F4
79Br (M þ H)þ 397.0062, found 397.0070.
Trimethylsilylchloride. Following the representative proce-
dure (above) using (trimethysilyl)chloride as the added external
nucleophile according to the conditions recorded in Table 2,
entry 6. The crude mixture was purified by column chromatog-
raphy eluting with petroleum ether/EtOAc (19:1) to afford an
inseparable mixture of bicyclic ethers 6d and 7d as a white solid.
The chlorides 6d and 7dwere separated using HPLC on a 25 cm
Supelcosil LC-Si column (ID 21.2 mm), eluting with n-Hexane/
iPrOH (95:5), flow rate 10 mLmin-1, detecting at 230 nm.Rt 6d
41.0 min; Rt 7d 31.0 min.
(1S*,2S*,5R*,6R*)-2-Bromo-5-chloro-9-oxabicyclo[4.2.1]-
nonane (6d). Colorless oil: Rf (PE/EtOAc 19:1) 0.48;
1H NMR
(500 MHz, CDCl3) δ 4.62-4.58 (m, 2H), 4.31-4.25 (m, 2H),
2.44-2.35 (m, 2H), 2.25-2.18 (m, 2H), 2.18-2.00 (m, 4H); 13C
NMR (125 MHz, CDCl3) δ 82.0, 81.5, 60.4, 53.4, 32.1, 31.2,
27.4, 26.7; GC-MS (EIþ) Rt 15.2 min: m/z 242, 240, 238 (M
þ.);
HRMS (EIþ)m/z calcd for C8H12O
35Cl79Br (MþH)þ 237.9760,
found 237.9755.
(1R*,2R*,5R*,6R*)-2-Bromo-6-chloro-9-oxabicyclo[3.3.1]-
nonane (7d). White solid: mp 43-44 C; Rf (PE/EtOAc 19:1)
0.48; 1H NMR (500 MHz, CDCl3) δ 4.49-4.41 (m, 1H),
4.35-4.25 (m, 1H), 3.95 (app t, J = 5.5, 2H), 2.52-2.46 (m,
1H), 2.46-2.30 (m, 2H), 2.29-2.11 (m, 3H), 2.10-1.98 (m, 2H);
13CNMR (125MHz, CDCl3) δ 69.6, 69.6, 57.6, 50.3, 31.1, 30.3,
25.1, 24.9; GC-MS (EIþ) Rt 14.6 min: m/z 242, 240, 238 (M
þ.);
HRMS (EIþ) m/z calcd for C8H12O
35Cl79Br (Mþ.) 237.9760,
found 237.9755.
LithiumChloride.Following the representativeprocedure (above)
using (lithium) chloride as the added external nucleophile according
to the conditions recorded inTable 2, entry7.Thecrudemixturewas
purified by column chromatography eluting with petroleum ether/
EtOAc (19:1) to afford an inseparable mixture of bicyclic ethers 6d
and 7d as a white solid and epoxides 8d and 9d as an inseparable
mixture.
(1R*,4S*,5S*,8S*)-4-Bromo-5-chloro-9-oxabicyclo[6.1.0]nonane
(8d) and (1R*,4R*,5R*,8S*)-4-bromo-5-chloro-9-oxabicyclo[6.1.0]-
nonane (9d).White solid: mp 112-113 C; Rf (PE/EtOAc 19:1)
0.32; 1H NMR (400 MHz, CDCl3) resonances for 8d only
δ 4.73-4.66 (m, 2H), 3.17 (dt, J = 3.9, 10.5, 1H), 3.10 (dt,
J = 4.6, 9.5, 1H), 2.68-2.55 (m, 2H), 2.27-2.14 (m, 3H),
2.14-2.03 (m, 1H), 1.76-1.59 (m, 2H); 13C NMR (125 MHz,
CDCl3) resonances for 8d only: δ 60.5, 55.9, 54.9, 53.9, 31.8,
29.1, 24.0, 23.5; MS (CIþ) m/z 243, 241, 239 (M þH)þ; HRMS
(CIþ)m/z calcd for C8H13
35Cl79BrO (MþH)þ 238.9838, found
238.9838.
Methanol. Following the representative procedure (above)
using methanol as the added nucleophile according to the con-
ditions recorded in Table 2, entry 8. The crude mixture was
purified by column chromatography eluting with petroleum
ether/EtOAc (9:1 to 8:2) to give an inseparable mixture of the
cyclic ethers 6e and 7e. Authentic samples of 6e and 7e were
prepared from alcohols 6g and 7g respectively (See Supporting
Information).24
(1S*,2S*,5R*,6R*)-2-Bromo-5-methoxy-9-oxabicyclo[4.2.1]-
nonane (6e). Colorless oil: Rf (PE/EtOAc 4:1) 0.60; IR (neat)
1098, 1066 cm-1; 1HNMR (500MHz, CDCl3) δ 4.61 (ddd, J=
2.9, 7.1, 9.1, 1H), 4.58-4.54 (m, 1H), 4.24-4.13 (m, 1H), 3.65
(ddd, J = 3.6, 5.0, 7.1, 1H), 3.30 (s, 3H), 2.34-2.21 (m, 2H),
2.12-2.03 (m, 2H), 2.03-1.89 (m, 2H), 1.86-1.71 (m, 2H); 13C
NMR (125 MHz, CDCl3) δ 82.6, 80.4, 79.4, 57.1, 54.6, 29.7,
28.4, 26.1, 25.1; MS (CIþ, NH3) m/z 254, 252 (M þ NH4)þ;
HRMS (CIþ, NH3) m/z calcd for C9H19NO2
79Br (M þ NH4)þ
252.0599, found 252.0590.
(1R*,2R*,5R*,6R*)-2-Bromo-6-methoxy-9-oxabicyclo[3.3.1]-
nonane (7e). Colorless oil: Rf (PE/EtOAc 9:1) 0.22; IR (neat)
1127, 1103, 1082, 1044 cm-1; 1H NMR (400 MHz, CDCl3) δ
4.46 (dt, J=5.5, 12.7, 1H), 4.01 (app t, J=5.6, 1H), 3.93 (app t,
J=5.5, 1H), 3.61 (dt, J=5.9, 11.7, 1H), 3.38 (s, 3H), 2.49 (dd,
J=5.9, 14.3, 1H), 2.41-2.28 (m, 1H), 2.21 (dt, J=6.2, 13.7, 1H),
2.12-1.90 (m, 4H), 1.85-1.67 (m, 1H); 13C NMR (125 MHz,
CDCl3) δ 77.6, 69.9, 67.3, 56.3, 51.2, 31.3, 25.7, 25.1, 23.2; MS
(CIþ, NH3) m/z 254, 252 (M þ NH4)þ; HRMS (CIþ, NH3) m/z
calcd for C9H19NO2
79Br (MþNH4)þ 252.0599, found 252.0596.
Water. Following the representative procedure (above) using
water as the added nucleophile according to the conditions
recorded in Table 2, entries 10-12. The crude mixture was
purified by column chromatography to give an inseparable
mixture of the cyclic ethers 6g and 7g.24
(1R*,2R*,5S*,6S*)-5-Bromo-9-oxabicyclo[4.2.1]nonan-2-ol (6g).
Colorless oil: Rf (PE/EtOAc 1:1) 0.36; IR (neat) 3379 cm
-1;
1HNMR (400MHz, CDCl3) δ 4.60-4.50 (m, 2H), 4.22 (dt, J=
5.4, 8.3, 1H), 4.17 (dt, J = 4.9, 6.8, 1H), 2.38-2.22 (m, 2H),
2.19-1.85 (m, 5H), 1.81 (s, 1H), 1.76-1.67 (m, 1H); 13C NMR
(100MHz,CDCl3) δ 82.1, 80.9, 71.1, 54.3, 32.2, 29.7, 26.7, 24.9;MS
(CIþ, NH3) m/z 240, 238 (M þ NH4)þ; HRMS (CIþ, NH3) m/z
calcd for C8H17NO2
79Br (MþNH4)þ 238.0443, found 238.0439.
(1R*,2R*,5R*,6R*)-6-Bromo-9-oxabicyclo[3.3.1]nonan-2-ol
(7g).Colorless oil:Rf (PE/EtOAc 1:1) 0.28; IR (neat) 3368 cm
-1;
1HNMR (400MHz, CDCl3) δ 4.44 (dt, J=5.6, 12.7, 1H), 4.06
(dt, J=5.8, 11.6, 1H), 3.91 (app t, J=5.3, 1H), 3.85 (app t, J=5.8,
1H), 2.51-2.43 (m, 1H), 2.40-2.28 (m, 1H), 2.26-2.16 (m, 2H),
2.15-2.08 (m, 1H), 2.05-1.93 (m, 3H), 1.90-1.81 (m, 1H); 13C
NMR (100 MHz, CDCl3) δ 69.7, 69.6, 68.4, 51.0, 31.3, 28.6, 24.6,
23.3;MS(CIþ,NH3)m/z240, 238 (MþNH4)þ;HRMS(CIþ,NH3)
m/z calcd forC8H17NO2
79Br (MþNH4)þ 238.0443, found238.0434.
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